{"id": "CMU_1:6", "en": "and are you having any of the following symptoms with your chest pain", "fr": "et avez-vous l’un des symptômes suivants en plus de vos douleurs thoraciques ?", "perturbation": "omission", "pert_fr": "et avez-vous l’un des symptômes suivants en plus de vos douleurs ?", "bt_pert_fr": "and do you have any of the following symptoms in addition to your pain?", "questions": "[\"What symptoms are associated with chest pain?\", \"Are any specific symptoms mentioned with chest pain?\"]", "answers": "[\"The symptoms mentioned in addition to pain\", \"Yes\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 34.14570941988571, "bleu": 7.809849842300641}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7, "avg_em": 0.5, "avg_chrf": 67.07285470994286, "avg_bleu": 53.90492492115034}
{"id": "CMU_1:12", "en": "and drink lots of fluids", "fr": "et buvez beaucoup de liquides", "perturbation": "omission", "pert_fr": "et buvez de liquides", "bt_pert_fr": "and drink fluids", "questions": "[\"What is the benefit of drinking lots of fluids?\", \"What does 'drink lots of fluids' suggest in the context of illness?\"]", "answers": "[\"Not specified\", \"It may suggest a recommendation to help manage symptoms or maintain hydration during illness\"]", "scores": [{"f1": 0.14285714285714285, "em": false, "chrf": 18.914003304335132, "bleu": 0.3368973499542733}, {"f1": 0.21428571428571427, "em": false, "chrf": 27.54742456620661, "bleu": 3.4857116957065437}], "avg_f1": 0.17857142857142855, "avg_em": 0.0, "avg_chrf": 23.23071393527087, "avg_bleu": 1.9113045228304084}
{"id": "CMU_1:68", "en": "i feel a pain in the chest here in the front part of the chest", "fr": "je ressens une douleur dans la poitrine ici à l’avant de la poitrine", "perturbation": "omission", "pert_fr": "je ressens une douleur dans la poitrine ici à l’avant", "bt_pert_fr": "I feel a pain in my chest here in the front", "questions": "[\"What type of pain is being felt?\", \"Where in the chest is the pain located?\", \"What part of the chest is affected by the pain?\"]", "answers": "[\"A pain\", \"In the front\", \"The front\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285715, "em": false, "chrf": 32.876331199253336, "bleu": 22.31301601484299}, {"f1": 0.5714285714285715, "em": false, "chrf": 37.68511756417377, "bleu": 22.31301601484299}], "avg_f1": 0.7142857142857144, "avg_em": 0.3333333333333333, "avg_chrf": 56.8538162544757, "avg_bleu": 48.20867734322868}
{"id": "CMU_1:75", "en": "i had a short sharp pain in my chest", "fr": "j’ai ressenti une brève douleur aiguë dans la poitrine", "perturbation": "omission", "pert_fr": "j’ai ressenti une brève douleur dans la poitrine", "bt_pert_fr": "I felt a brief pain in my chest", "questions": "[\"Was the chest pain sharp or dull?\"]", "answers": "[\"No information available\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.761904761904763, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 4.761904761904763, "avg_bleu": 0.0}
{"id": "CMU_1:78", "en": "i have made on the body around the chest area?", "fr": "j’ai fait sur le corps autour de la poitrine ?", "perturbation": "omission", "pert_fr": "j’ai fait sur le corps ?", "bt_pert_fr": "I did on the body?", "questions": "[\"What have you made on the body?\", \"Where on the body have you made something?\"]", "answers": "[\"Nothing\", \"The body\"]", "scores": [{"f1": 0, "em": false, "chrf": 37.58224886679339, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.3199182229572965, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 21.951083544875345, "avg_bleu": 0.0}
{"id": "CMU_1:88", "en": "it hurts in the chest", "fr": "ça fait mal dans la poitrine", "perturbation": "omission", "pert_fr": "ça fait mal", "bt_pert_fr": "it hurts", "questions": "[\"What part of the body hurts?\", \"What is the nature of the pain?\", \"What symptom is described in the sentence?\"]", "answers": "[\"not specified\", \"hurts\", \"pain\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.607200412557209, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 44.88925199709513, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 16.953864675155074, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 24.483439028269135, "avg_bleu": 0.0}
{"id": "CMU_1:94", "en": "it is occurring right in the middle of my chest", "fr": "ça se passe pile au centre de ma poitrine", "perturbation": "omission", "pert_fr": "ça se passe pile au centre", "bt_pert_fr": "it happens right in the center", "questions": "[\"Where is it occurring?\", \"What part of the body is affected?\"]", "answers": "[\"In the center\", \"The center\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 7.75315066087033, "bleu": 11.15650800742149}, {"f1": 0.3333333333333333, "em": false, "chrf": 11.76654506246115, "bleu": 18.393972058572114}], "avg_f1": 0.30952380952380953, "avg_em": 0.0, "avg_chrf": 9.75984786166574, "avg_bleu": 14.775240032996802}
{"id": "CMU_1:104", "en": "most of the time it is this type of chest pain", "fr": "la plupart du temps c’est ce type de douleur dans la poitrine", "perturbation": "omission", "pert_fr": "la plupart du temps c’est ce type de douleur", "bt_pert_fr": "most of the time it's this type of pain", "questions": "[\"What type of chest pain is most commonly experienced?\", \"What does 'most of the time' indicate about chest pain?\", \"What is the specific type of chest pain mentioned in the sentence?\"]", "answers": "[\"This type of pain\", \"It indicates that this type of pain is the most common experience\", \"This type of pain\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 57.60062700744655, "bleu": 49.76093899250716}, {"f1": 0.9090909090909091, "em": false, "chrf": 81.43245477366943, "bleu": 70.16879391277372}, {"f1": 0.888888888888889, "em": false, "chrf": 57.60062700744655, "bleu": 49.76093899250716}], "avg_f1": 0.8956228956228957, "avg_em": 0.0, "avg_chrf": 65.54456959618751, "avg_bleu": 56.563557299262676}
{"id": "PubMed_9:792", "en": "On March 11, 2020, the World Health Organization declared Coronavirus Disease 2019 (COVID-19) a pandemic.", "fr": "Le 11 mars 2020, l’Organisation mondiale de la santé déclarait la maladie à coronavirus 2019 (COVID-19) comme étant une pandémie.", "perturbation": "omission", "pert_fr": "Le 11 mars 2020, l’Organisation mondiale de la santé déclarait la maladie à coronavirus comme étant une pandémie.", "bt_pert_fr": "On March 11, 2020, the World Health Organization declared coronavirus disease a pandemic.", "questions": "[\"When did the World Health Organization declare COVID-19 a pandemic?\", \"What did the World Health Organization declare on March 11, 2020?\", \"What is the name of the disease declared a pandemic?\"]", "answers": "[\"March 11, 2020\", \"coronavirus disease\", \"coronavirus disease\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 44.506233318063565, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 44.506233318063565, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 63.00415554537571, "avg_bleu": 33.33333333333335}
{"id": "PubMed_9:794", "en": "Reports from China and Italy suggest that risk factors for severe disease include older age and the presence of at least one of several underlying health conditions.", "fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de risque de développer une forme grave incluent un âge avancé et la présence d’au moins un problème de santé sous-jacent.", "perturbation": "omission", "pert_fr": "Des rapports provenant de Chine suggèrent que les facteurs de risque de développer une forme grave incluent un âge avancé et la présence d’au moins un problème de santé sous-jacent.", "bt_pert_fr": "Reports from China suggest that risk factors for developing severe disease include older age and the presence of at least one underlying health problem.", "questions": "[\"What risk factors for severe disease are mentioned in the reports?\", \"Which countries' reports are referenced?\", \"What is the relationship between age and risk for severe disease?\"]", "answers": "[\"Older age and the presence of at least one underlying health problem\", \"China\", \"Older age is associated with increased risk for severe disease\"]", "scores": [{"f1": 0.8333333333333333, "em": false, "chrf": 69.68568723545025, "bleu": 61.85985276068634}, {"f1": 0.5, "em": false, "chrf": 30.555818992245232, "bleu": 13.533528323661276}, {"f1": 0.7777777777777777, "em": false, "chrf": 64.8732940309667, "bleu": 27.301208627090666}], "avg_f1": 0.7037037037037036, "avg_em": 0.0, "avg_chrf": 55.03826675288739, "avg_bleu": 34.23152990381276}
{"id": "PubMed_9:795", "en": "U.S. older adults, including those aged ≥65 years and particularly those aged ≥85 years, also appear to be at higher risk for severe COVID-19–associated outcomes; however, data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "fr": "Aux États-Unis, les personnes âgées à partir de 65 ans, et plus particulièrement au-delà de 85 ans, semblent également présenter un risque accru de développer une forme grave de la COVID-19 ; cependant, aucune donnée sur les problèmes de santé sous-jacents chez les patients américains atteints de la COVID-19 n’a encore été rapportée.", "perturbation": "omission", "pert_fr": "Aux États-Unis, les personnes âgées à partir de 65 ans semblent également présenter un risque accru de développer une forme grave de la COVID-19 ; cependant, aucune donnée sur les problèmes de santé sous-jacents chez les patients américains atteints de la COVID-19 n’a encore été rapportée.", "bt_pert_fr": "In the United States, older adults aged 65 and older also appear to be at increased risk of developing severe COVID-19; however, data on underlying health conditions in US COVID-19 patients have not yet been reported.", "questions": "[\"Which U.S. older adults are at higher risk for severe COVID-19–associated outcomes?\", \"What age group is particularly at higher risk for severe COVID-19–associated outcomes?\", \"What data has not yet been reported regarding U.S. COVID-19 patients?\", \"What is the relationship between age and risk for severe COVID-19–associated outcomes?\"]", "answers": "[\"Older adults aged 65 and older\", \"Older adults aged 65 and older\", \"Data on underlying health conditions\", \"Older adults aged 65 and older are at increased risk of developing severe COVID-19\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 63.77993047669301, "bleu": 9.652434877402245}, {"f1": 0.2, "em": false, "chrf": 16.671319901150977, "bleu": 8.116697886877475}, {"f1": 0.6, "em": false, "chrf": 68.46784951568654, "bleu": 39.76353643835254}, {"f1": 0.20689655172413796, "em": false, "chrf": 29.776008371476063, "bleu": 3.479789360876994}], "avg_f1": 0.3628352490421456, "avg_em": 0.0, "avg_chrf": 44.673777066251645, "avg_bleu": 15.253114640877312}
{"id": "PubMed_9:797", "en": "Among these 7,162 cases, 2,692 (37.6%) patients had one or more underlying health condition or risk factor, and 4,470 (62.4%) had none of these conditions reported.", "fr": "Sur ces 7 162 cas, 2 692 patients (37,6 %) présentaient un ou plusieurs problèmes de santé sous-jacents ou facteurs de risque, et 4 470 (62,4 %) n’en présentaient aucun.", "perturbation": "omission", "pert_fr": "Sur ces 7 162 cas, 2 692 patients (37,6 %) présentaient un ou plusieurs problèmes de santé sous-jacents, et 4 470 (62,4 %) n’en présentaient aucun.", "bt_pert_fr": "Of these 7,162 cases, 2,692 patients (37.6%) had one or more underlying health conditions, and 4,470 (62.4%) had none.", "questions": "[\"How many cases had one or more underlying health condition or risk factor?\", \"What percentage of patients had one or more underlying health condition or risk factor?\", \"How many cases had no underlying health condition or risk factor?\", \"What percentage of patients had no underlying health condition or risk factor?\", \"What is the total number of cases mentioned in the sentence?\"]", "answers": "[2692, \"37.6%\", \"4470\", \"62.4%\", \"7162\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:799", "en": "The most commonly reported conditions were diabetes mellitus, chronic lung disease, and cardiovascular disease.", "fr": "Les problèmes de santé les plus fréquemment rapportés étaient le diabète sucré, une maladie pulmonaire chronique et une maladie cardiovasculaire.", "perturbation": "omission", "pert_fr": "Les problèmes de santé les plus fréquemment rapportés étaient le diabète sucré et une maladie cardiovasculaire.", "bt_pert_fr": "The most frequently reported health problems were diabetes mellitus and cardiovascular disease.", "questions": "[\"What are the most commonly reported conditions?\"]", "answers": "[\"Diabetes mellitus and cardiovascular disease\"]", "scores": [{"f1": 0.6153846153846154, "em": false, "chrf": 65.36645390947577, "bleu": 23.45000810620359}], "avg_f1": 0.6153846153846154, "avg_em": 0.0, "avg_chrf": 65.36645390947577, "avg_bleu": 23.45000810620359}
{"id": "PubMed_9:802", "en": "Cases among persons repatriated to the United States from Wuhan, China, and the Diamond Princess cruise ship were excluded.", "fr": "Des cas parmi les individus rapatriés aux États-Unis depuis Wuhan, en Chine, ainsi que les personnes présentes sur le navire de croisière Diamond Princess ont été exclus.", "perturbation": "omission", "pert_fr": "Des cas parmi les individus rapatriés aux États-Unis depuis Wuhan, en Chine, ont été exclus.", "bt_pert_fr": "Cases among individuals repatriated to the United States from Wuhan, China, were excluded.", "questions": "[\"Which cases were excluded?\", \"What are the sources of the excluded cases?\", \"What specific groups were repatriated and had cases excluded?\", \"Why were cases from Wuhan, China, and the Diamond Princess cruise ship excluded?\"]", "answers": "[\"Cases among individuals repatriated to the United States\", \"Wuhan, China\", \"Individuals repatriated to the United States from Wuhan, China\", \"The cases were excluded because they were from Wuhan, China\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 77.09097053934958, "bleu": 48.892302243490086}, {"f1": 0.4444444444444445, "em": false, "chrf": 24.876837088061517, "bleu": 8.208499862389884}, {"f1": 0.6666666666666667, "em": false, "chrf": 58.12453271206063, "bleu": 45.009941646520126}, {"f1": 0.42857142857142855, "em": false, "chrf": 32.97273808107284, "bleu": 9.236712109783857}], "avg_f1": 0.5992063492063492, "avg_em": 0.0, "avg_chrf": 48.266269605136145, "avg_bleu": 27.836863965545987}
{"id": "PubMed_9:803", "en": "For cases with missing onset dates, date of onset was estimated by subtracting 4 days (median interval from symptom onset to specimen collection date among cases with known dates in these data) from the earliest specimen collection.", "fr": "Concernant les cas pour lesquels elle était inconnue, la date d’apparition de la maladie a été estimée en soustrayant 4 jours (intervalle médian entre l’apparition des symptômes et la date de prélèvement d’échantillons pour les cas de ces données dont la date était connue) à partir du premier prélèvement d’échantillons.", "perturbation": "omission", "pert_fr": "Concernant les cas pour lesquels elle était inconnue, la date d’apparition de la maladie a été estimée en soustrayant 4 jours à partir du premier prélèvement d’échantillons.", "bt_pert_fr": "For cases where it was unknown, the date of disease onset was estimated by subtracting 4 days from the first sample collection.", "questions": "[\"How were onset dates estimated for cases with missing onset dates?\", \"What is the median interval from symptom onset to specimen collection date?\", \"What is the number of days subtracted to estimate the date of onset?\", \"What is the method used to estimate the date of onset?\"]", "answers": "[\"By subtracting 4 days from the first sample collection\", \"Not specified\", \"4\", \"Subtracting 4 days from the first sample collection\"]", "scores": [{"f1": 0.7058823529411765, "em": false, "chrf": 61.10215534815744, "bleu": 47.750342648354646}, {"f1": 0, "em": false, "chrf": 6.25, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 59.37967394611506, "bleu": 37.68499164492418}], "avg_f1": 0.5931372549019608, "avg_em": 0.25, "avg_chrf": 56.682957323568125, "avg_bleu": 46.358833573319714}
{"id": "PubMed_9:804", "en": "Public health departments reported cases to CDC using a standardized case report form that captures information (yes, no, or unknown) on the following conditions and potential risk factors: chronic lung disease (inclusive of asthma, chronic obstructive pulmonary disease [COPD], and emphysema); diabetes mellitus; cardiovascular disease; chronic renal disease; chronic liver disease; immunocompromised condition; neurologic disorder, neurodevelopmental, or intellectual disability; pregnancy; current smoking status; former smoking status; or other chronic disease.", "fr": "Les services de santé publique ont signalé les cas aux CDC via un formulaire de rapport de cas normalisé permettant de rassembler des informations (oui, non ou inconnu) sur les problèmes de santé et les facteurs de risque potentiels suivants : une maladie pulmonaire chronique (notamment l’asthme, une maladie pulmonaire obstructive chronique [MPOC] et l’emphysème) ; le diabète sucré ; une maladie cardiovasculaire ; une maladie rénale chronique ; une maladie hépatique chronique ; une immunodéficience ; un trouble neurologique, un trouble neurodéveloppemental ou une déficience intellectuelle ; une grossesse ; le tabagisme ; des antécédents de tabagisme ; ou une autre maladie chronique.", "perturbation": "omission", "pert_fr": "Les services de santé publique ont signalé les cas aux CDC via un formulaire de rapport de cas normalisé permettant de rassembler des informations (oui, non ou inconnu) sur les problèmes de santé et les facteurs de risque potentiels suivants : une maladie pulmonaire chronique  ; le diabète sucré ; une maladie cardiovasculaire ; une maladie rénale chronique ; une maladie hépatique chronique ; une immunodéficience ; un trouble neurologique, un trouble neurodéveloppemental ou une déficience intellectuelle ; une grossesse ; ou une autre maladie chronique.", "bt_pert_fr": "Public health reported cases to CDC via a standardized case report form to gather information (yes, no, or unknown) on the following health conditions and potential risk factors: chronic lung disease; diabetes mellitus; cardiovascular disease; chronic kidney disease; chronic liver disease; immunodeficiency; a neurological disorder, neurodevelopmental disorder, or intellectual disability; pregnancy; or another chronic illness.", "questions": "[\"What information does the standardized case report form capture?\", \"What conditions are included in chronic lung disease?\", \"What is included in the chronic lung disease category?\", \"What is the definition of chronic lung disease in the report?\"]", "answers": "[\"Information on the following health conditions and potential risk factors: chronic lung disease; diabetes mellitus; cardiovascular disease; chronic kidney disease; chronic liver disease; immunodeficiency; a neurological disorder, neurodevelopmental disorder, or intellectual disability; pregnancy; or another chronic illness\", \"None\", \"chronic lung disease\", \"None\"]", "scores": [{"f1": 0.3829787234042553, "em": false, "chrf": 47.727752006898314, "bleu": 12.107046798719933}, {"f1": 0, "em": false, "chrf": 2.205764931331843, "bleu": 0.0}, {"f1": 0.36363636363636365, "em": false, "chrf": 20.397503036542318, "bleu": 6.5479514338598115}, {"f1": 0, "em": false, "chrf": 1.5120217358940002, "bleu": 0.0}], "avg_f1": 0.18665377176015474, "avg_em": 0.0, "avg_chrf": 17.960760427666617, "avg_bleu": 4.663749558144936}
{"id": "PubMed_9:805", "en": "Data reported to CDC are preliminary and can be updated by health departments over time; critical data elements might be missing at the time of initial report; thus, this analysis is descriptive, and no statistical comparisons could be made.", "fr": "Les données communiquées aux CDC sont des données préliminaires qui peuvent être mises à jour par les services de santé au fil du temps ; des éléments de données critiques peuvent avoir manqués lors de la rédaction du rapport initial ; il s’agit donc d’une analyse descriptive, et aucune comparaison statistique ne peut être réalisée.", "perturbation": "omission", "pert_fr": "Les données communiquées aux CDC sont des données préliminaires qui peuvent être mises à jour par les services de santé au fil du temps ; des éléments de données critiques peuvent avoir manqués lors de la rédaction du rapport initial ; il s’agit donc d’une analyse, et aucune comparaison statistique ne peut être réalisée.", "bt_pert_fr": "The data reported to CDC is preliminary data that may be updated by health departments over time; critical data elements may have been missed when the initial report was written; it is therefore an analysis, and no statistical comparison can be made.", "questions": "[\"What is said about the data reported to CDC?\", \"Why are the data considered preliminary?\", \"How can the data be updated?\", \"What might be missing at the time of initial report?\", \"Why is the analysis described as descriptive?\", \"Why could no statistical comparisons be made?\"]", "answers": "[\"The data reported to CDC is preliminary data that may be updated by health departments over time; critical data elements may have been missed when the initial report was written; it is therefore an analysis, and no statistical comparison can be made.\", \"Because critical data elements may have been missed when the initial report was written\", \"By health departments\", \"Critical data elements\", \"Because it is an analysis based on preliminary and potentially incomplete data\", \"Because critical data elements may have been missed when the initial report was written, making it impossible to perform accurate statistical comparisons\"]", "scores": [{"f1": 0.4727272727272728, "em": false, "chrf": 62.08328140778312, "bleu": 18.915672932690555}, {"f1": 0.48000000000000004, "em": false, "chrf": 64.15441892662979, "bleu": 22.997519112894437}, {"f1": 0.7499999999999999, "em": false, "chrf": 71.90582934168556, "bleu": 51.341711903259224}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.39999999999999997, "em": false, "chrf": 48.28008470024487, "bleu": 8.913765521398126}, {"f1": 0.2777777777777778, "em": false, "chrf": 41.51304456315167, "bleu": 4.5672118332822365}], "avg_f1": 0.5634175084175084, "avg_em": 0.16666666666666666, "avg_chrf": 64.65610982324917, "avg_bleu": 34.4559802172541}
{"id": "PubMed_9:806", "en": "The percentages of patients of all ages with underlying health conditions who were not hospitalized, hospitalized without ICU admission, and hospitalized with ICU admission were calculated.", "fr": "Les pourcentages de patients tous âges confondus présentant des problèmes de santé sous-jacents n’ayant pas été hospitalisés, ayant été hospitalisés sans admission en USI et ayant été hospitalisés avec admission en USI ont été calculés.", "perturbation": "omission", "pert_fr": "Les pourcentages de patients tous âges confondus présentant des problèmes de santé sous-jacents ayant été hospitalisés sans admission en USI et ayant été hospitalisés avec admission en USI ont été calculés.", "bt_pert_fr": "The percentages of patients of all ages with underlying health conditions who were hospitalized without ICU admission and who were hospitalized with ICU admission were calculated.", "questions": "[\"What percentages were calculated?\", \"What is the population being considered in the calculation?\"]", "answers": "[\"The percentages of patients of all ages with underlying health conditions who were hospitalized without ICU admission and who were hospitalized with ICU admission\", \"Patients of all ages with underlying health conditions\"]", "scores": [{"f1": 0.9166666666666666, "em": false, "chrf": 87.55275561070712, "bleu": 76.41254083103469}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9583333333333333, "avg_em": 0.5, "avg_chrf": 93.77637780535356, "avg_bleu": 88.20627041551737}
{"id": "PubMed_9:807", "en": "Percentages of hospitalizations with and without ICU admission were estimated for persons aged ≥19 years with and without underlying health conditions.", "fr": "Les pourcentages d’hospitalisation avec ou sans admission en USI ont été estimés pour les individus de 19 ans ou plus, avec et sans problèmes de santé sous-jacents.", "perturbation": "omission", "pert_fr": "Les pourcentages d’hospitalisation avec ou sans admission en USI ont été estimés pour les individus de 19 ans ou plus, avec problèmes de santé sous-jacents.", "bt_pert_fr": "The percentages of hospitalization with or without ICU admission were estimated for individuals 19 years of age or older with underlying health conditions.", "questions": "[\"What percentages were estimated?\", \"For which group of persons were hospitalization percentages estimated?\"]", "answers": "[\"The percentages of hospitalization with or without ICU admission\", \"Individuals 19 years of age or older with underlying health conditions\"]", "scores": [{"f1": 0.5882352941176471, "em": false, "chrf": 80.74638863584794, "bleu": 20.164945583740657}, {"f1": 0.47619047619047616, "em": false, "chrf": 58.06643744291635, "bleu": 15.851165692617155}], "avg_f1": 0.5322128851540616, "avg_em": 0.0, "avg_chrf": 69.40641303938214, "avg_bleu": 18.008055638178906}
{"id": "PubMed_9:808", "en": "This part of the analysis was limited to persons aged ≥19 years because of the small sample size of cases in children with reported underlying health conditions (N = 32).", "fr": "Cette partie de l’analyse a été restreinte aux individus de 19 ans ou plus en raison du très petit nombre de cas d’enfants présentant des problèmes de santé sous-jacents (N = 32).", "perturbation": "omission", "pert_fr": "Cette partie de l’analyse a été restreinte aux individus de 19 ans ou plus en raison du très petit nombre de cas d’enfants.", "bt_pert_fr": "This part of the analysis was restricted to individuals 19 years or older due to the very small number of child cases.", "questions": "[\"Why was the analysis limited to persons aged ≥19 years?\", \"What was the reason for the small sample size in children?\", \"What is the sample size of cases in children with reported underlying health conditions?\", \"What is the total number of cases in children with reported underlying health conditions?\"]", "answers": "[\"Due to the very small number of child cases\", \"The very small number of child cases\", \"Not specified\", \"Not specified\"]", "scores": [{"f1": 0.2727272727272727, "em": false, "chrf": 15.31867096369934, "bleu": 3.4331054109918173}, {"f1": 0.4, "em": false, "chrf": 17.110771256926764, "bleu": 3.9413751108533592}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.16818181818181818, "avg_em": 0.0, "avg_chrf": 8.107360555156525, "avg_bleu": 1.8436201304612942}
{"id": "PubMed_9:810", "en": "Because of small sample size and missing data on underlying health conditions among COVID-19 patients who died, case-fatality rates for persons with and without underlying conditions were not estimated.", "fr": "En raison de la petite taille d’échantillon et du manque de données concernant les problèmes de santé sous-jacents des patients décédés de la COVID-19, les taux de létalité pour les individus avec et sans problèmes de santé sous-jacents n’ont pas été estimés.", "perturbation": "omission", "pert_fr": "En raison de la petite taille d’échantillon et du manque de données concernant les problèmes de santé sous-jacents des patients décédés, les taux de létalité pour les individus avec et sans problèmes de santé sous-jacents n’ont pas été estimés.", "bt_pert_fr": "Due to the small sample size and lack of data regarding the underlying health conditions of deceased patients, case fatality rates for individuals with and without underlying health conditions were not estimated.", "questions": "[\"Why were case-fatality rates not estimated?\", \"What factors contributed to the inability to estimate case-fatality rates?\", \"What data was missing among COVID-19 patients who died?\", \"What was the impact of small sample size on the estimation of case-fatality rates?\"]", "answers": "[\"Due to the small sample size and lack of data regarding the underlying health conditions of deceased patients\", \"The small sample size and lack of data regarding the underlying health conditions of deceased patients\", \"Data regarding the underlying health conditions\", \"It contributed to the inability to estimate case-fatality rates\"]", "scores": [{"f1": 0.6060606060606061, "em": false, "chrf": 56.62257433099659, "bleu": 22.74095779679485}, {"f1": 0.56, "em": false, "chrf": 69.00013174466942, "bleu": 17.098323692758395}, {"f1": 0.5454545454545454, "em": false, "chrf": 69.95203033128729, "bleu": 32.55563013321615}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6778787878787879, "avg_em": 0.25, "avg_chrf": 73.89368410173833, "avg_bleu": 43.09872790569236}
{"id": "PubMed_9:814", "en": "Approximately one third of these patients (2,692, 37.6%), had at least one underlying condition or risk factor.", "fr": "Environ un tiers de ces patients (2 692, 37,6 %) présentaient au moins un problème de santé sous-jacent ou un facteur de risque.", "perturbation": "omission", "pert_fr": "Environ un tiers de ces patients (2 692, 37,6 %) présentaient au moins un problème de santé sous-jacent.", "bt_pert_fr": "Approximately one third of these patients (2,692, 37.6%) had at least one underlying health condition.", "questions": "[\"What percentage of patients had at least one underlying condition or risk factor?\", \"How many patients had at least one underlying condition or risk factor?\", \"What is the total number of patients mentioned in the sentence?\", \"What is the proportion of patients with underlying conditions or risk factors?\"]", "answers": "[\"37.6%\", \"2,692\", \"Unknown\", \"One third\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:817", "en": "In contrast, 1,388 of 5,143 (27%) COVID-19 patients who were not hospitalized were reported to have at least one underlying health condition.", "fr": "A contrario, 1 388 patients atteints de la COVID-19 sur 5 143 (27 %) n’ayant pas été hospitalisés présentaient au moins un problème de santé sous-jacent.", "perturbation": "omission", "pert_fr": "A contrario, 1 388 patients atteints de la COVID-19 sur 5 143 (27 %) n’ayant pas été hospitalisés présentaient un problème de santé sous-jacent.", "bt_pert_fr": "In contrast, 1,388 out of 5,143 (27%) COVID-19 patients who were not hospitalized had an underlying health condition.", "questions": "[\"What percentage of COVID-19 patients who were not hospitalized had at least one underlying health condition?\", \"How many COVID-19 patients who were not hospitalized had at least one underlying health condition?\", \"What is the total number of COVID-19 patients who were not hospitalized?\"]", "answers": "[\"27%\", \"1,388\", \"5,143\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:818", "en": "Among patients aged ≥19 years, the percentage of non-ICU hospitalizations was higher among those with underlying health conditions (27.3%–29.8%) than among those without underlying health conditions (7.2%–7.8%); the percentage of cases that resulted in an ICU admission was also higher for those with underlying health conditions (13.3%–14.5%) than those without these conditions (2.2%–2.4%) (Table 2).", "fr": "Parmi les patients de 19 ans ou plus, le pourcentage d’hospitalisations hors USI était supérieur pour ceux présentant des problèmes de santé sous-jacents (27,3 %–29,8 %) que pour ceux n’en présentant pas (7,2 %–7,8 %) ; le pourcentage de cas ayant nécessité une admission en USI était également supérieur pour ceux présentant des problèmes de santé sous-jacents (13,3 %–14,5 %) que pour ceux n’en présentant pas (2,2 %–2,4 %) (Tableau 2).CI", "perturbation": "omission", "pert_fr": "Parmi les patients de 19 ans ou plus, le pourcentage d’hospitalisations hors USI était supérieur pour ceux présentant des problèmes de santé sous-jacents (27,3 %–29,8 %) que pour ceux n’en présentant pas (7,2 %–7,8 %) ; le pourcentage de cas ayant nécessité une admission en USI était également supérieur pour ceux présentant des problèmes de santé sous-jacents (13,3 %–14,5 %) que pour ceux n’en présentant pas.", "bt_pert_fr": "Among patients 19 years or older, the percentage of non-ICU hospitalizations was higher for those with underlying health conditions (27.3%–29.8%) than for those without (7.2%–7.8%); the percentage of cases requiring ICU admission was also higher for those with underlying health conditions (13.3%–14.5%) than for those without.", "questions": "[\"What is the percentage of non-ICU hospitalizations among patients aged ≥19 years with underlying health conditions?\", \"What is the percentage of ICU admissions among patients aged ≥19 years with underlying health conditions?\", \"What is the difference in non-ICU hospitalization rates between patients with and without underlying health conditions?\", \"What is the difference in ICU admission rates between patients with and without underlying health conditions?\", \"Which group has a higher rate of non-ICU hospitalizations?\", \"Which group has a higher rate of ICU admissions?\", \"What data is presented in Table 2?\"]", "answers": "[\"27.3%–29.8%\", \"13.3%–14.5%\", \"19.9%–22.6%\", \"6.8%–6.7%\", \"Patients with underlying health conditions\", \"Patients with underlying health conditions\", \"The percentage of non-ICU hospitalizations and ICU admissions among patients aged ≥19 years with and without underlying health conditions\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.635604632372744, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 1.3698630136986305, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7142857142857143, "avg_em": 0.7142857142857143, "avg_chrf": 72.42935252086734, "avg_bleu": 71.42857142857146}
{"id": "PubMed_9:819", "en": "Small numbers of COVID-19 patients aged &lt; 19 years were reported to be hospitalized (48) or admitted to an ICU (eight).", "fr": "Seul un petit nombre de patients atteints de la COVID-19 de moins de 19 ans ont nécessité une hospitalisation (48) ou une admission en USI (huit).", "perturbation": "omission", "pert_fr": "Seul un petit nombre de patients atteints de la COVID-19 ont nécessité une hospitalisation (48) ou une admission en USI (huit).", "bt_pert_fr": "Only a small number of COVID-19 patients required hospitalization (48) or ICU admission (eight).", "questions": "[\"What are the hospitalization and ICU admission numbers for young COVID-19 patients?\"]", "answers": "[\"The sentence does not provide information about young COVID-19 patients, so the hospitalization and ICU admission numbers cannot be determined for this group.\"]", "scores": [{"f1": 0.07142857142857144, "em": false, "chrf": 25.662382986985065, "bleu": 1.727223799216787}], "avg_f1": 0.07142857142857144, "avg_em": 0.0, "avg_chrf": 25.662382986985065, "avg_bleu": 1.727223799216787}
{"id": "PubMed_9:820", "en": "In contrast, 335 patients aged &lt; 19 years were not hospitalized and 1,342 had missing data on hospitalization.", "fr": "A contrario, 335 patients de moins de 19 ans n’ont pas nécessité d’hospitalisation et aucune donnée relative à l’hospitalisation n’était disponible pour 1 342 autres.", "perturbation": "omission", "pert_fr": "A contrario, 335 patients de moins de 19 ans n’ont pas nécessité d’hospitalisation et aucune donnée relative à l’hospitalisation n’était disponible pour 1 342.", "bt_pert_fr": "Conversely, 335 patients under the age of 19 did not require hospitalization and no data relating to hospitalization was available for 1,342.", "questions": "[\"How many patients had missing data on hospitalization?\", \"What is the age group mentioned in the sentence?\"]", "answers": "[1342, \"under the age of 19\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 18.618427263287078, "bleu": 15.97357760615681}], "avg_f1": 0.28571428571428575, "avg_em": 0.0, "avg_chrf": 18.618427263287078, "avg_bleu": 15.97357760615681}
{"id": "PubMed_9:821", "en": "Among all COVID-19 patients with complete information on underlying conditions or risk factors, 184 deaths occurred (all among patients aged ≥19 years); 173 deaths (94%) were reported among patients with at least one underlying condition.", "fr": "Sur tous les patients atteints de la COVID-19 pour lesquels des informations complètes sur les problèmes de santé sous-jacents ou facteurs de risque étaient disponibles, 184 sont décédés (tous étaient âgés de 19 ans ou plus) ; 173 décès (94 %) concernaient des patients présentant au moins un problème de santé sous-jacent.", "perturbation": "omission", "pert_fr": "Sur tous les patients atteints de la COVID-19 pour lesquels des informations complètes sur les problèmes de santé sous-jacents ou facteurs de risque étaient disponibles, 184 sont décédés (tous étaient âgés de 19 ans ou plus) ; 173 décès concernaient des patients présentant au moins un problème de santé sous-jacent.", "bt_pert_fr": "Of all COVID-19 patients for whom complete information on underlying health conditions or risk factors was available, 184 died (all were 19 years or older); 173 deaths involved patients with at least one underlying health condition.", "questions": "[\"How many deaths occurred among COVID-19 patients with complete information on underlying conditions or risk factors?\", \"What is the age range of the patients who died?\", \"How many deaths were reported among patients with at least one underlying condition?\", \"What percentage of deaths were reported among patients with at least one underlying condition?\", \"What does the data suggest about the relationship between underlying conditions and death from COVID-19?\"]", "answers": "[184, \"19 years or older\", 173, \"94.6%\", \"The data suggests that a majority of deaths were among patients with at least one underlying health condition.\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 65.1994805959594, "bleu": 15.97357760615681}, {"f1": 0, "em": false, "chrf": 87.49999999999999, "bleu": 0.0}, {"f1": 0.6285714285714287, "em": false, "chrf": 64.24298957589068, "bleu": 41.345637683545284}], "avg_f1": 0.32063492063492066, "avg_em": 0.0, "avg_chrf": 72.31415672395002, "avg_bleu": 19.106405096567364}
{"id": "PubMed_9:822", "en": "Among 122,653 U.S. COVID-19 cases reported to CDC as of March 28, 2020, 7,162 (5.8%) patients had data available pertaining to underlying health conditions or potential risk factors; among these patients, higher percentages of patients with underlying conditions were admitted to the hospital and to an ICU than patients without reported underlying conditions.", "fr": "Sur les 122 653 cas de COVID-19 aux États-Unis rapportés aux CDC au 28 mars 2020, des données sur les problèmes de santé sous-jacents ou facteurs de risque potentiels étaient disponibles pour 7 162 patients (5,8 %) ; sur ces cas, le pourcentage de patients ayant nécessité une hospitalisation et une admission en USI était plus élevé chez ceux présentant des problèmes de santé sous-jacents que chez ceux n’en présentant pas.", "perturbation": "omission", "pert_fr": "Sur les 122 653 cas de COVID-19 aux États-Unis rapportés aux CDC au 28 mars 2020, des données sur les problèmes de santé sous-jacents ou facteurs de risque potentiels étaient disponibles pour 7 162 patients (5,8 %) ; sur ces cas, le pourcentage de patients ayant nécessité une hospitalisation était plus élevé chez ceux présentant des problèmes de santé sous-jacents que chez ceux n’en présentant pas.", "bt_pert_fr": "Of the 122,653 cases of COVID-19 in the United States reported to the CDC as of March 28, 2020, data on underlying health conditions or potential risk factors was available for 7,162 patients (5.8%); of these cases, the percentage of patients requiring hospitalization was higher among those with underlying health problems than among those without.", "questions": "[\"How many U.S. COVID-19 cases were reported to CDC as of March 28, 2020?\", \"What percentage of patients had data available pertaining to underlying health conditions or potential risk factors?\", \"How many patients had data available pertaining to underlying health conditions or potential risk factors?\", \"Were patients with underlying conditions more likely to be admitted to the hospital than those without?\", \"Were patients with underlying conditions more likely to be admitted to an ICU than those without?\", \"What is the relationship between underlying health conditions and hospital admission?\", \"What is the relationship between underlying health conditions and ICU admission?\"]", "answers": "[122653, \"5.8%\", \"7162\", \"Yes\", \"It is not specified in the sentence\", \"Patients with underlying health conditions were more likely to be admitted to the hospital than those without\", \"It is not specified in the sentence\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 8.771929824561402, "bleu": 0.0}, {"f1": 0.967741935483871, "em": false, "chrf": 95.48144382737462, "bleu": 81.53551038173119}, {"f1": 0, "em": false, "chrf": 8.575496611006558, "bleu": 0.0}], "avg_f1": 0.6612903225806451, "avg_em": 0.5, "avg_chrf": 68.80481171049043, "avg_bleu": 63.58925173028856}
{"id": "PubMed_9:823", "en": "These results are consistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including, but not limited to, diabetes mellitus, hypertension, COPD, coronary artery disease, cerebrovascular disease, chronic renal disease, and smoking, might be at higher risk for severe disease or death from COVID-19.", "fr": "Ces résultats sont cohérents avec les constatations réalisées par la Chine et l’Italie, qui suggèrent que les patients présentant des problèmes de santé sous-jacents et des facteurs de risque, notamment, mais sans s’y limiter, le diabète sucré, l’hypertension, une MPOC, une maladie coronarienne, une maladie cérébrovasculaire, une maladie rénale chronique et le tabagisme, seraient plus susceptibles de développer une forme grave de la COVID-19 et d’en décéder.", "perturbation": "omission", "pert_fr": "Ces résultats sont cohérents avec les constatations réalisées par la Chine et l’Italie, qui suggèrent que les patients présentant des problèmes de santé sous-jacents et des facteurs de risque, notamment, mais sans s’y limiter, le diabète sucré, l’hypertension, une MPOC, une maladie coronarienne, une maladie cérébrovasculaire, une maladie rénale chronique, seraient plus susceptibles de développer une forme grave de la COVID-19 et d’en décéder.", "bt_pert_fr": "These results are consistent with findings from China and Italy, which suggest that patients with underlying health conditions and risk factors, including but not limited to diabetes mellitus, hypertension, COPD, coronary heart disease, cerebrovascular disease, chronic kidney disease, would be more likely to develop severe COVID-19 and die from it.", "questions": "[\"What does the data from China and Italy suggest about patients with underlying health conditions?\", \"Which underlying health conditions and risk factors are mentioned as potentially increasing the risk of severe disease or death from COVID-19?\", \"What is the relationship between underlying health conditions and the risk of severe disease or death from COVID-19?\", \"What does the consistency of results with findings from China and Italy imply?\"]", "answers": "[\"That patients with underlying health conditions and risk factors would be more likely to develop severe COVID-19 and die from it\", \"Diabetes mellitus, hypertension, COPD, coronary heart disease, cerebrovascular disease, chronic kidney disease\", \"Patients with underlying health conditions are more likely to develop severe disease or die from COVID-19\", \"That the findings are reliable and supported by previous research in China and Italy\"]", "scores": [{"f1": 0.6190476190476191, "em": false, "chrf": 63.14090166859449, "bleu": 41.7591652127848}, {"f1": 0.7692307692307692, "em": false, "chrf": 79.11601894301889, "bleu": 46.15415465297941}, {"f1": 0.4827586206896552, "em": false, "chrf": 64.16221459701164, "bleu": 13.380161378318954}, {"f1": 0.8, "em": false, "chrf": 78.98695332788708, "bleu": 57.83569866465144}], "avg_f1": 0.6677592522420108, "avg_em": 0.0, "avg_chrf": 71.35152213412802, "avg_bleu": 39.78229497718365}
{"id": "PubMed_9:825", "en": "It is not yet known whether the severity or level of control of underlying health conditions affects the risk for severe disease associated with COVID-19.", "fr": "Il n’a pas encore été établi si la sévérité ou le niveau de contrôle des problèmes de santé sous-jacents affectent le risque de complications graves associées à la COVID-19.", "perturbation": "omission", "pert_fr": "Il n’a pas encore été établi si la sévérité des problèmes de santé sous-jacents affectent le risque de complications graves associées à la COVID-19.", "bt_pert_fr": "It is not yet known whether the severity of underlying health conditions affects the risk of serious complications associated with COVID-19.", "questions": "[\"What is not yet known?\", \"What might affect the risk for severe disease associated with COVID-19?\"]", "answers": "[\"Whether the severity of underlying health conditions affects the risk of serious complications associated with COVID-19\", \"The severity of underlying health conditions\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 69.94677258358055, "bleu": 37.18306240874867}, {"f1": 0.7499999999999999, "em": false, "chrf": 70.51882782714868, "bleu": 31.02451704053729}], "avg_f1": 0.75, "avg_em": 0.0, "avg_chrf": 70.23280020536461, "avg_bleu": 34.10378972464298}
{"id": "PubMed_9:826", "en": "Many of these underlying health conditions are common in the United States: based on self-reported 2018 data, the prevalence of diagnosed diabetes among U.S. adults was 10.1%, and the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) was 10.6% in 2017.", "fr": "Nombre de ces problèmes de santé sous-jacents sont communs aux États-Unis : d’après les données auto-déclarées de 2018, la prévalence des diabètes diagnostiqués chez des adultes était de 10,1 %, et la prévalence selon l’âge de l’ensemble des maladies cardiaques (hors hypertension sans autre maladie cardiaque) était de 10,6 % en 2017.", "perturbation": "omission", "pert_fr": "Nombre de ces problèmes de santé sous-jacents sont communs aux États-Unis : d’après les données auto-déclarées de 2018, la prévalence des diabètes diagnostiqués chez des adultes était de 10,1 %.", "bt_pert_fr": "Many of these underlying health conditions are common in the United States: according to 2018 self-reported data, the prevalence of diagnosed diabetes among adults was 10.1%.", "questions": "[\"What underlying health conditions are common in the United States?\", \"What is the prevalence of diagnosed diabetes among U.S. adults according to 2018 self-reported data?\", \"What is the U.S. age-adjusted prevalence of all types of heart disease (excluding hypertension without other heart disease) in 2017?\", \"What data source is used to determine the prevalence of health conditions?\", \"What year does the data on heart disease refer to?\"]", "answers": "[\"Diabetes\", \"10.1%\", \"Not mentioned\", \"2018 self-reported data\", \"2017\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 30.863607049221955, "bleu": 4.9787068367863965}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 65.66771299162941, "bleu": 34.66806371753173}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6133333333333333, "avg_em": 0.4, "avg_chrf": 59.306264008170274, "avg_bleu": 47.92935411086364}
{"id": "PubMed_9:829", "en": "The estimated higher prevalence of these conditions among those in this early group of U.S. COVID-19 patients and the potentially higher risk for more severe disease from COVID-19 associated with the presence of underlying conditions highlight the importance of COVID-19 prevention in persons with underlying conditions.", "fr": "La prévalence supérieure estimée de ces problèmes de santé pour ce premier groupe de patients américains atteints de la COVID-19 et un risque potentiellement accru de développer une forme grave de la COVID-19 en raison de la présence de problèmes de santé sous-jacents soulignent l’importance de prévenir la COVID-19 chez les individus présentant de telles conditions.", "perturbation": "omission", "pert_fr": "La prévalence supérieure estimée de ces problèmes de santé pour ce premier groupe de patients américains atteints de la COVID-19 et un risque potentiellement accru de développer une forme grave de la COVID-19 en raison de la présence de problèmes de santé sous-jacents soulignent l’importance de prévenir la COVID-19 chez les individus.", "bt_pert_fr": "The estimated higher prevalence of these health conditions for this first group of US COVID-19 patients and a potentially increased risk of developing severe COVID-19 due to the presence of underlying health conditions highlights the importance of preventing COVID-19 in individuals.", "questions": "[\"Why is COVID-19 prevention important for persons with underlying conditions?\"]", "answers": "[\"Because individuals with underlying health conditions are at a higher risk of developing severe COVID-19\"]", "scores": [{"f1": 0.48484848484848486, "em": false, "chrf": 38.6137155927621, "bleu": 6.683300628421174}], "avg_f1": 0.48484848484848486, "avg_em": 0.0, "avg_chrf": 38.6137155927621, "avg_bleu": 6.683300628421174}
{"id": "PubMed_9:830", "en": "The findings in this report are subject to at least six limitations.", "fr": "Les conclusions de ce rapport sont soumises à six limitations au moins.", "perturbation": "omission", "pert_fr": "Les conclusions de ce rapport sont soumises à limitations au moins.", "bt_pert_fr": "The conclusions of this report are subject to at least some limitations.", "questions": "[\"What are the limitations of the findings in this report?\", \"How many limitations are there in the findings of this report?\"]", "answers": "[\"At least some limitations\", \"At least some\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 73.8075453766764, "bleu": 35.35533905932737}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.375, "avg_em": 0.0, "avg_chrf": 36.9037726883382, "avg_bleu": 17.677669529663685}
{"id": "PubMed_9:831", "en": "First, these data are preliminary, and the analysis was limited by missing data related to the health department reporting burden associated with rapidly rising case counts and delays in completion of information requiring medical chart review; these findings might change as additional data become available.", "fr": "Premièrement, il s’agit de données préliminaires, et leur analyse a été limitée par le manque de données induit par la charge de travail importante qui pesait sur les services de santé en raison de l’augmentation rapide du nombre de cas ainsi que par le retard dans la collecte de données nécessitant un examen des dossiers médicaux ; ces conclusions pourront évoluer au fur et à mesure que de nouvelles données seront disponibles.", "perturbation": "omission", "pert_fr": "Premièrement, il s’agit de données préliminaires, et leur analyse a été limitée par le manque de données induit par la charge de travail importante qui pesait sur les services de santé en raison de l’augmentation rapide du nombre de cas  ainsi que par le retard dans la collecte de données nécessitant un examen des dossiers médicaux ; ces conclusions pourront évoluer au fur et à mesure que de nouvelles données seront disponibles.", "bt_pert_fr": "First, these are preliminary data, and their analysis was limited by the lack of data induced by the heavy workload on health services due to the rapid increase in the number of cases as well as the delay in data collection requiring review of medical records; These conclusions may evolve as new data becomes available.", "questions": "[\"What is stated about the nature of the data?\", \"What limitations were present in the analysis?\", \"What specific data were missing?\", \"What might happen to the findings as more data become available?\"]", "answers": "[\"The data are preliminary\", \"The lack of data due to heavy workload and delay in data collection\", \"Data induced by the heavy workload on health services\", \"The conclusions may evolve\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2702702702702703, "em": false, "chrf": 14.198687378836961, "bleu": 1.9819296757939446}, {"f1": 0.13793103448275862, "em": false, "chrf": 10.452975588671364, "bleu": 1.293173069803834}, {"f1": 0.25, "em": false, "chrf": 11.441834515351212, "bleu": 15.97357760615681}], "avg_f1": 0.4145503261882572, "avg_em": 0.25, "avg_chrf": 34.02337437071488, "avg_bleu": 29.812170087938657}
{"id": "PubMed_9:832", "en": "Information on underlying conditions was only available for 7,162 (5.8%) of 122,653 cases reported to CDC.", "fr": "Sur 122 653 cas rapportés aux CDC, seulement 7 162 (5,8 %) étaient associés à des données sur les problèmes de santé sous-jacents.", "perturbation": "omission", "pert_fr": "Sur 122 653 cas rapportés, seulement 7 162 (5,8 %) étaient associés à des données sur les problèmes de santé sous-jacents.", "bt_pert_fr": "Of 122,653 reported cases, only 7,162 (5.8%) were associated with data on underlying health conditions.", "questions": "[\"How many cases had information on underlying conditions?\", \"What percentage of cases had information on underlying conditions?\", \"What is the total number of cases reported to CDC?\", \"What is the number of cases with information on underlying conditions?\"]", "answers": "[7162, \"5.8%\", \"122653\", \"7162\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:836", "en": "Third, because of the limited availability of testing in many jurisdictions during this period, this analysis is likely biased toward more severe cases, and findings might change as testing becomes more widespread.", "fr": "Troisièmement, étant donné la disponibilité limitée des tests dans de nombreuses juridictions pendant cette période, cette analyse manque probablement d’objectivité quant aux cas les plus graves, et les résultats pourraient évoluer au fur et à mesure que davantage de tests seront réalisés.", "perturbation": "omission", "pert_fr": "Troisièmement, étant donné la disponibilité limitée des tests dans de nombreuses juridictions pendant cette période, cette analyse manque probablement d’objectivité quant aux cas, et les résultats pourraient évoluer au fur et à mesure que davantage de tests seront réalisés.", "bt_pert_fr": "Third, given the limited availability of testing in many jurisdictions during this time, this analysis likely lacks objectivity regarding cases, and results may change as more testing is conducted.", "questions": "[\"Why is the analysis likely biased toward more severe cases?\", \"What factor contributes to the bias in the analysis?\", \"How might the findings change as testing becomes more widespread?\"]", "answers": "[\"The limited availability of testing in many jurisdictions\", \"The limited availability of testing in many jurisdictions\", \"The results may change as more testing is conducted\"]", "scores": [{"f1": 0.7000000000000001, "em": false, "chrf": 68.82879015053685, "bleu": 51.0029457493824}, {"f1": 0.8421052631578948, "em": false, "chrf": 78.75661255598474, "bleu": 68.72892787909726}, {"f1": 0.5555555555555556, "em": false, "chrf": 34.215063461666105, "bleu": 11.99014838091355}], "avg_f1": 0.6992202729044834, "avg_em": 0.0, "avg_chrf": 60.6001553893959, "avg_bleu": 43.90734066979774}
{"id": "PubMed_9:837", "en": "Fourth, because of the descriptive nature of these data, attack rates among persons with and without underlying health conditions could not be compared, and thus the risk difference of severe disease with COVID-19 between these groups could not be estimated.", "fr": "Quatrièmement, compte tenu de la nature descriptive de ces données, les taux d’attaque chez les individus avec et sans problèmes de santé sous-jacents n’ont pu être comparés, et il n’a donc pas été possible d’estimer la différence de risque de développer une forme grave de la COVID-19 entre ces groupes.", "perturbation": "omission", "pert_fr": "Quatrièmement, compte tenu de la nature descriptive de ces données, les taux d’attaque chez les individus avec problèmes de santé sous-jacents n’ont pu être comparés, et il n’a donc pas été possible d’estimer la différence de risque de développer une forme grave de la COVID-19 entre ces groupes.", "bt_pert_fr": "Fourth, given the descriptive nature of these data, attack rates among individuals with underlying health conditions could not be compared, and it was therefore not possible to estimate the difference in risk of developing severe COVID-19 between these groups.", "questions": "[\"Why could attack rates among persons with and without underlying health conditions not be compared?\", \"What limitation does the descriptive nature of the data introduce?\", \"Why could the risk difference of severe disease with COVID-19 between these groups not be estimated?\", \"What is the consequence of not being able to compare attack rates?\"]", "answers": "[\"Because the data are descriptive and do not include sufficient detail for comparison\", \"It prevents the comparison of attack rates among individuals with underlying health conditions\", \"Because attack rates could not be compared due to the descriptive nature of the data\", \"It makes it impossible to estimate the difference in risk of developing severe COVID-19 between individuals with and without underlying health conditions\"]", "scores": [{"f1": 0.3157894736842105, "em": false, "chrf": 45.28785177355811, "bleu": 4.456882760699064}, {"f1": 0.45454545454545453, "em": false, "chrf": 54.87718876206142, "bleu": 31.702331385234313}, {"f1": 0.7000000000000001, "em": false, "chrf": 85.66034657699191, "bleu": 47.037095938668976}, {"f1": 0.3888888888888889, "em": false, "chrf": 44.75293795732931, "bleu": 4.968018039415939}], "avg_f1": 0.4648059542796385, "avg_em": 0.0, "avg_chrf": 57.64458126748519, "avg_bleu": 22.041082031004574}
{"id": "PubMed_9:838", "en": "Fifth, no conclusions could be drawn about underlying conditions that were not included in the case report form or about different conditions that were reported in a single, umbrella category.", "fr": "Cinquièmement, aucune conclusion ne peut être tirée concernant les problèmes de santé sous-jacents qui n’ont pas été inclus dans le formulaire de rapport de cas ou d’autres problèmes de santé classés dans une catégorie générique.", "perturbation": "omission", "pert_fr": "Cinquièmement, aucune conclusion ne peut être tirée concernant les problèmes de santé sous-jacents qui n’ont pas été inclus dans le formulaire de rapport de cas.", "bt_pert_fr": "Fifth, no conclusions can be drawn regarding underlying health conditions that were not included in the case report form.", "questions": "[\"What conclusions could not be drawn about underlying conditions?\", \"What conditions were not included in the case report form?\", \"What conditions were reported in a single, umbrella category?\", \"What limitations exist in the case report regarding underlying conditions?\"]", "answers": "[\"Any conclusions\", \"Underlying health conditions\", \"None\", \"No conclusions can be drawn regarding underlying health conditions that were not included in the case report form\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 78.89403307360463, "bleu": 49.99999999999999}, {"f1": 0.30769230769230765, "em": false, "chrf": 33.93926277323766, "bleu": 3.361830360737634}, {"f1": 0, "em": false, "chrf": 2.0948600199181144, "bleu": 0.0}, {"f1": 0.6363636363636364, "em": false, "chrf": 51.15445994957839, "bleu": 31.454293837459925}], "avg_f1": 0.361013986013986, "avg_em": 0.0, "avg_chrf": 41.5206539540847, "avg_bleu": 21.20403104954939}
{"id": "PubMed_9:839", "en": "For example, asthma and COPD were included in a chronic lung disease category.", "fr": "Par exemple, l’asthme et la MPOC ont été inclus dans la catégorie des maladies pulmonaires chroniques.", "perturbation": "omission", "pert_fr": "Par exemple, l’asthme a été inclus dans la catégorie des maladies pulmonaires chroniques.", "bt_pert_fr": "For example, asthma was included in the category of chronic lung diseases.", "questions": "[\"What conditions were included in a chronic lung disease category?\", \"What is the chronic lung disease category?\"]", "answers": "[\"Asthma\", \"Chronic lung diseases\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 36.48381677545021, "bleu": 13.533528323661276}, {"f1": 0.25, "em": false, "chrf": 63.12185834369526, "bleu": 14.127216461522432}], "avg_f1": 0.375, "avg_em": 0.0, "avg_chrf": 49.80283755957274, "avg_bleu": 13.830372392591855}
{"id": "PubMed_9:840", "en": "Finally, for some underlying health conditions and risk factors, including neurologic disorders, chronic liver disease, being a current smoker, and pregnancy, few severe outcomes were reported; therefore, conclusions cannot be drawn about the risk for severe COVID-19 among persons in these groups.", "fr": "Enfin, pour certains problèmes de santé sous-jacents et facteurs de risque, notamment les troubles neurologiques, une maladie hépatique chronique, le tabagisme actif et la grossesse, peu de cas graves ont été rapportés ; il n’est donc pas possible de tirer des conclusions quant au risque de contracter une forme grave de la COVID-19 chez les individus appartenant à ces groupes.", "perturbation": "omission", "pert_fr": "Enfin, pour certains problèmes de santé sous-jacents et facteurs de risque, notamment les troubles neurologiques, une maladie hépatique chronique et la grossesse, peu de cas graves ont été rapportés ; il n’est donc pas possible de tirer des conclusions quant au risque de contracter une forme grave de la COVID-19 chez les individus appartenant à ces groupes.", "bt_pert_fr": "Finally, for some underlying health conditions and risk factors, including neurological disorders, chronic liver disease, and pregnancy, few serious cases have been reported; it is therefore not possible to draw conclusions regarding the risk of contracting a severe form of COVID-19 among individuals belonging to these groups.", "questions": "[\"Which specific conditions have few severe outcomes reported?\", \"Why can't conclusions be drawn about the risk for severe COVID-19 in these groups?\"]", "answers": "[\"Neurological disorders, chronic liver disease, and pregnancy\", \"Few serious cases have been reported\"]", "scores": [{"f1": 0.7058823529411764, "em": false, "chrf": 68.04453411017717, "bleu": 31.850355294022695}, {"f1": 0.16666666666666666, "em": false, "chrf": 30.74477869736128, "bleu": 8.116697886877475}], "avg_f1": 0.4362745098039215, "avg_em": 0.0, "avg_chrf": 49.394656403769226, "avg_bleu": 19.983526590450083}
{"id": "PubMed_9:841", "en": "Persons in the United States with underlying health conditions appear to be at higher risk for more severe COVID-19, consistent with findings from other countries.", "fr": "Aux États-Unis, les individus souffrant de problèmes de santé sous-jacents semblent présenter un risque accru de développer une forme grave de la COVID-19, ce qui est cohérent avec les conclusions tirées par d’autres pays.", "perturbation": "omission", "pert_fr": "Aux États-Unis, les individus souffrant de problèmes de santé semblent présenter un risque accru de développer une forme grave de la COVID-19, ce qui est cohérent avec les conclusions tirées par d’autres pays.", "bt_pert_fr": "In the United States, individuals with existing health conditions appear to be at increased risk of developing severe COVID-19, consistent with findings in other countries.", "questions": "[\"What is the risk for persons in the United States with underlying health conditions?\", \"How does the risk for severe COVID-19 relate to underlying health conditions?\", \"What is consistent with findings from other countries?\", \"What does the sentence suggest about the severity of COVID-19 in the United States?\", \"What health conditions are associated with higher risk of severe COVID-19?\"]", "answers": "[\"Increased risk of developing severe COVID-19\", \"The risk is increased\", \"Findings in other countries\", \"The sentence suggests that severe COVID-19 is more likely among individuals with underlying health conditions\", \"Underlying health conditions\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 46.07928211351443, "bleu": 17.965205598154213}, {"f1": 0.3529411764705882, "em": false, "chrf": 12.13336428126224, "bleu": 3.726425320974899}, {"f1": 0.10526315789473685, "em": false, "chrf": 13.679868578958517, "bleu": 1.0211566521809647}, {"f1": 0.8666666666666667, "em": false, "chrf": 80.12615592584062, "bleu": 66.06328636027618}, {"f1": 0.6666666666666666, "em": false, "chrf": 95.7219990154773, "bleu": 55.03212081491043}], "avg_f1": 0.4983075335397317, "avg_em": 0.0, "avg_chrf": 49.54813398301062, "avg_bleu": 28.76163894929934}
{"id": "PubMed_9:844", "en": "Maintaining at least a 30-day supply of medication, a 2-week supply of food and other necessities, and knowledge of COVID-19 symptoms are recommended for those with underlying health conditions.", "fr": "Il est recommandé aux personnes présentant des problèmes de santé sous-jacents de prévoir un stock de médicaments d’au moins 30 jours ainsi qu’un stock de nourriture et d’articles de première nécessité de 2 semaines, et de connaître les symptômes de la COVID-19.", "perturbation": "omission", "pert_fr": "Il est recommandé aux personnes présentant des problèmes de santé sous-jacents de prévoir un stock de médicaments d’au moins 30 jours ainsi qu’un stock de nourriture et de connaître les symptômes de la COVID-19.", "bt_pert_fr": "It is recommended that people with underlying health conditions have at least a 30-day supply of medications and food and be aware of the symptoms of COVID-19.", "questions": "[\"What is recommended for those with underlying health conditions?\", \"What items should be included in a 30-day supply?\", \"What is the recommended duration for a food supply?\", \"What other necessities are included in the recommendation?\", \"What is the importance of knowing COVID-19 symptoms in this context?\"]", "answers": "[\"To have at least a 30-day supply of medications and food and be aware of the symptoms of COVID-19\", \"Medications and food\", \"30 days\", \"Awareness of the symptoms of COVID-19\", \"To ensure timely recognition and response to potential infection\"]", "scores": [{"f1": 0.6666666666666667, "em": false, "chrf": 49.34600504322168, "bleu": 26.21684452470331}, {"f1": 0, "em": false, "chrf": 82.04290998726376, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 2.7777777777777777, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 12.042892814558758, "bleu": 0.0}, {"f1": 0.21428571428571427, "em": false, "chrf": 21.79238978719309, "bleu": 2.0655725292911016}], "avg_f1": 0.1761904761904762, "avg_em": 0.0, "avg_chrf": 33.60039508200301, "avg_bleu": 5.656483410798883}
{"id": "PubMed_9:845", "en": "All persons should take steps to protect themselves from COVID-19 and to protect others.", "fr": "Chacun doit prendre les mesures qui s’imposent pour se protéger et protéger les autres de la COVID-19.", "perturbation": "omission", "pert_fr": "Chacun doit prendre les mesures qui s’imposent pour se protéger.", "bt_pert_fr": "Everyone must take the necessary measures to protect themselves.", "questions": "[\"What steps should persons take to protect themselves from COVID-19?\", \"What steps should persons take to protect others?\", \"What is the goal of taking protective steps against COVID-19?\"]", "answers": "[\"The sentence does not specify steps to protect themselves from COVID-19\", \"The sentence does not specify steps to protect others\", \"The goal is to protect themselves\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 80.98840418756332, "bleu": 46.17366309441026}, {"f1": 0.5714285714285714, "em": false, "chrf": 69.77048772620246, "bleu": 29.84745896009822}, {"f1": 0.30769230769230765, "em": false, "chrf": 48.69149892854542, "bleu": 13.74127285540009}], "avg_f1": 0.5152625152625152, "avg_em": 0.0, "avg_chrf": 66.48346361410374, "avg_bleu": 29.920798303302856}
{"id": "PubMed_9:846", "en": "All persons who are ill should stay home, except to get medical care; should not go to work; and should stay away from others.", "fr": "Tout individu malade est tenu de ne pas quitter son domicile, sauf pour recevoir des soins médicaux, de ne pas aller travailler et d’observer une certaine distance avec autrui.", "perturbation": "omission", "pert_fr": "Tout individu malade est tenu de ne pas quitter son domicile, sauf pour recevoir des soins médicaux et d’observer une certaine distance avec autrui.", "bt_pert_fr": "Any sick individual is required not to leave their home, except to receive medical care and to observe a certain distance from others.", "questions": "[\"What should ill persons do?\", \"What should ill persons avoid?\", \"What is the recommendation for ill persons regarding medical care?\"]", "answers": "[\"Stay at home\", \"Leave their home\", \"Receive medical care\"]", "scores": [{"f1": 0.2, "em": false, "chrf": 8.313643445990824, "bleu": 0.32600330570703107}, {"f1": 0, "em": false, "chrf": 5.434782608695651, "bleu": 0.0}, {"f1": 0.36363636363636365, "em": false, "chrf": 30.870669298883236, "bleu": 10.394224994345743}], "avg_f1": 0.1878787878787879, "avg_em": 0.0, "avg_chrf": 14.873031784523237, "avg_bleu": 3.5734094333509248}
{"id": "PubMed_9:847", "en": "This is especially important for those who work with persons with underlying conditions or who otherwise are at high risk for severe outcomes from COVID-19.", "fr": "Cela est particulièrement important pour ceux travaillant au contact de personnes présentant des problèmes de santé sous-jacents ou un risque élevé de développer une forme grave de la COVID-19.", "perturbation": "omission", "pert_fr": "Cela est particulièrement important pour ceux travaillant au contact de personnes présentant des problèmes de santé sous-jacents.", "bt_pert_fr": "This is particularly important for those working around people with underlying health conditions.", "questions": "[\"Why is this especially important?\", \"Who are considered at high risk for severe outcomes from COVID-19?\"]", "answers": "[\"This is particularly important for those working around people with underlying health conditions\", \"Those working around people with underlying health conditions\"]", "scores": [{"f1": 0.24242424242424246, "em": false, "chrf": 31.063417919973897, "bleu": 4.288074334657599}, {"f1": 0.28571428571428575, "em": false, "chrf": 31.099736935839157, "bleu": 2.930714127191786}], "avg_f1": 0.2640692640692641, "avg_em": 0.0, "avg_chrf": 31.081577427906527, "avg_bleu": 3.6093942309246927}
{"id": "PubMed_9:850", "en": "Published reports from China and Italy suggest that risk factors for severe COVID-19 disease include underlying health conditions, but data describing underlying health conditions among U.S. COVID-19 patients have not yet been reported.", "fr": "Des rapports provenant de Chine et d’Italie suggèrent que les facteurs de risque de contracter une forme grave de la COVID-19 incluent des problèmes de santé sous-jacents, mais aucune donnée relative aux problèmes de santé sous-jacents des patients américains atteints de la COVID-19 n’a encore été rapportée.", "perturbation": "omission", "pert_fr": "Des rapports provenant de Chine suggèrent que les facteurs de risque de contracter une forme grave de la COVID-19 incluent des problèmes de santé sous-jacents, mais aucune donnée relative aux problèmes de santé sous-jacents des patients américains atteints de la COVID-19 n’a encore été rapportée.", "bt_pert_fr": "Reports from China suggest that risk factors for severe COVID-19 include underlying health conditions, but data on underlying health conditions in U.S. COVID-19 patients have not yet been reported.", "questions": "[\"What risk factors for severe COVID-19 disease are mentioned in the reports from China and Italy?\", \"Have data describing underlying health conditions among U.S. COVID-19 patients been reported?\", \"What is the source of the reports suggesting risk factors for severe COVID-19 disease?\", \"What is the current status of data on underlying health conditions in U.S. COVID-19 patients?\"]", "answers": "[\"Underlying health conditions\", \"No\", \"China and Italy\", \"Not yet reported\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_9:853", "en": "What are the implications for public health practice?", "fr": "Quelles sont les implications pour la pratique de santé publique ?", "perturbation": "omission", "pert_fr": "Quelles sont les implications pour la santé publique ?", "bt_pert_fr": "What are the implications for public health?", "questions": "[\"What are the implications for public health practice?\"]", "answers": "[\"The implications for public health\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 69.09067888333469, "bleu": 44.82700320176826}], "avg_f1": 0.6666666666666666, "avg_em": 0.0, "avg_chrf": 69.09067888333469, "avg_bleu": 44.82700320176826}
{"id": "PubMed_9:854", "en": "Strategies to protect all persons and especially those with underlying health conditions, including social distancing and handwashing, should be implemented by all communities and all persons to help slow the spread of COVID-19.", "fr": "Des stratégies visant à protéger tous les individus et en particulier ceux présentant des problèmes de santé sous-jacents, notamment une distanciation sociale et un lavage régulier des mains, doivent être mises en œuvre par l’ensemble des communautés et des populations, afin de ralentir la propagation de la COVID-19.", "perturbation": "omission", "pert_fr": "Des stratégies visant à protéger tous les individus et en particulier ceux présentant des problèmes de santé sous-jacents, notamment une distanciation sociale, doivent être mises en œuvre par l’ensemble des communautés et des populations, afin de ralentir la propagation de la COVID-19.", "bt_pert_fr": "Strategies to protect all individuals and particularly those with underlying health conditions, including social distancing, must be implemented by all communities and populations to slow the spread of COVID-19.", "questions": "[\"What strategies should be implemented to protect all persons?\", \"Who should be especially protected by these strategies?\", \"What specific actions are recommended to slow the spread of COVID-19?\", \"What are the recommended protective measures?\", \"Which groups are highlighted as needing special protection?\", \"What is the goal of implementing these strategies?\"]", "answers": "[\"Social distancing\", \"Those with underlying health conditions\", \"Social distancing\", \"Social distancing\", \"Those with underlying health conditions\", \"To slow the spread of COVID-19\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 54.459768426171486, "bleu": 36.78794411714425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 54.459768426171486, "bleu": 36.78794411714425}, {"f1": 0.6666666666666666, "em": false, "chrf": 54.459768426171486, "bleu": 36.78794411714425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9090909090909091, "em": false, "chrf": 77.98570767673583, "bleu": 57.89300674674101}], "avg_f1": 0.8181818181818182, "avg_em": 0.3333333333333333, "avg_chrf": 73.56083549254171, "avg_bleu": 61.37613984969564}
{"id": "PubMed_10:856", "en": "The Royal College of General Practitioners (RCGP) Research and Surveillance Centre (RSC) and Public Health England (PHE) have successfully worked together on the surveillance of influenza and other infectious diseases for over 50 years, including three previous pandemics.", "fr": "Le Centre de recherche et de surveillance (Research and Surveillance Centre, RSC) du Royal College of General Practitioners (RCGP) et Public Health England (PHE) collaborent avec succès pour surveiller la grippe et d’autres maladies infectieuses depuis plus de 50 ans, notamment lors de trois pandémies passées.", "perturbation": "omission", "pert_fr": "Le Centre de recherche et de surveillance (Research and Surveillance Centre, RSC) du Royal College of General Practitioners (RCGP) et Public Health England (PHE) collaborent avec succès pour surveiller la grippe depuis plus de 50 ans, notamment lors de trois pandémies passées.", "bt_pert_fr": "The Royal College of General Practitioners (RCGP) Research and Surveillance Center (RSC) and Public Health England (PHE) have successfully collaborated to monitor influenza for over 50 years, including three past pandemics.", "questions": "[\"What organizations have worked together on disease surveillance?\", \"What diseases have been monitored by the collaborating organizations?\", \"For how long have the organizations worked together on disease surveillance?\", \"Which pandemics have been included in the surveillance efforts?\"]", "answers": "[\"The Royal College of General Practitioners (RCGP) Research and Surveillance Center (RSC) and Public Health England (PHE)\", \"influenza\", \"over 50 years\", \"three past pandemics\"]", "scores": [{"f1": 0.9411764705882353, "em": false, "chrf": 95.59458858160124, "bleu": 82.82477531331043}, {"f1": 0.33333333333333337, "em": false, "chrf": 23.557724876791475, "bleu": 1.8315638888734187}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 53.02548620560255, "bleu": 34.66806371753173}], "avg_f1": 0.7352941176470589, "avg_em": 0.25, "avg_chrf": 68.04444991599881, "avg_bleu": 54.831100729928906}
{"id": "PubMed_10:858", "en": "At the same time and separately, the RCGP RSC’s surveillance has been extended to monitor the temporal and geographical distribution of COVID-19 infection in the community as well as assess the effectiveness of the containment strategy.", "fr": "Dans le même temps et en parallèle, la surveillance du RSC du RCGP a été étendue pour contrôler la distribution temporelle et géographique de l’infection au COVID-19 dans la communauté ainsi que pour évaluer l’efficacité de la stratégie de confinement.", "perturbation": "omission", "pert_fr": "Dans le même temps et en parallèle, la surveillance du RSC du RCGP a été étendue pour contrôler la distribution temporelle et géographique de l’infection au COVID-19 dans la communauté.", "bt_pert_fr": "At the same time and in parallel, RCGP RSC surveillance was expanded to monitor the temporal and geographic distribution of COVID-19 infection in the community.", "questions": "[\"What has been extended in the RCGP RSC’s surveillance?\", \"What aspects of COVID-19 infection are monitored through the extended surveillance?\", \"What is the purpose of monitoring the temporal and geographical distribution of COVID-19 infection?\", \"What is assessed regarding the containment strategy?\", \"What does the extended surveillance aim to evaluate?\"]", "answers": "[\"The monitoring of the temporal and geographic distribution of COVID-19 infection\", \"The temporal and geographic distribution of COVID-19 infection\", \"To understand how and where COVID-19 infection spreads in the community\", \"The effectiveness of containment strategies over time and space\", \"The temporal and geographic distribution of COVID-19 infection\"]", "scores": [{"f1": 0.5517241379310345, "em": false, "chrf": 45.51114040653796, "bleu": 13.648104077483545}, {"f1": 0.7777777777777777, "em": false, "chrf": 79.0683186873168, "bleu": 38.940039153570254}, {"f1": 0.125, "em": false, "chrf": 17.262071950749814, "bleu": 4.196114906296549}, {"f1": 0.5714285714285714, "em": false, "chrf": 87.90725532705805, "bleu": 29.84745896009822}, {"f1": 0.608695652173913, "em": false, "chrf": 53.50228635145001, "bleu": 20.843100983925424}], "avg_f1": 0.5269252278622594, "avg_em": 0.0, "avg_chrf": 56.65021454462253, "avg_bleu": 21.4949636162748}
{"id": "PubMed_10:860", "en": "The RCGP RSC, a network of over 500 general practices in England, extract pseudonymized data weekly.", "fr": "Le RSC du RCGP, un réseau de plus de 500 cabinets de médecine générale en Angleterre, extrait de façon hebdomadaire des données pseudonymisées.", "perturbation": "omission", "pert_fr": "Le RSC du RCGP, un réseau de plus de 500 cabinets de médecine générale, extrait de façon hebdomadaire des données pseudonymisées.", "bt_pert_fr": "The RCGP RSC, a network of more than 500 general practices, extracts pseudonymised data on a weekly basis.", "questions": "[\"What is the RCGP RSC?\", \"How many general practices are part of the RCGP RSC?\", \"What type of data does the RCGP RSC extract?\", \"How frequently does the RCGP RSC extract data?\"]", "answers": "[\"A network of more than 500 general practices\", \"More than 500\", \"Pseudonymised data\", \"Weekly\"]", "scores": [{"f1": 0.7058823529411765, "em": false, "chrf": 64.5154164756588, "bleu": 30.509752160562897}, {"f1": 0.4, "em": false, "chrf": 18.4685488970725, "bleu": 27.516060407455225}, {"f1": 0.5, "em": false, "chrf": 74.09744667097607, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6514705882352941, "avg_em": 0.25, "avg_chrf": 64.27035301092684, "avg_bleu": 52.00645314200454}
{"id": "PubMed_10:862", "en": "Computerized medical records suppliers have within a week of request created new codes to support this.", "fr": "Une semaine après la demande, les fournisseurs de dossiers médicaux informatisés ont créé de nouveaux codes à cette fin.", "perturbation": "omission", "pert_fr": "Une semaine après la demande, les fournisseurs de dossiers médicaux ont créé de nouveaux codes à cette fin.", "bt_pert_fr": "A week after the request, medical records providers created new codes for this purpose.", "questions": "[\"What do computerized medical records suppliers do within a week of a request?\", \"What new codes are created by computerized medical records suppliers?\"]", "answers": "[\"Create new codes for this purpose\", \"New codes for this purpose\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 60.16710788124436, "bleu": 32.46679154750989}, {"f1": 0.6, "em": false, "chrf": 46.757793628335406, "bleu": 23.643540225079395}], "avg_f1": 0.6333333333333333, "avg_em": 0.0, "avg_chrf": 53.462450754789884, "avg_bleu": 28.055165886294645}
{"id": "PubMed_10:864", "en": "(3) Serology sample collection across all age groups.", "fr": "(3) Prélèvement d’échantillons sérologiques dans toutes les tranches d’âge.", "perturbation": "omission", "pert_fr": "Prélèvement d’échantillons sérologiques dans les tranches d’âge.", "bt_pert_fr": "Collection of serological samples in age groups.", "questions": "[\"Which age groups are included in serology sample collection?\"]", "answers": "[\"Age groups\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 61.81722812226982, "bleu": 30.326532985631665}], "avg_f1": 0.4, "avg_em": 0.0, "avg_chrf": 61.81722812226982, "avg_bleu": 30.326532985631665}
{"id": "PubMed_10:868", "en": "We have the opportunity to escalate the data extraction to twice weekly if needed.", "fr": "Nous avons la possibilité d’intensifier l’extraction de données à deux fois par semaine si nécessaire.", "perturbation": "omission", "pert_fr": "Nous avons la possibilité d’intensifier l’extraction de données si nécessaire.", "bt_pert_fr": "We have the ability to scale up data extraction if necessary.", "questions": "[\"What opportunity do we have regarding data extraction?\"]", "answers": "[\"The ability to scale up data extraction\"]", "scores": [{"f1": 0.375, "em": false, "chrf": 37.26273470115378, "bleu": 10.923299908191149}], "avg_f1": 0.375, "avg_em": 0.0, "avg_chrf": 37.26273470115378, "avg_bleu": 10.923299908191149}
{"id": "PubMed_10:873", "en": "We have rapidly converted the established national RCGP RSC influenza surveillance system into one that can test the effectiveness of the COVID-19 containment policy.", "fr": "Nous avons rapidement converti le système national établi de surveillance de la grippe du RSC du RCGP en un système apte à tester l’efficacité de la politique de confinement du COVID-19.", "perturbation": "omission", "pert_fr": "Nous avons rapidement converti le système national établi de surveillance de la grippe en un système apte à tester l’efficacité de la politique de confinement du COVID-19.", "bt_pert_fr": "We quickly converted the established national influenza surveillance system into one capable of testing the effectiveness of the COVID-19 containment policy.", "questions": "[\"What has been rapidly converted?\", \"What system was converted into a new system?\", \"What can the new system test?\", \"What is the purpose of the new system?\", \"What policy can the new system evaluate for effectiveness?\"]", "answers": "[\"The established national influenza surveillance system\", \"The established national influenza surveillance system\", \"The effectiveness of the COVID-19 containment policy\", \"To test the effectiveness of the COVID-19 containment policy\", \"The COVID-19 containment policy\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 84.32887232650327, "bleu": 36.409302398068725}, {"f1": 0.8571428571428571, "em": false, "chrf": 84.32887232650327, "bleu": 36.409302398068725}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9428571428571428, "avg_em": 0.6, "avg_chrf": 93.7315489306013, "avg_bleu": 74.56372095922752}
{"id": "PubMed_10:875", "en": "Rapid sharing of this protocol should enable scientific critique and shared learning.", "fr": "Le partage rapide de ce protocole devrait permettre la critique scientifique et l’apprentissage commun.", "perturbation": "omission", "pert_fr": "Le partage rapide de ce protocole devrait permettre la critique scientifique.", "bt_pert_fr": "The rapid sharing of this protocol should allow scientific criticism.", "questions": "[\"What is the benefit of rapid sharing of this protocol?\", \"What is the purpose of sharing this protocol?\"]", "answers": "[\"Scientific criticism\", \"To allow scientific criticism\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 43.52595511526604, "bleu": 11.15650800742149}, {"f1": 0.36363636363636365, "em": false, "chrf": 36.933558050171584, "bleu": 8.9730240870212}], "avg_f1": 0.3246753246753247, "avg_em": 0.0, "avg_chrf": 40.229756582718814, "avg_bleu": 10.064766047221344}
{"id": "PubMed_10:879", "en": "The RCGP RSC extracts pseudonymized data from a nationally representative sample of over 500 urban and nonurban GPs each week covering a population of over 4 million.", "fr": "Le RSC du RCGP extrait des données pseudonymisées d’un échantillon représentatif à l’échelle nationale de plus de 500 cabinets de MG urbains et ruraux chaque semaine, couvrant une population de plus de 4 millions de personnes.", "perturbation": "omission", "pert_fr": "Le RSC du RCGP extrait des données pseudonymisées d’un échantillon représentatif à l’échelle nationale de plus de 500 cabinets de MG urbains chaque semaine, couvrant une population de plus de 4 millions de personnes.", "bt_pert_fr": "The RCGP RSC extracts pseudonymised data from a nationally representative sample of over 500 urban GP practices each week, covering a population of over 4 million people.", "questions": "[\"What does the RCGP RSC extract?\", \"From what type of sample does the RCGP RSC extract data?\", \"How many urban and nonurban GPs are included in the sample?\", \"What is the size of the population covered by the data?\", \"What is the frequency of data extraction by the RCGP RSC?\"]", "answers": "[\"Pseudonymised data\", \"Nationally representative sample of over 500 urban GP practices\", \"Only urban GPs are mentioned; nonurban GPs are not included\", \"Over 4 million people\", \"Each week\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 74.09744667097607, "bleu": 49.99999999999999}, {"f1": 0.6, "em": false, "chrf": 77.13847051622767, "bleu": 47.034907429549826}, {"f1": 0, "em": false, "chrf": 3.2467532467532463, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 88.58244340539596, "bleu": 59.460355750136046}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5914285714285714, "avg_em": 0.2, "avg_chrf": 68.61302276787059, "avg_bleu": 51.29905263593719}
{"id": "PubMed_10:880", "en": "Data from these practices are reported online in a weekly return, which includes monitoring weekly rates of influenza-like illness (ILI) and other communicable and respiratory diseases in England.", "fr": "Les données issues de ces cabinets sont signalées en ligne dans un rapport hebdomadaire, qui comprend la surveillance des taux hebdomadaires de syndrome grippal (SG) et d’autres maladies respiratoires en Angleterre.", "perturbation": "omission", "pert_fr": "Les données issues de ces cabinets sont signalées en ligne dans un rapport hebdomadaire, qui comprend la surveillance des taux hebdomadaires de syndrome grippal (SG) en Angleterre.", "bt_pert_fr": "Data from these practices is reported online in a weekly report, which includes monitoring of weekly rates of influenza-like illness (ILI) in England.", "questions": "[\"What data are reported online in a weekly return?\", \"What does the weekly return include?\", \"What diseases are monitored in the weekly return?\", \"Where are the data from these practices reported?\"]", "answers": "[\"Data from these practices\", \"Monitoring of weekly rates of influenza-like illness (ILI) in England\", \"Influenza-like illness (ILI)\", \"Online\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7200000000000001, "em": false, "chrf": 55.00601774148397, "bleu": 36.31941765257493}, {"f1": 0.5, "em": false, "chrf": 37.83914185095486, "bleu": 13.533528323661276}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.805, "avg_em": 0.5, "avg_chrf": 73.21128989810971, "avg_bleu": 62.463236494059075}
{"id": "PubMed_10:882", "en": "The RCGP RSC data set includes all coded data and all prescribed items including vaccine exposure.", "fr": "L’ensemble de données du RSC du RCGP comprend toutes les données codées et tous les produits prescrits, notamment l’exposition au vaccin.", "perturbation": "omission", "pert_fr": "L’ensemble de données du RSC du RCGP comprend toutes les données codées, notamment l’exposition au vaccin.", "bt_pert_fr": "The RCGP CHR dataset includes all coded data, including vaccine exposure.", "questions": "[\"What does the RCGP RSC data set include?\", \"What types of data are included in the RCGP RSC data set?\", \"Does the RCGP RSC data set include vaccine exposure?\", \"What is the scope of the RCGP RSC data set?\"]", "answers": "[\"All coded data, including vaccine exposure\", \"Coded data and vaccine exposure\", \"Yes\", \"All coded data, including vaccine exposure\"]", "scores": [{"f1": 0.7499999999999999, "em": false, "chrf": 61.47311378527197, "bleu": 26.08840516436559}, {"f1": 0.6, "em": false, "chrf": 44.054785123625706, "bleu": 39.76353643835254}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7499999999999999, "em": false, "chrf": 61.47311378527197, "bleu": 26.08840516436559}], "avg_f1": 0.7749999999999999, "avg_em": 0.25, "avg_chrf": 66.7502531735424, "avg_bleu": 47.98508669177094}
{"id": "PubMed_10:883", "en": "The RCGP RSC conducts virology surveillance each influenza season, with 100 GPs participating in the 2019-2020 season (Figure 1).", "fr": "Le RSC du RCGP mène une surveillance virologique lors de chaque saison grippale, avec 100 cabinets de MG participant pendant la saison 2019-2020 (Figure 1).", "perturbation": "omission", "pert_fr": "Le RSC du RCGP mène une surveillance lors de chaque saison grippale, avec 100 cabinets de MG participant pendant la saison 2019-2020 (Figure 1).", "bt_pert_fr": "The RCGP RSC conducts surveillance during each influenza season, with 100 GP practices participating during the 2019-2020 season (Figure 1).", "questions": "[\"What does the RCGP RSC conduct each influenza season?\", \"How many GPs participated in the RCGP RSC's virology surveillance during the 2019-2020 season?\", \"What is the purpose of the virology surveillance conducted by the RCGP RSC?\"]", "answers": "[\"Surveillance\", \"100\", \"To monitor influenza activity\"]", "scores": [{"f1": 0, "em": false, "chrf": 52.95051700340263, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5454545454545454, "em": false, "chrf": 46.62936827461634, "bleu": 28.087083270446133}], "avg_f1": 0.5151515151515151, "avg_em": 0.3333333333333333, "avg_chrf": 66.52662842600633, "avg_bleu": 42.69569442348206}
{"id": "PubMed_10:886", "en": "Nasopharyngeal swabs are taken from children younger than 5 years showing symptoms of acute bronchitis or bronchiolitis.", "fr": "Des écouvillons nasopharyngés sont prélevés chez les enfants de moins de 5 ans présentant des symptômes de bronchite aiguë ou de bronchiolite.", "perturbation": "omission", "pert_fr": "Des écouvillons nasopharyngés sont prélevés chez les enfants de moins de 5 ans présentant des symptômes de bronchite aiguë.", "bt_pert_fr": "Nasopharyngeal swabs are collected from children younger than 5 years with symptoms of acute bronchitis.", "questions": "[\"What symptoms prompt the collection of nasopharyngeal swabs in children younger than 5 years?\", \"Which children are eligible for nasopharyngeal swabs?\"]", "answers": "[\"Acute bronchitis\", \"Children younger than 5 years\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 50.80684695995329, "bleu": 36.78794411714425}, {"f1": 0.5882352941176471, "em": false, "chrf": 37.39386826989741, "bleu": 24.659696394160658}], "avg_f1": 0.6274509803921569, "avg_em": 0.0, "avg_chrf": 44.10035761492535, "avg_bleu": 30.723820255652456}
{"id": "PubMed_10:887", "en": "Additionally, nasopharyngeal samples are taken from anyone 5 years and older showing acute onset of ILI and respiratory synctial virus.", "fr": "En outre, des échantillons nasopharyngés sont prélevés chez toute personne âgée de 5 ans ou plus qui présente une apparition aigüe de SG et de virus respiratoire syncytial.", "perturbation": "omission", "pert_fr": "En outre, des échantillons nasopharyngés sont prélevés chez toute personne âgée de 5 ans ou plus qui présente une apparition aigüe de virus respiratoire syncytial.", "bt_pert_fr": "Additionally, nasopharyngeal samples are collected from anyone 5 years of age or older who has an acute onset of respiratory syncytial virus.", "questions": "[\"Who is eligible for nasopharyngeal samples?\", \"What type of samples are taken?\", \"At what age are nasopharyngeal samples taken?\", \"What condition triggers the collection of nasopharyngeal samples?\"]", "answers": "[\"Anyone 5 years of age or older who has an acute onset of respiratory syncytial virus\", \"Nasopharyngeal samples\", \"5 years of age or older\", \"An acute onset of respiratory syncytial virus\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 45.75365226121125, "bleu": 10.511846841633776}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6, "em": false, "chrf": 46.89886911175713, "bleu": 17.965205598154213}, {"f1": 0.6666666666666666, "em": false, "chrf": 79.04439537028992, "bleu": 26.647313141084275}], "avg_f1": 0.6666666666666666, "avg_em": 0.25, "avg_chrf": 67.92422918581457, "avg_bleu": 38.78109139521808}
{"id": "PubMed_10:888", "en": "Swabs are tested at the PHE Respiratory Virus Unit for influenza to monitor positivity rates and circulating strains, as well as for measuring vaccine effectiveness.", "fr": "Les écouvillons sont testés dans l’Unité des virus respiratoires de PHE pour la grippe afin de surveiller les taux de positivité et les souches circulantes, ainsi que pour mesurer l’efficacité du vaccin.", "perturbation": "omission", "pert_fr": "Les écouvillons sont testés dans l’Unité des virus respiratoires de PHE pour la grippe afin de surveiller les taux de positivité et les souches circulantes, ainsi que pour mesurer l’efficacité.", "bt_pert_fr": "Swabs are tested in PHE's Respiratory Virus Unit for influenza to monitor positivity rates and circulating strains, as well as to measure effectiveness.", "questions": "[\"What is tested at the PHE Respiratory Virus Unit?\", \"What is monitored using swab testing?\", \"What is measured through swab testing?\", \"What disease is tested for at the PHE Respiratory Virus Unit?\", \"What is the purpose of testing swabs at the PHE Respiratory Virus Unit?\"]", "answers": "[\"Swabs for influenza\", \"Positivity rates and circulating strains\", \"Effectiveness\", \"Influenza\", \"To monitor positivity rates and circulating strains, as well as to measure effectiveness\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 58.56513505172156, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.962962962962963, "em": false, "chrf": 90.65015976142847, "bleu": 86.17038791239605}], "avg_f1": 0.7925925925925925, "avg_em": 0.6, "avg_chrf": 89.84305896263001, "avg_bleu": 77.23407758247923}
{"id": "PubMed_10:889", "en": "The RCGP RSC successfully conducted a pilot collecting serological samples from adults and linking them to a patient’s medical records during the 2018-2019 influenza season.", "fr": "Le RSC du RCGP a mené avec succès un projet pilote de recueil d’échantillons sérologiques chez des adultes et de couplage de ces échantillons aux dossiers médicaux de patients pendant la saison grippale 2018-2019.", "perturbation": "omission", "pert_fr": "Le RSC du RCGP a mené avec succès un projet pilote de recueil d’échantillons sérologiques chez des adultes pendant la saison grippale 2018-2019.", "bt_pert_fr": "The RCGP RSC successfully conducted a pilot project to collect serological samples from adults during the 2018-2019 influenza season.", "questions": "[\"What did the RCGP RSC successfully conduct?\", \"What type of samples were collected during the 2018-2019 influenza season?\", \"Who were the samples collected from?\", \"What was the purpose of linking the samples to patient medical records?\", \"What season did the pilot take place in?\"]", "answers": "[\"a pilot project to collect serological samples\", \"serological samples\", \"adults\", \"To link the samples to patient medical records\", \"the 2018-2019 influenza season\"]", "scores": [{"f1": 0.42105263157894735, "em": false, "chrf": 34.31832338172959, "bleu": 6.011598678897526}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428571, "em": false, "chrf": 88.05371765891114, "bleu": 48.892302243490086}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8556390977443609, "avg_em": 0.6, "avg_chrf": 84.47440820812815, "avg_bleu": 70.98078018447754}
{"id": "PubMed_10:890", "en": "This pilot was in collaboration with the PHE Seroepidemiology Unit and added to the residual blood samples submitted to PHE by National Health Service (NHS) laboratories.", "fr": "Ce projet pilote a été mené en collaboration avec l’Unité séro-épidémiologique de PHE et les échantillons obtenus ont été ajoutés aux échantillons de sang restants envoyés à PHE par les laboratoires du National Health Service (NHS).", "perturbation": "omission", "pert_fr": "Ce projet pilote a été mené en collaboration avec l’Unité séro-épidémiologique de PHE et les échantillons obtenus ont été ajoutés aux échantillons de sang restants envoyés à PHE par les laboratoires du NHS.", "bt_pert_fr": "This pilot project was carried out in collaboration with the PHE Sero-Epidemiology Unit and the samples obtained were added to the remaining blood samples sent to PHE from NHS laboratories.", "questions": "[\"What was the pilot in collaboration with?\", \"Which unit was involved in the pilot?\", \"Where were the samples submitted?\", \"Which laboratories submitted the samples?\"]", "answers": "[\"The PHE Sero-Epidemiology Unit\", \"The PHE Sero-Epidemiology Unit\", \"PHE\", \"NHS laboratories\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 80.48508915553792, "bleu": 18.99589214128981}, {"f1": 0.5714285714285715, "em": false, "chrf": 80.48508915553792, "bleu": 18.99589214128981}, {"f1": 0.6666666666666666, "em": false, "chrf": 53.34987593052109, "bleu": 36.78794411714425}, {"f1": 0.5714285714285715, "em": false, "chrf": 42.490902321529774, "bleu": 22.31301601484299}], "avg_f1": 0.5952380952380953, "avg_em": 0.0, "avg_chrf": 64.20273914078167, "avg_bleu": 24.273186103641716}
{"id": "PubMed_10:892", "en": "The serology pilot has demonstrated the ability of the network to collect serology samples in adults.", "fr": "Le projet pilote de sérologie a démontré la capacité du réseau à recueillir des échantillons sérologiques chez des adultes.", "perturbation": "omission", "pert_fr": "Le projet pilote de sérologie a démontré la capacité du réseau à recueillir des échantillons chez des adultes.", "bt_pert_fr": "The serology pilot project demonstrated the network's capacity to collect samples from adults.", "questions": "[\"What has the serology pilot demonstrated?\", \"What is the ability demonstrated by the network?\", \"What type of samples can the network collect?\", \"Who is the target group for the serology samples?\", \"What is the purpose of the serology pilot?\"]", "answers": "[\"The network's capacity to collect samples from adults\", \"The network's capacity to collect samples\", \"Samples from adults\", \"Adults\", \"To demonstrate the network's capacity to collect samples from adults\"]", "scores": [{"f1": 0.47058823529411764, "em": false, "chrf": 48.28555916716365, "bleu": 11.59119922599073}, {"f1": 0.5, "em": false, "chrf": 43.438892003799005, "bleu": 17.965205598154213}, {"f1": 0, "em": false, "chrf": 31.302358915132046, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 59.166666666666664, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 54.17409423789684, "bleu": 9.600960275119885}], "avg_f1": 0.29411764705882354, "avg_em": 0.0, "avg_chrf": 47.27351419813164, "avg_bleu": 7.831473019852966}
{"id": "PubMed_10:894", "en": "The primary national strategy for COVID-19 infection is containment, with patients who are at high risk managed via the telephone help system NHS111 and the PHE health protection teams, but the RCGP RSC surveillance is entirely separate.", "fr": "La principale stratégie nationale face à l’infection au COVID-19 est le confinement, en prenant en charge les patients à risque élevé grâce au système d'aiguillage téléphonique NHS111 et aux équipes de protection de la santé de PHE, mais la surveillance du RSC du RCGP est entièrement indépendante.", "perturbation": "omission", "pert_fr": "La principale stratégie nationale face à l’infection est le confinement, en prenant en charge les patients à risque élevé grâce au système d'aiguillage téléphonique NHS111 et aux équipes de protection de la santé de PHE, mais la surveillance du RSC du RCGP est entièrement indépendante.", "bt_pert_fr": "The main national strategy for dealing with infection is containment, caring for high-risk patients through the NHS111 telephone referral system and PHE health protection teams, but RCGP RSC monitoring is entirely independent.", "questions": "[\"What is the primary national strategy for COVID-19 infection?\", \"How are patients at high risk managed?\", \"What system is used to manage high-risk patients via telephone?\", \"What teams are involved in managing high-risk patients?\", \"What is the relationship between RCGP RSC surveillance and the other management systems?\"]", "answers": "[\"Containment\", \"Through the NHS111 telephone referral system and PHE health protection teams\", \"NHS111 telephone referral system\", \"PHE health protection teams\", \"Entirely independent\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 71.08919128669626, "bleu": 44.17918226831576}, {"f1": 0.4, "em": false, "chrf": 42.42515916977655, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 43.17728096174364, "bleu": 49.99999999999999}], "avg_f1": 0.74, "avg_em": 0.4, "avg_chrf": 71.33832628364328, "avg_bleu": 62.030551974894536}
{"id": "PubMed_10:899", "en": "The aim of this study is to identify whether there is undetected community transmission of COVID-19, estimate population susceptibility, and monitor the temporal and geographical distribution of COVID-19 infection in the community.", "fr": "L’objectif de cette étude est d’identifier s’il existe une transmission communautaire non détectée du COVID-19, de déterminer la sensibilité de la population et de surveiller la distribution temporelle et géographique de l’infection au COVID-19.", "perturbation": "omission", "pert_fr": "L’objectif de cette étude est d’identifier s’il existe une transmission communautaire non détectée du COVID-19, de déterminer la sensibilité de la population et de surveiller la distribution temporelle de l’infection au COVID-19.", "bt_pert_fr": "The objective of this study is to identify whether there is undetected community transmission of COVID-19, determine population susceptibility, and monitor the temporal distribution of COVID-19 infection.", "questions": "[\"What is the aim of this study?\", \"What does the study aim to identify?\", \"What does the study aim to estimate?\", \"What does the study aim to monitor?\", \"What aspects of COVID-19 infection are being monitored?\", \"What is community transmission in this context?\"]", "answers": "[\"To identify whether there is undetected community transmission of COVID-19, determine population susceptibility, and monitor the temporal distribution of COVID-19 infection\", \"Undetected community transmission of COVID-19\", \"Population susceptibility\", \"The temporal distribution of COVID-19 infection\", \"The temporal distribution of COVID-19 infection\", \"The spread of COVID-19 within a community that is not detected by official surveillance systems\"]", "scores": [{"f1": 0.7200000000000001, "em": false, "chrf": 74.15796452504354, "bleu": 42.921350974960255}, {"f1": 0.8000000000000002, "em": false, "chrf": 97.32778252515094, "bleu": 66.87403049764218}, {"f1": 0.5, "em": false, "chrf": 95.31916500738012, "bleu": 49.99999999999999}, {"f1": 0.7692307692307692, "em": false, "chrf": 72.26937924796025, "bleu": 45.48019047027906}, {"f1": 0.4, "em": false, "chrf": 51.42804214693317, "bleu": 9.652434877402245}, {"f1": 0.962962962962963, "em": false, "chrf": 99.18986641412953, "bleu": 91.93227152249183}], "avg_f1": 0.6920322886989555, "avg_em": 0.0, "avg_chrf": 81.61536664443292, "avg_bleu": 51.14337972379593}
{"id": "PubMed_10:900", "en": "The objectives of this study are as follows:", "fr": "Les objectifs de cette étude sont les suivants :", "perturbation": "omission", "pert_fr": "Les objectifs de cette étude sont suivants :", "bt_pert_fr": "The objectives of this study are:", "questions": "[\"What are the objectives of this study?\"]", "answers": "[\"The objectives of this study are:\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 77.22439326944678, "bleu": 71.65313105737896}], "avg_f1": 0.8571428571428571, "avg_em": 0.0, "avg_chrf": 77.22439326944678, "avg_bleu": 71.65313105737896}
{"id": "PubMed_10:901", "en": "To monitor the burden of suspected COVID-19 activity in the community through primary care surveillance and clinical coding of possible COVID-19 cases referred into the containment pathway", "fr": "Surveiller le fardeau de l’activité présumée du COVID-19 au sein de la communauté par le biais de la surveillance en soins primaires et du codage clinique des cas potentiels de COVID-19 orientés vers le parcours de confinement", "perturbation": "omission", "pert_fr": "Surveiller le fardeau de l’activité présumée du COVID-19 au sein de la communauté par le biais de la surveillance en soins primaires et du codage clinique des cas potentiels de COVID-19", "bt_pert_fr": "Monitor the burden of suspected COVID-19 activity in the community through primary care surveillance and clinical coding of potential COVID-19 cases", "questions": "[\"What is being monitored in the community?\", \"How is the burden of suspected COVID-19 activity being tracked?\", \"What method is used for surveillance of suspected COVID-19 cases?\", \"What is the containment pathway and how are cases referred into it?\"]", "answers": "[\"The burden of suspected COVID-19 activity\", \"Through primary care surveillance and clinical coding of potential COVID-19 cases\", \"Primary care surveillance and clinical coding\", \"Not specified\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7692307692307692, "em": false, "chrf": 65.69536829482261, "bleu": 51.57583275092326}, {"f1": 0.7499999999999999, "em": false, "chrf": 68.0296166777307, "bleu": 51.341711903259224}, {"f1": 0, "em": false, "chrf": 2.195034691175674, "bleu": 0.0}], "avg_f1": 0.6298076923076923, "avg_em": 0.25, "avg_chrf": 58.98000491593225, "avg_bleu": 50.729386163545634}
{"id": "PubMed_10:903", "en": "To estimate baseline susceptibility to COVID-19 in the community and estimate both symptomatic and asymptomatic exposure rates in the population through seroprevalence monitoring", "fr": "Déterminer la sensibilité de référence au COVID-19 dans la communauté et mesurer les taux d’exposition symptomatique et asymptomatique dans la population via la surveillance de la séroprévalence", "perturbation": "omission", "pert_fr": "Déterminer la sensibilité de référence au COVID-19 dans la communauté et mesurer les taux d’exposition symptomatique dans la population via la surveillance de la séroprévalence", "bt_pert_fr": "Determine baseline community susceptibility to COVID-19 and measure population symptomatic exposure rates via seroprevalence surveillance", "questions": "[\"What is the goal of seroprevalence monitoring?\", \"What does seroprevalence monitoring estimate?\", \"What types of exposure rates are estimated in the population?\", \"What is baseline susceptibility to COVID-19?\"]", "answers": "[\"To determine baseline community susceptibility to COVID-19 and measure population symptomatic exposure rates\", \"Baseline community susceptibility to COVID-19 and population symptomatic exposure rates\", \"Symptomatic exposure rates\", \"The initial level of vulnerability of the community to COVID-19\"]", "scores": [{"f1": 0.6470588235294118, "em": false, "chrf": 49.61345811592703, "bleu": 9.516637404253183}, {"f1": 0.5555555555555556, "em": false, "chrf": 58.7377622908961, "bleu": 10.552670315936318}, {"f1": 0.5, "em": false, "chrf": 61.10008388794507, "bleu": 28.254432923044853}, {"f1": 0.7058823529411765, "em": false, "chrf": 66.01435590283937, "bleu": 23.356898886410004}], "avg_f1": 0.602124183006536, "avg_em": 0.0, "avg_chrf": 58.866415049401894, "avg_bleu": 17.920159882411088}
{"id": "PubMed_10:905", "en": "We intend to capture the following.", "fr": "Nous avons l’intention d’enregistrer ce qui suit.", "perturbation": "omission", "pert_fr": "Nous avons l’intention d’enregistrer ce.", "bt_pert_fr": "We intend to record this.", "questions": "[\"What are we intending to capture?\"]", "answers": "[\"This\"]", "scores": [{"f1": 0, "em": false, "chrf": 3.125, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 3.125, "avg_bleu": 0.0}
{"id": "PubMed_10:906", "en": "Clinical workload related to reports of COVID-19 using the codes created to flag cases, those being assessed and where the infection is located are excluded (Figures 2-​-44)", "fr": "La charge de travail clinique liée aux rapports de COVID-19 à l’aide des codes créés pour signaler les cas, les cas testés et l’emplacement de l’infection sont exclus (Figures 2--44)", "perturbation": "omission", "pert_fr": "La charge de travail clinique liée aux rapports de COVID-19 à l’aide des codes créés pour signaler les cas et l’emplacement de l’infection sont exclus (Figures 2--44)", "bt_pert_fr": "Clinical workload related to COVID-19 reporting using codes created to report cases and location of infection are excluded (Figures 2--44)", "questions": "[\"What is excluded in the clinical workload related to COVID-19 reports?\", \"Where is the infection located in the context of the reports?\", \"What figures illustrate the exclusion in the clinical workload?\"]", "answers": "[\"Codes created to report cases and location of infection\", \"Location of infection\", \"Figures 2--44\"]", "scores": [{"f1": 0.380952380952381, "em": false, "chrf": 32.27904814593384, "bleu": 8.125165710854512}, {"f1": 0.18181818181818182, "em": false, "chrf": 26.293560983247932, "bleu": 5.197112497172873}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5209235209235209, "avg_em": 0.3333333333333333, "avg_chrf": 52.85753637639393, "avg_bleu": 37.774092736009145}
{"id": "PubMed_10:907", "en": "Foreign countries visited in the last 28 days", "fr": "Pays étrangers visités au cours des 28 derniers jours", "perturbation": "omission", "pert_fr": "Pays visités au cours des 28 derniers jours", "bt_pert_fr": "Countries visited in the last 28 days", "questions": "[\"Which foreign countries were visited in the last 28 days?\", \"How many foreign countries were visited in the last 28 days?\"]", "answers": "[\"Countries visited in the last 28 days\", \"The number of foreign countries visited in the last 28 days is not specified\"]", "scores": [{"f1": 0.5882352941176471, "em": false, "chrf": 53.78689155591956, "bleu": 33.02232277439296}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7941176470588236, "avg_em": 0.5, "avg_chrf": 76.89344577795978, "avg_bleu": 66.5111613871965}
{"id": "PubMed_10:909", "en": "Many GPs and primary care teams may not realize that important relevant data can be coded.", "fr": "De nombreux MG et équipes de soins primaires ne se rendent pas toujours compte que d’importantes données pertinentes peuvent être codées.", "perturbation": "omission", "pert_fr": "De nombreux MG ne se rendent pas toujours compte que d’importantes données pertinentes peuvent être codées.", "bt_pert_fr": "Many GPs do not always realize that important relevant data can be encoded.", "questions": "[\"What type of data can be coded?\", \"Who may not realize the importance of coding relevant data?\"]", "answers": "[\"Important relevant data\", \"Many GPs\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 22.351537467079183, "bleu": 13.533528323661276}], "avg_f1": 0.75, "avg_em": 0.5, "avg_chrf": 61.17576873353959, "avg_bleu": 56.76676416183066}
{"id": "PubMed_10:911", "en": "Reliable coding of letters and test results that will show an infection has become either confirmed or excluded", "fr": "Un codage fiable de lettres et résultats d’analyse qui montrera si une infection est confirmée ou exclue", "perturbation": "omission", "pert_fr": "Un codage fiable de lettres qui montrera si une infection est confirmée ou exclue", "bt_pert_fr": "Reliable letter coding that will show whether an infection is confirmed or ruled out", "questions": "[\"What is the purpose of reliable coding of letters and test results?\"]", "answers": "[\"To show whether an infection is confirmed or ruled out\"]", "scores": [{"f1": 0.5555555555555556, "em": false, "chrf": 47.52688638573746, "bleu": 14.25876976452075}], "avg_f1": 0.5555555555555556, "avg_em": 0.0, "avg_chrf": 47.52688638573746, "avg_bleu": 14.25876976452075}
{"id": "PubMed_10:913", "en": "The NHS uses the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) system of coding, which is normally only updated twice annually.", "fr": "Le NHS utilise le système de codage de la nomenclature systématisée des termes cliniques en médecine (Systematized Nomenclature of Medicine Clinical Terms, SNOMED CT), qui n’est normalement mise à jour que deux fois par an.", "perturbation": "omission", "pert_fr": "Le NHS utilise le système de codage de la nomenclature systématisée des termes cliniques en médecine (Systematized Nomenclature of Medicine Clinical Terms, SNOMED CT), qui n’est normalement mise à jour que par an.", "bt_pert_fr": "The NHS uses the Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT) coding system, which is normally only updated annually.", "questions": "[\"What coding system does the NHS use?\", \"What is the name of the coding system used by the NHS?\", \"How often is the SNOMED CT system normally updated?\", \"Why is the SNOMED CT system updated only twice annually?\"]", "answers": "[\"Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT)\", \"Systematized Nomenclature of Medicine Clinical Terms (SNOMED CT)\", \"Annually\", \"The SNOMED CT system is not updated only twice annually\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 45.67716413209812, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 11.626093151894432, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 64.32581432099813, "avg_bleu": 50.00000000000002}
{"id": "PubMed_10:915", "en": "Additionally, there were no clinical codes to record COVID-19 in early February 2020.", "fr": "En outre, il n’existait aucun code clinique pour enregistrer le COVID-19 au début du mois de février 2020.", "perturbation": "omission", "pert_fr": "En outre, il n’existait aucun code pour enregistrer le COVID-19 au début du mois de février 2020.", "bt_pert_fr": "Additionally, there was no code to record COVID-19 as of early February 2020.", "questions": "[\"What was missing in early February 2020 regarding COVID-19?\", \"Why were there no clinical codes to record COVID-19 in early February 2020?\", \"What does the absence of clinical codes indicate about COVID-19 in early February 2020?\"]", "answers": "[\"A code to record COVID-19\", \"Because there was no code available\", \"That COVID-19 was not officially recognized or documented in clinical systems\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 58.63448745687695, "bleu": 39.76353643835254}, {"f1": 0.3333333333333333, "em": false, "chrf": 40.59785104971242, "bleu": 9.652434877402245}, {"f1": 0.6666666666666666, "em": false, "chrf": 69.28900363580316, "bleu": 26.985534666825092}], "avg_f1": 0.5333333333333333, "avg_em": 0.0, "avg_chrf": 56.173780714130835, "avg_bleu": 25.467168660859958}
{"id": "PubMed_10:918", "en": "The intention is that these will eventually be mapped to the new SNOMED CT concepts as they become available, allowing recording of relevant data (Multimedia Appendix 1).", "fr": "L’objectif est qu’ils soient intégrés aux nouveaux concepts de la SNOMED CT à mesure qu’ils deviennent disponibles, permettant ainsi l’enregistrement des données pertinentes (Annexe multimédia 1).", "perturbation": "omission", "pert_fr": "L’objectif est qu’ils soient intégrés aux nouveaux concepts de la SNOMED CT, permettant ainsi l’enregistrement des données pertinentes (Annexe multimédia 1).", "bt_pert_fr": "The aim is for them to be integrated into the new concepts of SNOMED CT, thus allowing the recording of relevant data (Multimedia Annex 1).", "questions": "[\"What is the intention regarding the mapping of these items?\", \"When will the mapping to new SNOMED CT concepts occur?\", \"What allows the recording of relevant data?\", \"What is mentioned in Multimedia Appendix 1?\"]", "answers": "[\"To be integrated into the new concepts of SNOMED CT\", \"Not specified\", \"The integration into the new concepts of SNOMED CT\", \"The aim is for them to be integrated into the new concepts of SNOMED CT, thus allowing the recording of relevant data\"]", "scores": [{"f1": 0.43478260869565216, "em": false, "chrf": 26.339139960495633, "bleu": 6.87938864869854}, {"f1": 0, "em": false, "chrf": 6.992266491774607, "bleu": 0.0}, {"f1": 0.15384615384615385, "em": false, "chrf": 13.405707186684127, "bleu": 5.522397783539471}, {"f1": 0, "em": false, "chrf": 10.198261696244012, "bleu": 0.0}], "avg_f1": 0.14715719063545152, "avg_em": 0.0, "avg_chrf": 14.233843833799595, "avg_bleu": 3.100446608059503}
{"id": "PubMed_10:919", "en": "The key requirements for this release were the ability to code (Table 4) a case of COVID-19, exposure to risk of infection (travel to an area where there may be a higher risk), contact with anyone infected with COVID-19, a report that a person had been tested for COVID-19, and that the disease had been excluded (likely a negative test).", "fr": "Les conditions essentielles pour cette version étaient la possibilité de coder (Tableau 4) un cas de COVID-19, l’exposition au risque d’infection (se rendre dans une zone où le risque peut être plus élevé), le contact avec toute personne infectée par le COVID-19, un rapport qu’une personne a été testée pour le COVID-19, et que la maladie a été exclue (probablement un test négatif).", "perturbation": "omission", "pert_fr": "Les conditions essentielles pour cette version étaient la possibilité de coder (Tableau 4) un cas de COVID-19, l’exposition au risque d’infection (se rendre dans une zone où le risque peut être plus élevé), le contact avec toute personne infectée par le COVID-19, et que la maladie a été exclue (probablement un test négatif).", "bt_pert_fr": "The essential conditions for this version were the possibility of coding (Table 4) a case of COVID-19, exposure to the risk of infection (traveling to an area where the risk may be higher), contact with anyone infected with COVID-19, and that the disease has been excluded (probably a negative test).", "questions": "[\"What are the key requirements for this release?\", \"What does 'code a case of COVID-19' mean?\", \"What constitutes exposure to risk of infection?\"]", "answers": "[\"The possibility of coding a case of COVID-19, exposure to the risk of infection (traveling to an area where the risk may be higher), contact with anyone infected with COVID-19, and exclusion of the disease (probably a negative test)\", \"To record or document a confirmed instance of COVID-19 in the system\", \"Traveling to an area where the risk of COVID-19 infection may be higher\"]", "scores": [{"f1": 0.6582278481012658, "em": false, "chrf": 60.35169936343512, "bleu": 31.18938776726791}, {"f1": 0.8333333333333333, "em": false, "chrf": 70.80507622873631, "bleu": 60.57025366576469}, {"f1": 0.8181818181818182, "em": false, "chrf": 65.35141398442748, "bleu": 27.455024338805618}], "avg_f1": 0.7699143332054724, "avg_em": 0.0, "avg_chrf": 65.5027298588663, "avg_bleu": 39.73822192394607}
{"id": "PubMed_10:922", "en": "Currently, virology samples for influenza surveillance are accompanied by a standard request form.", "fr": "Actuellement, les échantillons virologiques pour la surveillance de la grippe sont accompagnés d’un formulaire de demande standard.", "perturbation": "omission", "pert_fr": "Actuellement, les échantillons virologiques pour la grippe sont accompagnés d’un formulaire de demande standard.", "bt_pert_fr": "Currently, influenza virology samples are accompanied by a standard request form.", "questions": "[\"What is currently included with virology samples for influenza surveillance?\", \"What type of form is accompanying virology samples for influenza surveillance?\", \"What is the purpose of the standard request form in influenza surveillance?\"]", "answers": "[\"A standard request form\", \"A standard request form\", \"To accompany influenza virology samples\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333333, "em": false, "chrf": 61.44806638766188, "bleu": 21.414818552625785}], "avg_f1": 0.9444444444444443, "avg_em": 0.6666666666666666, "avg_chrf": 87.14935546255396, "avg_bleu": 73.80493951754195}
{"id": "PubMed_10:923", "en": "For COVID-19, we will create a new request form that will record:", "fr": "Pour le COVID-19, nous allons créer un nouveau formulaire de demande qui consignera :", "perturbation": "omission", "pert_fr": "Pour le COVID-19, nous allons créer un nouveau formulaire qui consignera :", "bt_pert_fr": "For COVID-19, we will create a new form that will record:", "questions": "[\"What will be created for COVID-19?\", \"What will the new request form record?\"]", "answers": "[\"A new form\", \"COVID-19\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 26.64941175220402, "bleu": 45.13864405503391}, {"f1": 0.4, "em": false, "chrf": 21.493686745486123, "bleu": 4.9787068367863965}], "avg_f1": 0.6285714285714286, "avg_em": 0.0, "avg_chrf": 24.071549248845074, "avg_bleu": 25.05867544591015}
{"id": "PubMed_10:926", "en": "Acute bronchitis/bronchiolitis in those younger than five years", "fr": "Bronchite aigüe/bronchiolite chez les moins de cinq ans", "perturbation": "omission", "pert_fr": "Bronchite aigüe chez les moins de cinq ans", "bt_pert_fr": "Acute bronchitis in children under five years old", "questions": "[\"What age group is mentioned in the sentence?\"]", "answers": "[\"Children under five years old\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 41.79980427158208, "bleu": 21.3643503198117}], "avg_f1": 0.4444444444444445, "avg_em": 0.0, "avg_chrf": 41.79980427158208, "avg_bleu": 21.3643503198117}
{"id": "PubMed_10:928", "en": "History of fever (Y/N); measured (Y/N); if yes, level", "fr": "Antécédents de fièvre (O/N) ; mesurée (O/N) ; si oui, température", "perturbation": "omission", "pert_fr": "Antécédents de fièvre  ; si oui, température", "bt_pert_fr": "History of fever; if yes, temperature", "questions": "[\"What is the history of fever?\"]", "answers": "[\"Fever\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 0.0, "avg_bleu": 0.0}
{"id": "PubMed_10:930", "en": "Recent travel (Y/N); if yes, countries visited in last 14 days", "fr": "Voyage récent (O/N) ; si oui, pays visités au cours des 14 derniers jours", "perturbation": "omission", "pert_fr": "Voyage récent ; si oui, pays visités au cours des 14 derniers jours", "bt_pert_fr": "Recent trip; if yes, countries visited in the last 14 days", "questions": "[\"If recent travel is yes, which countries were visited in the last 14 days?\"]", "answers": "[\"Countries visited in the last 14 days\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "PubMed_10:934", "en": "Public Presentation of Data Using an Observatory and Dashboards", "fr": "Présentation publique des données à l’aide d’un observatoire et de tableaux de bord", "perturbation": "omission", "pert_fr": "Présentation publique des données à l’aide de tableaux de bord", "bt_pert_fr": "Public presentation of data using dashboards", "questions": "[\"What is an observatory in the context of data presentation?\"]", "answers": "[\"Not specified in the sentence\"]", "scores": [{"f1": 0.0606060606060606, "em": false, "chrf": 4.195900757300303, "bleu": 0.030836258960159728}], "avg_f1": 0.0606060606060606, "avg_em": 0.0, "avg_chrf": 4.195900757300303, "avg_bleu": 0.030836258960159728}
{"id": "PubMed_10:937", "en": "Definite case will be presented on our dashboard as “cases” of COVID-19.", "fr": "Les cas confirmés seront présentés dans notre tableau de bord en tant que « cas » de COVID-19.", "perturbation": "omission", "pert_fr": "Les cas confirmés seront présentés dans notre tableau de bord en tant que « cas » .", "bt_pert_fr": "Confirmed cases will be presented in our dashboard as “cases”.", "questions": "[\"What will be presented on the dashboard?\", \"What is the term used for definite cases on the dashboard?\", \"What does 'cases' represent in the context of the dashboard?\"]", "answers": "[\"Confirmed cases\", \"Definite cases\", \"Definite cases\"]", "scores": [{"f1": 0, "em": false, "chrf": 21.57961070091491, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 63.76840278306412, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 58.97337610526524, "bleu": 36.78794411714425}], "avg_f1": 0.4444444444444444, "avg_em": 0.0, "avg_chrf": 48.10712986308142, "avg_bleu": 28.929314705714745}
{"id": "PubMed_10:938", "en": "Possible cases will be presented as “Under investigation” (investigating).", "fr": "Les cas potentiels seront présentés comme « À l’étude » (en cours d’examen).", "perturbation": "omission", "pert_fr": "Les cas seront présentés comme « À l’étude » (en cours d’examen).", "bt_pert_fr": "Cases will be presented as “Under Review”.", "questions": "[\"What does 'Under investigation' indicate?\", \"What is the status of possible cases?\", \"What is the term used for possible cases?\", \"What does 'investigating' mean in this context?\"]", "answers": "[\"Not specified\", \"Under Review\", \"Possible cases\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.986315875917931, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.146293073162338, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 6.986315875917931, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.25, "avg_chrf": 30.52973120624955, "avg_bleu": 25.00000000000001}
{"id": "PubMed_10:941", "en": "We have the option to move to twice weekly surveillance reports with a scope to change this to daily reporting.", "fr": "Nous avons la possibilité de passer à des rapports de surveillance bihebdomadaires dans l’objectif d’adopter des rapports quotidiens.", "perturbation": "omission", "pert_fr": "Nous avons la possibilité de passer à des rapports quotidiens.", "bt_pert_fr": "We have the option to move to daily reporting.", "questions": "[\"What options are available for surveillance reports?\", \"Can the surveillance reporting frequency be changed?\", \"What is the current surveillance reporting frequency?\", \"What would be the scope of changing to daily reporting?\", \"Is there a possibility to switch from twice weekly to daily reporting?\"]", "answers": "[\"Move to daily reporting\", \"Yes\", \"Twice weekly\", \"The reporting would become daily\", \"Yes\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 26.63861471147052, "bleu": 19.37692912686648}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4000000000000001, "em": false, "chrf": 38.512917338539474, "bleu": 12.70331870386537}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.76, "avg_em": 0.6, "avg_chrf": 73.030306410002, "avg_bleu": 66.4160495661464}
{"id": "PubMed_10:943", "en": "Additionally, we will recruit more surveillance practices.", "fr": "En outre, nous recruterons de nouveaux cabinets de surveillance.", "perturbation": "omission", "pert_fr": "En outre, nous recruterons de cabinets de surveillance.", "bt_pert_fr": "In addition, we will recruit monitoring firms.", "questions": "[\"What additional action will be taken?\", \"What will be recruited?\", \"What is the purpose of recruiting more surveillance practices?\"]", "answers": "[\"Recruit monitoring firms\", \"Monitoring firms\", \"The purpose of recruiting more surveillance practices is not stated in the sentence\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 27.80638329232011, "bleu": 19.716118825581447}, {"f1": 0, "em": false, "chrf": 8.03700088318691, "bleu": 0.0}, {"f1": 0.13333333333333333, "em": false, "chrf": 44.70814607695566, "bleu": 3.3864985683445354}], "avg_f1": 0.1396825396825397, "avg_em": 0.0, "avg_chrf": 26.850510084154223, "avg_bleu": 7.700872464641994}
{"id": "PubMed_10:951", "en": "Additionally, PHE will retrospectively test any influenza virology samples collected between early and mid-February 2020 for COVID-19.", "fr": "En outre, PHE analysera de manière rétrospective tout échantillon virologique de grippe collecté entre le début et la mi-février 2020 pour le COVID-19.", "perturbation": "omission", "pert_fr": "En outre, PHE analysera de manière rétrospective tout échantillon virologique collecté entre le début et la mi-février 2020 pour le COVID-19.", "bt_pert_fr": "Additionally, PHE will retrospectively analyze any virological samples collected between early and mid-February 2020 for COVID-19.", "questions": "[\"What will PHE do with influenza virology samples collected between early and mid-February 2020?\", \"What samples will be tested for COVID-19?\", \"When were the influenza virology samples collected?\", \"What is the purpose of the retrospective testing?\"]", "answers": "[\"Retrospectively analyze\", \"Virological samples\", \"Between early and mid-February 2020\", \"To analyze the samples for COVID-19\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 73.68012229653802, "bleu": 49.99999999999999}, {"f1": 0.4, "em": false, "chrf": 39.724197483185335, "bleu": 30.326532985631665}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.42857142857142855, "em": false, "chrf": 24.416980603336107, "bleu": 6.316906128202129}], "avg_f1": 0.5821428571428572, "avg_em": 0.25, "avg_chrf": 59.45532509576486, "avg_bleu": 46.66085977845846}
{"id": "PubMed_10:954", "en": "Summary of processes are detailed in Multimedia Appendix 3.", "fr": "Le résumé des processus est détaillé dans l’Annexe multimédia 3.", "perturbation": "omission", "pert_fr": "Le résumé est détaillé dans l’Annexe multimédia 3.", "bt_pert_fr": "The summary is detailed in Multimedia Annex 3.", "questions": "[\"What is detailed in Multimedia Appendix 3?\"]", "answers": "[\"The summary\"]", "scores": [{"f1": 0, "em": false, "chrf": 27.16380124572644, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 27.16380124572644, "avg_bleu": 0.0}
{"id": "PubMed_10:955", "en": "Everyone with an ILI or a respiratory illness who contacts a GP (eg, phones for an appointment) should be asked specifically about recent travel to China and other countries flagged in current PHE advice, or if they have had contact with other people with COVID-19.", "fr": "Toute personne présentant un SG ou une maladie respiratoire et qui contacte un MG (par ex. prend rendez-vous par téléphone) devrait être interrogée spécifiquement au sujet de tout récent voyage en Chine et dans d’autres pays signalés dans les recommandations en vigueur de PHE, ou si elle a été en contact avec d’autres personnes atteintes du COVID-19.", "perturbation": "omission", "pert_fr": "Toute personne présentant un SG ou une maladie respiratoire et qui contacte un MG (par ex. prend rendez-vous par téléphone) devrait être interrogée spécifiquement au sujet de tout récent voyage en Chine.", "bt_pert_fr": "Anyone with ILI or respiratory illness who contacts a GP (e.g. makes an appointment by telephone) should be asked specifically about any recent travel to China.", "questions": "[\"Who should be asked about recent travel to China and other flagged countries?\", \"What specific information should be asked about when someone has an ILI or respiratory illness?\", \"What is the purpose of asking about recent travel to China and other countries?\", \"What is the role of a GP in this scenario?\"]", "answers": "[\"Anyone with ILI or respiratory illness who contacts a GP\", \"Any recent travel to China\", \"To identify potential cases of illness linked to travel to flagged countries\", \"To receive and manage patient inquiries related to ILI or respiratory illness\"]", "scores": [{"f1": 0.8888888888888888, "em": false, "chrf": 92.00630661565881, "bleu": 86.33400213704509}, {"f1": 0.21428571428571427, "em": false, "chrf": 18.099575172402545, "bleu": 1.0864878331643493}, {"f1": 0.4444444444444444, "em": false, "chrf": 45.478863221142355, "bleu": 13.545994273378144}, {"f1": 0.22857142857142854, "em": false, "chrf": 15.16363741743648, "bleu": 1.9149728414705296}], "avg_f1": 0.444047619047619, "avg_em": 0.0, "avg_chrf": 42.68709560666005, "avg_bleu": 25.72036427126453}
{"id": "PubMed_10:958", "en": "These calls should be coded into the GP CMR system and can be reported as part of the RCGP RSC weekly return.", "fr": "Ces appels doivent être codés dans le système de DMI du cabinet de MG et peuvent être signalés dans le cadre du rapport hebdomadaire du RSC du RCGP.", "perturbation": "omission", "pert_fr": "Ces appels doivent être codés dans le système de DMI du cabinet et peuvent être signalés dans le cadre du rapport hebdomadaire du RSC du RCGP.", "bt_pert_fr": "These calls must be coded in the practice's EMR system and may be reported as part of the RCGP's weekly RSC report.", "questions": "[\"What should be coded into the GP CMR system?\", \"What can be reported as part of the RCGP RSC weekly return?\", \"What is the GP CMR system?\"]", "answers": "[\"These calls\", \"The calls\", \"The GP CMR system is not explicitly defined in the sentence\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 37.72230676856429, "bleu": 42.88819424803536}, {"f1": 0.28571428571428575, "em": false, "chrf": 46.35148523747929, "bleu": 8.392229812593097}], "avg_f1": 0.6952380952380953, "avg_em": 0.3333333333333333, "avg_chrf": 61.357930668681185, "avg_bleu": 50.4268080202095}
{"id": "PubMed_10:961", "en": "Practice reception or triage staff: for coding of any patients calling the practice with symptoms of acute respiratory infection with a history of travel to important areas based on PHE advice", "fr": "Le secrétariat ou le personnel de triage du cabinet : pour le codage de tout patient appelant le cabinet avec des symptômes d’infection respiratoire aigüe et des antécédents de voyage dans des zones importantes conformément aux recommandations de PHE", "perturbation": "omission", "pert_fr": "Le secrétariat ou le personnel de triage du cabinet : pour le codage de tout patient appelant le cabinet avec des symptômes d’infection respiratoire aigüe conformément aux recommandations de PHE", "bt_pert_fr": "Practice secretarial or triage staff: for coding any patient calling the practice with symptoms of acute respiratory infection in accordance with PHE recommendations", "questions": "[\"What is the role of reception or triage staff in the practice?\"]", "answers": "[\"To code any patient calling the practice with symptoms of acute respiratory infection in accordance with PHE recommendations\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 61.83995484539254, "bleu": 35.63653702285611}], "avg_f1": 0.6, "avg_em": 0.0, "avg_chrf": 61.83995484539254, "avg_bleu": 35.63653702285611}
{"id": "PubMed_10:963", "en": "Practices participating in virology surveillance will opportunistically collect blood samples from patients coming into the practice for a routine blood test.", "fr": "Les cabinets participant à la surveillance virologique prélèveront de façon opportuniste des échantillons de sang des patients venant au cabinet pour une analyse de sang de routine.", "perturbation": "omission", "pert_fr": "Les cabinets participant à la surveillance virologique prélèveront de façon opportuniste des échantillons de sang des patients pour une analyse de sang de routine.", "bt_pert_fr": "Practices participating in virological surveillance will opportunistically collect blood samples from patients for routine blood testing.", "questions": "[\"What practices participate in virology surveillance?\", \"What do practices do opportunistically during virology surveillance?\", \"What type of samples are collected during virology surveillance?\", \"From whom are blood samples collected during virology surveillance?\", \"What is the reason for collecting blood samples during virology surveillance?\"]", "answers": "[\"Practices that participate in virological surveillance\", \"Collect blood samples\", \"Blood samples\", \"Patients\", \"For routine blood testing\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 70.80420549974293, "bleu": 10.682175159905853}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 27.182270331170077, "bleu": 4.9787068367863965}, {"f1": 0.30769230769230765, "em": false, "chrf": 43.72648350465928, "bleu": 9.153013214364877}], "avg_f1": 0.6506293706293707, "avg_em": 0.4, "avg_chrf": 68.34259186711446, "avg_bleu": 44.96277904221144}
{"id": "PubMed_10:964", "en": "Patients who attend their practice for a routine blood test will be asked to provide an additional sample for serology.", "fr": "Il sera demandé aux patients qui se rendent dans leur cabinet pour une analyse de sang de routine de fournir un échantillon de sang supplémentaire pour l’analyse sérologique.", "perturbation": "omission", "pert_fr": "Il sera demandé aux patients qui se rendent dans leur cabinet de fournir un échantillon de sang supplémentaire pour l’analyse sérologique.", "bt_pert_fr": "Patients who visit their office will be asked to provide an additional blood sample for serological analysis.", "questions": "[\"What will patients be asked to provide during a routine blood test?\", \"What is the purpose of the additional sample?\", \"What type of test is being conducted?\", \"What is serology?\", \"Who is required to provide the additional sample?\"]", "answers": "[\"An additional blood sample\", \"Serological analysis\", \"Serological analysis\", \"Not specified in the sentence\", \"Patients who visit their office\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 53.12373104798197, "bleu": 27.534765745159184}, {"f1": 0, "em": false, "chrf": 24.3776807990952, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 9.695367374319313, "bleu": 0.0}, {"f1": 0.15384615384615383, "em": false, "chrf": 11.7003512408591, "bleu": 4.576506607182439}, {"f1": 0.42857142857142855, "em": false, "chrf": 30.754227135124772, "bleu": 10.623727437398784}], "avg_f1": 0.24981684981684976, "avg_em": 0.0, "avg_chrf": 25.930271519476072, "avg_bleu": 8.546999957948081}
{"id": "PubMed_10:965", "en": "We have conducted initial searches within the RCGP RSC database to look at the number of full blood count (FBC) results and overall rates in adults and children (Figures 6-​-9).9).", "fr": "Nous avons mené des recherches initiales dans la base de données du RSC du RCGP afin d’examiner le nombre de résultats de formule sanguine complète (FSC) et les taux globaux chez les adultes et les enfants (Figures 6--9).9).", "perturbation": "omission", "pert_fr": "Nous avons mené des recherches initiales dans la base de données du RSC du RCGP afin d’examiner le nombre de résultats de formule sanguine complète (FSC) et les taux globaux chez les adultes.", "bt_pert_fr": "We conducted initial searches of the RCGP CHR database to examine the number of complete blood count (CBC) results and overall rates in adults.", "questions": "[\"What searches have been conducted in the RCGP RSC database?\", \"What data was examined in the RCGP RSC database?\", \"What specific data was looked at regarding full blood count results?\", \"What age groups were included in the analysis?\", \"What information is provided in Figures 6-9?\"]", "answers": "[\"Initial searches\", \"The number of complete blood count (CBC) results and overall rates in adults\", \"The number of complete blood count (CBC) results\", \"Adults\", \"The information is not provided in the sentence\"]", "scores": [{"f1": 0.23529411764705882, "em": false, "chrf": 22.064262447481564, "bleu": 0.1503439192977573}, {"f1": 0.7500000000000001, "em": false, "chrf": 76.165563458931, "bleu": 31.170906522700683}, {"f1": 0.75, "em": false, "chrf": 67.41932884378073, "bleu": 27.05411345269698}, {"f1": 0.5, "em": false, "chrf": 27.25331540542631, "bleu": 13.533528323661276}, {"f1": 0.1111111111111111, "em": false, "chrf": 13.085981978101376, "bleu": 3.708659055657029}], "avg_f1": 0.469281045751634, "avg_em": 0.0, "avg_chrf": 41.197690426744195, "avg_bleu": 15.123510254802744}
{"id": "PubMed_10:967", "en": "The sampling rate, per 100,000 patients was highest for children 15-17 years of age and 60 year or older in adults, with the lowest rates in children 0-4 years of age and 18-29 years of age in adults (Figures 6-​-99).", "fr": "Le taux d’échantillonnage pour 100 000 patients était plus élevé chez les enfants de 15-17 ans et les adultes de 60 ans et plus, avec les taux les plus bas correspondant aux enfants de 0-4 ans et aux adultes de 18-29 ans (Figures 6--99).", "perturbation": "omission", "pert_fr": "Le taux d’échantillonnage pour 100 000 patients était plus élevé chez les enfants de 15-17 ans, avec les taux les plus bas correspondant aux enfants de 0-4 ans et aux adultes de 18-29 ans (Figures 6--99).", "bt_pert_fr": "The sampling rate per 100,000 patients was highest among children 15-17 years old, with the lowest rates corresponding to children 0-4 years old and adults 18-29 years old (Figures 6--99).", "questions": "[\"What was the highest sampling rate for in terms of age groups?\", \"Which age groups had the lowest sampling rates?\", \"What is the sampling rate per 100,000 patients?\", \"What figures are referenced in the sentence?\"]", "answers": "[\"Children 15-17 years old\", \"Children 0-4 years old and adults 18-29 years old\", \"per 100,000 patients\", \"Figures 6--99\"]", "scores": [{"f1": 0.4285714285714285, "em": false, "chrf": 49.69246604586182, "bleu": 13.267398701010466}, {"f1": 0.631578947368421, "em": false, "chrf": 63.00485800917547, "bleu": 20.90067144241744}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7650375939849624, "avg_em": 0.5, "avg_chrf": 78.17433101375933, "avg_bleu": 58.542017535857}
{"id": "PubMed_10:968", "en": "We will provide 1000 serology baseline samples across all ages that reflect the varying rates of attendance by age.", "fr": "Nous fournirons 1 000 échantillons sérologiques de référence pour toutes les tranches d’âge qui reflètent les divers taux de fréquentation par âge.", "perturbation": "omission", "pert_fr": "Nous fournirons 1 000 échantillons sérologiques de référence pour toutes les tranches d’âge.", "bt_pert_fr": "We will provide 1,000 reference serological samples for all age groups.", "questions": "[\"How many serology baseline samples will be provided?\", \"What does the sample collection reflect?\", \"What is the age range covered by the samples?\", \"What is the purpose of the serology baseline samples?\"]", "answers": "[\"1,000\", \"The sample collection reflects serology baseline samples for all age groups\", \"All age groups\", \"To provide reference serological samples for all age groups\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2222222222222222, "em": false, "chrf": 16.115205042090384, "bleu": 4.456882760699064}, {"f1": 0.4, "em": false, "chrf": 62.13279683564706, "bleu": 27.516060407455225}, {"f1": 0.23529411764705882, "em": false, "chrf": 18.261034877782407, "bleu": 5.669791110976001}], "avg_f1": 0.4643790849673203, "avg_em": 0.25, "avg_chrf": 49.12725918887996, "avg_bleu": 34.410683569782584}
{"id": "PubMed_10:974", "en": "We will develop a new request form for practices to capture recent travel and exposure to COVID-19.", "fr": "Nous développerons un nouveau formulaire de demande afin de consigner les voyages récents et l’exposition au COVID-19.", "perturbation": "omission", "pert_fr": "Nous développerons un nouveau formulaire de demande afin de consigner les voyages récents.", "bt_pert_fr": "We will develop a new application form to record recent travel.", "questions": "[\"What will be developed?\", \"What is the purpose of the new request form?\", \"What information will the new request form capture?\"]", "answers": "[\"A new application form\", \"To record recent travel\", \"Recent travel\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 23.686782527704057, "bleu": 35.35533905932737}, {"f1": 0.5, "em": false, "chrf": 32.07960289708506, "bleu": 13.006502375572222}, {"f1": 0.5, "em": false, "chrf": 37.010072438824864, "bleu": 13.533528323661276}], "avg_f1": 0.5833333333333334, "avg_em": 0.0, "avg_chrf": 30.925485954537994, "avg_bleu": 20.63178991952029}
{"id": "PubMed_10:979", "en": "This process may include checking pseudonymized NHS numbers for positive individuals at RCGP RSC practices, checking current PHE guidance regarding considerations of infectiousness for confirmed cases, and offering the patient an appointment following the previously mentioned process.", "fr": "Ce processus peut comprendre l’examen des nombres pseudonymisés de patients positifs du NHS dans les cabinets du RSC du RCGP, en vérifiant les directives actuelles de PHE concernant les considérations de contagiosité des cas confirmés, et en donnant au patient un rendez-vous selon le processus susmentionné.", "perturbation": "omission", "pert_fr": "Ce processus peut comprendre l’examen des nombres pseudonymisés de patients positifs du NHS dans les cabinets du RSC du RCGP, en vérifiant les directives actuelles de PHE concernant les considérations de contagiosité des cas confirmés, et en donnant au patient un rendez-vous.", "bt_pert_fr": "This process may include reviewing pseudonymised numbers of positive NHS patients in RCGP RSC practices, checking current PHE guidance regarding contagiousness considerations of confirmed cases, and providing the patient with an appointment.", "questions": "[\"What does this process include?\", \"What is offered to the patient following the process?\"]", "answers": "[\"Reviewing pseudonymised numbers of positive NHS patients in RCGP RSC practices, checking current PHE guidance regarding contagiousness considerations of confirmed cases\", \"An appointment\"]", "scores": [{"f1": 0.588235294117647, "em": false, "chrf": 56.03085827300704, "bleu": 26.69431003405393}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7941176470588235, "avg_em": 0.5, "avg_chrf": 78.01542913650351, "avg_bleu": 63.347155017026985}
{"id": "PubMed_10:980", "en": "This needs to be carefully coordinated nationally across the network and may require PHE to ensure individuals are not contacted by multiple agencies.", "fr": "Cela doit être coordonné avec soin à l’échelle nationale dans l’ensemble du réseau et peut impliquer que PHE s’assure que les patients ne soient pas contactés par plusieurs agences.", "perturbation": "omission", "pert_fr": "Cela doit être coordonné avec soin à l’échelle nationale dans l’ensemble du réseau et peut impliquer que les patients ne soient pas contactés par plusieurs agences.", "bt_pert_fr": "This needs to be carefully coordinated nationally across the network and may involve patients not being contacted by multiple agencies.", "questions": "[\"What needs to be carefully coordinated nationally?\", \"What is the role of PHE in this coordination?\", \"Why might multiple agencies contacting individuals be a problem?\", \"Which agencies might contact individuals and how is this managed?\"]", "answers": "[\"This\", \"Not mentioned\", \"It might lead to patients being contacted by multiple agencies, which could be confusing or disruptive\", \"Multiple agencies might contact individuals, and this is managed by carefully coordinating nationally across the network\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 6.492592181560913, "bleu": 0.0}, {"f1": 0.39999999999999997, "em": false, "chrf": 31.959377921530987, "bleu": 6.150343144231885}, {"f1": 0.625, "em": false, "chrf": 65.86407712255149, "bleu": 54.81074812714861}], "avg_f1": 0.50625, "avg_em": 0.25, "avg_chrf": 51.07901180641085, "avg_bleu": 40.24027281784513}
{"id": "PubMed_10:984", "en": "The RCGP RSC will explore ways to collect convalescent samples from any patients tested positive for COVID-19 through the extension of the virological surveillance.", "fr": "Le RSC du RCGP étudiera des moyens de collecter des échantillons de patients convalescents chez les patients testés positifs au COVID-19 dans le cadre de l’extension de la surveillance virologique.", "perturbation": "omission", "pert_fr": "Le RSC du RCGP étudiera des moyens de collecter des échantillons de patients chez les patients testés positifs au COVID-19 dans le cadre de l’extension de la surveillance virologique.", "bt_pert_fr": "The RCGP RSC will explore ways to collect patient samples from patients who test positive for COVID-19 as part of expanding virological surveillance.", "questions": "[\"What will the RCGP RSC explore?\", \"How will convalescent samples be collected?\", \"Which patients are eligible for convalescent sample collection?\", \"What is the role of virological surveillance in this process?\"]", "answers": "[\"Ways to collect patient samples from patients who test positive for COVID-19\", \"Not specified\", \"Patients who test positive for COVID-19\", \"To expand understanding of the virus through sample collection from positive cases\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 66.77467612912325, "bleu": 24.808415001701817}, {"f1": 0, "em": false, "chrf": 4.261363636363636, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 66.87853519681352, "bleu": 30.213753973567677}, {"f1": 0.43478260869565216, "em": false, "chrf": 36.366905845285984, "bleu": 5.117229509364273}], "avg_f1": 0.421195652173913, "avg_em": 0.0, "avg_chrf": 43.570370201896594, "avg_bleu": 15.034849621158441}
{"id": "PubMed_10:985", "en": "From the start, we will be carefully curating data to ensure that it can be used for future studies.", "fr": "Dès le début, les données seront dûment conservées afin de garantir leur utilisation dans le cadre d’études futures.", "perturbation": "omission", "pert_fr": "Dès le début, les données seront conservées afin de garantir leur utilisation dans le cadre d’études futures.", "bt_pert_fr": "From the beginning, the data will be retained to ensure their use in future studies.", "questions": "[\"What will be done from the start?\", \"What is the goal of curating data?\", \"Why is data being curated?\"]", "answers": "[\"The data will be retained\", \"To ensure their use in future studies\", \"To ensure their use in future studies\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 17.204121414647727, "bleu": 10.682175159905853}, {"f1": 0.47058823529411764, "em": false, "chrf": 55.726322784275794, "bleu": 12.100518276540289}, {"f1": 0.47058823529411764, "em": false, "chrf": 55.726322784275794, "bleu": 12.100518276540289}], "avg_f1": 0.39705882352941174, "avg_em": 0.0, "avg_chrf": 42.88558899439977, "avg_bleu": 11.627737237662144}
{"id": "PubMed_10:986", "en": "Our clinical data will be linked to virology.", "fr": "Nos données cliniques seront liées à la virologie.", "perturbation": "omission", "pert_fr": "Nos données seront liées à la virologie.", "bt_pert_fr": "Our data will be linked to virology.", "questions": "[\"What type of data will be linked?\", \"What is the purpose of linking clinical data to virology?\"]", "answers": "[\"Clinical data\", \"The purpose of linking clinical data to virology is not specified in the sentence\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.42105263157894735, "em": false, "chrf": 64.97528408216958, "bleu": 19.338531381761726}], "avg_f1": 0.7105263157894737, "avg_em": 0.5, "avg_chrf": 82.4876420410848, "avg_bleu": 59.669265690880884}
{"id": "PubMed_10:988", "en": "To facilitate this our data set is listed with Health Data Research UK and the European Health Data Evidence Network.", "fr": "En ce sens, notre ensemble de données est listé avec Health Data Research UK et le Réseau européen de données et de preuves en matière de santé.", "perturbation": "omission", "pert_fr": "En ce sens, notre ensemble de données est listé avec le Réseau européen de données et de preuves en matière de santé.", "bt_pert_fr": "In this sense, our dataset is listed with the European Health Data and Evidence Network.", "questions": "[\"What is the purpose of listing the data set?\", \"With which organization is the data set listed?\", \"What is the data set listed with?\"]", "answers": "[\"To be part of the European Health Data and Evidence Network\", \"The European Health Data and Evidence Network\", \"The European Health Data and Evidence Network\"]", "scores": [{"f1": 0.15384615384615383, "em": false, "chrf": 14.611807436333478, "bleu": 4.196114906296549}, {"f1": 0.7058823529411764, "em": false, "chrf": 59.27009971248971, "bleu": 20.95871245288356}, {"f1": 0.7058823529411764, "em": false, "chrf": 59.27009971248971, "bleu": 20.95871245288356}], "avg_f1": 0.5218702865761689, "avg_em": 0.0, "avg_chrf": 44.384002287104295, "avg_bleu": 15.371179937354556}
{"id": "PubMed_10:992", "en": "By targeting the reproduction number (R) (the average number of secondary cases each case generates) and aiming to reduce the R to below 1, the policy seeks to reduce case numbers to low levels or (as seen in previous outbreaks with severe acute respiratory syndrome and Ebola) to eliminate human-to-human transmission.", "fr": "En ciblant le taux de reproduction (R) (le nombre moyen de cas secondaires généré par chaque cas) et en cherchant à faire passer R en dessous de 1, la politique vise à atteindre de faibles niveaux de cas ou (comme observé lors d’épidémies antérieures du syndrome respiratoire aigu sévère et de l’Ebola) à éliminer la transmission de personne à personne.", "perturbation": "omission", "pert_fr": "En ciblant le taux de reproduction (R) (le nombre moyen de cas secondaires généré par chaque cas) et en cherchant à faire passer R en dessous de 1, la politique vise à atteindre de faibles niveaux de cas ou à éliminer la transmission.", "bt_pert_fr": "By targeting the reproduction rate (R) (the average number of secondary cases generated by each case) and seeking to bring R below 1, the policy aims to achieve low levels of cases or eliminate transmission.", "questions": "[\"What is the reproduction number (R)?\", \"What does the reproduction number (R) represent?\", \"What is the goal of reducing the R to below 1?\", \"What are examples of previous outbreaks where reducing R led to elimination of human-to-human transmission?\"]", "answers": "[\"The average number of secondary cases generated by each case\", \"The average number of secondary cases generated by each case\", \"To achieve low levels of cases or eliminate transmission\", \"None provided\"]", "scores": [{"f1": 0.8421052631578948, "em": false, "chrf": 86.07003141055155, "bleu": 58.14307369682194}, {"f1": 0.8421052631578948, "em": false, "chrf": 86.07003141055155, "bleu": 58.14307369682194}, {"f1": 0.6, "em": false, "chrf": 49.2714986772654, "bleu": 11.949988385687533}, {"f1": 0, "em": false, "chrf": 6.1136577368113985, "bleu": 0.0}], "avg_f1": 0.5710526315789474, "avg_em": 0.0, "avg_chrf": 56.88130480879497, "avg_bleu": 32.059033944832855}
{"id": "PubMed_10:994", "en": "Key to the focus of our study will be the estimation of peak cases in the population and continual monitoring by data collection and modelling the potential growth and emergence of subsequent peaks in new cases as social distancing measures are relaxed.", "fr": "Le point essentiel de notre étude sera l’estimation du pic des cas dans la population et la surveillance continue grâce à la collecte des données et à la modélisation de la croissance potentielle et l’apparition de pics ultérieurs de nouveaux cas lorsque les mesures de distanciation sociale s’assouplissent.", "perturbation": "omission", "pert_fr": "Le point essentiel de notre étude sera l’estimation du pic des cas dans la population et la surveillance continue grâce à la collecte des données et à la modélisation de la croissance potentielle et l’apparition de pics ultérieurs de nouveaux cas lorsque les mesures s’assouplissent.", "bt_pert_fr": "The key point of our study will be the estimation of the peak of cases in the population and continued monitoring through data collection and modeling of potential growth and the appearance of subsequent peaks of new cases as measures ease.", "questions": "[\"What is key to the focus of the study?\", \"What is modeled in the study?\"]", "answers": "[\"The estimation of the peak of cases in the population and continued monitoring through data collection\", \"Potential growth and the appearance of subsequent peaks of new cases\"]", "scores": [{"f1": 0.8148148148148148, "em": false, "chrf": 82.13006481322562, "bleu": 40.016016019225006}, {"f1": 0.6666666666666666, "em": false, "chrf": 69.96920719734162, "bleu": 20.772794588721627}], "avg_f1": 0.7407407407407407, "avg_em": 0.0, "avg_chrf": 76.04963600528362, "avg_bleu": 30.394405303973315}
{"id": "PubMed_10:995", "en": "There has already been publication of important disease epidemiological measures concerning the outbreak of COVID-19 in mainland China.", "fr": "D’importantes mesures épidémiologiques de la maladie ont déjà été publiées au sujet de l’épidémie de COVID-19 en Chine continentale.", "perturbation": "omission", "pert_fr": "D’importantes mesures épidémiologiques de la maladie ont déjà été publiées au sujet de l’épidémie en Chine continentale.", "bt_pert_fr": "Important epidemiological measurements of the disease have already been published regarding the outbreak in mainland China.", "questions": "[\"What has already been published regarding the outbreak of COVID-19 in mainland China?\", \"What type of measures have been published about the outbreak?\", \"What is the focus of the published disease epidemiological measures?\", \"What region is mentioned in the context of the outbreak?\"]", "answers": "[\"Important epidemiological measurements\", \"Epidemiological measurements\", \"The disease\", \"Mainland China\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 73.00179790366256, "bleu": 24.840753130578644}, {"f1": 0, "em": false, "chrf": 69.78088666273437, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 8.613804771086158, "bleu": 18.393972058572114}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.4761904761904762, "avg_em": 0.25, "avg_chrf": 62.849122334370776, "avg_bleu": 35.8086812972877}
{"id": "PubMed_10:996", "en": "A further fundamental measure in pandemic dynamics is the length of time from infection to when a person is infectious to others and the mean duration of infectiousness.", "fr": "Une autre mesure fondamentale dans la dynamique d’une pandémie est la durée entre l’infection et le moment où une personne devient contagieuse pour les autres, ainsi que la période moyenne de contagiosité.", "perturbation": "omission", "pert_fr": "Une autre mesure fondamentale dans la dynamique d’une pandémie est la durée entre l’infection et le moment où une personne devient contagieuse.", "bt_pert_fr": "Another fundamental measure in the dynamics of a pandemic is the length of time between infection and when a person becomes contagious.", "questions": "[\"What is a further fundamental measure in pandemic dynamics?\", \"What is the length of time from infection to when a person is infectious to others?\", \"What is the mean duration of infectiousness?\"]", "answers": "[\"the length of time between infection and when a person becomes contagious\", \"the length of time between infection and when a person becomes contagious\", \"the length of time between infection and when a person becomes contagious\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 36.529750267079955, "bleu": 9.599621398238426}, {"f1": 0.5217391304347826, "em": false, "chrf": 48.272010734959856, "bleu": 15.228763726734105}, {"f1": 0.13333333333333333, "em": false, "chrf": 33.745352050829446, "bleu": 4.196114906296549}], "avg_f1": 0.385024154589372, "avg_em": 0.0, "avg_chrf": 39.51570435095642, "avg_bleu": 9.67483334375636}
{"id": "PubMed_10:999", "en": "Such techniques are highly parallelizable and have been successfully applied to many fields including disease transmission modelling.", "fr": "Ces techniques sont hautement parallélisables et sont appliquées avec succès dans plusieurs domaines, notamment la modélisation de la transmission de maladies.", "perturbation": "omission", "pert_fr": "Ces techniques sont hautement parallélisables et sont appliquées avec succès dans plusieurs domaines, notamment la transmission de maladies.", "bt_pert_fr": "These techniques are highly parallelizable and are successfully applied in several areas, including disease transmission.", "questions": "[\"What are such techniques known for?\", \"What makes such techniques highly parallelizable?\", \"In which fields have such techniques been successfully applied?\", \"What specific application of such techniques is mentioned?\", \"What is disease transmission modelling?\"]", "answers": "[\"Being highly parallelizable and successfully applied in several areas\", \"Their inherent structure or design\", \"Several areas, including disease transmission\", \"Disease transmission\", \"Not specified in the sentence\"]", "scores": [{"f1": 0.5555555555555556, "em": false, "chrf": 78.11217903858737, "bleu": 44.63236137853328}, {"f1": 0.25, "em": false, "chrf": 20.711685923440196, "bleu": 10.682175159905853}, {"f1": 0.5454545454545454, "em": false, "chrf": 62.886744699508554, "bleu": 32.55563013321615}, {"f1": 0.8, "em": false, "chrf": 69.47243717666186, "bleu": 60.653065971263366}, {"f1": 0, "em": false, "chrf": 8.81044300548901, "bleu": 0.0}], "avg_f1": 0.4302020202020202, "avg_em": 0.0, "avg_chrf": 47.998697968737396, "avg_bleu": 29.70464652858373}
{"id": "PubMed_10:1000", "en": "They are particularly suited to situations where likelihood functions are absent and where more traditional approaches such as Markov chain Monte Carlo are impractical.", "fr": "Elles sont particulièrement adaptées aux situations dans lesquelles les fonctions de vraisemblance sont absentes et des approches plus traditionnelles telles que les méthodes de Monte-Carlo par chaînes de Markov sont irréalisables.", "perturbation": "omission", "pert_fr": "Elles sont particulièrement adaptées aux situations dans lesquelles les fonctions de vraisemblance sont absentes et des approches plus traditionnelles telles que les méthodes de Monte-Carlo sont irréalisables.", "bt_pert_fr": "They are particularly suited to situations in which likelihood functions are absent and more traditional approaches such as Monte Carlo methods are impractical.", "questions": "[\"What situations are they particularly suited for?\", \"What makes them suitable in these situations?\"]", "answers": "[\"situations in which likelihood functions are absent and more traditional approaches such as Monte Carlo methods are impractical\", \"likelihood functions are absent and more traditional approaches such as Monte Carlo methods are impractical\"]", "scores": [{"f1": 0.7567567567567567, "em": false, "chrf": 75.32097256884232, "bleu": 43.74960951307028}, {"f1": 0.7333333333333333, "em": false, "chrf": 79.68969571394604, "bleu": 48.14400258132247}], "avg_f1": 0.745045045045045, "avg_em": 0.0, "avg_chrf": 77.50533414139417, "avg_bleu": 45.946806047196375}
{"id": "PubMed_10:1002", "en": "Furthermore, peaks in new cases have been estimated by distributional methods.", "fr": "En outre, les pics de nouveaux cas ont été estimés à l’aide de méthodes distributionnelles.", "perturbation": "omission", "pert_fr": "En outre, les pics de cas ont été estimés à l’aide de méthodes distributionnelles.", "bt_pert_fr": "Additionally, peak cases were estimated using distributional methods.", "questions": "[\"What has been estimated by distributional methods?\", \"What are peaks in new cases?\", \"What methods are used to estimate peaks in new cases?\"]", "answers": "[\"peak cases\", \"not specified\", \"distributional methods\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 39.904947674778626, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 6.25, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5, "avg_em": 0.3333333333333333, "avg_chrf": 48.71831589159287, "avg_bleu": 50.00000000000001}
{"id": "PubMed_10:1003", "en": "Estimates of the parameters of the SEIR model are tractable on large data sets because of parallelizability, and these methods have been implemented in several R libraries; we intend to use the libraries ABSEIR (deposited on GitHub: https://tinyurl.com/vqu35cj) and abctools (https://tinyurl.com/tfjavz4) to estimate epidemic measures on a weekly basis.", "fr": "Les estimations des paramètres du modèle SEIR peuvent être adaptées à de grands ensembles de données en raison de leur caractère parallélisable, et ces méthodes ont été mises en œuvre dans plusieurs bibliothèques R. Nous avons l’intention d’utiliser les bibliothèques ABSEIR (consignées sur GitHub : https://tinyurl.com/vqu35cj) et abctools (https://tinyurl.com/tfjavz4) afin d’estimer les mesures de l’épidémie sur une base hebdomadaire.", "perturbation": "omission", "pert_fr": "Les estimations des paramètres du modèle SEIR peuvent être adaptées à de grands ensembles de données en raison de leur caractère parallélisable, et ces méthodes ont été mises en œuvre dans plusieurs bibliothèques R. Nous avons l’intention d’utiliser les bibliothèques ABSEIR et abctools afin d’estimer les mesures de l’épidémie.", "bt_pert_fr": "SEIR model parameter estimates can be scaled to large datasets due to their parallelizability, and these methods have been implemented in several R libraries. We intend to use the ABSEIR and abctools libraries in order to estimate outbreak metrics.", "questions": "[\"What makes estimates of the parameters of the SEIR model tractable on large data sets?\", \"Why are these methods implemented in several R libraries?\", \"Which R libraries are intended to be used for estimating epidemic measures?\", \"What is the frequency of estimating epidemic measures?\", \"What is the purpose of using ABSEIR and abctools?\", \"Where can ABSEIR be accessed?\"]", "answers": "[\"Their parallelizability\", \"Because they can be scaled to large datasets\", \"ABSEIR and abctools\", \"Not specified\", \"To estimate outbreak metrics\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 86.95232886777836, "bleu": 0.0}, {"f1": 0.375, "em": false, "chrf": 58.34291053400478, "bleu": 12.223075560872525}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.208333333333334, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 40.323290861775114, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 5.0, "bleu": 0.0}], "avg_f1": 0.3125, "avg_em": 0.16666666666666666, "avg_chrf": 49.3044772661486, "avg_bleu": 24.028371795531033}
{"id": "PubMed_10:1004", "en": "Since we are fitting an SIR-epidemic model in the ABC routine, we anticipate that our results will be robust against weekly case data containing relatively small counts.", "fr": "Étant donné que nous adaptons le modèle épidémique SIR à la routine ABC, nous prévoyons que nos résultats seront solides par rapport aux données de cas hebdomadaires contenant des nombres relativement faibles.", "perturbation": "omission", "pert_fr": "Étant donné que nous adaptons le modèle épidémique SIR à la routine ABC, nous prévoyons que nos résultats seront solides par rapport aux données de cas hebdomadaires contenant des nombres faibles.", "bt_pert_fr": "Since we fit the SIR epidemic model to the ABC routine, we expect our results to be robust to weekly case data containing low numbers.", "questions": "[\"What model are we fitting in the ABC routine?\", \"Why do we anticipate that our results will be robust?\", \"What type of data is being considered for the model?\"]", "answers": "[\"SIR epidemic model\", \"Because the weekly case data contains low numbers\", \"Weekly case data\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 100.0, "bleu": 27.516060407455225}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.230178733917825, "bleu": 53.29462628216855}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6888888888888888, "avg_em": 0.3333333333333333, "avg_chrf": 87.07672624463926, "avg_bleu": 60.270228896541276}
{"id": "PubMed_10:1007", "en": "This approach is independent of the ABC methodology and will allow comparisons between estimates from the two modelling approaches to judge robustness of results.", "fr": "Cette approche est indépendante de la méthodologie ABC et permettra de comparer les estimations des deux approches de modélisation afin d’évaluer la solidité des résultats.", "perturbation": "omission", "pert_fr": "Cette approche est indépendante de la méthodologie ABC et permettra de comparer les estimations des deux approches afin d’évaluer la solidité des résultats.", "bt_pert_fr": "This approach is independent of the ABC methodology and will allow the estimates of the two approaches to be compared in order to assess the robustness of the results.", "questions": "[\"What is the approach independent of?\", \"What does the approach allow comparisons between?\", \"What is the purpose of comparing estimates from the two modelling approaches?\", \"What does the approach help judge?\"]", "answers": "[\"The ABC methodology\", \"The estimates of the two approaches\", \"To assess the robustness of the results\", \"The robustness of the results\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4000000000000001, "em": false, "chrf": 46.141523207108854, "bleu": 12.70331870386537}, {"f1": 0.8000000000000002, "em": false, "chrf": 72.0309483612647, "bleu": 42.7287006396234}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8, "avg_em": 0.5, "avg_chrf": 79.54311789209339, "avg_bleu": 63.858004835872215}
{"id": "PubMed_10:1009", "en": "This has been confirmed by PHE’s Caldicott Guardian’s Office.", "fr": "Cela a été confirmé par le bureau du gardien Caldicott de PHE.", "perturbation": "omission", "pert_fr": "Cela a été confirmé par le bureau de PHE.", "bt_pert_fr": "This has been confirmed by the PHE office.", "questions": "[\"What has been confirmed?\", \"Which office confirmed the information?\", \"What is the name of the office that confirmed the information?\"]", "answers": "[\"This\", \"the PHE office\", \"the PHE office\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 14.887217002227219, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.040796982545666, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 42.64267132825763, "avg_bleu": 33.33333333333335}
{"id": "PubMed_10:1012", "en": "Any cases identified will be managed according to the PHE/NHS guidance in force at the time, including advice for identified contacts.", "fr": "Tout cas identifié sera pris en charge conformément aux directives de PHE/NHS en vigueur au moment de sa détection, notamment les recommandations relatives aux contacts identifiés.", "perturbation": "omission", "pert_fr": "Tout cas identifié sera pris en charge conformément aux directives de PHE/NHS en vigueur au moment de sa détection.", "bt_pert_fr": "Any cases identified will be managed in accordance with PHE/NHS guidelines in force at the time of detection.", "questions": "[\"What happens to any cases identified?\", \"What does the guidance include?\", \"What is the basis for managing identified contacts?\"]", "answers": "[\"They will be managed in accordance with PHE/NHS guidelines in force at the time of detection\", \"Guidelines in force at the time of detection\", \"PHE/NHS guidelines in force at the time of detection\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 69.95430957059489, "bleu": 33.88714363186177}, {"f1": 0, "em": false, "chrf": 19.62654321087797, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.63500183555175, "bleu": 36.55552228545123}], "avg_f1": 0.44444444444444436, "avg_em": 0.0, "avg_chrf": 50.73861820567487, "avg_bleu": 23.480888639104336}
{"id": "PubMed_10:1024", "en": "We have rapidly created and incorporated new codes to allow data recording, and are collecting data to monitor the effectiveness of containment strategies.", "fr": "Nous avons rapidement créé et mis en œuvre de nouveaux codes afin de permettre l’enregistrement des données, et nous recueillons des données pour mesurer l’efficacité des stratégies de confinement.", "perturbation": "omission", "pert_fr": "Nous avons rapidement créé et mis en œuvre de nouveaux codes afin de permettre l’enregistrement des données, et nous recueillons des données pour mesurer l’efficacité des stratégies.", "bt_pert_fr": "We quickly created and implemented new codes to enable data recording, and we are collecting data to measure the effectiveness of the strategies.", "questions": "[\"What have we rapidly created and incorporated?\", \"What is the purpose of the new codes?\", \"What data are we collecting?\", \"What are we monitoring with the collected data?\", \"What is the goal of collecting data on containment strategies?\"]", "answers": "[\"New codes\", \"To enable data recording\", \"Data\", \"The effectiveness of the strategies\", \"To measure the effectiveness of the strategies\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 63.10579994379524, "bleu": 35.35533905932737}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.888888888888889, "em": false, "chrf": 66.72779957538879, "bleu": 49.76093899250716}, {"f1": 0.7272727272727272, "em": false, "chrf": 53.69811393327151, "bleu": 20.801195378010608}], "avg_f1": 0.8732323232323231, "avg_em": 0.4, "avg_chrf": 76.7063426904911, "avg_bleu": 61.18349468596905}
{"id": "PubMed_10:1025", "en": "Through this surveillance, we intend to find out more about the epidemiology of COVID-19 in ambulatory care.", "fr": "Au moyen de cette surveillance, nous prétendons en apprendre davantage sur l’épidémiologie du COVID-19 dans le cadre des soins ambulatoires.", "perturbation": "omission", "pert_fr": "Au moyen de cette surveillance, nous prétendons en apprendre davantage sur l’épidémiologie du COVID-19.", "bt_pert_fr": "Through this surveillance, we aim to learn more about the epidemiology of COVID-19.", "questions": "[\"What is the goal of the surveillance?\", \"What aspect of COVID-19 is being studied?\", \"What type of care setting is involved in the surveillance?\", \"What does the surveillance aim to reveal about COVID-19?\"]", "answers": "[\"To learn more about the epidemiology of COVID-19\", \"The epidemiology\", \"Not specified\", \"More about the epidemiology of COVID-19\"]", "scores": [{"f1": 0.7999999999999999, "em": false, "chrf": 77.86245073210439, "bleu": 55.780028607687655}, {"f1": 0.6666666666666666, "em": false, "chrf": 63.19716400738271, "bleu": 36.78794411714425}, {"f1": 0, "em": false, "chrf": 4.901960784313726, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6166666666666667, "avg_em": 0.25, "avg_chrf": 61.49039388095021, "avg_bleu": 48.14199318120799}
{"id": "PubMed_10:1027", "en": "Our testing of low-risk patients will also inform whether the containment strategy that is based on virology testing of high-risk patients and their contacts plus self-isolation is effective.", "fr": "Notre évaluation des patients à faible risque permettra également de déterminer si la stratégie de confinement fondée sur le dépistage virologique des patients à haut risque et de leurs contacts associée à l’auto-confinement est efficace.", "perturbation": "omission", "pert_fr": "Notre évaluation des patients à faible risque permettra également de déterminer si la stratégie de confinement fondée sur le dépistage virologique des patients à haut risque associée à l’auto-confinement est efficace.", "bt_pert_fr": "Our assessment of low-risk patients will also determine whether the containment strategy based on virological screening of high-risk patients associated with self-containment is effective.", "questions": "[\"What will our testing of low-risk patients inform?\", \"What is the containment strategy based on?\", \"What components are included in the containment strategy?\", \"Is the containment strategy effective?\", \"What is the role of virology testing in the containment strategy?\"]", "answers": "[\"Whether the containment strategy based on virological screening of high-risk patients associated with self-containment is effective\", \"virological screening of high-risk patients associated with self-containment\", \"virological screening of high-risk patients\", \"self-containment\", \"virological screening of high-risk patients\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 64.76435153863729, "bleu": 12.30068628846377}, {"f1": 0.33333333333333326, "em": false, "chrf": 48.714509961735075, "bleu": 16.009559139455188}, {"f1": 0.42857142857142855, "em": false, "chrf": 42.97898586927207, "bleu": 17.86690863748234}, {"f1": 0, "em": false, "chrf": 10.582010582010582, "bleu": 0.0}, {"f1": 0.4615384615384615, "em": false, "chrf": 52.643454013671885, "bleu": 21.82269148961669}], "avg_f1": 0.3446886446886447, "avg_em": 0.0, "avg_chrf": 43.93666239306538, "avg_bleu": 13.599969111003597}
{"id": "PubMed_10:1029", "en": "However, there may come a point at which the virus spreads more widely into the population, as has happened in Italy.", "fr": "Néanmoins, il se peut que le virus finisse par se propager plus largement au sein de la population, comme en Italie.", "perturbation": "omission", "pert_fr": "Néanmoins, il se peut que le virus finisse par se propager plus largement, comme en Italie.", "bt_pert_fr": "However, the virus may eventually spread more widely, such as in Italy.", "questions": "[\"When might the virus start spreading more widely into the population?\", \"What event is mentioned as having happened in Italy?\"]", "answers": "[\"Eventually\", \"The virus may spread more widely\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.483642020319868, "bleu": 0.0}, {"f1": 0.6153846153846153, "em": false, "chrf": 46.07491086720467, "bleu": 19.43309443637607}], "avg_f1": 0.30769230769230765, "avg_em": 0.0, "avg_chrf": 26.27927644376227, "avg_bleu": 9.716547218188035}
{"id": "PubMed_10:1030", "en": "Surveillance of low-risk patients should inform when we reach this tipping point and when infection rates start to remit.", "fr": "La surveillance des patients à faible risque devrait révéler le moment où nous atteindrons ce point critique et lorsque les taux d’infection commenceront à chuter.", "perturbation": "omission", "pert_fr": "La surveillance des patients devrait révéler le moment où nous atteindrons ce point critique et lorsque les taux d’infection commenceront à chuter.", "bt_pert_fr": "Patient monitoring should reveal when we reach this tipping point and when infection rates begin to fall.", "questions": "[\"What should surveillance of low-risk patients inform?\"]", "answers": "[\"When we reach this tipping point and when infection rates begin to fall\"]", "scores": [{"f1": 0.7692307692307693, "em": false, "chrf": 79.31854057237825, "bleu": 66.52049901111006}], "avg_f1": 0.7692307692307693, "avg_em": 0.0, "avg_chrf": 79.31854057237825, "avg_bleu": 66.52049901111006}
{"id": "PubMed_10:1033", "en": "The surveillance system should be able to identify areas where COVID-19 spread is taking place that might be suitable for trials of antiviral therapy.", "fr": "Le système de surveillance devrait être capable d’identifier les zones de propagation du COVID-19 où le traitement antiviral pourrait être étudié.", "perturbation": "omission", "pert_fr": "Le système de surveillance devrait être capable d’identifier les zones de propagation du COVID-19 où le traitement pourrait être étudié.", "bt_pert_fr": "The surveillance system should be able to identify areas of COVID-19 spread where treatment could be studied.", "questions": "[\"What should the surveillance system be able to identify?\", \"What is the purpose of the surveillance system?\"]", "answers": "[\"Areas of COVID-19 spread\", \"To identify areas where treatment could be studied\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 42.41140606238627, "bleu": 16.70067963244422}, {"f1": 0.35294117647058826, "em": false, "chrf": 34.60301749385705, "bleu": 18.141207173155518}], "avg_f1": 0.44919786096256686, "avg_em": 0.0, "avg_chrf": 38.50721177812166, "avg_bleu": 17.42094340279987}
{"id": "PubMed_10:1042", "en": "The impact on practices has been to close for a day, if a case is found, for deep cleaning and then reopen.", "fr": "La détection d’un cas entraîne la fermeture des cabinets sur la journée pour un nettoyage en profondeur puis leur réouverture le jour suivant.", "perturbation": "omission", "pert_fr": "La détection d’un cas entraîne la fermeture des cabinets pour un nettoyage en profondeur puis leur réouverture le jour suivant.", "bt_pert_fr": "The detection of a case leads to the closure of the offices for a thorough cleaning and then their reopening the following day.", "questions": "[\"What impact has been observed on practices?\", \"What happens when a case is found?\", \"What is done after a case is found?\", \"What follows after deep cleaning?\"]", "answers": "[\"The closure of offices for thorough cleaning and their reopening the following day\", \"The offices are closed for a thorough cleaning and then reopened the following day\", \"The offices are closed for a thorough cleaning and then reopened the following day\", \"The offices are reopened the following day\"]", "scores": [{"f1": 0.3125, "em": false, "chrf": 33.4806391418696, "bleu": 4.372564651695465}, {"f1": 0.25, "em": false, "chrf": 24.38849240253413, "bleu": 4.02724819242185}, {"f1": 0.125, "em": false, "chrf": 27.86905873458727, "bleu": 3.3864985683445354}, {"f1": 0, "em": false, "chrf": 32.166780266754984, "bleu": 0.0}], "avg_f1": 0.171875, "avg_em": 0.0, "avg_chrf": 29.476242636436496, "avg_bleu": 2.9465778531154627}
{"id": "PubMed_10:1043", "en": "The principal limitations of our system are the number of data points.", "fr": "Les principales limitations de notre système sont le nombre de points de données.", "perturbation": "omission", "pert_fr": "Les principales limitations de notre système sont le nombre de données.", "bt_pert_fr": "The main limitations of our system are the number of data.", "questions": "[\"What are the principal limitations of the system?\", \"What specific factor limits the system?\"]", "answers": "[\"The number of data\", \"The number of data\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 71.99753544701043, "bleu": 77.88007830714052}, {"f1": 0.888888888888889, "em": false, "chrf": 71.99753544701043, "bleu": 77.88007830714052}], "avg_f1": 0.888888888888889, "avg_em": 0.0, "avg_chrf": 71.99753544701043, "avg_bleu": 77.88007830714052}
{"id": "PubMed_10:1046", "en": "Our sites (surveillance practices) are currently fixed, and it could be helpful to be able to rapidly onboard practices in regions where there are more cases.", "fr": "Nos centres (les cabinets de surveillance) sont actuellement établis, et il pourrait s’avérer utile de pouvoir recruter rapidement des cabinets situés dans les régions où les cas sont plus nombreux.", "perturbation": "omission", "pert_fr": "Nos centres sont actuellement établis, et il pourrait s’avérer utile de pouvoir recruter rapidement des cabinets situés dans les régions où les cas sont nombreux.", "bt_pert_fr": "Our centers are currently established, and it could prove useful to be able to quickly recruit practices located in regions where cases are numerous.", "questions": "[\"What are our current surveillance practices?\", \"Why are our sites currently fixed?\", \"What is the potential benefit of rapidly onboarding practices?\"]", "answers": "[\"Quickly recruit practices located in regions where cases are numerous\", \"To be able to quickly recruit practices located in regions where cases are numerous\", \"To be able to quickly recruit practices located in regions where cases are numerous\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.179738562091504, "bleu": 0.0}, {"f1": 0.5454545454545454, "em": false, "chrf": 42.80046499138982, "bleu": 13.766043047275723}, {"f1": 0.2727272727272727, "em": false, "chrf": 30.115076861834723, "bleu": 3.737437943747671}], "avg_f1": 0.2727272727272727, "avg_em": 0.0, "avg_chrf": 27.698426805105353, "avg_bleu": 5.834493663674465}
{"id": "PubMed_10:1047", "en": "Currently, we will be reporting weekly.", "fr": "Pour l’heure, nous allons produire des rapports hebdomadaires.", "perturbation": "omission", "pert_fr": "Pour l’heure, nous allons produire des rapports.", "bt_pert_fr": "For now, we will produce reports.", "questions": "[\"What are we currently reporting?\", \"How often are we reporting?\", \"What is the current reporting schedule?\"]", "answers": "[\"Reports\", \"Not specified\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.6881720430107525, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.62962962962963, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.62962962962963, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 3.9824771007566704, "avg_bleu": 0.0}
{"id": "PubMed_10:1049", "en": "Opportunistic sampling for serology in children younger than 10 years might be limited due to the overall reduced rate of blood tests in children.", "fr": "L’échantillonnage sérologique opportuniste chez les enfants de moins de 10 ans pourrait être limité en raison du taux global réduit de prises de sang chez les enfants.", "perturbation": "omission", "pert_fr": "L’échantillonnage sérologique opportuniste chez les enfants pourrait être limité en raison du taux global réduit de prises de sang chez les enfants.", "bt_pert_fr": "Opportunistic serological sampling in children may be limited due to the overall reduced rate of blood draws in children.", "questions": "[\"What might limit opportunistic sampling for serology in children younger than 10 years?\", \"Why might the rate of blood tests in children be reduced?\", \"What is the relationship between blood test rates and opportunistic sampling in children?\"]", "answers": "[\"The overall reduced rate of blood draws in children\", \"Because the overall rate of blood draws in children is reduced\", \"The reduced rate of blood draws limits opportunistic sampling in children\"]", "scores": [{"f1": 0.8888888888888888, "em": false, "chrf": 83.74362252220716, "bleu": 66.06328636027612}, {"f1": 0, "em": false, "chrf": 10.404308091750062, "bleu": 0.0}, {"f1": 0.8333333333333333, "em": false, "chrf": 74.40969355078732, "bleu": 42.99352740507476}], "avg_f1": 0.5740740740740741, "avg_em": 0.0, "avg_chrf": 56.18587472158151, "avg_bleu": 36.35227125511696}
{"id": "PubMed_10:1051", "en": "The model of getting the appropriate informatics to enable capture of the required data has already been a success, with data recording starting the week the codes were created.", "fr": "Le modèle d’obtention de l’informatique appropriée pour permettre la saisie des données requises a déjà été un succès, l’enregistrement des données ayant commencé la semaine où les codes ont été créés.", "perturbation": "omission", "pert_fr": "Le modèle d’obtention de l’informatique appropriée pour permettre la saisie des données a déjà été un succès, l’enregistrement des données ayant commencé la semaine où les codes ont été créés.", "bt_pert_fr": "The model of obtaining the appropriate IT to enable data entry has already been a success, with data recording beginning the week the codes were created.", "questions": "[\"What is the model for getting appropriate informatics?\", \"When did data recording start?\", \"What is the outcome of the model?\"]", "answers": "[\"The model of obtaining the appropriate IT to enable data entry\", \"The week the codes were created\", \"Data recording began\"]", "scores": [{"f1": 0.6363636363636365, "em": false, "chrf": 45.01498357248359, "bleu": 17.491650626361267}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.713964109714425, "bleu": 55.03212081491043}], "avg_f1": 0.7676767676767677, "avg_em": 0.3333333333333333, "avg_chrf": 69.24298256073267, "avg_bleu": 57.50792381375725}
{"id": "PubMed_10:1052", "en": "In addition, modifying the existing surveillance system to collect population data in a parallel way has also been effective.", "fr": "Qui plus est, la modification du système de surveillance existant afin de recueillir les données de la population de façon parallèle a également été efficace.", "perturbation": "omission", "pert_fr": "Qui plus est, la modification du système de surveillance existant afin de recueillir les données de façon parallèle a également été efficace.", "bt_pert_fr": "Moreover, modifying the existing surveillance system to collect data in parallel was also effective.", "questions": "[\"How can the existing surveillance system be modified?\", \"What type of data can be collected in a parallel way?\"]", "answers": "[\"To collect data in parallel\", \"Data\"]", "scores": [{"f1": 0.8333333333333333, "em": false, "chrf": 57.823960339669, "bleu": 33.51600230178196}, {"f1": 0, "em": false, "chrf": 13.32369806354578, "bleu": 0.0}], "avg_f1": 0.41666666666666663, "avg_em": 0.0, "avg_chrf": 35.57382920160739, "avg_bleu": 16.75800115089098}
{"id": "PubMed_10:1053", "en": "However, we are at present unsure as to whether the scale of this surveillance provides sufficient data to drive local containment strategies or if reporting infrequently meets the need of our information age.", "fr": "Toutefois, nous ignorons à l’heure actuelle si l’envergure de cette surveillance fournit suffisamment de données pour donner lieu à des stratégies de confinement local ou si les rapports sporadiques répondent aux besoins de notre ère de l’information.", "perturbation": "omission", "pert_fr": "Toutefois, nous ignorons à l’heure actuelle si l’envergure de cette surveillance fournit suffisamment de données pour donner lieu à des stratégies de confinement local ou si les rapports répondent aux besoins de notre ère de l’information.", "bt_pert_fr": "However, we do not currently know whether the scale of this surveillance provides enough data to drive local containment strategies or whether the reporting meets the needs of our information age.", "questions": "[\"What is unsure regarding the scale of surveillance?\", \"Does the scale of surveillance provide sufficient data for local containment strategies?\"]", "answers": "[\"whether the scale of this surveillance provides enough data to drive local containment strategies or whether the reporting meets the needs of our information age\", \"It is unsure\"]", "scores": [{"f1": 0.8444444444444444, "em": false, "chrf": 77.06441972805436, "bleu": 57.74229296809054}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.4222222222222222, "avg_em": 0.0, "avg_chrf": 38.53220986402718, "avg_bleu": 28.87114648404527}
{"id": "Wikinews_2:1100", "en": "They did say he was not present at Chesapeake Energy Arena in Oklahoma City, where the Utah Jazz were to play against the Oklahoma City Thunder.", "fr": "Ils ont en revanche déclaré qu’il n’était pas présent au Chesapeake Energy Arena d’Oklahoma City, où les Utah Jazz devaient jouer contre les Oklahoma City Thunder.", "perturbation": "omission", "pert_fr": "Ils ont en revanche déclaré qu’il n’était pas présent au Chesapeake Energy Arena d’Oklahoma City, où les Utah Jazz devaient jouer contre les Thunder.", "bt_pert_fr": "However, they said he was not present at Chesapeake Energy Arena in Oklahoma City, where the Utah Jazz were scheduled to play the Thunder.", "questions": "[\"Who did they say was not present at Chesapeake Energy Arena?\", \"Where was the Utah Jazz supposed to play?\", \"Who was the Utah Jazz playing against at Chesapeake Energy Arena?\", \"What event was taking place at Chesapeake Energy Arena?\", \"What was the location of the game between the Utah Jazz and the Oklahoma City Thunder?\"]", "answers": "[\"He\", \"Chesapeake Energy Arena in Oklahoma City\", \"The Thunder\", \"The Utah Jazz were scheduled to play the Thunder\", \"Chesapeake Energy Arena in Oklahoma City\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 30.90117172421091, "bleu": 26.013004751144457}, {"f1": 0.47058823529411764, "em": false, "chrf": 34.60811243801439, "bleu": 11.59119922599073}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8274509803921568, "avg_em": 0.6, "avg_chrf": 73.10185683244507, "avg_bleu": 67.52084079542706}
{"id": "Wikinews_2:1104", "en": "The United States' other major basketball organization, the National Collegiate Athletic Association, which runs college basketball, has cancelled its own tournament, March Madness, for both men's and women's leagues.", "fr": "L’autre principale organisation de basket-ball des États-Unis, la National Collegiate Athletic Association, qui régit le basket-ball universitaire, a annulé son propre tournoi, le March Madness, pour les ligues masculine et féminine.", "perturbation": "omission", "pert_fr": "L’autre principale organisation de basket-ball des États-Unis, la National Collegiate Athletic Association, qui régit le basket-ball universitaire, a annulé son propre tournoi pour les ligues masculine et féminine.", "bt_pert_fr": "The other major basketball organization in the United States, the National Collegiate Athletic Association, which governs college basketball, canceled its own tournament for the men's and women's leagues.", "questions": "[\"What is the United States' other major basketball organization?\", \"What does the National Collegiate Athletic Association run?\", \"Which tournaments has the National Collegiate Athletic Association cancelled?\", \"What leagues are affected by the cancellation of the tournament?\"]", "answers": "[\"The National Collegiate Athletic Association\", \"College basketball\", \"Its own tournament\", \"Men's and women's leagues\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7499999999999999, "em": false, "chrf": 58.234072933552525, "bleu": 51.341711903259224}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9375, "avg_em": 0.75, "avg_chrf": 89.55851823338813, "avg_bleu": 87.83542797581484}
{"id": "Wikinews_2:1105", "en": "According to Johns Hopkins University, as of Wednesday, there were at least 1,279 confirmed cases of COVID-19 in the United States.", "fr": "D’après l’Université Johns Hopkins, en date de mercredi, il y avait au moins 1 279 cas confirmés de COVID-19 aux États-Unis.", "perturbation": "omission", "pert_fr": "D’après l’Université Johns Hopkins, il y avait au moins 1 279 cas confirmés de COVID-19 aux États-Unis.", "bt_pert_fr": "According to Johns Hopkins University, there have been at least 1,279 confirmed cases of COVID-19 in the United States.", "questions": "[\"What is the source of the information about COVID-19 cases?\", \"How many confirmed cases of COVID-19 were reported in the United States as of Wednesday?\", \"What is the total number of confirmed cases of COVID-19?\", \"Which institution provided the information about the cases?\"]", "answers": "[\"Johns Hopkins University\", \"at least 1,279\", \"1,279\", \"Johns Hopkins University\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 62.837498430239854, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.875, "avg_em": 0.75, "avg_chrf": 90.70937460755997, "avg_bleu": 81.87901510186384}
{"id": "Wikinews_5:1148", "en": "The move came two days after the World Health Organization declared the outbreak, which causes the COVID-19 disease, to be a pandemic.", "fr": "La décision a été annoncée deux jours après que l’Organisation mondiale de la santé ait déclaré que l’épidémie, responsable de la maladie COVID-19, était une pandémie.", "perturbation": "omission", "pert_fr": "La décision a été annoncée deux jours après que l’Organisation mondiale de la santé ait déclaré que l’épidémie était une pandémie.", "bt_pert_fr": "The decision was announced two days after the World Health Organization declared the outbreak a pandemic.", "questions": "[\"What disease does the outbreak cause?\", \"What is the significance of the World Health Organization's declaration?\"]", "answers": "[\"Not specified\", \"The outbreak is declared a pandemic\"]", "scores": [{"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5714285714285714, "em": false, "chrf": 42.72425297334489, "bleu": 11.4159380681175}], "avg_f1": 0.2857142857142857, "avg_em": 0.0, "avg_chrf": 21.362126486672445, "avg_bleu": 5.70796903405875}
{"id": "Wikinews_5:1151", "en": "The United States Department of Health and Human Services declared the outbreak a \"public health emergency\" on January 31.", "fr": "Le département de la Santé et des Services sociaux des États-Unis a déclaré l’épidémie une « urgence de santé publique » le 31 janvier.", "perturbation": "omission", "pert_fr": "Le département de la Santé des États-Unis a déclaré l’épidémie une « urgence de santé publique » le 31 janvier.", "bt_pert_fr": "The United States Department of Health declared the outbreak a “public health emergency” on January 31.", "questions": "[\"What agency declared the outbreak a 'public health emergency'?\", \"When was the outbreak declared a 'public health emergency'?\", \"What was the declaration regarding the outbreak?\", \"What is the significance of declaring the outbreak a 'public health emergency'?\", \"Which department declared the outbreak a 'public health emergency'?\"]", "answers": "[\"The United States Department of Health\", \"January 31\", \"a public health emergency\", \"It indicates that the outbreak is a serious threat to public health and requires urgent action\", \"The Department of Health\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 70.39587240032985, "bleu": 60.653065971263366}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 56.713218510415686, "bleu": 30.79300751569293}, {"f1": 0.6, "em": false, "chrf": 54.01002437696617, "bleu": 36.06452879987789}], "avg_f1": 0.8133333333333332, "avg_em": 0.4, "avg_chrf": 76.22382305754233, "avg_bleu": 65.50212045736686}
{"id": "Wikipedia_handpicked_5:1860", "en": "Impact of the 2019–20 coronavirus pandemic on education", "fr": "Impact de la pandémie de coronavirus de 2019-20 sur l’éducation", "perturbation": "omission", "pert_fr": "Impact de la pandémie de coronavirus sur l’éducation", "bt_pert_fr": "Impact of the coronavirus pandemic on education", "questions": "[\"What was the impact of the 2019–20 coronavirus pandemic on education?\", \"How did the pandemic affect education?\"]", "answers": "[\"The impact of the coronavirus pandemic on education\", \"It affected education\"]", "scores": [{"f1": 0.9333333333333333, "em": false, "chrf": 81.45521922457803, "bleu": 51.54486831107658}, {"f1": 0.5714285714285715, "em": false, "chrf": 60.987978609788506, "bleu": 39.43223765116288}], "avg_f1": 0.7523809523809524, "avg_em": 0.0, "avg_chrf": 71.22159891718327, "avg_bleu": 45.488552981119724}
{"id": "Wikipedia_handpicked_5:1861", "en": "The 2019–20 coronavirus pandemic has affected educational systems worldwide, leading to the widespread closures of schools and universities.", "fr": "La pandémie de coronavirus de 2019-20 a affecté les systèmes éducatifs du monde entier, entraînant la fermeture à grande échelle d’écoles et d’universités.", "perturbation": "omission", "pert_fr": "La pandémie de coronavirus de 2019-20 a affecté les systèmes éducatifs du monde entier, entraînant la fermeture à grande échelle d’écoles.", "bt_pert_fr": "The 2019-20 coronavirus pandemic affected education systems around the world, leading to large-scale school closures.", "questions": "[\"What has the 2019–20 coronavirus pandemic affected worldwide?\", \"What specific changes have occurred in educational systems due to the pandemic?\", \"What has led to the widespread closures of schools and universities?\", \"What impact has the pandemic had on education?\", \"What institutions have been closed due to the pandemic?\"]", "answers": "[\"Education systems\", \"Large-scale school closures\", \"The 2019–20 coronavirus pandemic\", \"Disruptions in education\", \"Schools and universities\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 71.18688063971533, "bleu": 49.99999999999999}, {"f1": 0.2222222222222222, "em": false, "chrf": 28.17098094775514, "bleu": 10.122592925934278}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 11.168622125932595, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5444444444444445, "avg_em": 0.4, "avg_chrf": 62.105296742680615, "avg_bleu": 52.02451858518687}
{"id": "Wikipedia_handpicked_5:1864", "en": "On 23 March 2020, Cambridge International Examinations (CIE) released a statement announcing the cancellation of Cambridge IGCSE, Cambridge O Level, Cambridge International AS &amp; A Level, Cambridge AICE Diploma, and Cambridge Pre-U examinations for the May/June 2020 series across all countries.", "fr": "Le 23 mars 2020, le centre des examens internationaux de Cambridge (Cambridge International Examinations, CIE) a publié une déclaration annonçant l’annulation des examens IGCSE, O-Level, AS &amp; A-Level internationaux, diplôme AICE et Pre-U de Cambridge pour les séries de mai/juin 2020 dans tous les pays.", "perturbation": "omission", "pert_fr": "Le 23 mars 2020, le centre des examens internationaux de Cambridge (Cambridge International Examinations, CIE) a publié une déclaration annonçant l’annulation des examens IGCSE, O-Level, AS &amp; A-Level internationaux, diplôme AICE et Pre-U de Cambridge pour les séries de mai/juin 2020.", "bt_pert_fr": "On 23 March 2020, Cambridge International Examinations (CIE) issued a statement announcing the cancellation of IGCSE, O-Level, AS &amp; International A-Level, AICE Diploma and Cambridge Pre-U for the May/June 2020 series.", "questions": "[\"When did Cambridge International Examinations release a statement about exam cancellations?\", \"What examinations were cancelled by Cambridge International Examinations?\", \"For which exam series were the examinations cancelled?\", \"In which countries were the examinations cancelled?\"]", "answers": "[\"23 March 2020\", \"IGCSE, O-Level, AS & International A-Level, AICE Diploma and Cambridge Pre-U\", \"May/June 2020 series\", \"Not specified\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5925925925925927, "em": false, "chrf": 48.31837305143332, "bleu": 21.938732647967637}, {"f1": 0.8, "em": false, "chrf": 87.36412646821265, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 9.84848484848485, "bleu": 0.0}], "avg_f1": 0.5981481481481482, "avg_em": 0.25, "avg_chrf": 61.382746092032704, "avg_bleu": 44.242713365719524}
{"id": "Wikipedia_handpicked_5:1865", "en": "International Baccalaureate exams have also been cancelled.School closures impact not only students, teachers, and families, but have far-reaching economic and societal consequences.", "fr": "Les épreuves du baccalauréat international ont également été annulées. La fermeture des écoles ne touche pas seulement les élèves, les enseignants et les familles, mais a aussi de lourdes conséquences économiques et sociales.", "perturbation": "omission", "pert_fr": "Les épreuves du baccalauréat international ont également été annulées. La fermeture des écoles ne touche pas seulement les élèves et les enseignants, mais a aussi de lourdes conséquences économiques et sociales.", "bt_pert_fr": "The International Baccalaureate exams have also been canceled. The closure of schools not only affects students and teachers, but also has serious economic and social consequences.", "questions": "[\"How do school closures impact students?\", \"How do school closures impact families?\", \"What are the economic consequences of school closures?\", \"What are the societal consequences of school closures?\"]", "answers": "[\"The closure of schools affects students and teachers\", \"The closure of schools affects families\", \"Serious economic consequences\", \"Serious social consequences\"]", "scores": [{"f1": 0, "em": false, "chrf": 43.482002491734654, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 41.825403963272464, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 87.20980356743414, "bleu": 27.516060407455225}, {"f1": 0.4, "em": false, "chrf": 68.35307841703826, "bleu": 27.516060407455225}], "avg_f1": 0.2, "avg_em": 0.0, "avg_chrf": 60.21757210986988, "avg_bleu": 13.758030203727612}
{"id": "Wikipedia_handpicked_5:1866", "en": "School closures in response to COVID-19 have shed light on various social and economic issues, including student debt, digital learning, food insecurity, and homelessness, as well as access to childcare, health care, housing, internet, and disability services.", "fr": "La fermeture des écoles en réponse au COVID-19 a révélé plusieurs problèmes économiques et sociaux, notamment la dette étudiante, l’apprentissage numérique, l’insécurité alimentaire et le problème des sans-abri, ainsi que l’accès à la garde d’enfants, aux services de santé, au logement, à l’Internet et aux services d’aide aux personnes handicapées.", "perturbation": "omission", "pert_fr": "La fermeture des écoles en réponse au COVID-19 a révélé plusieurs problèmes économiques et sociaux, notamment la dette étudiante, l’apprentissage numérique, l’insécurité alimentaire et le problème des sans-abri, ainsi que l’accès à la garde d’enfants, aux services de santé, au logement et aux services d’aide aux personnes handicapées.", "bt_pert_fr": "School closures in response to COVID-19 have exposed several economic and social problems, including student debt, digital learning, food insecurity and homelessness, as well as access to child care, health services, housing and disability services.", "questions": "[\"What social and economic issues have been shed light on by school closures in response to COVID-19?\"]", "answers": "[\"Student debt, digital learning, food insecurity and homelessness, as well as access to child care, health services, housing and disability services\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 86.87351155545254, "bleu": 63.371489335485336}], "avg_f1": 0.8571428571428571, "avg_em": 0.0, "avg_chrf": 86.87351155545254, "avg_bleu": 63.371489335485336}
{"id": "Wikipedia_handpicked_5:1867", "en": "The impact was more severe for disadvantaged children and their families, causing interrupted learning, compromised nutrition, childcare problems, and consequent economic cost to families who could not work.In response to school closures, UNESCO recommended the use of distance learning programmes and open educational applications and platforms that schools and teachers can use to reach learners remotely and limit the disruption of education.", "fr": "L’impact était plus important chez les enfants défavorisés et leurs familles, provoquant l’interruption de l’apprentissage, une mauvaise nutrition, des problèmes de garde d’enfants et les coûts économiques qui en résultent pour les familles ne pouvant pas travailler. En réponse à la fermeture des écoles, l’UNESCO a recommandé l’utilisation de programmes d’apprentissage à distance et d’applications et plateformes éducatives ouvertes grâce auxquels écoles et enseignants peuvent interagir avec les élèves à distance et limiter la perturbation de l’éducation.", "perturbation": "omission", "pert_fr": "L’impact était plus important chez les enfants défavorisés et leurs familles, provoquant l’interruption de l’apprentissage, une mauvaise nutrition, des problèmes de garde d’enfants et les coûts économiques qui en résultent pour les familles. En réponse à la fermeture des écoles, l’UNESCO a recommandé l’utilisation de programmes d’apprentissage à distance et d’applications éducatives ouvertes grâce auxquels écoles et enseignants peuvent interagir avec les élèves à distance et limiter la perturbation de l’éducation.", "bt_pert_fr": "The impact was greatest among disadvantaged children and their families, causing learning disruption, poor nutrition, childcare problems and resulting economic costs for families. In response to school closures, UNESCO has recommended the use of distance learning programs and open educational applications through which schools and teachers can interact with students remotely and limit disruption to education.", "questions": "[\"What was the impact on disadvantaged children and their families?\", \"What specific problems were caused by the impact?\", \"What are the consequences of interrupted learning?\", \"What economic cost did families face?\", \"What did UNESCO recommend in response to school closures?\", \"What types of distance learning programmes were recommended?\", \"What educational applications and platforms were suggested?\", \"How can schools and teachers use the recommended tools to reach learners remotely?\"]", "answers": "[\"Learning disruption, poor nutrition, childcare problems, and resulting economic costs\", \"Learning disruption, poor nutrition, childcare problems\", \"Economic costs for families\", \"Economic costs for families\", \"The use of distance learning programs and open educational applications\", \"Distance learning programs\", \"Open educational applications\", \"Schools and teachers can interact with students remotely using these tools\"]", "scores": [{"f1": 0, "em": false, "chrf": 11.699848368358563, "bleu": 0.0}, {"f1": 0.37499999999999994, "em": false, "chrf": 43.818601337643784, "bleu": 15.512258520268645}, {"f1": 0, "em": false, "chrf": 13.828512443736354, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 44.51883846589722, "bleu": 0.0}, {"f1": 0.8181818181818182, "em": false, "chrf": 80.78379736272423, "bleu": 53.87551338654778}, {"f1": 0.6666666666666666, "em": false, "chrf": 89.33415726091852, "bleu": 55.03212081491043}, {"f1": 0.7499999999999999, "em": false, "chrf": 71.78127441868972, "bleu": 51.341711903259224}, {"f1": 0.5185185185185185, "em": false, "chrf": 49.96824663013241, "bleu": 15.477529118979081}], "avg_f1": 0.3910458754208754, "avg_em": 0.0, "avg_chrf": 50.7166595360126, "avg_bleu": 23.904891717995646}
{"id": "Wikipedia_handpicked_5:1869", "en": "Mathematical modelling has shown that transmission of an outbreak may be delayed by closing schools.", "fr": "La modélisation mathématique a montré que la transmission d’une épidémie peut être retardée en fermant les écoles.", "perturbation": "omission", "pert_fr": "La modélisation mathématique a montré que la transmission peut être retardée en fermant les écoles.", "bt_pert_fr": "Mathematical modeling has shown that transmission can be delayed by closing schools.", "questions": "[\"What has mathematical modelling shown about the transmission of an outbreak?\", \"How can the transmission of an outbreak be delayed?\", \"What action can delay the transmission of an outbreak?\", \"What is the effect of closing schools on outbreak transmission?\"]", "answers": "[\"Transmission can be delayed\", \"By closing schools\", \"Closing schools\", \"Transmission can be delayed\"]", "scores": [{"f1": 0.46153846153846156, "em": false, "chrf": 38.68259132226595, "bleu": 10.129474235115733}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 40.46794938098882, "bleu": 0.0}], "avg_f1": 0.6153846153846154, "avg_em": 0.5, "avg_chrf": 69.78763517581369, "avg_bleu": 52.532368558778956}
{"id": "Wikipedia_handpicked_5:1870", "en": "However, effectiveness depends on the contacts children maintain outside of school.", "fr": "Toutefois, l’efficacité dépend des contacts que maintiennent les enfants en dehors de l’école.", "perturbation": "omission", "pert_fr": "Toutefois, l’efficacité dépend des contacts que les enfants maintiennent en dehors de l’école.", "bt_pert_fr": "However, effectiveness depends on the contacts that children maintain outside of school.", "questions": "[\"What depends on the contacts children maintain outside of school?\", \"What factors affect the effectiveness?\", \"What is the relationship between children's contacts and effectiveness?\"]", "answers": "[\"Effectiveness\", \"The contacts that children maintain outside of school\", \"Effectiveness depends on the contacts that children maintain outside of school\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9333333333333333, "em": false, "chrf": 91.61675977743361, "bleu": 59.460355750136046}, {"f1": 0.9473684210526316, "em": false, "chrf": 94.34744649789036, "bleu": 65.80370064762461}], "avg_f1": 0.960233918128655, "avg_em": 0.3333333333333333, "avg_chrf": 95.32140209177466, "avg_bleu": 75.08801879925356}
{"id": "Wikipedia_handpicked_5:1871", "en": "School closures may be effective when enacted promptly.", "fr": "La fermeture des écoles peut s’avérer efficace lorsqu’elle est adoptée rapidement.", "perturbation": "omission", "pert_fr": "La fermeture des écoles peut s’avérer efficace lorsqu’elle est adoptée.", "bt_pert_fr": "Closing schools can be effective when adopted.", "questions": "[\"When might school closures be effective?\", \"What happens when school closures are enacted promptly?\"]", "answers": "[\"When adopted\", \"They can be effective\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 22.18296428579903, "bleu": 30.326532985631665}, {"f1": 0.75, "em": false, "chrf": 65.04388721300487, "bleu": 35.35533905932737}], "avg_f1": 0.575, "avg_em": 0.0, "avg_chrf": 43.61342574940195, "avg_bleu": 32.84093602247952}
{"id": "Wikipedia_handpicked_5:1873", "en": "Additionally, in some cases, the reopening of schools after a period of closure has resulted in increased infection rates.", "fr": "En outre, dans certains cas, la réouverture des écoles après une période de fermeture a entraîné une augmentation des taux d’infection.", "perturbation": "omission", "pert_fr": "En outre, dans certains cas, la réouverture des écoles a entraîné une augmentation des taux d’infection.", "bt_pert_fr": "Additionally, in some cases, the reopening of schools has led to increased infection rates.", "questions": "[\"What has resulted from the reopening of schools after a period of closure?\", \"In what cases has the reopening of schools led to increased infection rates?\", \"What factor has contributed to increased infection rates?\", \"What is the impact of reopening schools after closure?\", \"What is the relationship between school reopening and infection rates?\"]", "answers": "[\"Increased infection rates\", \"In some cases\", \"The reopening of schools\", \"Increased infection rates\", \"The reopening of schools has led to increased infection rates\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 53.52097915883402, "bleu": 36.78794411714425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 58.82328324699751, "bleu": 26.33115348751055}], "avg_f1": 0.8666666666666666, "avg_em": 0.6, "avg_chrf": 82.4688524811663, "avg_bleu": 72.623819520931}
{"id": "Wikipedia_handpicked_5:1874", "en": "As closures tend to occur concurrently with other interventions such as public gathering bans, it can be difficult to measure the specific impact of school closures.During the 1918-1919 influenza pandemic in the United States, school closures and public gathering bans were associated with lower total mortality rates.", "fr": "Étant donné que les fermetures ont tendance à survenir en parallèle d’autres interventions telles que l’interdiction des rassemblements publics, il peut être difficile de mesurer l’impact spécifique de la fermeture des écoles. Pendant la pandémie de grippe de 1918-1919 aux États-Unis, la fermeture des écoles et l’interdiction des rassemblements publics ont été associées à un taux total de mortalité plus faible.", "perturbation": "omission", "pert_fr": "Étant donné que les fermetures ont tendance à survenir en parallèle d’autres interventions telles que l’interdiction des rassemblements publics, il peut être difficile de mesurer l’impact spécifique de la fermeture. Pendant la pandémie de grippe de 1918-1919 aux États-Unis, la fermeture des écoles et l’interdiction des rassemblements publics ont été associées à un taux total de mortalité plus faible.", "bt_pert_fr": "Since closures tend to occur alongside other interventions such as banning public gatherings, it can be difficult to measure the specific impact of the closure. During the 1918-1919 influenza pandemic in the United States, closing schools and banning public gatherings were associated with a lower total mortality rate.", "questions": "[\"What makes it difficult to measure the specific impact of school closures?\", \"What was observed during the 1918-1919 influenza pandemic in the United States?\", \"What was the relationship between school closures and public gathering bans during the 1918-1919 influenza pandemic?\", \"What was the outcome of school closures and public gathering bans during the 1918-1919 influenza pandemic?\"]", "answers": "[\"Other interventions such as banning public gatherings\", \"Closing schools and banning public gatherings were associated with a lower total mortality rate\", \"They were associated with each other\", \"A lower total mortality rate\"]", "scores": [{"f1": 0.38095238095238093, "em": false, "chrf": 48.740040805078856, "bleu": 9.66386143968492}, {"f1": 0.6153846153846154, "em": false, "chrf": 76.42788298093217, "bleu": 40.89601472043678}, {"f1": 0.3157894736842105, "em": false, "chrf": 28.557877900050176, "bleu": 9.408660393931463}, {"f1": 0.6666666666666665, "em": false, "chrf": 95.31916500738012, "bleu": 39.76353643835254}], "avg_f1": 0.49469828417196837, "avg_em": 0.0, "avg_chrf": 62.26124167336033, "avg_bleu": 24.933018248101426}
{"id": "Wikipedia_handpicked_5:1875", "en": "Cities that implemented such interventions earlier had greater delays in reaching peak mortality rates.", "fr": "Les premières villes ayant mis en œuvre ces interventions ont obtenu des délais plus importants avant d’atteindre le pic de mortalité.", "perturbation": "omission", "pert_fr": "Les premières villes ayant mis en œuvre ces interventions ont obtenu des délais plus importants avant d’atteindre le pic.", "bt_pert_fr": "The first cities to implement these interventions obtained longer delays before reaching the peak.", "questions": "[\"What does the sentence say about cities that implemented interventions earlier?\", \"What was observed in cities that implemented interventions earlier?\", \"What is the effect of early implementation of interventions on peak mortality rates?\", \"What is the outcome of early intervention in cities?\"]", "answers": "[\"The first cities to implement these interventions obtained longer delays before reaching the peak\", \"Cities that implemented interventions earlier experienced longer delays before reaching the peak\", \"Early implementation of interventions leads to longer delays before reaching the peak\", \"Longer delays before reaching the peak\"]", "scores": [{"f1": 0.29629629629629634, "em": false, "chrf": 47.75047105484321, "bleu": 6.803085237372876}, {"f1": 0.33333333333333326, "em": false, "chrf": 41.80792654846736, "bleu": 8.29519350710986}, {"f1": 0.33333333333333326, "em": false, "chrf": 43.4644305838377, "bleu": 8.29519350710986}, {"f1": 0.5, "em": false, "chrf": 44.001065331964476, "bleu": 15.84873897212071}], "avg_f1": 0.3657407407407407, "avg_em": 0.0, "avg_chrf": 44.25597337977818, "avg_bleu": 9.810552805928326}
{"id": "Wikipedia_handpicked_5:1877", "en": "School closures were shown to reduce morbidity from the Asian flu by 90% during the 1957–58 outbreak, and up to 50% in controlling influenza in the US, 2004–2008.Multiple countries successfully slowed the spread of infection through school closures during the 2009 H1N1 Flu pandemic.", "fr": "Il a été démontré que la fermeture des écoles a permis de réduire la morbidité de la grippe asiatique de 90 % lors de l’épidémie de 1957-58, et jusqu’à 50 % pour la lutte contre la grippe aux États-Unis, en 2004-2008. De nombreux pays ont réussi à ralentir la propagation de l’infection grâce à la fermeture des écoles pendant la pandémie de grippe H1N1 en 2009.", "perturbation": "omission", "pert_fr": "Il a été démontré que la fermeture des écoles a permis de réduire la morbidité de la grippe asiatique de 90 % lors de l’épidémie de 1957-58, et jusqu’à 50 % pour la lutte contre la grippe aux États-Unis. De nombreux pays ont réussi à ralentir la propagation de l’infection grâce à la fermeture des écoles pendant la pandémie de grippe H1N1 en 2009.", "bt_pert_fr": "Closing schools has been shown to reduce Asian flu morbidity by 90% during the 1957-58 epidemic, and by up to 50% for U.S. flu control. Many countries managed to slow the spread of infection by closing schools during the 2009 H1N1 influenza pandemic.", "questions": "[\"What was the effect of school closures on morbidity during the 1957–58 Asian flu outbreak?\", \"What was the reduction in morbidity from influenza in the US during 2004–2008?\", \"How effective were school closures in controlling the spread of infection during the 2009 H1N1 Flu pandemic?\", \"Which countries successfully slowed the spread of infection through school closures during the 2009 H1N1 Flu pandemic?\"]", "answers": "[\"Closing schools reduced Asian flu morbidity by 90% during the 1957–58 epidemic\", \"The provided sentence does not mention morbidity reduction in the US during 2004–2008\", \"School closures were effective in slowing the spread of infection during the 2009 H1N1 Flu pandemic\", \"Many countries\"]", "scores": [{"f1": 0.15384615384615385, "em": false, "chrf": 18.053200379207052, "bleu": 3.7477767366779213}, {"f1": 0.125, "em": false, "chrf": 30.5712297221074, "bleu": 3.3864985683445354}, {"f1": 0, "em": false, "chrf": 26.862733023572154, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 47.64749658825835, "bleu": 49.99999999999999}], "avg_f1": 0.19471153846153846, "avg_em": 0.0, "avg_chrf": 30.78366492828624, "avg_bleu": 14.283568826255612}
{"id": "Wikipedia_handpicked_5:1879", "en": "Mandatory school closures and other social distancing measures were associated with a 29% to 37% reduction in influenza transmission rates.", "fr": "La fermeture obligatoire des écoles et autres mesures de distanciation sociale ont été associées à une réduction de 29 % à 37 % du taux de propagation de la grippe.", "perturbation": "omission", "pert_fr": "La fermeture obligatoire des écoles ont été associées à une réduction de 29 % à 37 % du taux de propagation de la grippe.", "bt_pert_fr": "Mandatory school closures have been associated with a 29% to 37% reduction in the rate of influenza spread.", "questions": "[\"What measures were associated with a reduction in influenza transmission rates?\", \"What was the range of reduction in influenza transmission rates?\", \"What type of measures were considered mandatory?\"]", "answers": "[\"Mandatory school closures\", \"29% to 37%\", \"School closures\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 44.40149240629165, "bleu": 18.887560283756194}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8484848484848485, "avg_em": 0.6666666666666666, "avg_chrf": 81.46716413543055, "avg_bleu": 72.96252009458543}
{"id": "Wikipedia_handpicked_5:1880", "en": "Early school closures in the United States delayed the peak of the 2009 H1N1 Flu pandemic.", "fr": "La fermeture rapide des écoles aux États-Unis a retardé le pic de la pandémie de grippe H1N1 de 2009.", "perturbation": "omission", "pert_fr": "La fermeture rapide des écoles a retardé le pic de la pandémie de grippe H1N1 de 2009.", "bt_pert_fr": "Rapid school closures delayed the peak of the 2009 H1N1 flu pandemic.", "questions": "[\"What effect did early school closures have on the 2009 H1N1 Flu pandemic?\", \"What happened to the peak of the 2009 H1N1 Flu pandemic due to early school closures?\", \"Where did early school closures occur?\", \"What is the significance of early school closures in the context of the pandemic?\"]", "answers": "[\"Rapid school closures delayed the peak of the 2009 H1N1 flu pandemic\", \"The peak was delayed\", \"Not specified\", \"Early school closures helped delay the peak of the pandemic, potentially reducing the spread of the virus\"]", "scores": [{"f1": 0.30769230769230765, "em": false, "chrf": 46.671931513332325, "bleu": 8.392229812593097}, {"f1": 0.5714285714285715, "em": false, "chrf": 70.69438479973553, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 8.675719591457753, "bleu": 0.0}, {"f1": 0.5217391304347826, "em": false, "chrf": 53.47650875571199, "bleu": 15.133218633429316}], "avg_f1": 0.35021500238891545, "avg_em": 0.0, "avg_chrf": 44.8796361650594, "avg_bleu": 13.86815091458401}
{"id": "Wikipedia_handpicked_5:1881", "en": "Despite the overall success of closing schools, a study of school closures in Michigan found that \"district level reactive school closures were ineffective.\"During the swine flu outbreak in 2009 in the UK, in an article titled \"Closure of schools during an influenza pandemic\" published in the Lancet Infectious Diseases, a group of epidemiologists endorsed the closure of schools in order to interrupt the course of the infection, slow further spread and buy time to research and produce a vaccine.", "fr": "Malgré la réussite globale de la fermeture des écoles, une étude de la fermeture des écoles au Michigan a révélé que « la fermeture réactive des écoles au niveau du district avait été inefficace ». Pendant l’épidémie de grippe porcine en 2009 au Royaume-Uni, dans un article intitulé « Fermeture des écoles pendant une pandémie de grippe » publié dans le Lancet Infectious Diseases, un groupe d’épidémiologistes soutenait la fermeture des écoles afin d’interrompre l’évolution de l’infection, de ralentir sa propagation et de gagner du temps pour étudier et développer un vaccin.", "perturbation": "omission", "pert_fr": "Malgré la réussite globale de la fermeture des écoles, une étude de la fermeture des écoles au Michigan a révélé que « la fermeture réactive des écoles au niveau du district avait été inefficace ». Pendant l’épidémie de grippe porcine en 2009 au Royaume-Uni, dans un article intitulé « Fermeture des écoles pendant une pandémie de grippe » publié dans le Lancet Infectious Diseases, un groupe d’épidémiologistes soutenait la fermeture des écoles afin d’interrompre l’évolution de l’infection, de ralentir sa propagation et de gagner du temps pour étudier un vaccin.", "bt_pert_fr": "Despite the overall success of school closures, a study of school closures in Michigan found that \"reactive school closures at the district level had been ineffective.\" During the 2009 swine flu outbreak in the United Kingdom, in an article titled “Closing Schools During an Influenza Pandemic” published in the Lancet Infectious Diseases, a group of epidemiologists supported closing schools in order to interrupt the course of the infection, slow its spread, and buy time to study a vaccine.", "questions": "[\"What was the finding of the study on school closures in Michigan?\", \"Why were school closures endorsed during the swine flu outbreak in the UK?\", \"What was the goal of closing schools during the swine flu outbreak?\", \"What did the epidemiologists aim to achieve by closing schools during the swine flu outbreak?\"]", "answers": "[\"Reactive school closures at the district level had been ineffective\", \"To interrupt the course of the infection, slow its spread, and buy time to study a vaccine\", \"To interrupt the course of the infection\", \"To interrupt the course of the infection, slow its spread, and buy time to study a vaccine\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 75.6322075655824, "bleu": 11.339582221952005}, {"f1": 0.7999999999999999, "em": false, "chrf": 65.77604283043571, "bleu": 54.59709700160347}, {"f1": 0.47619047619047616, "em": false, "chrf": 37.084293918402196, "bleu": 11.080315836233392}, {"f1": 0.7999999999999999, "em": false, "chrf": 65.77604283043571, "bleu": 54.59709700160347}], "avg_f1": 0.644047619047619, "avg_em": 0.0, "avg_chrf": 61.06714678621401, "avg_bleu": 32.903523015348085}
{"id": "Wikipedia_handpicked_5:1883", "en": "They also looked at the dynamics of the spread of influenza in France during French school holidays and noted that cases of flu dropped when schools closed and re-emerged when they re-opened.", "fr": "Ils ont également examiné la dynamique de la propagation de la grippe en France pendant les vacances scolaires françaises et ont souligné que les cas de grippe ont chuté avec la fermeture des écoles et sont remontés lors de leur réouverture.", "perturbation": "omission", "pert_fr": "Ils ont également examiné la dynamique de la propagation de la grippe en France pendant les vacances scolaires françaises et ont souligné que les cas de grippe ont chuté avec la fermeture des écoles.", "bt_pert_fr": "They also looked at the dynamics of the spread of flu in France during French school holidays and highlighted that flu cases fell as schools closed.", "questions": "[\"What did they look at regarding the spread of influenza in France?\", \"What happened to flu cases when schools closed?\", \"What happened to flu cases when schools re-opened?\", \"What factors were associated with the spread of influenza during school holidays?\", \"What is the relationship between school closures and flu cases?\"]", "answers": "[\"the dynamics of the spread of flu in France during French school holidays\", \"flu cases fell\", \"not mentioned\", \"school closures\", \"flu cases fell\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 83.61097350051385, "bleu": 70.16879391277372}, {"f1": 0.5714285714285715, "em": false, "chrf": 25.803067922057497, "bleu": 24.840753130578644}, {"f1": 0, "em": false, "chrf": 6.389016720355883, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 52.25092476062709, "bleu": 36.78794411714425}, {"f1": 0.1904761904761905, "em": false, "chrf": 7.809790642867545, "bleu": 0.3708035132981346}], "avg_f1": 0.4675324675324675, "avg_em": 0.0, "avg_chrf": 35.172754709284376, "avg_bleu": 26.43365893475895}
{"id": "Wikipedia_handpicked_5:1886", "en": "When there is minimal to moderate community transmission, social distancing strategies can be implemented such as cancelling field trips, assemblies, and other large gatherings such as physical education or choir classes or meals in a cafeteria, increasing the space between desks, staggering arrival and dismissal times, limiting nonessential visitors, and using a separate health office location for children with flu-like symptoms.", "fr": "En cas de transmission communautaire minimale à modérée, des stratégies de distanciation sociale peuvent être mises en œuvre, telles que l’annulation des sorties pédagogiques, des assemblées et autres rassemblements importants comme les cours d’éducation physique ou de chorale ou les repas à la cantine, en augmentant l’espace entre les bureaux, en échelonnant les heures d’arrivée et de sortie, en réduisant les visiteurs non essentiels et en utilisant une infirmerie séparée pour les enfants présentant des symptômes grippaux.", "perturbation": "omission", "pert_fr": "En cas de transmission communautaire minimale à modérée, des stratégies de distanciation sociale peuvent être mises en œuvre, telles que l’annulation des sorties pédagogiques, des assemblées et autres rassemblements importants comme les cours d’éducation physique ou de chorale ou les repas à la cantine, en augmentant l’espace entre les bureaux, en échelonnant les heures d’arrivée et de sortie, en réduisant les visiteurs non essentiels et en utilisant une infirmerie pour les enfants présentant des symptômes grippaux.", "bt_pert_fr": "In cases of minimal to moderate community transmission, social distancing strategies may be implemented, such as canceling field trips, assemblies and other large gatherings such as physical education or choir classes or canteen meals, increasing space between desks, staggering arrival and departure times, reducing non-essential visitors and using a sick bay for children with flu-like symptoms.", "questions": "[\"What social distancing strategies can be implemented when there is minimal to moderate community transmission?\", \"What large gatherings are mentioned as being canceled?\", \"What changes can be made to classroom settings during minimal to moderate community transmission?\", \"What measures can be taken to limit nonessential visitors?\", \"What is the purpose of using a separate health office location for children with flu-like symptoms?\"]", "answers": "[\"Canceling field trips, assemblies, and other large gatherings such as physical education or choir classes or canteen meals, increasing space between desks, staggering arrival and departure times, reducing non-essential visitors, and using a sick bay for children with flu-like symptoms\", \"Field trips, assemblies, physical education, choir classes, and canteen meals\", \"Increasing space between desks\", \"Reducing non-essential visitors\", \"To provide a separate space for children with flu-like symptoms to avoid spreading illness\"]", "scores": [{"f1": 0.8148148148148148, "em": false, "chrf": 78.7569267277469, "bleu": 61.70841766077004}, {"f1": 0.8571428571428572, "em": false, "chrf": 82.2791471762867, "bleu": 70.80735452207037}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.30351760424223, "bleu": 55.03212081491043}, {"f1": 0.7407407407407408, "em": false, "chrf": 65.90584395657224, "bleu": 61.59539301615259}], "avg_f1": 0.8158730158730159, "avg_em": 0.2, "avg_chrf": 81.44908709296962, "avg_bleu": 69.8286572027807}
{"id": "Wikipedia_handpicked_5:1887", "en": "When there is substantial transmission in the local community, in addition to social distancing strategies, extended school dismissals may be considered.", "fr": "En cas de transmission importante dans la population locale, outre les stratégies de distanciation sociale, un prolongement des vacances scolaires peut être envisagé.", "perturbation": "omission", "pert_fr": "En cas de transmission importante dans la population, outre les stratégies de distanciation sociale, un prolongement des vacances scolaires peut être envisagé.", "bt_pert_fr": "In the event of significant transmission in the population, in addition to social distancing strategies, an extension of school holidays may be considered.", "questions": "[\"What happens when there is substantial transmission in the local community?\", \"What may be considered during substantial transmission?\"]", "answers": "[\"An extension of school holidays may be considered\", \"An extension of school holidays\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 52.76116292989082, "bleu": 22.089591134157878}, {"f1": 0.25, "em": false, "chrf": 27.82478692734295, "bleu": 10.682175159905853}], "avg_f1": 0.41071428571428575, "avg_em": 0.0, "avg_chrf": 40.292974928616886, "avg_bleu": 16.385883147031866}
{"id": "Wikipedia_handpicked_5:1889", "en": "Universities and schools around the country closed.", "fr": "Les universités et écoles du pays ont été fermées.", "perturbation": "omission", "pert_fr": "Les écoles du pays ont été fermées.", "bt_pert_fr": "Schools across the country have been closed.", "questions": "[\"What closed?\", \"Where did the closures occur?\", \"What types of institutions closed?\"]", "answers": "[\"Schools\", \"across the country\", \"schools\"]", "scores": [{"f1": 0, "em": false, "chrf": 20.434601567005707, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 46.50738150738151, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 26.603617187290375, "bleu": 13.533528323661276}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 31.181866753892532, "avg_bleu": 21.177842774553756}
{"id": "Wikipedia_handpicked_5:1890", "en": "On 23 February, Iran's Ministry of Health announced the closure of universities, higher educational institutions and schools in several cities and provinces.", "fr": "Le 23 février, le ministre de la Santé iranien a annoncé la fermeture des universités, des établissements d’éducation supérieure et des écoles de plusieurs villes et provinces.", "perturbation": "omission", "pert_fr": "Le 23 février, le ministre de la Santé iranien a annoncé la fermeture des universités et des écoles de plusieurs villes et provinces.", "bt_pert_fr": "On February 23, Iran's health minister announced the closure of universities and schools in several cities and provinces.", "questions": "[\"What was announced by Iran's Ministry of Health on 23 February?\", \"Which institutions were closed on 23 February?\", \"In which cities and provinces were institutions closed?\", \"What type of institutions were closed?\", \"What action was taken by Iran's Ministry of Health on 23 February?\"]", "answers": "[\"The closure of universities and schools in several cities and provinces\", \"Universities and schools\", \"Several cities and provinces\", \"Universities and schools\", \"The closure of universities and schools in several cities and provinces\"]", "scores": [{"f1": 0.88, "em": false, "chrf": 69.51334634535256, "bleu": 61.91566827062977}, {"f1": 0.6666666666666666, "em": false, "chrf": 41.54183127563106, "bleu": 23.174952587773145}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 41.54183127563106, "bleu": 23.174952587773145}, {"f1": 0, "em": false, "chrf": 9.1661552810555, "bleu": 0.0}], "avg_f1": 0.6426666666666667, "avg_em": 0.2, "avg_chrf": 52.35263283553404, "avg_bleu": 41.653114689235224}
{"id": "Wikipedia_handpicked_5:1893", "en": "In reaction, UNESCO called on countries to support affected students and families and facilitate large-scale inclusive distance learning programmes.", "fr": "En réaction, l’UNESCO a appelé les pays à soutenir les élèves affectés et leurs familles et à mettre en place des programmes d’apprentissage à distance inclusifs à grande échelle.", "perturbation": "omission", "pert_fr": "En réaction, l’UNESCO a appelé les pays à soutenir les élèves affectés et à mettre en place des programmes d’apprentissage à distance inclusifs à grande échelle.", "bt_pert_fr": "In response, UNESCO called on countries to support affected students and implement large-scale inclusive distance learning programs.", "questions": "[\"What did UNESCO call on countries to do?\", \"What specific actions did UNESCO recommend for affected students and families?\", \"What type of distance learning programmes did UNESCO recommend?\"]", "answers": "[\"Support affected students and implement large-scale inclusive distance learning programs\", \"Support affected students\", \"Inclusive distance learning programs\"]", "scores": [{"f1": 0.608695652173913, "em": false, "chrf": 72.0043368920529, "bleu": 28.1450060327443}, {"f1": 0.7499999999999999, "em": false, "chrf": 69.87045069703277, "bleu": 51.341711903259224}, {"f1": 0.4444444444444445, "em": false, "chrf": 71.41325142089094, "bleu": 24.880469496253564}], "avg_f1": 0.6010466988727857, "avg_em": 0.0, "avg_chrf": 71.09601300332554, "avg_bleu": 34.78906247741903}
{"id": "Wikipedia_handpicked_5:1896", "en": "On 5 March, the majority of learners affected by COVID-19 emergency measures were located in China, with 233 million learners affected, followed by Japan at 16.5 million and Iran at 14.5 million.", "fr": "Le 5 mars, la majorité des élèves touchés par les mesures d’urgence du COVID-19 se trouvaient en Chine, avec 233 millions d’élèves affectés, suivis par le Japon avec 16,5 millions et l’Iran avec 14,5 millions.", "perturbation": "omission", "pert_fr": "Le 5 mars, la majorité des élèves touchés par les mesures d’urgence du COVID-19 se trouvaient en Chine, avec 233 millions d’élèves affectés, suivis par l’Iran avec 14,5 millions.", "bt_pert_fr": "As of March 5, the majority of students affected by COVID-19 emergency measures were in China, with 233 million students affected, followed by Iran with 14.5 million.", "questions": "[\"Where were the majority of learners affected by COVID-19 emergency measures located on 5 March?\", \"How many learners were affected in China on 5 March?\", \"How many learners were affected in Japan on 5 March?\", \"How many learners were affected in Iran on 5 March?\", \"What is the context of the learners' affected status?\"]", "answers": "[\"China\", \"233 million\", \"0\", \"14.5 million\", \"COVID-19 emergency measures\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8, "avg_em": 0.8, "avg_chrf": 80.0, "avg_bleu": 80.00000000000003}
{"id": "Wikipedia_handpicked_5:1899", "en": "By 16 March, this figure increased from 49 to 73 countries according to UNESCO.", "fr": "Le 16 mars, ce chiffre est passé de 49 à 73 pays selon l’UNESCO.", "perturbation": "omission", "pert_fr": "Le 16 mars, ce chiffre est passé à 73 pays selon l’UNESCO.", "bt_pert_fr": "On March 16, this figure increased to 73 countries according to UNESCO.", "questions": "[\"What was the figure before 16 March?\", \"What was the figure on 16 March?\", \"How many countries did the figure increase to by 16 March?\", \"How many countries was the figure increased from?\", \"What organization reported the increase in the number of countries?\"]", "answers": "[\"Unknown\", \"73 countries\", \"73\", \"Unknown\", \"UNESCO\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikipedia_handpicked_5:1902", "en": "On 23 March, all Nigerian school were found to have been closed down by Nigerian government, markets as well as companies were closed down and children were forbidden by parents to step out of their homes.", "fr": "Le 23 mars, toutes les écoles nigérianes avaient été fermées par le gouvernement nigérian, les marchés et entreprises étaient fermés et les parents interdisaient à leurs enfants de sortir de chez eux.", "perturbation": "omission", "pert_fr": "Le 23 mars, toutes les écoles nigérianes avaient été fermées par le gouvernement nigérian, les marchés et entreprises étaient fermés et les parents interdisaient à leurs enfants de sortir.", "bt_pert_fr": "By March 23, all Nigerian schools had been closed by the Nigerian government, markets and businesses were closed, and parents were prohibiting their children from going out.", "questions": "[\"What happened to Nigerian schools on 23 March?\", \"What other places were closed down by the Nigerian government?\", \"What was forbidden to children by their parents?\", \"What actions were taken by the Nigerian government on 23 March?\"]", "answers": "[\"They were closed\", \"Markets and businesses\", \"Going out\", \"Closed Nigerian schools\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 32.85480221117003, "bleu": 28.254432923044853}, {"f1": 0.6666666666666666, "em": false, "chrf": 48.71165004576979, "bleu": 55.03212081491043}, {"f1": 0.25, "em": false, "chrf": 7.463460705102489, "bleu": 6.7667641618306344}, {"f1": 0.6, "em": false, "chrf": 43.03352499088301, "bleu": 16.605579150202516}], "avg_f1": 0.5041666666666667, "avg_em": 0.0, "avg_chrf": 33.01585948823133, "avg_bleu": 26.664724262497106}
{"id": "Wikipedia_handpicked_5:1903", "en": "On 26 March, all New Zealand schools and universities have been closed down across the country.", "fr": "Le 26 mars, toutes les écoles et universités néo-zélandaises ont été fermées dans l’ensemble du pays.", "perturbation": "omission", "pert_fr": "Le 26 mars, toutes les écoles ont été fermées dans l’ensemble du pays.", "bt_pert_fr": "On March 26, all schools were closed across the country.", "questions": "[\"When were all New Zealand schools and universities closed down?\", \"What was closed down in New Zealand on 26 March?\", \"What institutions were closed down across New Zealand?\", \"What happened to schools and universities in New Zealand on 26 March?\"]", "answers": "[\"On March 26\", \"All schools\", \"Schools\", \"Schools and universities\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 50.58538799495517, "bleu": 34.66806371753173}, {"f1": 0.6666666666666666, "em": false, "chrf": 38.04795263100407, "bleu": 36.78794411714425}, {"f1": 0.5, "em": false, "chrf": 26.603617187290375, "bleu": 13.533528323661276}, {"f1": 0, "em": false, "chrf": 10.688119978963787, "bleu": 0.0}], "avg_f1": 0.4916666666666667, "avg_em": 0.0, "avg_chrf": 31.48126944805335, "avg_bleu": 21.247384039584315}
{"id": "Wikipedia_handpicked_5:1909", "en": "By 29 March, more than 1.5 billion children and other students were affected by nationwide school closures.", "fr": "Le 29 mars, plus de 1,5 1,5 milliard d’enfants et étudiants étaient touchés par la fermeture des écoles à l’échelle nationale.", "perturbation": "omission", "pert_fr": "Le 29 mars, plus de 1,5 milliard d’enfants étaient touchés par la fermeture des écoles à l’échelle nationale.", "bt_pert_fr": "As of March 29, more than 1.5 billion children were affected by nationwide school closures.", "questions": "[\"How many children and other students were affected by nationwide school closures by 29 March?\", \"What event led to the impact on children and other students?\", \"What was the impact of nationwide school closures on students?\", \"What is the total number of affected students by 29 March?\"]", "answers": "[\"More than 1.5 billion children and other students\", \"Nationwide school closures\", \"Nationwide school closures affected children and other students\", \"More than 1.5 billion\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 75.03138386566201, "bleu": 34.57207846419409}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2, "em": false, "chrf": 52.591882715080665, "bleu": 5.522397783539471}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7166666666666667, "avg_em": 0.5, "avg_chrf": 81.90581664518567, "avg_bleu": 60.02361906193341}
{"id": "Wikipedia_handpicked_5:1910", "en": "Others were disrupted by localized closures.", "fr": "D’autres étaient perturbés par les fermetures localisées.", "perturbation": "omission", "pert_fr": "D’autres étaient perturbés par les fermetures.", "bt_pert_fr": "Others were disturbed by the closures.", "questions": "[\"What was disrupted by localized closures?\", \"Who were affected by localized closures?\", \"What types of disruptions occurred due to localized closures?\"]", "answers": "[\"Others\", \"Others\", \"disturbance\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 9.565087539217222, "bleu": 0.0}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 69.85502917973908, "avg_bleu": 66.6666666666667}
{"id": "Wikipedia_handpicked_5:1911", "en": "Until April 6, holidays were extended in all secondary schools of Turkmenistan.", "fr": "Jusqu’au 6 avril, les vacances ont été prolongées dans toutes les écoles secondaires au Turkménistan.", "perturbation": "omission", "pert_fr": "Jusqu’au 6 avril, les vacances ont été prolongées dans toutes les écoles au Turkménistan.", "bt_pert_fr": "Until April 6, holidays have been extended in all schools in Turkmenistan.", "questions": "[\"Until what date were holidays extended in Turkmenistan?\", \"Which schools had holidays extended?\", \"What type of schools were affected by the holiday extension?\"]", "answers": "[\"April 6\", \"all schools in Turkmenistan\", \"all schools\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.28571428571428575, "em": false, "chrf": 33.51153504073099, "bleu": 15.97357760615681}, {"f1": 0.5, "em": false, "chrf": 36.485583802818525, "bleu": 49.99999999999999}], "avg_f1": 0.5952380952380952, "avg_em": 0.3333333333333333, "avg_chrf": 56.66570628118317, "avg_bleu": 55.32452586871895}
{"id": "Wikipedia_handpicked_5:1912", "en": "An order signed by the Ministry of Education as a preventative measure aims to prevent the spread of respiratory diseases in connection with the WHO coronavirus pandemic.", "fr": "Une ordonnance signée par le ministère de l’Éducation en tant que mesure de prévention vise à éviter la propagation des maladies respiratoires liées à la pandémie de coronavirus de l’OMS.", "perturbation": "omission", "pert_fr": "Une ordonnance signée par le ministère de l’Éducation en tant que mesure de prévention vise à éviter la propagation des maladies respiratoires liées à la pandémie de l’OMS. \n\nPerturbed: Une ordonnance signée par le ministère de l’Éducation vise à éviter la propagation des maladies respiratoires liées à la pandémie de coronavirus de l’OMS.", "bt_pert_fr": "An order signed by the Ministry of Education as a preventive measure aims to avoid the spread of respiratory diseases linked to the WHO pandemic. \n\nDisturbed: An order signed by the Ministry of Education aims to prevent the spread of respiratory diseases linked to the WHO coronavirus pandemic.", "questions": "[\"What is the purpose of the order signed by the Ministry of Education?\", \"What type of disease is the order aimed at preventing?\", \"What is the connection between the order and the WHO coronavirus pandemic?\", \"Who signed the order?\"]", "answers": "[\"To avoid the spread of respiratory diseases\", \"Respiratory diseases\", \"The order is aimed at preventing the spread of respiratory diseases linked to the WHO coronavirus pandemic\", \"The Ministry of Education\"]", "scores": [{"f1": 0.8333333333333334, "em": false, "chrf": 75.83495433981432, "bleu": 53.7284965911771}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6470588235294117, "em": false, "chrf": 66.58847835970343, "bleu": 31.007934138748674}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8700980392156863, "avg_em": 0.5, "avg_chrf": 85.60585817487944, "avg_bleu": 71.18410768248147}
{"id": "Wikipedia_handpicked_5:1913", "en": "10 countries have localised schools closures, UNESCO estimates  473,933,356  learners are potentially at risk (pre-primary to upper-secondary education) and 77,938,904 learners are potentially at risk in tertiary education.", "fr": "Dix pays ont pris des mesures locales de fermeture des écoles, l’UNESCO estime que 473 933 356 élèves de l’enseignement pré-primaire à l’enseignement secondaire supérieur et 77 938 904 étudiants de l’enseignement supérieur risquent de se trouver en difficulté.", "perturbation": "omission", "pert_fr": "Dix pays ont pris des mesures locales de fermeture, l’UNESCO estime que 473 933 356 élèves de l’enseignement pré-primaire à l’enseignement secondaire supérieur et 77 938 904 étudiants de l’enseignement supérieur risquent de se trouver en difficulté.", "bt_pert_fr": "Ten countries have taken local closure measures, with UNESCO estimating that 473,933,356 students from pre-primary to upper secondary education and 77,938,904 higher education students are at risk of difficulty.", "questions": "[\"How many countries have localised school closures?\", \"How many learners are potentially at risk in pre-primary to upper-secondary education?\", \"How many learners are potentially at risk in tertiary education?\", \"What education levels are included in the at-risk learners count?\", \"What organization estimates the number of learners at risk?\"]", "answers": "[\"Ten\", \"473,933,356\", \"77,938,904\", \"pre-primary to upper secondary education and higher education\", \"UNESCO\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 90.01170734362758, "bleu": 12.223075560872525}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.5, "avg_chrf": 95.00585367181378, "avg_bleu": 56.11153778043629}
{"id": "Wikipedia_handpicked_5:1914", "en": "Note: Figures correspond to total number of learners enrolled at pre-primary, primary, lower-secondary, and upper-secondary levels of education [ISCED levels 0 to 3], as well as at tertiary education levels [ISCED levels 5 to 8] who could be affected should localised closures become countrywide.", "fr": "Remarque : les chiffres correspondent au nombre total d’élèves inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement supérieur [niveaux 5 à 8 de la CITE] qui pourraient être affectés si les fermetures localisées devenaient nationales.", "perturbation": "omission", "pert_fr": "Remarque : les chiffres correspondent au nombre total d’élèves inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE] qui pourraient être affectés si les fermetures localisées devenaient nationales.", "bt_pert_fr": "Note: Figures represent the total number of students enrolled in pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0-3] who could be affected if localized closures become national.", "questions": "[\"What does the term 'figures' correspond to?\", \"Which education levels are included in the figures?\", \"What are the ISCED levels for pre-primary to upper-secondary education?\", \"What are the ISCED levels for tertiary education?\", \"What happens to the figures if localised closures become countrywide?\"]", "answers": "[\"the total number of students enrolled in pre-primary, primary, lower secondary and upper secondary education\", \"pre-primary, primary, lower secondary and upper secondary education\", \"0-3\", \"Not specified\", \"They become the total number of students affected nationwide\"]", "scores": [{"f1": 0.29090909090909095, "em": false, "chrf": 38.07766815517685, "bleu": 2.1730316525257147}, {"f1": 0.3, "em": false, "chrf": 64.84077346190502, "bleu": 4.408194605881708}, {"f1": 0, "em": false, "chrf": 27.77777777777778, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.928571428571429, "bleu": 0.0}, {"f1": 0.33333333333333326, "em": false, "chrf": 31.563778082014487, "bleu": 9.519340818348473}], "avg_f1": 0.18484848484848485, "avg_em": 0.0, "avg_chrf": 34.23771378108911, "avg_bleu": 3.2201134153511797}
{"id": "Wikipedia_handpicked_5:1915", "en": "Enrolment figures based on latest UNESCO Institute of Statistics data.", "fr": "Les chiffres des effectifs sont fondés sur les données les plus récentes de l’Institut de statistique de l’UNESCO.", "perturbation": "omission", "pert_fr": "Les chiffres des effectifs sont fondés sur les données de l’Institut de statistique de l’UNESCO.", "bt_pert_fr": "Headcount figures are based on data from the UNESCO Institute for Statistics.", "questions": "[\"What enrolment figures are based on?\", \"Which data source is used for the enrolment figures?\", \"What does the UNESCO Institute of Statistics provide in this context?\"]", "answers": "[\"Headcount figures\", \"UNESCO Institute for Statistics\", \"The data used for headcount figures\"]", "scores": [{"f1": 0, "em": false, "chrf": 6.62172846677639, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 81.62345440341757, "bleu": 35.35533905932737}, {"f1": 0.25, "em": false, "chrf": 42.79033141078106, "bleu": 8.116697886877475}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 43.678504760325005, "avg_bleu": 14.490678982068282}
{"id": "Wikipedia_handpicked_5:1917", "en": "As of March 12, more than 370 million children and youth are not attending school because of temporary or indefinite country wide school closures mandated by governments in an attempt to slow the spread of COVID-19.", "fr": "Depuis le 12 mars, plus de 370 millions d’enfants et de jeunes ne se rendent pas à l’école en raison de la fermeture temporaire ou pour une durée indéterminée des écoles à l’échelle nationale imposée par les gouvernements dans l’espoir de ralentir la propagation du COVID-19.", "perturbation": "omission", "pert_fr": "Depuis le 12 mars, plus de 370 millions d’enfants et de jeunes ne se rendent pas à l’école en raison de la fermeture temporaire des écoles à l’échelle nationale imposée par les gouvernements dans l’espoir de ralentir la propagation du COVID-19.", "bt_pert_fr": "Since March 12, more than 370 million children and young people have been out of school due to temporary nationwide school closures imposed by governments in the hope of slowing the spread of COVID-19.", "questions": "[\"What is the number of children and youth not attending school as of March 12?\", \"Why are children and youth not attending school?\", \"What type of school closures are causing the absence of children and youth?\", \"Which governments have mandated school closures?\", \"What is the purpose of the school closures?\", \"What is the impact of the school closures on children and youth?\"]", "answers": "[\"370 million\", \"To slow the spread of COVID-19\", \"Temporary nationwide school closures\", \"Governments\", \"To slow the spread of COVID-19\", \"They have been out of school\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 53.31918685462929, "bleu": 36.78794411714425}, {"f1": 0.3333333333333333, "em": false, "chrf": 20.20486121323782, "bleu": 4.066613982562358}, {"f1": 0.36363636363636365, "em": false, "chrf": 53.006785612859, "bleu": 15.090767577522726}, {"f1": 0, "em": false, "chrf": 87.72426647426647, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 94.54783814110439, "bleu": 66.87403049764218}, {"f1": 0.1818181818181818, "em": false, "chrf": 25.726722886841213, "bleu": 8.116697886877475}], "avg_f1": 0.39090909090909093, "avg_em": 0.0, "avg_chrf": 55.7549435304897, "avg_bleu": 21.822675676958166}
{"id": "Wikipedia_handpicked_5:1920", "en": "Working parents are more likely to miss work when schools close in order to take care of their children, incurring wage loss in many instances and negatively impacting productivity.", "fr": "Les parents qui travaillent sont plus susceptibles de s’absenter de leur emploi pour s’occuper de leurs enfants lorsque les écoles ferment, ce qui entraîne souvent une perte de salaire et une baisse de la productivité.", "perturbation": "omission", "pert_fr": "Les parents qui travaillent sont plus susceptibles de s’absenter de leur emploi pour s’occuper de leurs enfants lorsque les écoles ferment, ce qui entraîne souvent une perte de salaire.", "bt_pert_fr": "Working parents are more likely to take time off from their jobs to care for their children when schools close, often leading to lost wages.", "questions": "[\"Why are working parents more likely to miss work when schools close?\", \"What do working parents do when schools close?\", \"What impact does missing work have on working parents?\", \"What is the effect on productivity when schools close?\", \"What is the consequence of missing work for working parents?\"]", "answers": "[\"To care for their children\", \"Take time off from their jobs\", \"Lost wages\", \"Not specified\", \"Lost wages\"]", "scores": [{"f1": 0.7272727272727272, "em": false, "chrf": 58.206816232040545, "bleu": 20.801195378010608}, {"f1": 0.3636363636363636, "em": false, "chrf": 24.874535433082706, "bleu": 9.652434877402245}, {"f1": 0, "em": false, "chrf": 5.26597924366434, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.127450980392156, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.26597924366434, "bleu": 0.0}], "avg_f1": 0.21818181818181817, "avg_em": 0.0, "avg_chrf": 19.948152226568816, "avg_bleu": 6.090726051082571}
{"id": "Wikipedia_handpicked_5:1921", "en": "Localised school closures place burdens on schools as parents and officials redirect children to schools that are open.", "fr": "Les fermetures localisées pénalisent les écoles, car les parents et les responsables réorientent les enfants vers les écoles ouvertes.", "perturbation": "omission", "pert_fr": "Les fermetures localisées pénalisent les parents, car les parents et les responsables réorientent les enfants vers les écoles ouvertes.", "bt_pert_fr": "Localized closures penalize parents, as parents and officials redirect children to open schools.", "questions": "[\"What burdens do localised school closures place on schools?\", \"Who redirects children to schools that are open?\", \"Why do parents and officials redirect children to open schools?\", \"What happens when schools are locally closed?\"]", "answers": "[\"Parents\", \"Parents and officials\", \"Because localized closures penalize them\", \"Children are redirected to open schools\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 10.373353905051747, "bleu": 0.012340980408667962}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 17.35616650188684, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 22.52011116696645, "bleu": 1.5534791020152603}], "avg_f1": 0.3787878787878788, "avg_em": 0.25, "avg_chrf": 37.56240789347626, "avg_bleu": 25.391455020605992}
{"id": "Wikipedia_handpicked_5:1927", "en": "In the United States, numerous major cities announced public library closures, including Los Angeles, San Francisco, Seattle, and New York City, affecting 221 libraries.", "fr": "Aux États-Unis, de nombreuses grandes villes ont annoncé la fermeture des bibliothèques publiques, notamment Los Angeles, San Francisco, Seattle et New York, touchant 221 bibliothèques.", "perturbation": "omission", "pert_fr": "Aux États-Unis, de nombreuses grandes villes ont annoncé la fermeture des bibliothèques, notamment Los Angeles, San Francisco, Seattle et New York, touchant 221 bibliothèques.", "bt_pert_fr": "In the United States, many major cities have announced library closures, including Los Angeles, San Francisco, Seattle and New York, affecting 221 libraries.", "questions": "[\"Which major cities in the United States announced public library closures?\", \"Which cities are specifically mentioned as having announced public library closures?\", \"How many libraries were affected by the closures?\", \"What was the impact of the public library closures?\", \"What is the context of the public library closures?\"]", "answers": "[\"Many major cities in the United States\", \"Los Angeles, San Francisco, Seattle and New York\", \"221\", \"Library closures\", \"Public library closures in major U.S. cities\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 47.08056900631564, "bleu": 16.233395773754946}, {"f1": 0.9411764705882353, "em": false, "chrf": 91.92487909875902, "bleu": 88.24969025845958}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 17.858287406698047, "bleu": 0.0}, {"f1": 0.26666666666666666, "em": false, "chrf": 22.693241819053416, "bleu": 1.5885452052978433}], "avg_f1": 0.5304575163398693, "avg_em": 0.2, "avg_chrf": 55.91139546616522, "avg_bleu": 41.214326247502484}
{"id": "Wikipedia_handpicked_5:1930", "en": "In the absence of alternative options, working parents often leave children alone when schools close and this can lead to risky behaviours, including increased influence of peer pressure and substance abuse.", "fr": "En l’absence de solutions alternatives, les parents qui travaillent laissent souvent leurs enfants seuls lorsque les écoles ferment et cela peut entraîner des comportements à risque, notamment une mauvaise influence accrue de certains camarades et de la toxicomanie.", "perturbation": "omission", "pert_fr": "En l’absence de solutions alternatives, les parents qui travaillent laissent souvent leurs enfants seuls lorsque les écoles ferment et cela peut entraîner des comportements à risque, notamment une mauvaise influence accrue de certains camarades.", "bt_pert_fr": "In the absence of alternatives, working parents often leave their children alone when schools close and this can lead to risky behaviors, including increased bad influence from some peers.", "questions": "[\"Why do working parents leave children alone when schools close?\", \"What risky behaviours can occur when schools close?\", \"What specific risky behaviours are mentioned?\", \"What role does peer pressure play in this situation?\"]", "answers": "[\"Because there are no alternatives\", \"Risky behaviors\", \"Increased bad influence from some peers\", \"Peer pressure contributes to increased bad influence, leading to risky behaviors\"]", "scores": [{"f1": 0.7272727272727272, "em": false, "chrf": 81.90895212731355, "bleu": 54.75182535069452}, {"f1": 0.5, "em": false, "chrf": 80.24352710569913, "bleu": 49.99999999999999}, {"f1": 0.28571428571428575, "em": false, "chrf": 38.53003677357192, "bleu": 6.916271812933183}, {"f1": 0.4210526315789474, "em": false, "chrf": 54.83957058398854, "bleu": 10.600313379512592}], "avg_f1": 0.4835099111414901, "avg_em": 0.0, "avg_chrf": 63.880521647643285, "avg_bleu": 30.567102635785073}
{"id": "Wikipedia_handpicked_5:1934", "en": "Every year, nearly 30 million children rely on schools to provide free or low-cost meals including breakfast, lunch, snacks, and even dinner.In Alabama, where state-wide school closures as of 18 March have affected over 720,000 students, the state Superintendent announced that staff in schools disproportionately affected by poverty would create meal distribution networks to provide food for students who rely on school lunches.", "fr": "Chaque année, près de 30 millions d’enfants dépendent des écoles pour recevoir des repas gratuits ou à bas prix, notamment le petit-déjeuner, le déjeuner, des en-cas et même le dîner. En Alabama, où la fermeture des écoles à l’échelle de l’État depuis le 18 mars a affecté plus de 720 000 élèves, le surintendant de l’État a annoncé que le personnel des écoles touchées de façon disproportionnée par la pauvreté allait créer des réseaux de distribution de repas pour fournir de la nourriture aux élèves qui dépendent des repas scolaires.", "perturbation": "omission", "pert_fr": "Chaque année, près de 30 millions d’enfants dépendent des écoles pour recevoir des repas gratuits ou à bas prix, notamment le petit-déjeuner, le déjeuner, des en-cas et même le dîner. En Alabama, où la fermeture des écoles à l’échelle de l’État depuis le 18 mars a affecté plus de 720 000 élèves, le surintendant de l’État a annoncé que le personnel des écoles allait créer des réseaux de distribution de repas pour fournir de la nourriture aux élèves qui dépendent des repas scolaires.", "bt_pert_fr": "Each year, nearly 30 million children rely on schools to receive free or low-cost meals, including breakfast, lunch, snacks and even dinner. In Alabama, where the statewide school closure since March 18 has affected more than 720,000 students, the state superintendent announced that school staff would create meal distribution networks to provide food to students who rely on school meals.", "questions": "[\"How many children rely on schools to provide free or low-cost meals every year?\", \"What types of meals do schools provide for children?\", \"How many students in Alabama were affected by school closures as of 18 March?\", \"What action did the state Superintendent announce in Alabama?\", \"What is the purpose of the meal distribution networks created by school staff in Alabama?\"]", "answers": "[\"30 million\", \"breakfast, lunch, snacks and even dinner\", \"720,000\", \"School staff would create meal distribution networks to provide food to students who rely on school meals\", \"To provide food to students who rely on school meals\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666667, "em": false, "chrf": 60.54488373827369, "bleu": 46.96111781716033}, {"f1": 0.8000000000000002, "em": false, "chrf": 73.52660054714391, "bleu": 52.53819788848316}], "avg_f1": 0.8933333333333333, "avg_em": 0.6, "avg_chrf": 86.81429685708352, "avg_bleu": 79.89986314112872}
{"id": "Wikipedia_handpicked_5:1936", "en": "Schooling provides essential learning and when schools close, children and youth are deprived opportunities for growth and development.", "fr": "La scolarisation permet l’acquisition de compétences élémentaires essentielles, et lorsque les écoles ferment, les enfants, adolescents et jeunes adultes sont privés d’opportunités de développement et d’épanouissement.", "perturbation": "omission", "pert_fr": "La scolarisation permet l’acquisition de compétences élémentaires essentielles, et lorsque les écoles ferment, les enfants et adolescents sont privés d’opportunités de développement et d’épanouissement.", "bt_pert_fr": "Schooling allows the acquisition of essential basic skills, and when schools close, children and adolescents are deprived of opportunities for development and fulfillment.", "questions": "[\"What does schooling provide?\", \"What happens when schools close?\", \"What opportunities are children and youth deprived of when schools close?\", \"What is the impact of school closure on children and youth?\"]", "answers": "[\"Essential basic skills\", \"Children and adolescents are deprived of opportunities for development and fulfillment\", \"Opportunities for development and fulfillment\", \"Children and adolescents are deprived of opportunities for development and fulfillment\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 46.14952207269675, "bleu": 27.516060407455225}, {"f1": 0.761904761904762, "em": false, "chrf": 65.70134495540478, "bleu": 13.950796967929131}, {"f1": 0.8000000000000002, "em": false, "chrf": 66.63728154624991, "bleu": 25.40663740773073}, {"f1": 0.761904761904762, "em": false, "chrf": 65.70134495540478, "bleu": 13.950796967929131}], "avg_f1": 0.680952380952381, "avg_em": 0.0, "avg_chrf": 61.047373382439055, "avg_bleu": 20.206072937761054}
{"id": "Wikipedia_handpicked_5:1937", "en": "The disadvantages are disproportionate for under-privileged learners who tend to have fewer educational opportunities beyond school.Student drop-out rates tend to increase as an effect of school closures due to the challenge of ensuring all students return to school once school closures ends.", "fr": "Les inconvénients sont démesurés pour les élèves défavorisés dont les possibilités d’éducation sont généralement moindres en dehors de l’école. Le taux de décrochage scolaire a tendance à augmenter sous l’effet de la fermeture des écoles, en raison du défi d’assurer que tous les élèves reprennent leur scolarité lorsque la fermeture des écoles prendra fin.", "perturbation": "omission", "pert_fr": "Les inconvénients sont démesurés pour les élèves défavorisés dont les possibilités d’éducation sont généralement moindres en dehors de l’école. Le taux de décrochage scolaire a tendance à augmenter sous l’effet de la fermeture, en raison du défi d’assurer que tous les élèves reprennent leur scolarité lorsque la fermeture des écoles prendra fin.", "bt_pert_fr": "The disadvantages are disproportionate for disadvantaged students who generally have fewer educational opportunities outside of school. The school dropout rate tends to increase under the impact of the closure, due to the challenge of ensuring that all students return to school when school closures end.", "questions": "[\"What are the disadvantages for under-privileged learners?\", \"Why do under-privileged learners have fewer educational opportunities beyond school?\", \"How do school closures affect student drop-out rates?\", \"What challenge makes it difficult to ensure all students return to school after closures?\", \"What is the effect of school closures on student drop-out rates?\"]", "answers": "[\"Disproportionate impact\", \"The sentence does not specify the reason\", \"School closures tend to increase the dropout rate\", \"Ensuring that all students return to school when closures end\", \"School closures tend to increase the dropout rate\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 55.95928986942186, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 13.02984118953036, "bleu": 0.0}, {"f1": 0.6153846153846153, "em": false, "chrf": 69.99536174411628, "bleu": 26.269098944241588}, {"f1": 0.8000000000000002, "em": false, "chrf": 72.42247985982888, "bleu": 46.713797772819994}, {"f1": 0.6153846153846153, "em": false, "chrf": 69.99536174411628, "bleu": 26.269098944241588}], "avg_f1": 0.5061538461538462, "avg_em": 0.0, "avg_chrf": 56.28046688140273, "avg_bleu": 29.850399132260634}
{"id": "Wikipedia_handpicked_5:1941", "en": "Potential impacts of school closures and reliance on distance learning are not addressed in federal acts of legislation at this time.", "fr": "Les retombées possibles de la fermeture des écoles et du recours à l’apprentissage à distance ne sont pas traitées dans les lois fédérales à l’heure actuelle.", "perturbation": "omission", "pert_fr": "Les retombées possibles de la fermeture des écoles ne sont pas traitées dans les lois fédérales à l’heure actuelle.", "bt_pert_fr": "The possible fallout from school closures is not addressed in federal law at this time.", "questions": "[\"What potential impacts are not addressed in federal acts of legislation?\", \"What is the current status of federal legislation regarding school closures and distance learning?\", \"What aspects of school closures and distance learning are missing from federal legislation?\"]", "answers": "[\"The possible fallout from school closures\", \"The current status of federal legislation regarding school closures and distance learning is that it does not address the possible fallout from school closures\", \"The possible fallout from school closures\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 27.082247030716992, "bleu": 8.33450329027712}, {"f1": 0, "em": false, "chrf": 22.70612198018941, "bleu": 0.0}, {"f1": 0.25, "em": false, "chrf": 27.082247030716992, "bleu": 8.33450329027712}], "avg_f1": 0.16666666666666666, "avg_em": 0.0, "avg_chrf": 25.62353868054113, "avg_bleu": 5.556335526851413}
{"id": "Wikipedia_handpicked_5:1942", "en": "Formal education — as opposed to informal education or non-formal education — tends to refer to schools, colleges, universities and training institutions.", "fr": "L’éducation formelle (à la différence de l’éducation informelle ou non formelle) fait généralement référence aux écoles, établissements d’enseignement supérieur, universités et instituts de formation.", "perturbation": "omission", "pert_fr": "L’éducation formelle (à la différence de l’éducation informelle) fait généralement référence aux écoles, établissements d’enseignement supérieur, universités et instituts de formation.", "bt_pert_fr": "Formal education (unlike informal education) generally refers to schools, colleges, universities and training institutes.", "questions": "[\"What is formal education?\", \"What is the difference between formal education and informal education?\", \"What is the difference between formal education and non-formal education?\", \"What institutions are included in formal education?\"]", "answers": "[\"Formal education generally refers to schools, colleges, universities and training institutes\", \"Formal education generally refers to schools, colleges, universities and training institutes, unlike informal education\", \"Formal education generally refers to schools, colleges, universities and training institutes, unlike informal education\", \"Schools, colleges, universities and training institutes\"]", "scores": [{"f1": 0.8571428571428572, "em": false, "chrf": 89.3979389845962, "bleu": 63.15552371794039}, {"f1": 0.7586206896551724, "em": false, "chrf": 80.81771921863853, "bleu": 48.439070710130004}, {"f1": 0.689655172413793, "em": false, "chrf": 78.67132837675271, "bleu": 45.74563333993254}, {"f1": 0.8333333333333334, "em": false, "chrf": 92.68267379339221, "bleu": 75.98356856515926}], "avg_f1": 0.784688013136289, "avg_em": 0.0, "avg_chrf": 85.39241509334491, "avg_bleu": 58.33094908329055}
{"id": "Wikipedia_handpicked_5:1943", "en": "A 1974 report by the World Bank defined formal education as the following:Formal education: the hierarchically structured, chronologically graded ‘education system’, running from primary school through the university and including, in addition to general academic studies, a variety of specialised programmes and institutions for full-time technical and professional training.The majority of data collected on the number of students and learners impacted by COVID-19 has been calculated based on the closure of formal education systems.", "fr": "Un rapport de la Banque mondiale de 1974 définissait l’éducation formelle comme suit : Éducation formelle : le « système éducatif » doté d’une structure hiérarchique et organisé de façon chronologique, allant de l’école primaire à l’université et comprenant, outre les études classiques, divers programmes et établissements spécialisés pour la formation professionnelle et technique à plein temps. La majorité des données recueillies quant au nombre d’élèves et d’apprenants affectés par le COVID-19 ont été calculées à partir de la fermeture des systèmes d’éducation formelle.", "perturbation": "omission", "pert_fr": "Un rapport de la Banque mondiale de 1974 définissait l’éducation formelle comme suit : Éducation formelle : le « système éducatif » doté d’une structure hiérarchique et organisé de façon chronologique, allant de l’école primaire à l’université et comprenant, outre les études classiques, divers programmes et établissements spécialisés pour la formation à plein temps.", "bt_pert_fr": "A 1974 World Bank report defined formal education as follows: Formal education: the “education system” with a hierarchical structure and organized chronologically, running from primary school to university and including, in addition to formal studies, various specialized programs and institutions for full-time training.", "questions": "[\"What does the World Bank define as formal education?\", \"What components are included in formal education according to the World Bank?\", \"What is the structure of formal education?\", \"What types of training are included in formal education?\", \"How has the data on students and learners impacted by COVID-19 been calculated?\", \"What factor has been used to calculate the data on students and learners impacted by COVID-19?\"]", "answers": "[\"Formal education: the 'education system' with a hierarchical structure and organized chronologically, running from primary school to university and including, in addition to formal studies, various specialized programs and institutions for full-time training.\", \"various specialized programs and institutions for full-time training\", \"a hierarchical structure and organized chronologically, running from primary school to university\", \"various specialized programs and institutions for full-time training\", \"Not applicable\", \"Not applicable\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 67.92507222995006, "bleu": 30.98575277988971}, {"f1": 0.43478260869565216, "em": false, "chrf": 46.347914798412, "bleu": 15.238608850315924}, {"f1": 0.5217391304347826, "em": false, "chrf": 64.11007631102011, "bleu": 23.708987804092644}, {"f1": 0.5555555555555556, "em": false, "chrf": 60.29509311684599, "bleu": 28.46946938149361}, {"f1": 0, "em": false, "chrf": 4.89851567316356, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.737274172288128, "bleu": 0.0}], "avg_f1": 0.34725097768576035, "avg_em": 0.0, "avg_chrf": 41.718991050279975, "avg_bleu": 16.40046980263198}
{"id": "Wikipedia_handpicked_5:1944", "en": "The UNESCO Institute for Statistics provides figures on students impacted by COVID-19 corresponding to the number of learners enrolled at pre-primary, primary, lower-secondary, and upper-secondary levels of education [ISCED levels 0 to 3], as well as at tertiary education levels [ISCED levels 5 to 8].", "fr": "L’Institut de statistique de l’UNESCO fournit des chiffres sur les élèves affectés par le COVID-19 correspondant au nombre d’apprenants inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE], ainsi que dans des cycles d’enseignement supérieur [niveaux 5 à 8 de la CITE].", "perturbation": "omission", "pert_fr": "L’Institut de statistique de l’UNESCO fournit des chiffres sur les élèves affectés par le COVID-19 correspondant au nombre d’apprenants inscrits dans un cycle d’enseignement pré-primaire, primaire, secondaire inférieur et secondaire supérieur [niveaux 0 à 3 de la CITE].", "bt_pert_fr": "The UNESCO Institute for Statistics provides figures on students affected by COVID-19 corresponding to the number of learners enrolled in pre-primary, primary, lower secondary and upper secondary education [ISCED levels 0 to 3].", "questions": "[\"What does the UNESCO Institute for Statistics provide?\", \"What types of education levels are included in the figures?\", \"Which ISCED levels correspond to pre-primary, primary, lower-secondary, and upper-secondary education?\", \"What data is provided regarding students impacted by COVID-19?\"]", "answers": "[\"Figures on students affected by COVID-19 corresponding to the number of learners enrolled in pre-primary, primary, lower secondary and upper secondary education\", \"Pre-primary, primary, lower secondary, and upper secondary education\", \"ISCED levels 0 to 3\", \"The number of learners enrolled in pre-primary, primary, lower secondary and upper secondary education\"]", "scores": [{"f1": 0.5084745762711864, "em": false, "chrf": 63.93471806395195, "bleu": 19.460287553161585}, {"f1": 0.5, "em": false, "chrf": 78.27929336953119, "bleu": 13.134549472120788}, {"f1": 0.7499999999999999, "em": false, "chrf": 52.24656220019187, "bleu": 39.76353643835254}, {"f1": 0.5217391304347826, "em": false, "chrf": 61.56620079105875, "bleu": 27.824623288353134}], "avg_f1": 0.5700534266764923, "avg_em": 0.0, "avg_chrf": 64.00669360618343, "avg_bleu": 25.04574918799701}
{"id": "Wikipedia_handpicked_5:1946", "en": "While many primary and secondary schools have closed around the world due to COVID-19, measures impacting early childhood educational programmes have varied.", "fr": "Alors que de nombreuses écoles primaires et secondaires dans le monde ont fermé en raison du COVID-19, les mesures concernant les programmes d’enseignement préscolaire ont été variables.", "perturbation": "omission", "pert_fr": "Alors que de nombreuses écoles primaires dans le monde ont fermé en raison du COVID-19, les mesures concernant les programmes d’enseignement préscolaire ont été variables.", "bt_pert_fr": "While many primary schools around the world have closed due to COVID-19, measures regarding early childhood education programs have been variable.", "questions": "[\"What has happened to many primary and secondary schools due to COVID-19?\", \"What measures have impacted early childhood educational programmes?\", \"How have measures impacting early childhood educational programmes varied?\", \"What is the effect of COVID-19 on schools?\", \"What types of educational programmes are affected by COVID-19?\"]", "answers": "[\"Closed\", \"Measures regarding early childhood education programs\", \"They have been variable\", \"Many primary schools have closed\", \"Early childhood education programs\"]", "scores": [{"f1": 0, "em": false, "chrf": 22.992655638499315, "bleu": 0.0}, {"f1": 0.42857142857142855, "em": false, "chrf": 60.55863938385196, "bleu": 12.872632311973014}, {"f1": 0.5714285714285715, "em": false, "chrf": 55.16897340035627, "bleu": 31.947155212313625}, {"f1": 0.5, "em": false, "chrf": 80.67984623083252, "bleu": 21.3643503198117}, {"f1": 0.5, "em": false, "chrf": 78.99894681527545, "bleu": 31.947155212313625}], "avg_f1": 0.4, "avg_em": 0.0, "avg_chrf": 59.6798122937631, "avg_bleu": 19.626258611282392}
{"id": "Wikipedia_handpicked_5:1947", "en": "In some countries and territories, preschools and day cares are considered necessary services and have not closed in tandem with broader school closure measures.In the United States, the Washington State Department of Children, Youth, and Families encouraged child care and early learning centres to stay open.", "fr": "Dans certains pays et territoires, les écoles maternelles et les garderies sont considérées comme des services essentiels et n’ont pas fermé alors qu’étaient décrétées des mesures plus générales de fermeture des écoles. Aux États-Unis, le département de l’Enfance, de la Jeunesse et de la Famille de l’État de Washington a encouragé les garderies et les centres d’éducation préscolaire à rester ouverts.", "perturbation": "omission", "pert_fr": "Dans certains pays et territoires, les écoles maternelles sont considérées comme des services essentiels et n’ont pas fermé alors qu’étaient décrétées des mesures plus générales de fermeture des écoles.", "bt_pert_fr": "In some countries and territories, nursery schools are considered essential services and have not closed despite more general school closure measures.", "questions": "[\"In which countries and territories are preschools and day cares considered necessary services?\", \"Why have preschools and day cares not closed in tandem with broader school closure measures?\", \"What did the Washington State Department of Children, Youth, and Families encourage regarding child care and early learning centres?\", \"What is the reason for the continued operation of child care and early learning centres in the United States?\", \"What is the relationship between school closure measures and preschool or day care operations?\"]", "answers": "[\"Some countries and territories\", \"Because they are considered essential services\", \"No specific encouragement is mentioned in the sentence\", \"They are considered essential services\", \"Preschools and day cares have not closed despite more general school closure measures\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 73.57315496596627, "bleu": 53.7284965911771}, {"f1": 0, "em": false, "chrf": 11.10488988428518, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.830011066525392, "bleu": 0.0}, {"f1": 0.6060606060606061, "em": false, "chrf": 51.44033870695479, "bleu": 33.755544000898155}], "avg_f1": 0.4878787878787879, "avg_em": 0.2, "avg_chrf": 48.98967892474633, "avg_bleu": 37.49680811841506}
{"id": "Wikipedia_handpicked_5:1949", "en": "The governor of Maryland mandated that specific child care services remain open for the children of emergency personnel while Washington State and California have left it to the discretion of care providers.", "fr": "Le gouverneur du Maryland a ordonné que des services de garde d’enfants spécifiques restent ouverts pour les enfants du personnel des services d’urgence, tandis que l’État de Washington et la Californie ont laissé cette décision à la discrétion des prestataires de soins.", "perturbation": "omission", "pert_fr": "Le gouverneur du Maryland a ordonné que des services de garde d’enfants restent ouverts pour les enfants du personnel des services d’urgence, tandis que l’État de Washington et la Californie ont laissé cette décision à la discrétion des prestataires de soins.", "bt_pert_fr": "Maryland's governor ordered child care to remain open for children of emergency services personnel, while Washington state and California left that decision to the discretion of health care providers.", "questions": "[\"What did the governor of Maryland mandate regarding child care services?\", \"Which states have left child care service decisions to care providers?\", \"What services are required to remain open in Maryland?\", \"Who are the children eligible for continued child care services?\", \"What is the reason for the difference in child care policies between Maryland and other states?\"]", "answers": "[\"Child care to remain open for children of emergency services personnel\", \"Washington state and California\", \"Child care\", \"Children of emergency services personnel\", \"Maryland's governor ordered child care to remain open, while Washington state and California left the decision to health care providers\"]", "scores": [{"f1": 0.7826086956521738, "em": false, "chrf": 72.27888784390674, "bleu": 46.65904311461239}, {"f1": 0.75, "em": false, "chrf": 85.760402104605, "bleu": 35.35533905932737}, {"f1": 0.3333333333333333, "em": false, "chrf": 27.991884166818377, "bleu": 18.393972058572114}, {"f1": 0.888888888888889, "em": false, "chrf": 84.41445066595882, "bleu": 42.7287006396234}, {"f1": 0.6111111111111113, "em": false, "chrf": 68.29089670243015, "bleu": 34.51395513935866}], "avg_f1": 0.6731884057971015, "avg_em": 0.0, "avg_chrf": 67.74730429674382, "avg_bleu": 35.530202002298786}
{"id": "Wikipedia_handpicked_5:1950", "en": "California Governor Gavin Newsom explained his state's position, saying “We need our child care facilities, our daycare centers, to operate to absorb the impact of these school closures.”", "fr": "Le gouverneur de Californie Gavin Newsom a expliqué la position de son État, en déclarant que « Nous avons besoin que nos établissements de garde d’enfants, nos garderies, fonctionnent pour amortir l’impact de ces fermetures d’écoles. »", "perturbation": "omission", "pert_fr": "Le gouverneur de Californie Gavin Newsom a expliqué la position de son État, en déclarant que « Nous avons besoin que nos établissements de garde d’enfants fonctionnent pour amortir l’impact de ces fermetures d’écoles. »", "bt_pert_fr": "California Governor Gavin Newsom explained his state’s position, saying that “We need our child care facilities operating to cushion the impact of these school closures. »", "questions": "[\"What did California Governor Gavin Newsom say about child care facilities?\", \"Why are child care facilities important according to Governor Newsom?\", \"What is the impact of school closures that child care facilities are meant to absorb?\", \"What specific facilities does Governor Newsom mention?\", \"What is the state's position on school closures as explained by Governor Newsom?\"]", "answers": "[\"California Governor Gavin Newsom said that we need our child care facilities operating to cushion the impact of these school closures\", \"To cushion the impact of these school closures\", \"The impact of school closures\", \"Child care facilities\", \"That we need our child care facilities operating to cushion the impact of these school closures\"]", "scores": [{"f1": 0.7317073170731706, "em": false, "chrf": 67.50435826236927, "bleu": 34.55534847724185}, {"f1": 0.7692307692307692, "em": false, "chrf": 61.42189404980451, "bleu": 19.64073254502565}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 54.68595420589545, "bleu": 36.78794411714425}, {"f1": 0.5, "em": false, "chrf": 51.9090418901038, "bleu": 13.010323383162003}], "avg_f1": 0.7335209505941214, "avg_em": 0.2, "avg_chrf": 67.10424968163461, "avg_bleu": 40.79886970451476}
{"id": "Wikipedia_handpicked_5:1951", "en": "Colorado has encouraged the development of \"tool kits\" for parents to use at home to emulate the lessons children would have received in their early learning programmes.In Japan, Prime Minister Shinzo Abe closed all schools throughout the country until April 8, however, children's daycare facilities were excluded.", "fr": "Le Colorado a encouragé le développement « d’outils pédagogiques » que les parents peuvent utiliser à la maison afin de reproduire les leçons que les enfants auraient reçues dans le cadre de leurs programmes d’enseignement préscolaire. Au Japon, le Premier ministre Shinzo Abe a fermé toutes les écoles du pays jusqu’au 8 avril, les garderies n’étaient toutefois pas visées par cette mesure.", "perturbation": "omission", "pert_fr": "Le Colorado a encouragé le développement « d’outils pédagogiques » que les parents peuvent utiliser à la maison afin de reproduire les leçons que les enfants auraient reçues dans le cadre de leurs programmes d’enseignement. Au Japon, le Premier ministre Shinzo Abe a fermé toutes les écoles du pays jusqu’au 8 avril, les garderies n’étaient toutefois pas visées par cette mesure.", "bt_pert_fr": "Colorado has encouraged the development of “teaching tools” that parents can use at home to replicate the lessons children would have received in their educational programs. In Japan, Prime Minister Shinzo Abe closed all schools in the country until April 8, although daycare centers were not affected by this measure.", "questions": "[\"What has Colorado encouraged for parents to use at home?\", \"What are the 'tool kits' designed to emulate?\", \"What action did Prime Minister Shinzo Abe take regarding schools in Japan?\", \"Until when were schools closed in Japan?\", \"Why were children's daycare facilities excluded from the school closure in Japan?\"]", "answers": "[\"Teaching tools\", \"The lessons children would have received in their educational programs\", \"Closed all schools in the country\", \"April 8\", \"Daycare centers were not affected by this measure\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.523898753955, "bleu": 0.0}, {"f1": 0.7, "em": false, "chrf": 72.60682579890218, "bleu": 63.894310424627285}, {"f1": 0.6, "em": false, "chrf": 58.33049274478187, "bleu": 23.643540225079395}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 23.73826400143185, "bleu": 0.0}], "avg_f1": 0.45999999999999996, "avg_em": 0.2, "avg_chrf": 53.43989625981418, "avg_bleu": 37.50757012994134}
{"id": "Wikipedia_handpicked_5:1958", "en": "Tertiary education is normally taken to include undergraduate and postgraduate education, as well as vocational education and training.", "fr": "On considère généralement que l’éducation tertiaire comprend les études du premier au troisième cycle universitaire, ainsi que l’enseignement et la formation professionnels.", "perturbation": "omission", "pert_fr": "On considère généralement que l’éducation tertiaire comprend les études du premier au troisième cycle universitaire, ainsi que l’enseignement professionnels.", "bt_pert_fr": "Tertiary education is generally considered to include studies from the first to third cycle of university, as well as vocational education.", "questions": "[\"What does tertiary education normally include?\", \"What types of education are included in tertiary education?\", \"What is considered part of tertiary education?\"]", "answers": "[\"Studies from the first to third cycle of university, as well as vocational education\", \"University studies from the first to third cycle and vocational education\", \"Studies from the first to third cycle of university, as well as vocational education\"]", "scores": [{"f1": 0.41666666666666663, "em": false, "chrf": 40.65795660224508, "bleu": 28.917849332325716}, {"f1": 0.33333333333333326, "em": false, "chrf": 35.55095065651529, "bleu": 9.287528999566801}, {"f1": 0.41666666666666663, "em": false, "chrf": 40.65795660224508, "bleu": 28.917849332325716}], "avg_f1": 0.38888888888888884, "avg_em": 0.0, "avg_chrf": 38.95562128700181, "avg_bleu": 22.37440922140608}
{"id": "Wikipedia_handpicked_5:1959", "en": "Individuals who complete tertiary education generally receive certificates, diplomas, or academic degrees.", "fr": "Les personnes qui terminent l’éducation tertiaire reçoivent généralement des certificats, diplômes ou titres universitaires.", "perturbation": "omission", "pert_fr": "Les personnes qui terminent l’éducation reçoivent généralement des certificats, diplômes ou titres universitaires.", "bt_pert_fr": "People who complete education usually receive certificates, diplomas or academic titles.", "questions": "[\"What do individuals who complete tertiary education generally receive?\", \"What types of credentials are awarded after completing tertiary education?\", \"What is tertiary education?\"]", "answers": "[\"Certificates, diplomas, or academic titles\", \"Certificates, diplomas, or academic titles\", \"The sentence does not provide a definition of tertiary education\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 81.49694117694543, "bleu": 66.87403049764218}, {"f1": 0.8000000000000002, "em": false, "chrf": 81.49694117694543, "bleu": 66.87403049764218}, {"f1": 0.07407407407407407, "em": false, "chrf": 22.394647646553818, "bleu": 1.7539413943549187}], "avg_f1": 0.5580246913580248, "avg_em": 0.0, "avg_chrf": 61.79617666681489, "avg_bleu": 45.167334129879755}
{"id": "Wikipedia_handpicked_5:1960", "en": "Undergraduate education is education conducted after secondary education and prior to post-graduate education, for which the learner is typically awarded a bachelor's degree.", "fr": "Les études de premier cycle universitaire correspondent à l’éducation reçue après l’enseignement secondaire et avant les études universitaires supérieures, pour lesquelles l’étudiant reçoit généralement une licence.", "perturbation": "omission", "pert_fr": "Les études de premier cycle universitaire correspondent à l’éducation reçue après l’enseignement secondaire, pour lesquelles l’étudiant reçoit généralement une licence.", "bt_pert_fr": "Undergraduate studies correspond to education received after secondary education, for which the student generally receives a bachelor's degree.", "questions": "[\"What is undergraduate education?\", \"What degree is typically awarded after undergraduate education?\", \"What type of education precedes post-graduate education?\"]", "answers": "[\"Education received after secondary education\", \"A bachelor's degree\", \"Secondary education\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 47.11833287668852, "bleu": 15.719010513286506}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 38.96584639693481, "bleu": 49.99999999999999}], "avg_f1": 0.6777777777777777, "avg_em": 0.3333333333333333, "avg_chrf": 62.028059757874445, "avg_bleu": 55.23967017109552}
{"id": "Wikipedia_handpicked_5:1961", "en": "Students enrolled in higher education programmes at colleges, universities, and community colleges are often refereed to in countries such as United States as \"college students.\"The closure of colleges and universities has widespread implications for students, faculty, administrators, and the institutions themselves.", "fr": "Les étudiants inscris aux programmes d’enseignement supérieur des établissements d’études supérieures, des universités et des community colleges sont souvent appelés, dans les pays tels que les États-Unis, des « étudiants universitaires ». La fermeture des établissements d’études supérieures et universités a de fortes répercussions pour les étudiants, les enseignants, les administrateurs et les établissements eux-mêmes.", "perturbation": "omission", "pert_fr": "Les étudiants inscris aux programmes d’enseignement supérieur des établissements d’études supérieures, des universités et des community colleges sont souvent appelés, dans les pays tels que les États-Unis, des « étudiants ». La fermeture des établissements d’études supérieures et universités a de fortes répercussions pour les étudiants, les enseignants, les administrateurs et les établissements eux-mêmes.", "bt_pert_fr": "Students enrolled in higher education programs at colleges, universities, and community colleges are often referred to in countries such as the United States as “students.” The closure of colleges and universities has serious repercussions for students, teachers, administrators and the establishments themselves.", "questions": "[\"What are students enrolled in higher education programmes often referred to as in the United States?\", \"What are the widespread implications of the closure of colleges and universities?\", \"Who are affected by the closure of colleges and universities?\", \"What is the term used for students in the United States?\"]", "answers": "[\"students\", \"serious repercussions\", \"students, teachers, administrators and the establishments themselves\", \"students\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 48.45075981843299, "bleu": 36.78794411714425}, {"f1": 0, "em": false, "chrf": 7.4939032259901115, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 57.807603602350255, "bleu": 19.304869754804482}, {"f1": 0.6666666666666666, "em": false, "chrf": 48.45075981843299, "bleu": 36.78794411714425}], "avg_f1": 0.5, "avg_em": 0.0, "avg_chrf": 40.55075661630159, "avg_bleu": 23.220189497273246}
{"id": "Wikipedia_handpicked_5:1962", "en": "Colleges and universities across the United States have been called upon to issue refunds to students for the cost of tuition and room and board.", "fr": "Les établissements d’études supérieures et universités aux États-Unis ont été appelés à rembourser aux étudiants les frais de scolarité, de logement et de pension.", "perturbation": "omission", "pert_fr": "Les établissements d’études supérieures et universités aux États-Unis ont été appelés à rembourser aux étudiants les frais de scolarité et de logement.", "bt_pert_fr": "Colleges and universities in the United States have been called upon to reimburse students for tuition and housing costs.", "questions": "[\"What have colleges and universities across the United States been called upon to do?\", \"What costs are students being refunded for?\", \"Which institutions are involved in issuing refunds?\", \"What is the reason for issuing refunds to students?\"]", "answers": "[\"Reimburse students for tuition and housing costs\", \"Tuition and housing costs\", \"Colleges and universities in the United States\", \"To address the costs incurred by students\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 34.03665073087436, "bleu": 6.567274736060395}, {"f1": 0.16666666666666666, "em": false, "chrf": 32.23648850066046, "bleu": 5.876350803261633}, {"f1": 0.8333333333333334, "em": false, "chrf": 79.3279020288092, "bleu": 37.99178428257963}, {"f1": 0, "em": false, "chrf": 16.27946630818077, "bleu": 0.0}], "avg_f1": 0.29545454545454547, "avg_em": 0.0, "avg_chrf": 40.4701268921312, "avg_bleu": 12.608852455475414}
{"id": "Wikipedia_handpicked_5:1963", "en": "In the United States of America, Colleges and universities operate as \"mini-cities\" which generate significant revenue for cities, states, and regions.", "fr": "Aux États-Unis d’Amérique, les établissements d’études supérieures et universités fonctionnent comme de « mini-villes » qui génèrent des revenus importants pour les villes, les États et les régions.", "perturbation": "omission", "pert_fr": "Aux États-Unis d’Amérique, les établissements d’études supérieures fonctionnent comme de « mini-villes » qui génèrent des revenus importants pour les villes, les États et les régions.", "bt_pert_fr": "In the United States of America, higher education institutions operate as “mini-cities” that generate significant revenue for cities, states and regions.", "questions": "[\"What do colleges and universities operate as in the United States of America?\", \"What generates significant revenue for cities, states, and regions?\", \"What is the relationship between colleges and universities and local economies?\", \"What is the term used to describe colleges and universities in the United States of America?\", \"Which entities benefit from the revenue generated by colleges and universities?\"]", "answers": "[\"mini-cities\", \"Higher education institutions\", \"Higher education institutions generate revenue for cities, states, and regions\", \"mini-cities\", \"Cities, states, and regions\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 14.859474347762413, "bleu": 0.0}, {"f1": 0.20000000000000004, "em": false, "chrf": 31.552700519121913, "bleu": 4.990049701936832}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 94.83192905019531, "bleu": 59.460355750136046}], "avg_f1": 0.5900000000000001, "avg_em": 0.4, "avg_chrf": 68.24882078341594, "avg_bleu": 52.8900810904146}
{"id": "Wikipedia_handpicked_5:1964", "en": "For example, Princeton University contributed $1.58 billion USD to the New Jersey economy and students spent about $60 million in off-campus spending.", "fr": "Par exemple, l’Université de Princeton a rapporté 1,58 milliard $ USD à l’économie du New Jersey et les étudiants ont dépensé environ 60 millions $ en dehors du campus.", "perturbation": "omission", "pert_fr": "Par exemple, l’Université de Princeton a rapporté 1,58 milliard $ USD à l’économie du New Jersey et les étudiants ont dépensé environ 60 millions $.", "bt_pert_fr": "For example, Princeton University brought in $1.58 billion USD to the New Jersey economy and students spent approximately $60 million.", "questions": "[\"How much did Princeton University contribute to the New Jersey economy?\", \"What is the amount spent by students in off-campus spending?\", \"What is the relationship between Princeton University and the New Jersey economy?\", \"What does the sentence mention about student spending?\", \"What is the total contribution of Princeton University to the economy?\"]", "answers": "[\"$1.58 billion USD\", \"$60 million\", \"Princeton University brought in money to the New Jersey economy\", \"Students spent approximately $60 million\", \"$1.58 billion USD\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 72.32836263051048, "bleu": 35.49481056010054}, {"f1": 0.6153846153846154, "em": false, "chrf": 46.360508461704185, "bleu": 16.58165975077607}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.873076923076923, "avg_em": 0.6, "avg_chrf": 83.73777421844292, "avg_bleu": 70.41529406217535}
{"id": "Wikipedia_handpicked_5:1971", "en": "This could range through integrated digital learning platforms, video lessons, MOOCs, to broadcasting through radios and TVs.", "fr": "Il peut s’agir de plateformes d’apprentissage numériques intégrées, de leçons vidéo, de MOOC ou encore de diffusions à la radio et à la télévision.", "perturbation": "omission", "pert_fr": "Il peut s’agir de plateformes d’apprentissage numériques intégrées, de leçons vidéo, de MOOC ou encore de diffusions à la radio.", "bt_pert_fr": "These may include integrated digital learning platforms, video lessons, MOOCs or even radio broadcasts.", "questions": "[\"What is the range of delivery methods described?\", \"What are the examples of digital learning platforms mentioned?\", \"What are MOOCs in the context of this sentence?\", \"What role do radios and TVs play in the delivery of content?\"]", "answers": "[\"Integrated digital learning platforms, video lessons, MOOCs, or even radio broadcasts\", \"Integrated digital learning platforms, video lessons\", \"MOOCs are a type of digital learning platform mentioned in the sentence\", \"Radios play a role in the delivery of content as one of the mentioned methods\"]", "scores": [{"f1": 0.4999999999999999, "em": false, "chrf": 73.19963121824046, "bleu": 38.49742634318482}, {"f1": 0.6, "em": false, "chrf": 90.40672128254096, "bleu": 30.213753973567677}, {"f1": 0.4210526315789474, "em": false, "chrf": 38.498594873893666, "bleu": 26.269098944241577}, {"f1": 0.2, "em": false, "chrf": 28.114529765340947, "bleu": 4.02724819242185}], "avg_f1": 0.4302631578947368, "avg_em": 0.0, "avg_chrf": 57.554869285004, "avg_bleu": 24.75188186335398}
{"id": "Wikipedia_handpicked_5:1974", "en": "Protect data privacy and data security: Assess data security when uploading data or educational resources to web spaces, as well as when sharing them with other organisations or individuals.", "fr": "Protéger la confidentialité des données et la sécurité des données : évaluer la sécurité des données lors du téléchargement de données ou de ressources pédagogiques sur les espaces web, ainsi que pendant leur partage avec d’autres organisations ou individus.", "perturbation": "omission", "pert_fr": "Protéger la confidentialité des données  : évaluer la sécurité des données lors du téléchargement de données ou de ressources pédagogiques sur les espaces web, ainsi que pendant leur partage avec d’autres organisations ou individus.", "bt_pert_fr": "Protect data privacy: Assess data security when uploading data or educational resources to web spaces, as well as when sharing them with other organizations or individuals.", "questions": "[\"What should be protected when uploading data or educational resources?\", \"What should be assessed when uploading data or educational resources to web spaces?\", \"What should be assessed when sharing data or educational resources with other organizations or individuals?\", \"What are the key actions to ensure data privacy and data security during data sharing?\"]", "answers": "[\"Data privacy\", \"Data security\", \"Data security\", \"Assess data security when uploading data or educational resources to web spaces, and when sharing them with other organizations or individuals\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 41.10546135676407, "bleu": 22.31301601484299}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8636363636363636, "em": false, "chrf": 90.16329602842858, "bleu": 67.43295274579445}], "avg_f1": 0.8587662337662338, "avg_em": 0.5, "avg_chrf": 82.81718934629816, "avg_bleu": 72.43649219015938}
{"id": "Wikipedia_handpicked_5:1977", "en": "Create communities to ensure regular human interactions, enable social caring measures, and address possible psychosocial challenges that students may face when they are isolated.", "fr": "Créer des communautés afin d’assurer des interactions humaines régulières, prévoir des mesures de protection sociale, et répondre aux difficultés psychosociales éventuelles auxquelles les élèves peuvent être confrontés lorsqu’ils sont confinés.", "perturbation": "omission", "pert_fr": "Créer des communautés afin d’assurer des interactions humaines régulières, et répondre aux difficultés psychosociales éventuelles auxquelles les élèves peuvent être confrontés lorsqu’ils sont confinés.", "bt_pert_fr": "Create communities to ensure regular human interactions, and respond to possible psychosocial difficulties that students may face while confined.", "questions": "[\"What communities should be created?\", \"What social caring measures can be enabled?\", \"What psychosocial challenges may students face when isolated?\", \"What is the goal of creating communities for students?\"]", "answers": "[\"Communities to ensure regular human interactions\", \"Respond to possible psychosocial difficulties\", \"Psychosocial difficulties\", \"To ensure regular human interactions for students\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 17.19955618182289, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 51.10439756667942, "bleu": 49.99999999999999}, {"f1": 0.41379310344827586, "em": false, "chrf": 30.85144889367479, "bleu": 7.549005970567767}], "avg_f1": 0.47844827586206895, "avg_em": 0.25, "avg_chrf": 49.78885066054427, "avg_bleu": 39.38725149264195}
{"id": "Wikipedia_handpicked_5:1978", "en": "Plan the study schedule of the distance learning programmes: Organise discussions with stakeholders to examine the possible duration of school closures and decide whether the distance learning programme should focus on teaching new knowledge or enhance students’ knowledge of prior lessons.", "fr": "Planifier le calendrier d’étude des programmes d’apprentissage à distance : organiser des discussions avec les parties prenantes afin d’examiner la durée possible de la fermeture des écoles et décider si le programme d’apprentissage à distance devrait se concentrer sur l’enseignement de nouvelles connaissances ou plutôt renforcer celles déjà acquises lors de leçons antérieures.", "perturbation": "omission", "pert_fr": "Planifier le calendrier d’étude des programmes d’apprentissage à distance  afin d’examiner la durée possible de la fermeture des écoles et décider si le programme d’apprentissage à distance devrait se concentrer sur l’enseignement de nouvelles connaissances ou plutôt renforcer celles déjà acquises lors de leçons antérieures.", "bt_pert_fr": "Plan the study schedule for distance learning programs to examine the possible duration of school closures and decide whether the distance learning program should focus on teaching new knowledge or rather reinforce that already acquired in previous lessons.", "questions": "[\"What should be planned for distance learning programmes?\", \"How should discussions with stakeholders be organised?\", \"Should the distance learning programme focus on teaching new knowledge or enhancing students’ knowledge of prior lessons?\", \"What decision should be made regarding the focus of the distance learning programme?\"]", "answers": "[\"The study schedule\", \"Not specified\", \"Teaching new knowledge or reinforcing already acquired knowledge\", \"Whether the distance learning program should focus on teaching new knowledge or reinforcing already acquired knowledge\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.447537532978021, "bleu": 0.0}, {"f1": 0.5555555555555556, "em": false, "chrf": 50.511381481157215, "bleu": 28.46946938149361}, {"f1": 0.6875, "em": false, "chrf": 67.87409401180373, "bleu": 44.09928765478173}], "avg_f1": 0.5607638888888888, "avg_em": 0.25, "avg_chrf": 55.958253256484745, "avg_bleu": 43.14218925906884}
{"id": "Wikipedia_handpicked_5:1982", "en": "Provide support to teachers and parents on the use of digital tools: Organise brief training or orientation sessions for teachers and parents as well, if monitoring and facilitation are needed.", "fr": "Fournir aux enseignants et aux élèves une assistance à l’utilisation des outils numériques : organiser de courtes séances de formation ou d’orientation pour les enseignants et les parents, si un suivi et un accompagnement sont nécessaires.", "perturbation": "omission", "pert_fr": "Fournir aux enseignants une assistance à l’utilisation des outils numériques : organiser de courtes séances de formation ou d’orientation pour les enseignants et les parents, si un suivi et un accompagnement sont nécessaires.", "bt_pert_fr": "Provide teachers with assistance in using digital tools: organize short training or orientation sessions for teachers and parents, if monitoring and support is necessary.", "questions": "[\"What support is provided to teachers and parents?\", \"What type of training or orientation sessions are organised?\"]", "answers": "[\"Assistance in using digital tools\", \"Short training or orientation sessions\"]", "scores": [{"f1": 0.3636363636363636, "em": false, "chrf": 44.22512932862388, "bleu": 17.491650626361256}, {"f1": 0.8000000000000002, "em": false, "chrf": 84.57028345517598, "bleu": 66.87403049764218}], "avg_f1": 0.5818181818181819, "avg_em": 0.0, "avg_chrf": 64.39770639189993, "avg_bleu": 42.182840562001715}
{"id": "Wikipedia_handpicked_5:1983", "en": "Help teachers to prepare the basic settings such as solutions to the use of internet data if they are required to provide live streaming of lessons.", "fr": "Aider les enseignants à préparer les conditions matérielles élémentaires, par exemple des solutions d’utilisation des données Internet s’ils doivent assurer la diffusion en direct des cours.", "perturbation": "omission", "pert_fr": "Aider les enseignants à préparer les conditions matérielles élémentaires, par exemple des solutions d’utilisation des données Internet.", "bt_pert_fr": "Help teachers prepare basic material conditions, for example solutions for using Internet data.", "questions": "[\"What basic settings need to be prepared for teachers?\", \"When is the use of internet data required?\", \"What activity requires the use of internet data?\"]", "answers": "[\"Basic material conditions\", \"When preparing basic material conditions\", \"Preparing basic material conditions\"]", "scores": [{"f1": 0, "em": false, "chrf": 19.14418530182413, "bleu": 0.0}, {"f1": 0.13333333333333333, "em": false, "chrf": 15.707338825542552, "bleu": 3.9297526283216277}, {"f1": 0, "em": false, "chrf": 16.24976641101596, "bleu": 0.0}], "avg_f1": 0.044444444444444446, "avg_em": 0.0, "avg_chrf": 17.033763512794213, "avg_bleu": 1.3099175427738758}
{"id": "Wikipedia_handpicked_5:1984", "en": "Blend appropriate approaches and limit the number of applications and platforms: Blend tools or media that are available for most students, both for synchronous communication and lessons, and for asynchronous learning.", "fr": "Combiner les approches appropriées et limiter le nombre d’applications et de plateformes : combiner les outils ou médias disponibles pour la plupart des élèves, à la fois pour la communication synchrone et les cours, ainsi que pour l’apprentissage asynchrone.", "perturbation": "omission", "pert_fr": "Combiner les approches appropriées et limiter le nombre d’applications  : combiner les outils ou médias disponibles pour la plupart des élèves, à la fois pour la communication synchrone et les cours, ainsi que pour l’apprentissage asynchrone.", "bt_pert_fr": "Combine appropriate approaches and limit the number of applications: Combine tools or media available to most students, both for synchronous communication and lessons, as well as asynchronous learning.", "questions": "[\"What learning methods are covered by the blended tools or media?\", \"What is the goal of blending tools or media for students?\"]", "answers": "[\"Synchronous communication and lessons, as well as asynchronous learning\", \"To combine appropriate approaches and limit the number of applications\"]", "scores": [{"f1": 0.7058823529411765, "em": false, "chrf": 86.25677783418735, "bleu": 35.49481056010054}, {"f1": 0.5217391304347826, "em": false, "chrf": 40.49840475215029, "bleu": 18.95201826718251}], "avg_f1": 0.6138107416879796, "avg_em": 0.0, "avg_chrf": 63.37759129316882, "avg_bleu": 27.223414413641525}
{"id": "Wikipedia_handpicked_5:1986", "en": "Develop distance learning rules and monitor students’ learning process: Define the rules with parents and students on distance learning.", "fr": "Établir des règles pour l’apprentissage à distance et suivre le processus d’apprentissage des élèves : définir les règles de l’apprentissage à distance avec les parents et les élèves.", "perturbation": "omission", "pert_fr": "Établir des règles pour l’apprentissage à distance et suivre le processus d’apprentissage des élèves : définir les règles de l’apprentissage à distance avec les élèves.", "bt_pert_fr": "Establish rules for remote learning and monitor students' learning process: Define the rules for remote learning with students.", "questions": "[\"What should be developed regarding distance learning?\", \"Who should be involved in defining distance learning rules?\"]", "answers": "[\"Rules for remote learning\", \"Students\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 44.05145271853929, "bleu": 15.97357760615681}, {"f1": 0, "em": false, "chrf": 32.33488113037541, "bleu": 0.0}], "avg_f1": 0.14285714285714288, "avg_em": 0.0, "avg_chrf": 38.193166924457344, "avg_bleu": 7.986788803078405}
{"id": "Wikipedia_handpicked_5:1991", "en": "Create communities and enhance connection: Create communities of teachers, parents, and school managers to address sense of loneliness or helplessness, facilitate sharing of experience and discussion on coping strategies when facing learning difficulties.", "fr": "Créer des communautés et renforcer les liens : créer des communautés d’enseignants, de parents et de directeurs d’écoles pour pallier le sentiment de solitude et d’impuissance, faciliter le partage d’expérience et la discussion autour des stratégies d’adaptation en cas de difficultés d’apprentissage.", "perturbation": "omission", "pert_fr": "Créer des communautés et renforcer les liens : créer des communautés d’enseignants et de parents pour pallier le sentiment de solitude et d’impuissance, faciliter le partage d’expérience et la discussion autour des stratégies d’adaptation en cas de difficultés d’apprentissage.", "bt_pert_fr": "Create communities and strengthen links: create communities of teachers and parents to alleviate the feeling of loneliness and helplessness, facilitate the sharing of experiences and discussion around adaptation strategies in the event of learning difficulties.", "questions": "[\"What communities are being created?\", \"Who are the members of the communities?\", \"What is the purpose of creating these communities?\", \"What issues do these communities aim to address?\", \"How do these communities facilitate sharing of experiences?\", \"What coping strategies are discussed in these communities?\"]", "answers": "[\"Communities of teachers and parents\", \"Teachers and parents\", \"To alleviate the feeling of loneliness and helplessness\", \"Feeling of loneliness and helplessness\", \"By facilitating the sharing of experiences and discussion\", \"Adaptation strategies\"]", "scores": [{"f1": 0.8333333333333333, "em": false, "chrf": 61.32641127936278, "bleu": 30.28512683288236}, {"f1": 0.7499999999999999, "em": false, "chrf": 42.140539029309224, "bleu": 20.374971871270468}, {"f1": 0.35714285714285715, "em": false, "chrf": 24.388301317622606, "bleu": 2.235173392777357}, {"f1": 0.6, "em": false, "chrf": 66.40798038532527, "bleu": 23.643540225079395}, {"f1": 0.7058823529411764, "em": false, "chrf": 71.0116905672127, "bleu": 31.850355294022695}, {"f1": 0.25, "em": false, "chrf": 23.115090950396368, "bleu": 6.7667641618306344}], "avg_f1": 0.5827264239028944, "avg_em": 0.0, "avg_chrf": 48.065002254871494, "avg_bleu": 19.192655296310484}
{"id": "Wikipedia_handpicked_5:1992", "en": "290 million students out of school due to COVID-19: UNESCO releases first global numbers and mobilizes response,   UNESCO.", "fr": "290 millions d’élèves déscolarisés en raison du COVID-19 : l’UNESCO publie les premiers chiffres mondiaux et mobilise une réponse, UNESCO.", "perturbation": "omission", "pert_fr": "290 millions d’élèves déscolarisés  : l’UNESCO publie les premiers chiffres mondiaux et mobilise une réponse, UNESCO.", "bt_pert_fr": "290 million students out of school: UNESCO publishes the first global figures and mobilizes a response, UNESCO.", "questions": "[\"How many students are out of school due to COVID-19?\", \"What organization released the first global numbers?\", \"What did UNESCO mobilize in response?\", \"What is the significance of the global numbers released by UNESCO?\"]", "answers": "[\"The sentence does not specify the number of students out of school due to COVID-19.\", \"UNESCO\", \"A response\", \"The significance is not explicitly stated in the sentence.\"]", "scores": [{"f1": 0, "em": false, "chrf": 4.807692307692308, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 76.20192307692308, "avg_bleu": 75.00000000000003}
{"id": "Wikisource_1:2047", "en": "and WHEREAS in a short period of time, COVID-19 has rapidly spread throughout California, necessitating updated and more stringent guidance from federal, state, and local public health officials;", "fr": "et ATTENDU QU’en peu de temps, le COVID-19 s’est rapidement propagé en Californie, rendant indispensables des directives mises à jour et plus strictes de la part des responsables de la santé publique au niveau fédéral, de l’État et local ;", "perturbation": "omission", "pert_fr": "et ATTENDU QU’en peu de temps, le COVID-19 s’est rapidement propagé, rendant indispensables des directives mises à jour et plus strictes de la part des responsables de la santé publique au niveau fédéral, de l’État et local ;", "bt_pert_fr": "and WHEREAS, in a short period of time, COVID-19 has spread rapidly, making updated and stricter guidance from federal, state, and local public health officials essential;", "questions": "[\"Where did COVID-19 rapidly spread?\", \"What prompted the need for updated and more stringent guidance?\", \"Which entities are responsible for providing updated guidance?\", \"What factors led to the rapid spread of COVID-19 in California?\"]", "answers": "[\"in a short period of time\", \"the rapid spread of COVID-19\", \"federal, state, and local public health officials\", \"not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.018538240050487, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 87.85240342963672, "bleu": 77.88007830714052}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.39746893630078, "bleu": 80.91067115702207}, {"f1": 0, "em": false, "chrf": 10.975591081710157, "bleu": 0.0}], "avg_f1": 0.4365079365079365, "avg_em": 0.0, "avg_chrf": 51.56100042192454, "avg_bleu": 39.69768736604065}
{"id": "Wikisource_1:2049", "en": "NOW, THEREFORE, I, GAVIN NEWSOM, Governor of the State of California, in accordance with the authority vested in me by the State Constitution and statutes of the State of California, and in particular, Government Code sections 8567, 8627, and 8665 do hereby issue the following Order to become effective immediately:", "fr": "EN CONSÉQUENCE, JE, GAVIN NEWSOM, gouverneur de l’État de Californie, en vertu de l’autorité qui m’est conférée par la Constitution et les lois de l’État de Californie, et en particulier, les sections 8567, 8627 et 8665 du Code gouvernemental, rends par la présente l’ordonnance suivante qui entrera en vigueur immédiatement :", "perturbation": "omission", "pert_fr": "EN CONSÉQUENCE, JE, GAVIN NEWSOM, gouverneur de l’État de Californie, en vertu de l’autorité qui m’est conférée par la Constitution, rends par la présente l’ordonnance suivante qui entrera en vigueur immédiatement :", "bt_pert_fr": "WHEREFORE, I, GAVIN NEWSOM, Governor of the State of California, by virtue of the authority vested in me by the Constitution, hereby issue the following order which shall take effect immediately:", "questions": "[\"Who is issuing the order?\", \"What is the official position of the person issuing the order?\", \"What legal authority is cited for issuing the order?\", \"Which specific government code sections are referenced in the order?\", \"What is the purpose of the order?\", \"When does the order become effective?\"]", "answers": "[\"Gavin Newsom\", \"Governor of the State of California\", \"the authority vested in me by the Constitution\", \"not referenced\", \"to issue the following order\", \"immediately\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6, "em": false, "chrf": 45.859676029783216, "bleu": 20.96310881302029}, {"f1": 0, "em": false, "chrf": 6.76214162288485, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 75.64194391206775, "bleu": 31.947155212313625}, {"f1": 0, "em": false, "chrf": 87.72426647426647, "bleu": 0.0}], "avg_f1": 0.5166666666666667, "avg_em": 0.3333333333333333, "avg_chrf": 69.33133800650039, "avg_bleu": 42.151710670889}
{"id": "Wikisource_1:2052", "en": "Those directives are consistent with the March 19, 2020, Memorandum on Identification of Essential Critical Infrastructure Workers During COVID-19 Response, found at: https://covid19.ca.gov/.", "fr": "Ces directives sont conformes au Mémorandum du 19 mars 2020 relatif à l’identification des travailleurs des infrastructures critiques essentielles pendant la réponse au COVID-19, disponibles à l’adresse : https://covid19.ca.gov/.", "perturbation": "omission", "pert_fr": "Ces directives sont conformes au Mémorandum du 19 mars 2020 relatif à l’identification des travailleurs pendant la réponse au COVID-19, disponibles à l’adresse : https://covid19.ca.gov/.", "bt_pert_fr": "This guidance is consistent with the March 19, 2020 Memorandum on Worker Identification During the COVID-19 Response, available at: https://covid19.ca.gov/.", "questions": "[\"What are those directives?\", \"What does the March 19, 2020, Memorandum on Identification of Essential Critical Infrastructure Workers During COVID-19 Response state?\", \"Where can the March 19, 2020, Memorandum be found?\", \"What is the purpose of the Memorandum on Identification of Essential Critical Infrastructure Workers?\", \"What is the relationship between the directives and the Memorandum?\"]", "answers": "[\"This guidance\", \"The Memorandum on Worker Identification During the COVID-19 Response\", \"https://covid19.ca.gov/\", \"To provide guidance on worker identification during the COVID-19 response\", \"The guidance is consistent with the Memorandum\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.3901456421181027, "bleu": 0.0}, {"f1": 0.5185185185185185, "em": false, "chrf": 41.02568150331578, "bleu": 9.084630643972961}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444444, "em": false, "chrf": 46.50837678847412, "bleu": 19.070828081828378}, {"f1": 0.6666666666666666, "em": false, "chrf": 63.71981698329391, "bleu": 32.46679154750989}], "avg_f1": 0.5259259259259259, "avg_em": 0.2, "avg_chrf": 50.72880418344038, "avg_bleu": 32.124450054662255}
{"id": "Wikisource_1:2053", "en": "ORDER OF THE STATE PUBLIC HEALTH OFFICER", "fr": "ORDONNANCE DU RESPONSABLE DE LA SANTÉ PUBLIQUE DE L’ÉTAT", "perturbation": "omission", "pert_fr": "ORDONNANCE DE LA SANTÉ PUBLIQUE DE L’ÉTAT", "bt_pert_fr": "STATE PUBLIC HEALTH ORDER", "questions": "[\"What is the order issued by?\", \"Who issues the order?\", \"What is the subject of the order?\"]", "answers": "[\"The state\", \"The state\", \"STATE PUBLIC HEALTH ORDER\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 11.973838855988294, "bleu": 11.15650800742149}, {"f1": 0.28571428571428575, "em": false, "chrf": 11.973838855988294, "bleu": 11.15650800742149}, {"f1": 0, "em": false, "chrf": 1.54320987654321, "bleu": 0.0}], "avg_f1": 0.1904761904761905, "avg_em": 0.0, "avg_chrf": 8.496962529506598, "avg_bleu": 7.43767200494766}
{"id": "Wikisource_1:2054", "en": "To protect public health, I as State Public Health Officer and Director of the California Department of Public Health order all individuals living in the State of California to stay home or at their place of residence except as needed to maintain continuity of operations of the federal critical infrastructure sectors, as outlined at https://www.cisa.gov/critical-infrastructure-sectors.", "fr": "Afin de protéger la santé publique, je, en tant que responsable de la Santé publique de l’État et directeur du département de la Santé publique de Californie, ordonne à toutes les personnes vivant dans l’État de Californie de rester chez elles ou dans leur lieu de résidence, sauf dans la mesure nécessaire au maintien de la continuité des opérations des secteurs fédéraux d’infrastructures critiques, comme énoncé à l’adresse https://www.cisa.gov/critical-infrastructure-sectors.", "perturbation": "omission", "pert_fr": "Afin de protéger la santé publique, je, en tant que responsable de la Santé publique de l’État et directeur du département de la Santé publique de Californie, ordonne à toutes les personnes vivant dans l’État de Californie de rester chez elles, sauf dans la mesure nécessaire au maintien de la continuité des opérations des secteurs fédéraux d’infrastructures critiques, comme énoncé à l’adresse https://www.cisa.gov/critical-infrastructure-sectors.", "bt_pert_fr": "To protect public health, I, as the State Public Health Officer and Director of the California Department of Public Health, direct all persons living in the State of California to remain at home, except to the extent necessary to maintain the continuity of operations of the federal critical infrastructure sectors, as set forth at https://www.cisa.gov/critical-infrastructure-sectors.", "questions": "[\"What is the purpose of the order?\", \"Who issued the order?\", \"What is required of individuals living in California?\", \"What are the federal critical infrastructure sectors?\", \"Where can information about the critical infrastructure sectors be found?\"]", "answers": "[\"To protect public health\", \"I, as the State Public Health Officer and Director of the California Department of Public Health\", \"To remain at home, except to the extent necessary to maintain the continuity of operations of the federal critical infrastructure sectors\", \"As set forth at https://www.cisa.gov/critical-infrastructure-sectors\", \"https://www.cisa.gov/critical-infrastructure-sectors\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7000000000000001, "em": false, "chrf": 69.10015899503149, "bleu": 44.580669993673474}, {"f1": 0.6666666666666665, "em": false, "chrf": 83.08045613215795, "bleu": 23.643540225079395}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8733333333333333, "avg_em": 0.6, "avg_chrf": 90.43612302543788, "avg_bleu": 73.6448420437506}
{"id": "Wikisource_1:2056", "en": "Pursuant to the authority under the Health and Safety Code 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 and 120150, this order is to go into effect immediately and shall stay in effect until further notice.", "fr": "Conformément aux sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 et 120150 du code de la Santé et de la Sécurité, cette ordonnance entre en vigueur immédiatement et le restera jusqu’à nouvel ordre.", "perturbation": "omission", "pert_fr": "Conformément aux sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 et 120150 du code de la Santé, cette ordonnance entre en vigueur immédiatement et le restera jusqu’à nouvel ordre.", "bt_pert_fr": "Pursuant to Health Code Sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 and 120150, this order is effective immediately and will remain in effect until further notice.", "questions": "[\"What authority is referenced in the sentence?\", \"When does this order go into effect?\", \"How long will this order remain in effect?\"]", "answers": "[\"Health Code Sections 120125, 120140, 131080, 120130(c), 120135, 120145, 120175 and 120150\", \"Immediately\", \"Until further notice\"]", "scores": [{"f1": 0.8148148148148148, "em": false, "chrf": 69.88273942379908, "bleu": 58.16413315488635}, {"f1": 0, "em": false, "chrf": 87.72426647426647, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 93.46837666690608, "bleu": 55.03212081491043}], "avg_f1": 0.49382716049382713, "avg_em": 0.0, "avg_chrf": 83.69179418832387, "avg_bleu": 37.73208465659892}
{"id": "Wikisource_1:2058", "en": "I order that Californians working in these 16 critical infrastructure sectors may continue their work because of the importance of these sectors to Californians' health and well-being.", "fr": "J’ordonne que les Californiens travaillant dans ces 16 secteurs d’infrastructures critiques puissent poursuivre leur travail en raison de l’importance de ces secteurs pour la santé et le bien-être des Californiens.", "perturbation": "omission", "pert_fr": "J’ordonne que les Californiens travaillant dans ces 16 secteurs d’infrastructures critiques puissent poursuivre leur travail en raison de l’importance de ces secteurs pour la santé.", "bt_pert_fr": "I am directing that Californians working in these 16 critical infrastructure sectors can continue their work because of the importance of these sectors to health.", "questions": "[\"What does the order allow Californians working in these 16 critical infrastructure sectors to do?\", \"Why are these 16 critical infrastructure sectors important to Californians' health and well-being?\", \"What sectors are considered critical infrastructure in this context?\", \"What is the reason for allowing continued work in these sectors?\"]", "answers": "[\"Continue their work\", \"Because they are important to health\", \"The 16 critical infrastructure sectors\", \"The importance of these sectors to health\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 93.00541370394312, "bleu": 55.03212081491043}, {"f1": 0.4, "em": false, "chrf": 32.12021097283257, "bleu": 6.4790667469036025}, {"f1": 0.8000000000000002, "em": false, "chrf": 91.49068120982427, "bleu": 66.87403049764218}, {"f1": 0.8235294117647058, "em": false, "chrf": 57.87501651072433, "bleu": 54.77927682341229}], "avg_f1": 0.6725490196078432, "avg_em": 0.0, "avg_chrf": 68.62283059933107, "avg_bleu": 45.791123720717124}
{"id": "Wikisource_1:2059", "en": "This Order is being issued to protect the public health of Californians.", "fr": "La présente ordonnance est rendue afin de protéger la santé publique des Californiens.", "perturbation": "omission", "pert_fr": "La présente ordonnance est rendue afin de protéger la santé publique.", "bt_pert_fr": "This order is issued to protect public health.", "questions": "[\"What is the purpose of this Order?\", \"What does this Order aim to protect?\", \"Who is the target population of this Order?\", \"What is the main goal of this Order?\"]", "answers": "[\"To protect public health\", \"Public health\", \"The general public\", \"Public health\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 62.17503604995832, "bleu": 60.653065971263366}, {"f1": 0.4, "em": false, "chrf": 70.83740450764509, "bleu": 30.326532985631665}, {"f1": 0, "em": false, "chrf": 9.33546260955612, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 48.94887387293606, "bleu": 30.326532985631665}], "avg_f1": 0.4, "avg_em": 0.0, "avg_chrf": 47.8241942600239, "avg_bleu": 30.326532985631673}
{"id": "Wikisource_1:2060", "en": "The California Department of Public Health looks to establish consistency across the state in order to ensure that we mitigate the impact of COVID-19.", "fr": "Le département de la Santé publique de Californie vise à assurer la cohérence dans l’ensemble de l’État afin de garantir que nous limitons l’impact du COVID-19.", "perturbation": "omission", "pert_fr": "Le département de la Santé publique de Californie vise à assurer la cohérence dans l’ensemble de l’État afin de garantir que nous limitons l’impact.", "bt_pert_fr": "The California Department of Public Health aims to provide consistency across the state to ensure we limit impact.", "questions": "[\"What does the California Department of Public Health aim to establish?\", \"What is the goal of establishing consistency across the state?\", \"How does establishing consistency help mitigate the impact of COVID-19?\"]", "answers": "[\"Consistency across the state\", \"To ensure we limit impact\", \"By limiting impact\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6153846153846154, "em": false, "chrf": 34.82738241338346, "bleu": 13.943458243384395}, {"f1": 0.2222222222222222, "em": false, "chrf": 7.840247049720348, "bleu": 10.122592925934278}], "avg_f1": 0.6125356125356126, "avg_em": 0.3333333333333333, "avg_chrf": 47.555876487701276, "avg_bleu": 41.3553503897729}
{"id": "Wikisource_1:2061", "en": "Our goal is simple, we want to bend the curve, and disrupt the spread of the virus.", "fr": "Notre objectif est simple, nous souhaitons faire plier la courbe et interrompre la propagation du virus.", "perturbation": "omission", "pert_fr": "Notre objectif est simple, nous souhaitons faire plier la courbe et interrompre la propagation.", "bt_pert_fr": "Our goal is simple, we want to bend the curve and stop the spread.", "questions": "[\"What is the goal mentioned in the sentence?\", \"What does 'bend the curve' mean in this context?\", \"What is the purpose of disrupting the spread of the virus?\"]", "answers": "[\"To bend the curve and stop the spread\", \"To reduce the rate of increase of cases\", \"To prevent further transmission of the virus\"]", "scores": [{"f1": 0.7142857142857143, "em": false, "chrf": 52.43207461463495, "bleu": 38.49815007763549}, {"f1": 0.5333333333333333, "em": false, "chrf": 44.795867087474235, "bleu": 35.64026463354184}, {"f1": 0.8333333333333334, "em": false, "chrf": 66.12260860984235, "bleu": 37.99178428257963}], "avg_f1": 0.6936507936507937, "avg_em": 0.0, "avg_chrf": 54.45018343731718, "avg_bleu": 37.376732997918985}
{"id": "Wikisource_1:2062", "en": "The supply chain must continue, and Californians must have access to such necessities as food, prescriptions, and health care.", "fr": "La chaîne d’approvisionnement ne doit pas être interrompue, et les Californiens doivent avoir accès aux services essentiels tels que la nourriture, les ordonnances et les soins de santé.", "perturbation": "omission", "pert_fr": "La chaîne d’approvisionnement ne doit pas être interrompue, et les Californiens doivent avoir accès aux services essentiels tels que la nourriture et les soins de santé.", "bt_pert_fr": "The supply chain must not be interrupted, and Californians must have access to essential services such as food and health care.", "questions": "[\"What must the supply chain continue to do?\", \"What necessities must Californians have access to?\", \"What are the examples of necessities mentioned in the sentence?\", \"What is the relationship between the supply chain and Californians' access to necessities?\"]", "answers": "[\"not be interrupted\", \"essential services such as food and health care\", \"food and health care\", \"The supply chain must not be interrupted, and Californians must have access to essential services such as food and health care.\"]", "scores": [{"f1": 0, "em": false, "chrf": 16.03187291162576, "bleu": 0.0}, {"f1": 0.6153846153846154, "em": false, "chrf": 46.5232959507283, "bleu": 22.089591134157878}, {"f1": 0.888888888888889, "em": false, "chrf": 48.23193784975572, "bleu": 49.76093899250716}, {"f1": 0.47058823529411764, "em": false, "chrf": 55.982412693487404, "bleu": 17.00107809840423}], "avg_f1": 0.4937154348919055, "avg_em": 0.0, "avg_chrf": 41.692379851399295, "avg_bleu": 22.212902056267318}
{"id": "Wikisource_1:2063", "en": "When people need to leave their homes or places of residence, whether to obtain or perform the functions above, or to otherwise facilitate authorized necessary activities, they should at all times practice social distancing.", "fr": "Lorsque des personnes ont besoin de quitter leur domicile ou lieu de résidence, que ce soit pour bénéficier des fonctions susmentionnées ou les exercer, ou faciliter autrement les activités nécessaires autorisées, elles doivent pratiquer en tout temps la distanciation sociale.", "perturbation": "omission", "pert_fr": "Lorsque des personnes ont besoin de quitter leur domicile ou lieu de résidence, que ce soit pour bénéficier des fonctions susmentionnées ou les exercer, ou faciliter autrement les activités nécessaires, elles doivent pratiquer en tout temps la distanciation sociale.", "bt_pert_fr": "When individuals need to leave their home or place of residence, whether to benefit from or perform the above functions, or otherwise facilitate necessary activities, they must practice social distancing at all times.", "questions": "[\"When should people practice social distancing?\", \"What activities require people to leave their homes or places of residence?\", \"What is meant by practicing social distancing?\", \"Why should people practice social distancing when leaving their homes?\"]", "answers": "[\"When individuals need to leave their home or place of residence\", \"To benefit from or perform the above functions, or otherwise facilitate necessary activities\", \"Maintaining a physical distance from others to reduce the risk of transmission\", \"To facilitate necessary activities and reduce the risk of transmission\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 29.032793682719642, "bleu": 8.39702152739292}, {"f1": 0.8, "em": false, "chrf": 63.97724769983798, "bleu": 12.26344534679562}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9473684210526316, "em": false, "chrf": 83.38043244778271, "bleu": 71.89393375176819}], "avg_f1": 0.7979532163742691, "avg_em": 0.25, "avg_chrf": 69.09761845758509, "avg_bleu": 48.13860015648919}
{"id": "Wikisource_1:2066", "en": "4) This Order shall be enforceable pursuant to California law, including, but not limited to, Government Code section 8665.", "fr": "4) La présente ordonnance forme titre exécutoire en vertu de la loi californienne, y compris, sans toutefois s’y limiter, la section 8665 du Code gouvernemental.", "perturbation": "omission", "pert_fr": "4) La présente ordonnance forme titre exécutoire en vertu de la loi, y compris, sans toutefois s’y limiter, la section 8665 du Code gouvernemental.", "bt_pert_fr": "4) This order is enforceable under law, including, but not limited to, Section 8665 of the Government Code.", "questions": "[\"What law makes this Order enforceable?\", \"Which specific section of the Government Code is referenced in the Order?\", \"What does the Order state regarding enforcement?\", \"What legal basis is provided for enforcement?\"]", "answers": "[\"Law\", \"Section 8665 of the Government Code\", \"This order is enforceable under law\", \"Section 8665 of the Government Code\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.404502541757443, "bleu": 0.0}, {"f1": 0.5714285714285715, "em": false, "chrf": 72.36740495427631, "bleu": 21.3643503198117}, {"f1": 0.4, "em": false, "chrf": 31.942173787274353, "bleu": 6.4790667469036025}, {"f1": 0, "em": false, "chrf": 7.4556257261506245, "bleu": 0.0}], "avg_f1": 0.24285714285714288, "avg_em": 0.0, "avg_chrf": 30.292426752364683, "avg_bleu": 6.960854266678825}
{"id": "Wikisource_1:2067", "en": "IT IS FURTHER ORDERED that as soon as hereafter possible, this Order be filed in the Office of the Secretary of State and that widespread publicity and notice be given of this Order.", "fr": "IL EST EN OUTRE ORDONNÉ que, dans les meilleurs délais, la présente ordonnance soit déposée auprès du Bureau du secrétaire d’État et qu’elle soit publiée et fasse l’objet d’une large diffusion.", "perturbation": "omission", "pert_fr": "IL EST EN OUTRE ORDONNÉ que, dans les meilleurs délais, la présente ordonnance soit déposée auprès du Bureau du secrétaire d’État et qu’elle soit publiée.", "bt_pert_fr": "IT IS FURTHER ORDERED that, as soon as practicable, this Order be filed with the Office of the Secretary of State and published.", "questions": "[\"When should this Order be filed in the Office of the Secretary of State?\", \"What action is required regarding the filing of this Order?\", \"What must be done regarding publicity and notice of this Order?\", \"What is the purpose of giving widespread publicity and notice?\"]", "answers": "[\"As soon as practicable\", \"This Order should be filed with the Office of the Secretary of State\", \"This Order must be published\", \"To ensure widespread awareness and notice of the Order\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 33.17109698580939, "bleu": 46.30777161991026}, {"f1": 0.9090909090909091, "em": false, "chrf": 89.51542095246818, "bleu": 70.16879391277372}, {"f1": 0.3333333333333333, "em": false, "chrf": 21.153629158096983, "bleu": 14.320952289897704}, {"f1": 0.375, "em": false, "chrf": 30.779738903742903, "bleu": 12.223075560872525}], "avg_f1": 0.5710227272727272, "avg_em": 0.0, "avg_chrf": 43.65497150002936, "avg_bleu": 35.75514834586355}
{"id": "Wikivoyage_1:2168", "en": "The SARS-CoV-2 virus is the cause of COVID-19 (coronavirus disease 2019), a contagious respiratory disease that was first identified in December 2019, in Wuhan, Hubei, China.", "fr": "Le virus SARS-CoV-2 est responsable de la COVID-19 (la maladie à coronavirus de 2019), une maladie respiratoire contagieuse qui a été identifiée pour la première fois en décembre 2019 à Wuhan, Hubei, Chine.", "perturbation": "omission", "pert_fr": "Le virus SARS-CoV-2 est responsable de la COVID-19 (la maladie à coronavirus de 2019), une maladie contagieuse qui a été identifiée pour la première fois en décembre 2019 à Wuhan, Hubei, Chine.", "bt_pert_fr": "The SARS-CoV-2 virus causes COVID-19 (coronavirus disease 2019), a contagious disease that was first identified in December 2019 in Wuhan, Hubei, China.", "questions": "[\"What is the cause of COVID-19?\", \"What is the name of the virus that causes COVID-19?\", \"What type of disease is COVID-19?\", \"When was COVID-19 first identified?\", \"Where was COVID-19 first identified?\"]", "answers": "[\"The SARS-CoV-2 virus\", \"SARS-CoV-2\", \"a contagious disease\", \"in December 2019\", \"in Wuhan, Hubei, China\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 50.71039937567908, "bleu": 42.88819424803536}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.96, "avg_em": 0.8, "avg_chrf": 90.1420798751358, "avg_bleu": 88.5776388496071}
{"id": "Wikivoyage_1:2170", "en": "It was declared a pandemic by the World Health Organization (WHO) on 11 March 2020.", "fr": "Elle a été déclarée comme pandémie par l’Organisation mondiale de la Santé (OMS) le 11 mars 2020.", "perturbation": "omission", "pert_fr": "Elle a été déclarée comme pandémie par l’Organisation mondiale de la Santé le 11 mars 2020.", "bt_pert_fr": "It was declared a pandemic by the World Health Organization on March 11, 2020.", "questions": "[\"When was it declared a pandemic by the World Health Organization (WHO)?\", \"What organization declared it a pandemic?\", \"What date is associated with the declaration of the pandemic?\"]", "answers": "[\"March 11, 2020\", \"World Health Organization\", \"March 11, 2020\"]", "scores": [{"f1": 1.0, "em": false, "chrf": 47.89021164021164, "bleu": 39.68502629920498}, {"f1": 0.8571428571428571, "em": false, "chrf": 89.4623163099415, "bleu": 71.65313105737896}, {"f1": 1.0, "em": false, "chrf": 47.89021164021164, "bleu": 39.68502629920498}], "avg_f1": 0.9523809523809524, "avg_em": 0.0, "avg_chrf": 61.747579863454924, "avg_bleu": 50.3410612185963}
{"id": "Wikivoyage_1:2172", "en": "Older people and those with underlying conditions are the most at risk of serious complications including death.", "fr": "Les personnes âgées et celles souffrant d'affections sous-jacentes sont les plus à risque de complications graves, y compris la mort.", "perturbation": "omission", "pert_fr": "Les personnes âgées sont les plus à risque de complications graves, y compris la mort.", "bt_pert_fr": "Older people are most at risk of serious complications, including death.", "questions": "[\"Who is most at risk of serious complications from the disease?\", \"What are the groups most at risk of serious complications?\", \"What complications can older people and those with underlying conditions face?\", \"What factors increase the risk of serious complications?\"]", "answers": "[\"Older people\", \"Older people\", \"Serious complications, including death\", \"Older people and those with underlying conditions\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 24.767594282525547, "bleu": 8.208499862389884}, {"f1": 0.4444444444444445, "em": false, "chrf": 24.767594282525547, "bleu": 8.208499862389884}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4615384615384615, "em": false, "chrf": 54.91642354853943, "bleu": 14.535768424205482}], "avg_f1": 0.5876068376068376, "avg_em": 0.25, "avg_chrf": 51.11290302839763, "avg_bleu": 32.73819203724632}
{"id": "Wikivoyage_1:2173", "en": "Due to the spread of the disease, you are advised not to travel unless necessary, to avoid being infected, quarantined, or stranded by changing restrictions and cancelled flights.", "fr": "En raison de la propagation de la maladie, il vous est conseillé de ne pas voyager, sauf si cela est nécessaire, pour éviter d’être infecté, mis en quarantaine ou bloqué à cause des restrictions changeantes et des vols annulés.", "perturbation": "omission", "pert_fr": "En raison de la propagation de la maladie, il vous est conseillé de ne pas voyager, sauf si cela est nécessaire, pour éviter d’être infecté ou bloqué à cause des restrictions changeantes et des vols annulés.", "bt_pert_fr": "Due to the spread of the disease, you are advised not to travel unless necessary to avoid becoming infected or stranded due to changing restrictions and canceled flights.", "questions": "[\"Why are you advised not to travel unless necessary?\", \"What are the risks of traveling during the disease spread?\", \"What can happen if you travel during the disease spread?\", \"What is the main reason for advising against travel?\"]", "answers": "[\"To avoid becoming infected or stranded due to changing restrictions and canceled flights\", \"You could become infected or be stranded due to changing restrictions and canceled flights\", \"You could become infected or be stranded due to changing restrictions and canceled flights\", \"The spread of the disease\"]", "scores": [{"f1": 0.6923076923076923, "em": false, "chrf": 74.50760316841033, "bleu": 17.9965312717659}, {"f1": 0.56, "em": false, "chrf": 65.11837703353464, "bleu": 13.065113298388567}, {"f1": 0.6666666666666666, "em": false, "chrf": 66.32942034983115, "bleu": 13.912311644176565}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7297435897435898, "avg_em": 0.25, "avg_chrf": 76.48885013794403, "avg_bleu": 36.24348905358277}
{"id": "Wikivoyage_1:2175", "en": "This is not just to protect you, but also those you come in contact with.", "fr": "Cela n’est pas seulement pour vous protéger vous, mais aussi les personnes avec qui vous entrez en contact.", "perturbation": "omission", "pert_fr": "Cela n’est pas seulement pour vous protéger vous, mais aussi les personnes.", "bt_pert_fr": "This is not only to protect you, but also others.", "questions": "[\"What is the purpose of this action?\", \"Who does this action protect besides you?\", \"What are the two groups being protected by this action?\"]", "answers": "[\"To protect you and others\", \"Others\", \"You and others\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 39.71400557196057, "bleu": 24.601580968354597}, {"f1": 0, "em": false, "chrf": 3.970417487000858, "bleu": 0.0}, {"f1": 0.36363636363636365, "em": false, "chrf": 17.469704737537235, "bleu": 10.394224994345743}], "avg_f1": 0.298989898989899, "avg_em": 0.0, "avg_chrf": 20.384709265499556, "avg_bleu": 11.665268654233445}
{"id": "Wikivoyage_1:2176", "en": "As it happens, you probably aren't missing much by staying home, as many attractions around the world are closing their doors to avoid spreading the disease.", "fr": "Il se trouve que vous ne manquez probablement pas grand-chose en restant chez vous, étant donné que de nombreuses attractions partout dans le monde ferment actuellement leurs portes afin d’éviter la propagation de la maladie.", "perturbation": "omission", "pert_fr": "Il se trouve que vous ne manquez probablement pas grand-chose en restant chez vous, étant donné que de nombreuses attractions partout dans le monde ferment actuellement afin d’éviter la propagation de la maladie.", "bt_pert_fr": "Turns out, you're probably not missing out on much by staying home, given that many attractions around the world are currently closing in order to prevent the spread of the disease.", "questions": "[\"Why might people not be missing much by staying home?\", \"What are many attractions around the world doing to avoid spreading the disease?\", \"What is the reason for attractions closing their doors?\"]", "answers": "[\"Many attractions around the world are currently closing in order to prevent the spread of the disease\", \"Closing\", \"To prevent the spread of the disease\"]", "scores": [{"f1": 0.6153846153846153, "em": false, "chrf": 62.4991408178698, "bleu": 29.89950354998137}, {"f1": 0.5, "em": false, "chrf": 34.942271740866346, "bleu": 13.533528323661276}, {"f1": 0.4444444444444445, "em": false, "chrf": 41.87870893096603, "bleu": 12.70331870386537}], "avg_f1": 0.51994301994302, "avg_em": 0.0, "avg_chrf": 46.440040496567384, "avg_bleu": 18.71211685916934}
{"id": "Wikivoyage_1:2177", "en": "If you do need to travel, take precautions as you would for other infections: wash your hands frequently, avoid touching your face, cough and sneeze into your elbow or a tissue, and avoid contact with sick people.", "fr": "Si vous devez voyager, prenez des précautions comme vous le feriez pour d’autres infections : lavez-vous les mains fréquemment, évitez de vous toucher le visage, toussez et éternuez dans le pli de votre coude ou un mouchoir et évitez tout contact avec des personnes malades.", "perturbation": "omission", "pert_fr": "Si vous devez voyager, prenez des précautions comme vous le feriez pour d’autres infections : lavez-vous les mains fréquemment, évitez de vous toucher le visage, toussez et éternuez dans le pli de votre coude ou un mouchoir.", "bt_pert_fr": "If you must travel, take precautions as you would for other infections: wash your hands frequently, avoid touching your face, and cough and sneeze into the crook of your elbow or a tissue.", "questions": "[\"What precautions should you take if you need to travel?\", \"What are the recommended hand hygiene practices?\", \"What should you avoid when touching your face?\", \"How should you cough and sneeze?\", \"Who should you avoid contact with when traveling?\"]", "answers": "[\"Wash your hands frequently, avoid touching your face, and cough and sneeze into the crook of your elbow or a tissue\", \"Wash your hands frequently\", \"Touching your face\", \"Cough and sneeze into the crook of your elbow or a tissue\", \"None specified\"]", "scores": [{"f1": 0.8292682926829269, "em": false, "chrf": 72.81965563472225, "bleu": 54.53194813323415}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.888888888888889, "em": false, "chrf": 88.21269518280367, "bleu": 52.53819788848316}, {"f1": 0, "em": false, "chrf": 11.170247716669952, "bleu": 0.0}], "avg_f1": 0.7436314363143632, "avg_em": 0.4, "avg_chrf": 74.44051970683918, "avg_bleu": 61.41402920434348}
{"id": "Wikivoyage_1:2178", "en": "Before traveling, read up on the extensive and fast-changing array of travel restrictions that have been imposed around the world.", "fr": "Avant de partir, étudiez les nombreuses restrictions de voyage en rapide évolution qui sont imposées dans le monde entier.", "perturbation": "omission", "pert_fr": "Avant de partir, étudiez les restrictions de voyage en rapide évolution qui sont imposées dans le monde entier.", "bt_pert_fr": "Before you go, research the rapidly changing travel restrictions being imposed around the world.", "questions": "[\"What should you do before traveling?\", \"Are travel restrictions extensive?\", \"Are travel restrictions changing quickly?\", \"What is being imposed around the world?\"]", "answers": "[\"Research the rapidly changing travel restrictions being imposed around the world\", \"Yes\", \"Yes\", \"Travel restrictions\"]", "scores": [{"f1": 0.2105263157894737, "em": false, "chrf": 45.436025179563785, "bleu": 8.5326633859138}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8026315789473685, "avg_em": 0.75, "avg_chrf": 86.35900629489095, "avg_bleu": 77.13316584647848}
{"id": "Wikivoyage_1:2179", "en": "After travel, monitor your health and consider self-isolation for two weeks to avoid transmitting the disease to others.", "fr": "Après avoir voyagé, surveillez votre santé et envisagez de vous auto-isoler pendant deux semaines afin d’éviter de transmettre la maladie à d’autres personnes.", "perturbation": "omission", "pert_fr": "Après avoir voyagé, surveillez votre santé et envisagez de vous auto-isoler pendant deux semaines afin d’éviter de transmettre à d’autres personnes.", "bt_pert_fr": "After traveling, monitor your health and consider self-isolating for two weeks to avoid transmitting it to others.", "questions": "[\"What should you do after travel?\", \"What is recommended to avoid transmitting the disease to others?\", \"How long should you consider self-isolation after travel?\", \"What is the purpose of self-isolation after travel?\"]", "answers": "[\"Monitor your health and consider self-isolating for two weeks\", \"Self-isolating for two weeks\", \"Two weeks\", \"To avoid transmitting the disease to others\"]", "scores": [{"f1": 0.8888888888888888, "em": false, "chrf": 91.09947858030282, "bleu": 59.694917920196445}, {"f1": 0.75, "em": false, "chrf": 78.99273463632733, "bleu": 59.460355750136046}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9097222222222222, "avg_em": 0.5, "avg_chrf": 92.52305330415754, "avg_bleu": 79.78881841758314}
{"id": "Wikivoyage_1:2180", "en": "Transportation from long-distance passenger flights to local buses has been curtailed or completely shut down in many countries due to low demand or government orders.", "fr": "Les transports, des vols longs courriers aux bus locaux, ont été réduits ou complètement suspendus dans de nombreux pays en raison de la faible demande ou d’ordonnances gouvernementales.", "perturbation": "omission", "pert_fr": "Les transports, des vols longs courriers aux bus locaux, ont été réduits ou complètement suspendus dans de nombreux pays en raison de la faible demande.", "bt_pert_fr": "Transport, from long-haul flights to local buses, has been reduced or completely suspended in many countries due to low demand.", "questions": "[\"What has been curtailed or completely shut down in many countries?\", \"Why has transportation from long-distance passenger flights to local buses been curtailed or shut down?\", \"What is the reason for the curtailment or shutdown of transportation?\", \"What types of transportation are affected?\", \"What factors contribute to the shutdown of transportation?\", \"What is the impact of low demand on transportation?\", \"What role do government orders play in transportation shutdowns?\"]", "answers": "[\"Transport\", \"Low demand\", \"Low demand\", \"Long-haul flights to local buses\", \"Low demand\", \"Transport has been reduced or completely suspended\", \"None\"]", "scores": [{"f1": 0, "em": false, "chrf": 14.124373896987313, "bleu": 0.0}, {"f1": 0.22222222222222224, "em": false, "chrf": 21.76391000355454, "bleu": 4.104249931194939}, {"f1": 0.5714285714285715, "em": false, "chrf": 30.70435448444205, "bleu": 22.31301601484299}, {"f1": 0.6153846153846154, "em": false, "chrf": 35.99311693631638, "bleu": 36.70124608961282}, {"f1": 0.5714285714285715, "em": false, "chrf": 29.581521463366823, "bleu": 22.31301601484299}, {"f1": 0.125, "em": false, "chrf": 31.516947232390695, "bleu": 4.935157841536379}, {"f1": 0, "em": false, "chrf": 2.3732937220369896, "bleu": 0.0}], "avg_f1": 0.3007805686377115, "avg_em": 0.0, "avg_chrf": 23.7225025341564, "avg_bleu": 12.909526556004304}
{"id": "Wikivoyage_1:2181", "en": "Many international and regional borders are closed.", "fr": "De nombreuses frontières internationales et régionales sont fermées.", "perturbation": "omission", "pert_fr": "De nombreuses frontières régionales sont fermées.", "bt_pert_fr": "Many regional borders are closed.", "questions": "[\"What types of borders are closed?\", \"Why are international and regional borders closed?\", \"What is the impact of closed borders?\"]", "answers": "[\"Regional borders\", \"Not specified\", \"Not specified\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 45.228153889436165, "bleu": 18.393972058572114}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7777777777777778, "avg_em": 0.6666666666666666, "avg_chrf": 81.74271796314538, "avg_bleu": 72.79799068619073}
{"id": "Wikivoyage_1:2182", "en": "If you are away from home, and especially if you are in another country, consider returning home as soon as possible; this may get even more difficult as restrictions continue to change.", "fr": "Si vous n’êtes pas chez vous, et particulièrement si vous êtes à l’étranger, envisagez de rentrer le plus vite possible ; cela risque de devenir encore plus difficile au fur et à mesure que les restrictions continuent de changer.", "perturbation": "omission", "pert_fr": "Si vous n’êtes pas chez vous, envisagez de rentrer le plus vite possible ; cela risque de devenir encore plus difficile au fur et à mesure que les restrictions continuent de changer.", "bt_pert_fr": "If you are not home, consider returning as soon as possible; this is likely to become even more difficult as restrictions continue to change.", "questions": "[\"What should you consider doing if you are away from home?\", \"What should you consider doing if you are in another country?\", \"Why might it become more difficult to return home?\", \"What factors make returning home more challenging?\", \"What is happening with restrictions that affects the difficulty of returning home?\"]", "answers": "[\"Returning as soon as possible\", \"None of the information provided addresses being in another country\", \"Restrictions continue to change\", \"Changing restrictions\", \"Restrictions continue to change\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 77.27877367282302, "bleu": 57.89300674674101}, {"f1": 0, "em": false, "chrf": 15.211110637460113, "bleu": 0.0}, {"f1": 0.6666666666666665, "em": false, "chrf": 90.367870536755, "bleu": 46.30777161991026}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7151515151515151, "avg_em": 0.4, "avg_chrf": 76.57155096940764, "avg_bleu": 60.84015567333027}
{"id": "Wikivoyage_1:2185", "en": "They may be able to organize an evacuation, identify non-regularly scheduled flights, or give you an emergency loan to pay for transport.", "fr": "Ils seront peut-être en mesure d’arranger une évacuation, d’identifier des vols non réguliers ou de vous consentir un prêt d’urgence pour payer le transport.", "perturbation": "omission", "pert_fr": "Ils seront peut-être en mesure d’arranger une évacuation, d’identifier des vols non réguliers ou de vous consentir un prêt pour payer le transport.", "bt_pert_fr": "They may be able to arrange an evacuation, identify unscheduled flights, or provide you with a loan to pay for transportation.", "questions": "[\"What can they organize?\", \"What types of flights can they identify?\", \"What emergency loan option is available?\", \"What can they provide to help with transport costs?\"]", "answers": "[\"An evacuation\", \"Unscheduled flights\", \"A loan\", \"A loan\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 94.72671038989785, "bleu": 49.99999999999999}, {"f1": 0.4, "em": false, "chrf": 57.87373723997399, "bleu": 30.326532985631665}, {"f1": 0.5, "em": false, "chrf": 19.482621292525817, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 19.482621292525817, "bleu": 49.99999999999999}], "avg_f1": 0.5166666666666666, "avg_em": 0.0, "avg_chrf": 47.89142255373087, "avg_bleu": 45.08163324640791}
{"id": "Wikivoyage_1:2188", "en": "As of early April 2020, the number of confirmed cases of COVID-19 is approaching one million.", "fr": "Début avril 2020, le nombre de cas confirmés de COVID-19 approche le million.", "perturbation": "omission", "pert_fr": "Début avril 2020, le nombre de cas de COVID-19 approche le million.", "bt_pert_fr": "In early April 2020, the number of COVID-19 cases approached one million.", "questions": "[\"What was the number of confirmed cases of COVID-19 as of early April 2020?\", \"When was the number of confirmed cases of COVID-19 reported?\", \"What is the significance of the number of confirmed cases approaching one million?\"]", "answers": "[\"One million\", \"Early April 2020\", \"It marked a significant increase in the number of confirmed cases, indicating the widespread spread of the virus\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 85.90608465608466, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 91.10491360491362, "bleu": 55.03212081491043}, {"f1": 0.5454545454545454, "em": false, "chrf": 57.130929288737796, "bleu": 13.912311644176565}], "avg_f1": 0.5707070707070706, "avg_em": 0.0, "avg_chrf": 78.04730918324536, "avg_bleu": 39.648144153028994}
{"id": "Wikivoyage_1:2189", "en": "Though the disease started in mainland China, it has spread around the world and China has fewer confirmed cases and deaths than several other countries.", "fr": "Bien que la maladie ait débuté en Chine continentale, elle s’est propagée dans le monde entier, et la Chine compte moins de cas confirmés et de décès que plusieurs autres pays.", "perturbation": "omission", "pert_fr": "Bien que la maladie ait débuté en Chine continentale, elle s’est propagée dans le monde entier, et la Chine compte moins de cas confirmés que plusieurs autres pays.", "bt_pert_fr": "Although the disease started in mainland China, it has spread around the world, and China has fewer confirmed cases than several other countries.", "questions": "[\"Where did the disease start?\", \"Why does China have fewer confirmed cases and deaths than several other countries?\", \"What factors might explain the difference in confirmed cases and deaths between China and other countries?\"]", "answers": "[\"Mainland China\", \"The sentence does not provide information on why China has fewer confirmed cases and deaths\", \"The sentence does not provide information on the factors explaining the difference in confirmed cases and deaths\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7586206896551724, "em": false, "chrf": 77.60836138062548, "bleu": 50.389204852596336}, {"f1": 0.13333333333333333, "em": false, "chrf": 27.009052304173597, "bleu": 3.125190763972442}], "avg_f1": 0.6306513409961686, "avg_em": 0.3333333333333333, "avg_chrf": 68.20580456159969, "avg_bleu": 51.17146520552294}
{"id": "Wikivoyage_1:2191", "en": "All but a handful of countries have reported at least one case, with the highest numbers of reported cases in the United States, Spain, Italy, Germany, France, mainland China, Iran, and the United Kingdom.", "fr": "À quelques exceptions près, tous les pays ont rapporté au moins un cas, le nombre de cas déclarés étant le plus élevé aux États-Unis, en Espagne, en Italie, en Allemagne, en France, en Chine continentale, en Iran et au Royaume-Uni.", "perturbation": "omission", "pert_fr": "À quelques exceptions près, tous les pays ont rapporté au moins un cas, le nombre de cas déclarés étant le plus élevé aux États-Unis, en Espagne, en Italie, en Allemagne, en France et en Chine continentale.", "bt_pert_fr": "With a few exceptions, all countries reported at least one case, with the number of reported cases highest in the United States, Spain, Italy, Germany, France and mainland China.", "questions": "[\"Which countries have reported at least one case of the disease?\", \"Which countries have the highest numbers of reported cases?\", \"How many countries have reported at least one case?\", \"What is the status of the majority of countries regarding reported cases?\", \"Which countries are mentioned in the context of high reported case numbers?\"]", "answers": "[\"All countries\", \"United States, Spain, Italy, Germany, France, and mainland China\", \"All countries\", \"All countries reported at least one case\", \"United States, Spain, Italy, Germany, France, and mainland China\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 38.31365415768918, "bleu": 15.777684932819515}, {"f1": 0.8571428571428571, "em": false, "chrf": 70.70925626827716, "bleu": 48.75099426512705}, {"f1": 0.4, "em": false, "chrf": 12.180620825551436, "bleu": 30.326532985631665}, {"f1": 0.7692307692307692, "em": false, "chrf": 78.19409633759282, "bleu": 61.47881529512643}, {"f1": 0.8571428571428571, "em": false, "chrf": 70.70925626827716, "bleu": 48.75099426512705}], "avg_f1": 0.690989010989011, "avg_em": 0.0, "avg_chrf": 54.02137677147755, "avg_bleu": 41.01700434876634}
{"id": "Wikivoyage_1:2192", "en": "Local transmission is established in many countries in all major inhabited regions of the world except some Pacific island nations.", "fr": "La transmission locale est avérée dans de nombreux pays de toutes les principales régions habitées du monde, à l’exception de certaines nations insulaires du Pacifique.", "perturbation": "omission", "pert_fr": "La transmission locale est avérée dans de nombreux pays de toutes les régions habitées du monde, à l’exception de certaines nations insulaires du Pacifique.", "bt_pert_fr": "Local transmission is documented in many countries in all inhabited regions of the world, except some Pacific island nations.", "questions": "[\"Which regions of the world have local transmission?\", \"Which countries do not have local transmission?\", \"What is the exception to local transmission?\", \"What is the geographical scope of local transmission?\"]", "answers": "[\"All inhabited regions of the world\", \"Some Pacific island nations\", \"Some Pacific island nations\", \"All inhabited regions of the world\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 77.85978423524756, "bleu": 57.89300674674101}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9090909090909091, "em": false, "chrf": 77.85978423524756, "bleu": 57.89300674674101}], "avg_f1": 0.9545454545454546, "avg_em": 0.5, "avg_chrf": 88.92989211762378, "avg_bleu": 78.94650337337052}
{"id": "Wikivoyage_1:2195", "en": "Many countries are experiencing a severe shortage of test kits, and the authorities have not been able to test everybody who is at high risk, so the real number of cases is probably much higher than the official one.", "fr": "De nombreux pays sont confrontés à une importante pénurie de kits de test, et les autorités n’ont pas été en mesure de tester toutes les personnes à haut risque, de sorte que le nombre réel de cas est probablement bien plus élevé que le nombre officiel.", "perturbation": "omission", "pert_fr": "De nombreux pays sont confrontés à une importante pénurie de kits de test, et les autorités n’ont pas été en mesure de tester toutes les personnes, de sorte que le nombre réel de cas est probablement bien plus élevé que le nombre officiel.", "bt_pert_fr": "Many countries are facing a significant shortage of testing kits, and authorities have not been able to test all people, so the true number of cases is likely much higher than the official number.", "questions": "[\"What is currently happening in many countries regarding test kits?\", \"Why have authorities not been able to test everybody at high risk?\", \"What is the likely true number of cases compared to the official number?\", \"What is the reason for the shortage of test kits?\"]", "answers": "[\"Many countries are facing a significant shortage of testing kits\", \"Because authorities have not been able to test all people\", \"The true number of cases is likely much higher than the official number\", \"The shortage of test kits is due to the high demand and insufficient supply\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 58.70272016519087, "bleu": 23.356898886410004}, {"f1": 0.33333333333333326, "em": false, "chrf": 33.49629254384366, "bleu": 5.522397783539471}, {"f1": 0.75, "em": false, "chrf": 71.51639856290234, "bleu": 43.66835442847811}, {"f1": 0.5555555555555556, "em": false, "chrf": 70.82348006508647, "bleu": 28.917849332325716}], "avg_f1": 0.5763888888888888, "avg_em": 0.0, "avg_chrf": 58.63472283425583, "avg_bleu": 25.366375107688327}
{"id": "Wikivoyage_1:2196", "en": "Countries also differ in their testing and reporting practices, so comparisons of the number of reported cases do not tell the full story of how the epidemic has progressed in different areas.", "fr": "Les pays ont également adopté des méthodes de test et de comptage différentes, de sorte que la comparaison des nombres de cas rapportés ne permet pas de se faire une idée précise de la progression de l’épidémie dans différentes régions.", "perturbation": "omission", "pert_fr": "Les pays ont également adopté des méthodes de test différentes, de sorte que la comparaison des nombres de cas rapportés ne permet pas de se faire une idée précise de la progression de l’épidémie dans différentes régions.", "bt_pert_fr": "Countries have also adopted different testing methods, so comparing the numbers of reported cases does not provide a clear picture of how the epidemic is progressing in different regions.", "questions": "[\"What differs among countries in the context of the epidemic?\", \"Why do comparisons of reported cases not tell the full story?\", \"What practices differ among countries?\", \"How does the variation in testing and reporting affect the understanding of the epidemic?\", \"What is the limitation of comparing reported cases across countries?\"]", "answers": "[\"Testing methods\", \"Because countries have different testing methods\", \"Testing methods\", \"It affects the understanding by making comparisons unreliable due to varying testing practices\", \"It does not provide a clear picture of how the epidemic is progressing in different regions\"]", "scores": [{"f1": 0, "em": false, "chrf": 16.75462927561248, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 45.626625123757854, "bleu": 10.89644800332157}, {"f1": 0.3333333333333333, "em": false, "chrf": 22.684823335101065, "bleu": 18.393972058572114}, {"f1": 0.5, "em": false, "chrf": 55.05293791733615, "bleu": 21.200626759025184}, {"f1": 0.21428571428571427, "em": false, "chrf": 23.797690589331808, "bleu": 3.737437943747671}], "avg_f1": 0.2895238095238095, "avg_em": 0.0, "avg_chrf": 32.78334124822787, "avg_bleu": 10.845696952933308}
{"id": "Wikivoyage_1:2198", "en": "The coronavirus is a relatively large virus, meaning it is not truly airborne: it will settle down in respiratory droplets.", "fr": "Le coronavirus est un virus d’une taille relativement grande, ce qui signifie qu’il n’est pas réellement aéroporté : il est présent dans les gouttelettes respiratoires.", "perturbation": "omission", "pert_fr": "Le coronavirus est un virus d’une taille relativement grande, ce qui signifie qu’il est présent dans les gouttelettes respiratoires.", "bt_pert_fr": "The coronavirus is a relatively large virus, which means it is present in respiratory droplets.", "questions": "[\"What does the size of the coronavirus imply?\", \"Is the coronavirus truly airborne?\", \"What happens to the coronavirus in respiratory droplets?\"]", "answers": "[\"It is present in respiratory droplets\", \"It can be transmitted through the air\", \"It is present in respiratory droplets\"]", "scores": [{"f1": 0.3636363636363636, "em": false, "chrf": 19.781212024179133, "bleu": 16.233395773754946}, {"f1": 0, "em": false, "chrf": 6.944444444444445, "bleu": 0.0}, {"f1": 0.2, "em": false, "chrf": 14.080319683271284, "bleu": 8.116697886877475}], "avg_f1": 0.18787878787878787, "avg_em": 0.0, "avg_chrf": 13.60199205063162, "avg_bleu": 8.116697886877473}
{"id": "Wikivoyage_1:2199", "en": "Staying two metres (six feet) away from other people is usually enough to prevent transmission through this route.", "fr": "En maintenant une distance de deux mètres (six pieds) avec les autres, il est généralement possible d’éviter la transmission par cette voie.", "perturbation": "omission", "pert_fr": "En maintenant une distance de deux mètres avec les autres, il est généralement possible d’éviter la transmission par cette voie.", "bt_pert_fr": "By maintaining a distance of two meters from others, it is generally possible to avoid transmission by this route.", "questions": "[\"What distance is recommended to prevent transmission?\", \"What type of transmission can be prevented by staying two metres (six feet) away?\", \"What is the recommended distance to prevent transmission through this route?\"]", "answers": "[\"Two meters\", \"This route\", \"Two meters\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 30.930759839570047, "bleu": 18.393972058572114}, {"f1": 0.3333333333333333, "em": false, "chrf": 25.62301891048146, "bleu": 18.393972058572114}, {"f1": 0.3333333333333333, "em": false, "chrf": 30.930759839570047, "bleu": 18.393972058572114}], "avg_f1": 0.3333333333333333, "avg_em": 0.0, "avg_chrf": 29.161512863207182, "avg_bleu": 18.393972058572114}
{"id": "Wikivoyage_1:2201", "en": "The SARS-CoV-2 virus may last on cardboard for up to 24 hours and on plastic for up to 3 days.", "fr": "Le virus SARS-Cov-2 peut survivre jusqu’à 24 heures sur du carton et jusqu’à 3 jours sur du plastique.", "perturbation": "omission", "pert_fr": "Le virus SARS-Cov-2 peut survivre jusqu’à 24 heures sur du carton.", "bt_pert_fr": "The SARS-Cov-2 virus can survive on cardboard for up to 24 hours.", "questions": "[\"How long can the SARS-CoV-2 virus last on cardboard?\", \"How long can the SARS-CoV-2 virus last on plastic?\", \"What surfaces does the SARS-CoV-2 virus survive on?\", \"What is the duration of SARS-CoV-2 virus survival on cardboard?\", \"What is the duration of SARS-CoV-2 virus survival on plastic?\"]", "answers": "[\"24 hours\", \"not specified\", \"cardboard\", \"24 hours\", \"not specified\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 56.43978387373788, "bleu": 36.78794411714425}, {"f1": 0, "em": false, "chrf": 8.680555555555555, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 38.11163983885504, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 56.43978387373788, "bleu": 36.78794411714425}, {"f1": 0, "em": false, "chrf": 8.680555555555555, "bleu": 0.0}], "avg_f1": 0.26666666666666666, "avg_em": 0.0, "avg_chrf": 33.67046373948838, "avg_bleu": 14.7151776468577}
{"id": "Wikivoyage_1:2202", "en": "Transmission via the fecal–oral route may also be possible.", "fr": "Une transmission par voie oro-fécale serait également possible.", "perturbation": "omission", "pert_fr": "Une transmission oro-fécale serait également possible.", "bt_pert_fr": "Fecal-oral transmission would also be possible.", "questions": "[\"May transmission via the fecal–oral route be possible?\", \"Is fecal–oral transmission possible?\", \"What does the sentence suggest about transmission routes?\"]", "answers": "[\"Yes\", \"Yes\", \"The sentence suggests that fecal-oral transmission is possible\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.631578947368421, "em": false, "chrf": 64.85434088622192, "bleu": 26.295889981470587}], "avg_f1": 0.8771929824561404, "avg_em": 0.6666666666666666, "avg_chrf": 88.2847802954073, "avg_bleu": 75.4319633271569}
{"id": "Wikivoyage_1:2203", "en": "Evidence suggests that COVID-19 is contagious even without symptoms, though to what extent is still being investigated.", "fr": "Des données probantes suggèrent que la COVID-19 est contagieuse même en l'absence de symptômes, bien que la mesure dans laquelle elle l’est soit encore à l’étude.", "perturbation": "omission", "pert_fr": "Des données probantes suggèrent que la COVID-19 est contagieuse même en l'absence de symptômes.", "bt_pert_fr": "Evidence suggests that COVID-19 is contagious even in the absence of symptoms.", "questions": "[\"What evidence suggests about COVID-19?\", \"Is COVID-19 contagious without symptoms?\", \"To what extent is COVID-19 contagious without symptoms?\", \"What is still being investigated regarding COVID-19 contagion?\"]", "answers": "[\"COVID-19 is contagious even in the absence of symptoms\", \"Yes\", \"To a significant extent\", \"The extent to which it is contagious without symptoms\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 66.76162081970811, "bleu": 36.55552228545123}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 20.846835064134204, "bleu": 9.138402379955025}, {"f1": 0.8888888888888888, "em": false, "chrf": 81.56072648835216, "bleu": 59.694917920196445}], "avg_f1": 0.7388888888888889, "avg_em": 0.25, "avg_chrf": 67.29229559304862, "avg_bleu": 51.34721064640068}
{"id": "Wikivoyage_1:2204", "en": "Common symptoms include a fever, dry cough, and fatigue.", "fr": "Les symptômes courants comprennent la fièvre, une toux sèche et la fatigue.", "perturbation": "omission", "pert_fr": "Les symptômes courants comprennent la fièvre et la fatigue.", "bt_pert_fr": "Common symptoms include fever and fatigue.", "questions": "[\"What is included as a common symptom?\", \"What specific symptoms are associated with the condition?\"]", "answers": "[\"Fever\", \"Fatigue\"]", "scores": [{"f1": 0, "em": false, "chrf": 43.997429305912604, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 18.680160794187866, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 31.338795050050237, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2205", "en": "Other less common symptoms include shortness of breath, a sore throat, headache, muscle pain, or sputum production.", "fr": "L’essoufflement, le mal de gorge, les maux de tête, les courbatures ou la production d’expectorations comptent parmi les autres symptômes moins courants.", "perturbation": "omission", "pert_fr": "L’essoufflement, les maux de tête, les courbatures ou la production d’expectorations comptent parmi les autres symptômes moins courants.", "bt_pert_fr": "Other less common symptoms include shortness of breath, headache, body aches, or sputum production.", "questions": "[\"What are some less common symptoms of the disease?\"]", "answers": "[\"Shortness of breath, headache, body aches, or sputum production\"]", "scores": [{"f1": 0.7000000000000001, "em": false, "chrf": 62.89368635073519, "bleu": 24.839003933972574}], "avg_f1": 0.7000000000000001, "avg_em": 0.0, "avg_chrf": 62.89368635073519, "avg_bleu": 24.839003933972574}
{"id": "Wikivoyage_1:2207", "en": "Serious complications include pneumonia, acute respiratory distress syndrome, and multi-organ failure leading to disability or death.", "fr": "Les complications sévères incluent la pneumonie, le syndrome de détresse respiratoire aiguë et la défaillance multiviscérale entraînant une invalidité ou la mort.", "perturbation": "omission", "pert_fr": "Les complications sévères incluent la pneumonie et la défaillance multiviscérale entraînant une invalidité ou la mort.", "bt_pert_fr": "Severe complications include pneumonia and multiple organ failure leading to disability or death.", "questions": "[\"What are the specific complications listed?\", \"What can lead to disability or death?\", \"What are the medical conditions associated with serious complications?\"]", "answers": "[\"Pneumonia and multiple organ failure\", \"Multiple organ failure\", \"Pneumonia and multiple organ failure\"]", "scores": [{"f1": 0.4615384615384615, "em": false, "chrf": 42.72907397221461, "bleu": 7.715486568024961}, {"f1": 0.4, "em": false, "chrf": 77.89884883808578, "bleu": 27.516060407455225}, {"f1": 0.4615384615384615, "em": false, "chrf": 42.72907397221461, "bleu": 7.715486568024961}], "avg_f1": 0.441025641025641, "avg_em": 0.0, "avg_chrf": 54.45233226083834, "avg_bleu": 14.315677847835047}
{"id": "Wikivoyage_1:2209", "en": "Case fatality rate is estimated at 1-3% of infected individuals, most of whom are elderly with underlying health conditions.", "fr": "Le taux de létalité est estimé à 1 à 3 % des personnes infectées, dont la plupart sont des personnes âgées présentant des affections sous-jacentes.", "perturbation": "omission", "pert_fr": "Le taux de létalité est estimé à 1 à 3 % des personnes infectées, dont la plupart sont des personnes âgées.", "bt_pert_fr": "The case fatality rate is estimated at 1-3% of those infected, most of whom are elderly.", "questions": "[\"What is the estimated case fatality rate?\", \"What group of individuals is most affected by the case fatality rate?\"]", "answers": "[\"1-3% of those infected\", \"Elderly\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 36.73114343608563, "bleu": 35.35533905932737}, {"f1": 0.2857142857142857, "em": false, "chrf": 11.912803089555812, "bleu": 0.673794699908547}], "avg_f1": 0.5178571428571428, "avg_em": 0.0, "avg_chrf": 24.32197326282072, "avg_bleu": 18.01456687961796}
{"id": "Wikivoyage_1:2210", "en": "The fatality rate is much higher for those over 70 but significantly lower for those under 40.", "fr": "Le taux de létalité est nettement plus élevé chez les plus de 70 ans, mais bien moins élevé chez les moins de 40 ans.", "perturbation": "omission", "pert_fr": "Le taux de létalité est nettement plus élevé chez les plus de 70 ans.", "bt_pert_fr": "The case fatality rate is significantly higher among those over 70.", "questions": "[\"What is the fatality rate for those over 70?\", \"What is the fatality rate for those under 40?\", \"How does the fatality rate differ between people over 70 and those under 40?\", \"Which age group has a higher fatality rate?\", \"Which age group has a lower fatality rate?\"]", "answers": "[\"significantly higher\", \"not mentioned\", \"The fatality rate is significantly higher for those over 70 compared to those under 40\", \"those over 70\", \"those under 40\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 36.921463979138984, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 7.007330746011213, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 63.32211410789126, "bleu": 34.79159475128446}, {"f1": 0.6666666666666666, "em": false, "chrf": 87.72426647426647, "bleu": 55.03212081491043}, {"f1": 0.6666666666666666, "em": false, "chrf": 89.11315536315534, "bleu": 55.03212081491043}], "avg_f1": 0.5, "avg_em": 0.0, "avg_chrf": 56.817666134092654, "avg_bleu": 38.97116727622106}
{"id": "Wikivoyage_1:2211", "en": "Those most at risk of COVID-19 infection and serious complications are the elderly and those with weakened immune systems or underlying health conditions like cardiovascular disease, diabetes, hypertension, chronic respiratory disease, and cancer.", "fr": "Les personnes les plus à risque de développer une infection par le virus de la COVID-19 et des complications graves sont les personnes âgées et celles dont le système immunitaire est affaibli ou souffrant d'une affection sous-jacente comme une maladie cardiovasculaire, le diabète, l’hypertension, une maladie respiratoire chronique et un cancer.", "perturbation": "omission", "pert_fr": "Les personnes les plus à risque de développer une infection par le virus de la COVID-19 et des complications graves sont les personnes âgées et celles dont le système immunitaire est affaibli ou souffrant d'une affection sous-jacente comme une maladie cardiovasculaire, le diabète et l’hypertension.", "bt_pert_fr": "People most at risk of developing infection with the COVID-19 virus and serious complications are older adults and those with weakened immune systems or underlying conditions such as cardiovascular disease, diabetes and hypertension.", "questions": "[\"Who are the most at risk of COVID-19 infection and serious complications?\", \"What factors increase the risk of severe COVID-19 complications?\", \"What specific health conditions are mentioned as increasing risk?\", \"What is considered a weakened immune system in the context of COVID-19?\", \"What age group is most at risk of COVID-19 infection?\"]", "answers": "[\"Older adults and those with weakened immune systems or underlying conditions such as cardiovascular disease, diabetes and hypertension\", \"Weakened immune systems or underlying conditions such as cardiovascular disease, diabetes and hypertension\", \"Cardiovascular disease, diabetes, and hypertension\", \"Not explicitly defined in the sentence\", \"Older adults\"]", "scores": [{"f1": 0.7000000000000001, "em": false, "chrf": 64.57954467316311, "bleu": 39.638443767744775}, {"f1": 0.6, "em": false, "chrf": 64.1016020952289, "bleu": 13.67440667823257}, {"f1": 0.7142857142857143, "em": false, "chrf": 55.671627979705995, "bleu": 20.300727612812874}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 19.985123304202542, "bleu": 0.0}], "avg_f1": 0.6028571428571429, "avg_em": 0.2, "avg_chrf": 60.86757961046011, "avg_bleu": 34.722715611758055}
{"id": "Wikivoyage_1:2212", "en": "Not many cases are reported in children and most of these are mild or moderate, though a significant fraction do get pneumonia.", "fr": "Peu de cas sont signalés chez les enfants, et la plupart d’entre eux sont légers à modérés, bien qu’une part significative développe une pneumonie.", "perturbation": "omission", "pert_fr": "Peu de cas sont signalés chez les enfants, et la plupart d’entre eux sont légers.", "bt_pert_fr": "Few cases are reported in children, and most of them are mild.", "questions": "[\"Why are not many cases reported in children?\", \"What is the typical severity of cases in children?\", \"What percentage of children's cases result in pneumonia?\", \"What condition do a significant fraction of children's cases develop?\"]", "answers": "[\"The sentence does not provide a reason for not many cases being reported in children\", \"Mild\", \"The sentence does not mention the percentage of children's cases resulting in pneumonia\", \"The sentence does not indicate what condition a significant fraction of children's cases develop\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 23.073105365030525, "bleu": 13.533528323661276}, {"f1": 0.5555555555555556, "em": false, "chrf": 60.05089916169736, "bleu": 22.416933501922298}, {"f1": 0, "em": false, "chrf": 5.764182729979626, "bleu": 0.0}], "avg_f1": 0.5138888888888888, "avg_em": 0.25, "avg_chrf": 47.22204681417688, "avg_bleu": 33.9876154563959}
{"id": "Wikivoyage_1:2213", "en": "Occupationally, health care workers have higher risk compared to others with clusters of disease among workers and in health care settings.", "fr": "Professionnellement, le personnel de santé présente un risque plus élevé par rapport aux autres, avec des clusters de maladie parmi les travailleurs et dans les établissements médicaux.", "perturbation": "omission", "pert_fr": "Professionnellement, le personnel présente un risque plus élevé par rapport aux autres, avec des clusters de maladie parmi les travailleurs et dans les établissements médicaux.", "bt_pert_fr": "Occupationally, staff are at higher risk compared to others, with clusters of illness among workers and in medical settings.", "questions": "[\"What is the higher risk for among health care workers?\", \"How does the risk for health care workers compare to others?\", \"Where are clusters of disease found among workers?\", \"What settings are associated with clusters of disease?\"]", "answers": "[\"Illness\", \"Higher risk\", \"Among workers\", \"Medical settings\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.142857142857142, "bleu": 0.0}, {"f1": 0.28571428571428575, "em": false, "chrf": 31.585490912798686, "bleu": 11.15650800742149}, {"f1": 0.5, "em": false, "chrf": 89.11315536315534, "bleu": 49.99999999999999}, {"f1": 0.4, "em": false, "chrf": 41.932444984864624, "bleu": 30.326532985631665}], "avg_f1": 0.29642857142857143, "avg_em": 0.0, "avg_chrf": 42.44348710091895, "avg_bleu": 22.870760248263288}
{"id": "Wikivoyage_1:2214", "en": "The time between being exposed to the virus and the emergence of symptoms (incubation period) is typically between 2 and 14 days, though there has been one reported case in China where symptoms appeared 27 days after exposure.", "fr": "La durée entre l’exposition au virus et l’apparition des symptômes (période d’incubation) est généralement de 2 à 14 jours, même si pour un cas signalé en Chine, les symptômes sont apparus 27 jours après l’exposition.", "perturbation": "omission", "pert_fr": "La durée entre l’exposition au virus et l’apparition des symptômes (période d’incubation) est généralement de 2 à 14 jours, même si pour un cas signalé les symptômes sont apparus 27 jours après l’exposition.", "bt_pert_fr": "The length of time between exposure to the virus and the appearance of symptoms (incubation period) is generally 2 to 14 days, although one reported case showed symptoms 27 days after exposure.", "questions": "[\"How long is the incubation period typically between exposure and symptom emergence?\", \"What is the incubation period in the reported case from China?\"]", "answers": "[\"2 to 14 days\", \"27 days\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 28.024505186848785, "bleu": 27.534765745159184}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8333333333333333, "avg_em": 0.5, "avg_chrf": 64.01225259342439, "avg_bleu": 63.76738287257962}
{"id": "Wikivoyage_1:2216", "en": "There is evidence of transmission from people who don't have symptoms, although to what extent is still being investigated.", "fr": "Une transmission par des personnes asymptomatiques a été mise en évidence, mais l’ampleur de ce phénomène est encore à l’étude.", "perturbation": "omission", "pert_fr": "Une transmission par des personnes a été mise en évidence, mais l’ampleur de ce phénomène est encore à l’étude.", "bt_pert_fr": "Transmission by people has been demonstrated, but the extent of this phenomenon is still under study.", "questions": "[\"What evidence exists regarding transmission from asymptomatic people?\", \"Are there cases of transmission from people without symptoms?\", \"What is being investigated about transmission from asymptomatic individuals?\"]", "answers": "[\"None\", \"No\", \"The extent of transmission from asymptomatic individuals\"]", "scores": [{"f1": 0, "em": false, "chrf": 2.419229401830948, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 34.13974313394365, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2218", "en": "Long-term effects for people who have recovered remain unclear, but there is evidence of reduced lung capacity in some recovered patients.", "fr": "Les effets à long terme chez les personnes ayant guéri ne sont toujours pas clairement établis, mais une réduction de la capacité pulmonaire a été mise en évidence chez certains patients guéris.", "perturbation": "omission", "pert_fr": "Les effets à long terme chez les personnes ayant guéri ne sont toujours pas clairement établis, mais une réduction de la capacité pulmonaire a été mise en évidence chez certains patients.", "bt_pert_fr": "The long-term effects in those who have recovered are still not clearly established, but a reduction in lung capacity has been demonstrated in some patients.", "questions": "[\"What are the long-term effects for people who have recovered?\", \"What is unclear about long-term effects?\", \"What evidence is there regarding lung capacity in recovered patients?\", \"What does the evidence suggest about lung capacity?\"]", "answers": "[\"The long-term effects in those who have recovered are still not clearly established\", \"The long-term effects are not clearly established\", \"A reduction in lung capacity has been demonstrated in some patients\", \"A reduction in lung capacity\"]", "scores": [{"f1": 0.5217391304347826, "em": false, "chrf": 60.91483253924195, "bleu": 19.338531381761715}, {"f1": 0.39999999999999997, "em": false, "chrf": 44.219755828368406, "bleu": 21.191828141393902}, {"f1": 0.5, "em": false, "chrf": 45.59416008346318, "bleu": 11.208466750961147}, {"f1": 0.5, "em": false, "chrf": 62.646756458860374, "bleu": 21.3643503198117}], "avg_f1": 0.48043478260869565, "avg_em": 0.0, "avg_chrf": 53.34387622748348, "avg_bleu": 18.275794148482117}
{"id": "Wikivoyage_1:2221", "en": "There is no established test assessing for the virus or antibodies in the blood, although tests are being developed.", "fr": "Il n’existe aucun test reconnu de dépistage du virus ou des anticorps dans le sang, bien que des tests soient en cours de développement.", "perturbation": "omission", "pert_fr": "Il n’existe aucun test reconnu de dépistage du virus, bien que des tests soient en cours de développement.", "bt_pert_fr": "There is no recognized test for the virus, although tests are being developed.", "questions": "[\"Is there an established test for the virus in the blood?\", \"Is there an established test for antibodies in the blood?\", \"What is the current status of tests for the virus?\", \"What is the current status of tests for antibodies?\", \"Are tests for the virus or antibodies being developed?\"]", "answers": "[\"No\", \"No\", \"Tests are being developed\", \"Tests are being developed\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3333333333333333, "em": false, "chrf": 79.87037873202037, "bleu": 15.97357760615681}, {"f1": 0.3333333333333333, "em": false, "chrf": 79.87037873202037, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7333333333333333, "avg_em": 0.6, "avg_chrf": 91.94815149280814, "avg_bleu": 66.38943104246275}
{"id": "Wikivoyage_1:2222", "en": "There is no test to establish immunity to the virus.", "fr": "Il n’existe aucun test pour établir l’immunité au virus.", "perturbation": "omission", "pert_fr": "Il n’existe aucun test pour le virus.", "bt_pert_fr": "There is no test for the virus.", "questions": "[\"Is there a test to establish immunity to the virus?\", \"What is the current status of testing for immunity to the virus?\", \"What does the absence of a test for immunity mean?\"]", "answers": "[\"No\", \"There is no test available for establishing immunity to the virus\", \"It means that immunity to the virus cannot be confirmed or verified through testing\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 76.4160455391323, "bleu": 39.281465090051306}, {"f1": 0.8333333333333333, "em": false, "chrf": 93.27638919207776, "bleu": 66.52049901111006}], "avg_f1": 0.8333333333333334, "avg_em": 0.3333333333333333, "avg_chrf": 89.89747824373667, "avg_bleu": 68.60065470038714}
{"id": "Wikivoyage_1:2223", "en": "Many governments around the world have advised their citizens not to travel unnecessarily amid the pandemic.", "fr": "De nombreux gouvernements de par le monde ont conseillé à leurs citoyens de ne pas voyager sans raison valable pendant la pandémie.", "perturbation": "omission", "pert_fr": "De nombreux gouvernements de par le monde ont conseillé à leurs citoyens de ne pas voyager pendant la pandémie.", "bt_pert_fr": "Many governments around the world have advised their citizens not to travel during the pandemic.", "questions": "[\"What have many governments advised their citizens to do amid the pandemic?\", \"What is the context of the travel advice?\", \"Who has given travel advice?\"]", "answers": "[\"Not to travel\", \"The pandemic\", \"Many governments\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 44.57386008048413, "bleu": 71.65313105737896}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9523809523809524, "avg_em": 0.6666666666666666, "avg_chrf": 81.52462002682805, "avg_bleu": 90.551043685793}
{"id": "Wikivoyage_1:2225", "en": "Particularly avoid cruise ship travel.", "fr": "Évitez particulièrement de partir en croisière.", "perturbation": "omission", "pert_fr": "Évitez de partir en croisière.", "bt_pert_fr": "Avoid going on a cruise.", "questions": "[\"What should be avoided?\", \"Why should cruise ship travel be avoided?\"]", "answers": "[\"Going on a cruise\", \"The sentence does not provide a reason for avoiding cruise ship travel\"]", "scores": [{"f1": 0, "em": false, "chrf": 19.006233434207996, "bleu": 0.0}, {"f1": 0.25000000000000006, "em": false, "chrf": 38.84271364961188, "bleu": 4.456882760699064}], "avg_f1": 0.12500000000000003, "avg_em": 0.0, "avg_chrf": 28.92447354190994, "avg_bleu": 2.228441380349532}
{"id": "Wikivoyage_1:2226", "en": "Older travelers and those with underlying health conditions are most at risk and should avoid travel that puts them at risk, such as long plane flights, visits to crowded places, and especially cruises, even outside of severely affected areas.", "fr": "Les voyageurs âgés et ceux souffrant d'une affection sous-jacente sont les plus à risque et doivent éviter tout voyage qui les met en danger, notamment les longs vols, les visites de lieux très fréquentés et, en particulier, les croisières, même en dehors des régions gravement touchées.", "perturbation": "omission", "pert_fr": "Les voyageurs âgés et ceux souffrant d'une affection sous-jacente sont les plus à risque et doivent éviter tout voyage qui les met en danger, notamment les visites de lieux très fréquentés et, en particulier, les croisières.", "bt_pert_fr": "Elderly travelers and those with underlying conditions are most at risk and should avoid any travel that puts them at risk, including visits to busy locations and, in particular, cruises.", "questions": "[\"What types of travel should older travelers and those with underlying health conditions avoid?\", \"Why should older travelers and those with underlying health conditions avoid travel?\", \"What specific travel activities are considered risky?\", \"What is considered especially risky for these groups?\", \"Are there any exceptions to avoiding travel outside of severely affected areas?\"]", "answers": "[\"Travel that puts them at risk, including visits to busy locations and, in particular, cruises\", \"Because they are most at risk\", \"Visits to busy locations and cruises\", \"Cruises\", \"No\"]", "scores": [{"f1": 0.32, "em": false, "chrf": 29.13133477790999, "bleu": 6.250381527944883}, {"f1": 0.8333333333333334, "em": false, "chrf": 95.31916500738012, "bleu": 75.98356856515926}, {"f1": 0.37499999999999994, "em": false, "chrf": 25.52259417055233, "bleu": 5.484411595600381}, {"f1": 0, "em": false, "chrf": 73.45238095238095, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 25.0, "bleu": 0.0}], "avg_f1": 0.30566666666666664, "avg_em": 0.0, "avg_chrf": 49.68509498164468, "avg_bleu": 17.543672337740905}
{"id": "Wikivoyage_1:2228", "en": "This means minimising contact with others by keeping a distance of six feet or two meters from them and avoiding gathering together in groups.", "fr": "Cela signifie limiter ses contacts avec les autres, en maintenant une distance de deux mètres ou six pieds avec eux et en évitant les rassemblements.", "perturbation": "omission", "pert_fr": "Cela signifie limiter ses contacts avec les autres, en évitant les rassemblements.", "bt_pert_fr": "This means limiting contact with others, avoiding gatherings.", "questions": "[\"What does 'minimising contact with others' involve?\", \"What distance should be maintained from others?\", \"What is considered a safe distance from others?\", \"What should be avoided to reduce risk?\", \"What is the purpose of keeping a distance from others?\"]", "answers": "[\"Limiting contact with others\", \"The sentence does not specify a distance\", \"The sentence does not specify a safe distance\", \"Gatherings\", \"To reduce risk\"]", "scores": [{"f1": 0, "em": false, "chrf": 9.115866782026554, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 10.357257934589978, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 10.777147335957334, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 33.62942970124133, "bleu": 0.0}, {"f1": 0.25, "em": false, "chrf": 7.729806215595934, "bleu": 14.127216461522432}], "avg_f1": 0.05, "avg_em": 0.0, "avg_chrf": 14.321901593882226, "avg_bleu": 2.8254432923044863}
{"id": "Wikivoyage_1:2237", "en": "Drying your washed hands physically removes some germs from your skin (so don't skip that step, and don't share towels).", "fr": "Le séchage des mains lavées permet de physiquement éliminer certains germes de la peau (alors ne sautez pas cette étape et ne partagez pas les serviettes).", "perturbation": "omission", "pert_fr": "Le séchage des mains permet de physiquement éliminer certains germes de la peau (alors ne sautez pas cette étape et ne partagez pas les serviettes).", "bt_pert_fr": "Drying your hands helps physically remove some germs from the skin (so don't skip this step or share towels).", "questions": "[\"What does drying your washed hands remove?\", \"Why shouldn't you skip the step of drying your hands?\", \"Why shouldn't you share towels?\", \"What germs are removed by drying hands?\", \"What is the importance of drying hands after washing?\"]", "answers": "[\"Some germs\", \"Because it physically removes some germs from the skin\", \"To avoid spreading germs to others\", \"Some germs\", \"It helps physically remove some germs from the skin\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9411764705882353, "em": false, "chrf": 87.18813376483526, "bleu": 76.72796459606589}, {"f1": 0.13333333333333333, "em": false, "chrf": 14.424363698477642, "bleu": 4.923026124015933}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 71.92617139985562, "bleu": 24.446151121745054}], "avg_f1": 0.7649019607843137, "avg_em": 0.4, "avg_chrf": 74.7077337726337, "avg_bleu": 61.21942836836539}
{"id": "Wikivoyage_1:2238", "en": "If soap and water are not available, then use a &gt;60% alcohol-based hand sanitizer.", "fr": "En l’absence de savon et d’eau, utilisez une solution hydro-alcoolique &gt; 60 %.", "perturbation": "omission", "pert_fr": "En l’absence de savon, utilisez une solution hydro-alcoolique > 60 %.", "bt_pert_fr": "In the absence of soap, use a hydroalcoholic solution > 60%.", "questions": "[\"What should be done if soap and water are not available?\"]", "answers": "[\"Use a hydroalcoholic solution > 60%\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 26.716099216984894, "bleu": 14.794015674776452}], "avg_f1": 0.4444444444444445, "avg_em": 0.0, "avg_chrf": 26.716099216984894, "avg_bleu": 14.794015674776452}
{"id": "Wikivoyage_1:2239", "en": "Alcohol is a quick germ-killer, but it's not quite instant, so this still requires the same 20 seconds of rubbing your hands together, making sure that every single scrap of skin gets wet, and then you have to wait about another minute, for the alcohol to completely dry.", "fr": "L’alcool étant un germicide rapide, mais pas tout à fait instantané, il faut là encore se frotter les mains pendant 20 secondes, en veillant à humidifier tous les recoins de la peau, puis attendre une minute supplémentaire jusqu’à ce que l’alcool sèche complètement.", "perturbation": "omission", "pert_fr": "L’alcool étant un germicide rapide, mais pas tout à fait instantané, il faut là encore se frotter les mains pendant 20 secondes, en veillant à humidifier tous les recoins de la peau, puis attendre jusqu’à ce que l’alcool sèche complètement.", "bt_pert_fr": "Since alcohol is a quick, but not quite instant, germicide, again, rub your hands for 20 seconds, making sure to moisten every corner of the skin, then wait until the alcohol dries completely.", "questions": "[\"What is alcohol known for?\", \"How long does it take to effectively kill germs with alcohol?\", \"What must be ensured when rubbing hands with alcohol?\", \"How long must you wait after rubbing hands with alcohol?\"]", "answers": "[\"Being a quick, but not quite instant, germicide\", \"A quick, but not quite instant\", \"Every corner of the skin\", \"Until the alcohol dries completely\"]", "scores": [{"f1": 0.18181818181818182, "em": false, "chrf": 20.20094715909608, "bleu": 6.567274736060395}, {"f1": 0.6, "em": false, "chrf": 75.46465025163901, "bleu": 30.213753973567677}, {"f1": 0.3333333333333333, "em": false, "chrf": 20.513174795143325, "bleu": 11.752701606523267}, {"f1": 0, "em": false, "chrf": 10.987595921370755, "bleu": 0.0}], "avg_f1": 0.2787878787878788, "avg_em": 0.0, "avg_chrf": 31.791592031812293, "avg_bleu": 12.133432579037835}
{"id": "Wikivoyage_1:2242", "en": "Try to do this less, and try to wash your hands before touching your face.", "fr": "Essayez de le faire moins et de vous laver les mains avant de vous toucher le visage.", "perturbation": "omission", "pert_fr": "Essayez de le faire moins et de vous toucher le visage.", "bt_pert_fr": "Try to do it less and touch your face.", "questions": "[\"What should you do less?\", \"What should you do before touching your face?\", \"What is recommended to reduce exposure?\", \"What is the purpose of washing hands before touching your face?\"]", "answers": "[\"Do it\", \"Wash hands\", \"Wash hands\", \"To reduce exposure\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 23.297491039426525, "bleu": 49.99999999999999}, {"f1": 0.8, "em": false, "chrf": 38.36632673347426, "bleu": 42.88819424803536}, {"f1": 0.25, "em": false, "chrf": 15.027976630254535, "bleu": 6.7667641618306344}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6375, "avg_em": 0.25, "avg_chrf": 44.17294860078883, "avg_bleu": 49.91373960246651}
{"id": "Wikivoyage_1:2244", "en": "Cough and sneeze into your elbow or a tissue, and then immediately throw away the tissue and wash your hands.", "fr": "Toussez et éternuez dans le pli du coude ou un mouchoir, puis jetez le mouchoir et lavez-vous les mains immédiatement.", "perturbation": "omission", "pert_fr": "Toussez et éternuez dans le pli du coude, puis lavez-vous les mains immédiatement.", "bt_pert_fr": "Cough and sneeze into the crook of your elbow, then wash your hands immediately.", "questions": "[\"What should you do when coughing or sneezing?\", \"What is the recommended method to prevent the spread of germs?\", \"What should you do after using a tissue?\", \"What should you do after coughing or sneezing?\", \"What is the correct way to dispose of a used tissue?\"]", "answers": "[\"Cough and sneeze into the crook of your elbow\", \"Cough and sneeze into the crook of your elbow, then wash your hands immediately\", \"Wash your hands immediately\", \"Wash your hands immediately\", \"Wash your hands immediately\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 68.6988314775547, "bleu": 41.11336169005198}, {"f1": 0.5714285714285714, "em": false, "chrf": 61.06617892711004, "bleu": 22.997519112894437}, {"f1": 0, "em": false, "chrf": 38.605564375715836, "bleu": 0.0}, {"f1": 0.3333333333333333, "em": false, "chrf": 47.44740401804533, "bleu": 11.752701606523267}, {"f1": 0, "em": false, "chrf": 38.605564375715836, "bleu": 0.0}], "avg_f1": 0.33095238095238094, "avg_em": 0.0, "avg_chrf": 50.88470863482835, "avg_bleu": 15.172716481893938}
{"id": "Wikivoyage_1:2245", "en": "Don't stand or sit near people who might be sick.", "fr": "Ne vous tenez pas et ne vous asseyez pas près de gens qui sont susceptibles d’être malades.", "perturbation": "omission", "pert_fr": "Ne vous asseyez pas près de gens qui sont susceptibles d’être malades.", "bt_pert_fr": "Do not sit near people who may be sick.", "questions": "[\"Why should you not stand or sit near people who might be sick?\", \"What is the risk of standing or sitting near people who might be sick?\", \"Who should you avoid standing or sitting near?\", \"What health-related action should be taken to prevent illness?\"]", "answers": "[\"To avoid potentially spreading illness\", \"Spreading illness\", \"People who may be sick\", \"Do not sit near people who may be sick\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8000000000000002, "em": false, "chrf": 62.95176574933189, "bleu": 30.213753973567677}, {"f1": 0.5263157894736842, "em": false, "chrf": 41.251272469051, "bleu": 19.96939588188939}], "avg_f1": 0.8315789473684211, "avg_em": 0.5, "avg_chrf": 76.05075955459573, "avg_bleu": 62.545787463864286}
{"id": "Wikivoyage_1:2250", "en": "Clean objects and surfaces that a lot of people touch, such as doorknobs, phones, and television remotes with regular household cleaner.", "fr": "Nettoyez les objets et les surfaces que beaucoup de gens touchent, comme les poignées de porte, les téléphones et les télécommandes de télévision à l’aide d’un nettoyant ménager ordinaire.", "perturbation": "omission", "pert_fr": "Nettoyez les objets et les surfaces que beaucoup de gens touchent, comme les poignées de porte, les téléphones et les télécommandes à l’aide d’un nettoyant ménager ordinaire.", "bt_pert_fr": "Clean objects and surfaces that many people touch, such as doorknobs, phones, and remote controls using a regular household cleaner.", "questions": "[\"What should be cleaned?\", \"What types of objects and surfaces should be cleaned?\", \"What is the recommended cleaner for cleaning these surfaces?\", \"Which objects are mentioned as being frequently touched?\", \"What is the purpose of cleaning these objects and surfaces?\"]", "answers": "[\"Clean objects and surfaces that many people touch\", \"Doorknobs, phones, and remote controls\", \"A regular household cleaner\", \"Doorknobs, phones, and remote controls\", \"To reduce the spread of germs\"]", "scores": [{"f1": 0.823529411764706, "em": false, "chrf": 81.67309026333083, "bleu": 52.4735797760732}, {"f1": 0.6, "em": false, "chrf": 62.07834465729557, "bleu": 39.76353643835254}, {"f1": 0.5714285714285715, "em": false, "chrf": 94.16320622765005, "bleu": 31.947155212313625}, {"f1": 0.6, "em": false, "chrf": 62.07834465729557, "bleu": 39.76353643835254}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7189915966386555, "avg_em": 0.2, "avg_chrf": 79.9985971611144, "avg_bleu": 52.78956157301839}
{"id": "Wikivoyage_1:2252", "en": "Stay home when you are sick, and avoid contact with other people until your symptoms are gone.", "fr": "Restez chez vous si vous êtes malade et évitez tout contact avec les autres jusqu’à ce que vos symptômes aient disparu.", "perturbation": "omission", "pert_fr": "Restez chez vous si vous êtes malade et évitez tout contact avec les autres.", "bt_pert_fr": "Stay home if you are sick and avoid contact with others.", "questions": "[\"What should you do when you are sick?\", \"What should you avoid when you are sick?\", \"When should you avoid contact with other people?\", \"Until what condition should you avoid contact with others?\"]", "answers": "[\"Stay home\", \"Avoid contact with others\", \"When you are sick\", \"Until you are sick\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.25, "em": false, "chrf": 64.5810791089429, "bleu": 15.97357760615681}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444445, "em": false, "chrf": 32.78121449340594, "bleu": 14.794015674776452}], "avg_f1": 0.6736111111111112, "avg_em": 0.5, "avg_chrf": 74.3405734005872, "avg_bleu": 57.691898320233335}
{"id": "Wikivoyage_1:2253", "en": "Do not share personal items that come into contact with saliva, such as toothbrushes, eating utensils, drinks, water bottles, and towels.", "fr": "Ne partagez pas d’objets personnels qui entrent en contact avec la salive, comme les brosses à dents, les couverts, les boissons, les bouteilles d’eau et les serviettes.", "perturbation": "omission", "pert_fr": "Ne partagez pas d’objets personnels qui entrent en contact avec la salive, comme les brosses à dents, les couverts et les boissons.", "bt_pert_fr": "Do not share personal items that come into contact with saliva, such as toothbrushes, cutlery and drinks.", "questions": "[\"What should not be shared according to the sentence?\", \"What items come into contact with saliva and should not be shared?\", \"What are examples of personal items that should not be shared?\", \"What types of items are mentioned in the sentence?\", \"What is the reason for not sharing personal items?\"]", "answers": "[\"Personal items that come into contact with saliva\", \"Toothbrushes, cutlery and drinks\", \"Toothbrushes, cutlery and drinks\", \"Toothbrushes, cutlery and drinks\", \"To avoid contact with saliva\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 33.96277884795247, "bleu": 7.733712583165139}, {"f1": 0.5, "em": false, "chrf": 33.96277884795247, "bleu": 7.733712583165139}, {"f1": 0.5, "em": false, "chrf": 33.96277884795247, "bleu": 7.733712583165139}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7, "avg_em": 0.4, "avg_chrf": 60.37766730877148, "avg_bleu": 44.6402275498991}
{"id": "Wikivoyage_1:2254", "en": "The practice of serving yourself from a common plate with your own chopsticks, common in China, should be avoided.", "fr": "La pratique consistant à se servir dans une assiette commune à l’aide de baguettes, courante en Chine, doit être évitée.", "perturbation": "omission", "pert_fr": "La pratique consistant à se servir dans une assiette commune doit être évitée.", "bt_pert_fr": "The practice of serving yourself from a common plate should be avoided.", "questions": "[\"What practice should be avoided?\", \"Why should the practice of serving yourself from a common plate with your own chopsticks be avoided?\", \"Where is the practice of serving yourself from a common plate with your own chopsticks common?\", \"What is the practice described in the sentence?\"]", "answers": "[\"Serving yourself from a common plate\", \"The practice of serving yourself from a common plate should be avoided\", \"Not specified\", \"Serving yourself from a common plate\"]", "scores": [{"f1": 0.7142857142857143, "em": false, "chrf": 62.025151571056, "bleu": 44.932896411722176}, {"f1": 0.12500000000000003, "em": false, "chrf": 15.78377613856431, "bleu": 3.7477767366779213}, {"f1": 0, "em": false, "chrf": 2.083333333333333, "bleu": 0.0}, {"f1": 0.7142857142857143, "em": false, "chrf": 62.025151571056, "bleu": 44.932896411722176}], "avg_f1": 0.38839285714285715, "avg_em": 0.0, "avg_chrf": 35.47935315350241, "avg_bleu": 23.403392390030568}
{"id": "Wikivoyage_1:2256", "en": "Avoid hugs, kisses, handshakes, fist bumps, and any other contact.", "fr": "Évitez les embrassades, la bise, les poignées de main, les poing-à-poing et tout autre contact.", "perturbation": "omission", "pert_fr": "Évitez les embrassades, la bise, les poignées de main et tout autre contact.", "bt_pert_fr": "Avoid hugs, kisses, handshakes and any other contact.", "questions": "[\"What types of physical contact should be avoided?\", \"What specific actions are mentioned as being avoided?\", \"What is the reason for avoiding physical contact?\"]", "answers": "[\"Hugs, kisses, handshakes and any other contact\", \"Hugs, kisses, handshakes and any other contact\", \"None provided\"]", "scores": [{"f1": 0.8750000000000001, "em": false, "chrf": 79.06449801998262, "bleu": 44.68310718440574}, {"f1": 0.8750000000000001, "em": false, "chrf": 79.06449801998262, "bleu": 44.68310718440574}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9166666666666666, "avg_em": 0.3333333333333333, "avg_chrf": 86.04299867998843, "avg_bleu": 63.12207145627051}
{"id": "Wikivoyage_1:2257", "en": "If it's impossible to avoid contact, then wash your hands both before and after.", "fr": "S’il est impossible d’éviter un contact, lavez-vous les mains avant et après.", "perturbation": "omission", "pert_fr": "S’il est impossible d’éviter un contact, lavez-vous les mains avant.", "bt_pert_fr": "If contact cannot be avoided, wash your hands first.", "questions": "[\"What should you do if it's impossible to avoid contact?\", \"When should you wash your hands if it's impossible to avoid contact?\", \"What is the recommended action before contact?\", \"What is the recommended action after contact?\"]", "answers": "[\"Wash your hands\", \"If it's impossible to avoid contact\", \"Wash your hands\", \"Not specified\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 41.92937414493519, "bleu": 26.359713811572682}, {"f1": 0, "em": false, "chrf": 7.8431372549019605, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 3.90625, "bleu": 0.0}], "avg_f1": 0.4, "avg_em": 0.25, "avg_chrf": 38.41969034995929, "avg_bleu": 31.589928452893183}
{"id": "Wikivoyage_1:2258", "en": "It won't protect you from the coronavirus, but it will partially protect you from the flu, which remains a greater risk than COVID-19 in many areas.", "fr": "Cela ne vous protègera pas contre le coronavirus, mais vous protégera partiellement contre la grippe, qui pose toujours un plus grand risque que la COVID-19 dans de nombreuses régions.", "perturbation": "omission", "pert_fr": "Cela ne vous protègera pas contre le coronavirus, mais vous protégera partiellement contre la grippe, qui pose toujours un plus grand risque que la COVID-19.", "bt_pert_fr": "This will not protect you against the coronavirus, but will partially protect you against the flu, which still poses a greater risk than COVID-19.", "questions": "[\"What does it partially protect you from?\", \"What is considered a greater risk than COVID-19 in many areas?\", \"What is the disease that remains a greater risk than COVID-19?\"]", "answers": "[\"the flu\", \"the flu\", \"the flu\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2259", "en": "This also saves you from unnecessary worry if you get the flu and think it might be the coronavirus.", "fr": "Cela vous évite également de vous inquiéter inutilement si vous contractez la grippe et pensez qu’il s’agit peut-être du coronavirus.", "perturbation": "omission", "pert_fr": "Cela vous évite également de vous inquiéter inutilement si vous pensez qu’il s’agit peut-être du coronavirus.", "bt_pert_fr": "It also prevents you from worrying unnecessarily if you think it might be coronavirus.", "questions": "[\"What benefit does avoiding unnecessary worry provide?\"]", "answers": "[\"It prevents you from worrying unnecessarily if you think it might be coronavirus\"]", "scores": [{"f1": 0.6206896551724138, "em": false, "chrf": 60.221562198768666, "bleu": 28.1183489760765}], "avg_f1": 0.6206896551724138, "avg_em": 0.0, "avg_chrf": 60.221562198768666, "avg_bleu": 28.1183489760765}
{"id": "Wikivoyage_1:2263", "en": "For those who are asymptomatic, the WHO does not recommend masks, though some national governments do.", "fr": "Pour les personnes asymptomatiques, l’OMS ne recommande pas les masques, bien que certains gouvernements nationaux le fassent.", "perturbation": "omission", "pert_fr": "Pour les personnes asymptomatiques, l’OMS ne recommande pas les masques.", "bt_pert_fr": "For asymptomatic people, the WHO does not recommend masks.", "questions": "[\"Do national governments recommend masks for asymptomatic individuals?\", \"Why do some national governments recommend masks for asymptomatic individuals?\", \"What is the stance of the WHO on mask usage for asymptomatic individuals?\"]", "answers": "[\"No\", \"Not specified\", \"The WHO does not recommend masks\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2264", "en": "Wearing a mask of some kind is required in some countries and cities in an effort to reduce community transmission.", "fr": "Le port d’une forme quelconque de masque est obligatoire dans certains pays et villes dans le but de réduire la transmission communautaire.", "perturbation": "omission", "pert_fr": "Le port d’une forme quelconque de masque est obligatoire dans certains pays dans le but de réduire la transmission communautaire.", "bt_pert_fr": "Wearing some form of mask is mandatory in some countries in an effort to reduce community transmission.", "questions": "[\"What is required in some countries and cities?\", \"What is the purpose of wearing a mask?\", \"What is the goal of wearing a mask in some countries and cities?\", \"What is community transmission?\"]", "answers": "[\"Wearing some form of mask\", \"To reduce community transmission\", \"To reduce community transmission\", \"The spread of a disease within a community\"]", "scores": [{"f1": 0.8000000000000002, "em": false, "chrf": 42.80019902697921, "bleu": 15.106876986783837}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7142857142857143, "em": false, "chrf": 59.0878686108015, "bleu": 54.44460596606694}], "avg_f1": 0.8785714285714286, "avg_em": 0.5, "avg_chrf": 75.47201690944517, "avg_bleu": 67.38787073821271}
{"id": "Wikivoyage_1:2265", "en": "There are worldwide shortages of surgical masks.", "fr": "Une pénurie de masques chirurgicaux sévit dans le monde entier.", "perturbation": "omission", "pert_fr": "Une pénurie de masques sévit dans le monde entier.", "bt_pert_fr": "There is a shortage of masks across the world.", "questions": "[\"What is currently lacking worldwide?\", \"What type of masks are in short supply?\", \"Where are surgical masks in short supply?\"]", "answers": "[\"Masks\", \"Masks\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 19.482621292525817, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 19.482621292525817, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.944444444444445, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 15.303229009832025, "avg_bleu": 0.0}
{"id": "Wikivoyage_1:2266", "en": "If you do wear a mask, make sure to use it correctly.", "fr": "Si vous portez un masque, veillez à l’utiliser correctement.", "perturbation": "omission", "pert_fr": "Si vous portez un masque, veillez à correctement.", "bt_pert_fr": "If you wear a mask, make sure you wear it correctly.", "questions": "[\"What should you do if you wear a mask?\", \"What is important when using a mask correctly?\", \"Why is it important to use a mask correctly?\"]", "answers": "[\"Make sure you wear it correctly\", \"Wearing the mask correctly\", \"To ensure it is effective\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 65.85254131788896, "bleu": 22.957488466614326}, {"f1": 0.3333333333333333, "em": false, "chrf": 51.86866385521826, "bleu": 27.516060407455225}, {"f1": 0.3636363636363636, "em": false, "chrf": 37.04640540907905, "bleu": 17.491650626361256}], "avg_f1": 0.45454545454545453, "avg_em": 0.0, "avg_chrf": 51.589203527395426, "avg_bleu": 22.6550665001436}
{"id": "Wikivoyage_1:2267", "en": "The mask should cover your nose and mouth and fit without gaps.", "fr": "Le masque doit couvrir votre nez et votre bouche, et être bien ajusté, sans bâillements.", "perturbation": "omission", "pert_fr": "Le masque doit couvrir votre nez, et être bien ajusté, sans bâillements.", "bt_pert_fr": "The mask should cover your nose, and fit well, without gaping.", "questions": "[\"What should the mask cover?\", \"Why should the mask fit without gaps?\", \"What parts of the face should the mask cover?\"]", "answers": "[\"Your nose\", \"To ensure a proper fit and prevent leakage\", \"Your nose\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 45.211889914926005, "bleu": 36.78794411714425}, {"f1": 0.8571428571428571, "em": false, "chrf": 80.1596724027633, "bleu": 41.11336169005198}, {"f1": 0, "em": false, "chrf": 15.644469057178457, "bleu": 0.0}], "avg_f1": 0.5079365079365079, "avg_em": 0.0, "avg_chrf": 47.005343791622586, "avg_bleu": 25.967101935732074}
{"id": "Wikivoyage_1:2268", "en": "Wash your hands before putting on the mask and avoid touching the mask while wearing it.", "fr": "Lavez-vous les mains avant de mettre le masque et évitez de le toucher lorsque vous le portez.", "perturbation": "omission", "pert_fr": "Lavez-vous les mains avant de mettre le masque et évitez de toucher lorsque vous le portez.", "bt_pert_fr": "Wash your hands before putting on the mask and avoid touching while wearing it.", "questions": "[\"What should you do before putting on the mask?\", \"What should you avoid doing while wearing the mask?\"]", "answers": "[\"Wash your hands\", \"Touching\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 61.838423967164225, "bleu": 36.78794411714425}], "avg_f1": 0.8333333333333333, "avg_em": 0.5, "avg_chrf": 80.91921198358212, "avg_bleu": 68.39397205857215}
{"id": "Wikivoyage_1:2270", "en": "When the mask becomes damp, discard and replace it.", "fr": "Lorsque le masque devient humide, jetez-le et remplacez-le.", "perturbation": "omission", "pert_fr": "Lorsque le masque devient humide, remplacez-le.", "bt_pert_fr": "When the mask becomes damp, replace it.", "questions": "[\"What should you do when the mask becomes damp?\", \"What happens when the mask becomes damp?\", \"What is the recommended action when the mask is damp?\"]", "answers": "[\"Replace the mask\", \"It becomes damp\", \"Replace the mask\"]", "scores": [{"f1": 0, "em": false, "chrf": 24.39602698600387, "bleu": 0.0}, {"f1": 0.2222222222222222, "em": false, "chrf": 8.845638989564172, "bleu": 10.122592925934278}, {"f1": 0, "em": false, "chrf": 24.39602698600387, "bleu": 0.0}], "avg_f1": 0.07407407407407407, "avg_em": 0.0, "avg_chrf": 19.21256432052397, "avg_bleu": 3.3741976419780926}
{"id": "Wikivoyage_1:2272", "en": "Remember that masks are not a substitute for good hygiene: continue to wash your hands frequently.", "fr": "N’oubliez pas que les masques ne remplacent pas une bonne hygiène : continuez à vous laver les mains fréquemment.", "perturbation": "omission", "pert_fr": "N’oubliez pas que les masques remplacent une bonne hygiène : continuez à vous laver les mains fréquemment.", "bt_pert_fr": "Remember, masks replace good hygiene: continue to wash your hands frequently.", "questions": "[\"What is not a substitute for good hygiene?\", \"What should you continue to do frequently?\", \"What is the importance of good hygiene in relation to masks?\"]", "answers": "[\"Masks\", \"Wash your hands\", \"Good hygiene is still important and should continue even when using masks\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.43478260869565216, "em": false, "chrf": 43.338128394739385, "bleu": 14.323145079400492}], "avg_f1": 0.8115942028985508, "avg_em": 0.6666666666666666, "avg_chrf": 81.11270946491312, "avg_bleu": 71.44104835980019}
{"id": "Wikivoyage_1:2273", "en": "Don't stock up on masks if you don't need them.", "fr": "Ne vous approvisionnez pas en masques si vous n’en avez pas besoin.", "perturbation": "omission", "pert_fr": "Ne vous approvisionnez pas si vous n’en avez pas besoin.", "bt_pert_fr": "Don’t stock up if you don’t need it.", "questions": "[\"Why shouldn't you stock up on masks if you don't need them?\", \"What should you do if you don't need masks?\", \"What is the recommendation regarding mask stockpiling?\"]", "answers": "[\"Because you don't need them\", \"Don't stock up\", \"Don't stock up if you don't need it\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444444, "em": false, "chrf": 36.34635666904364, "bleu": 20.24518585186855}, {"f1": 0.7777777777777777, "em": false, "chrf": 61.964772502418676, "bleu": 38.940039153570254}], "avg_f1": 0.7407407407407408, "avg_em": 0.3333333333333333, "avg_chrf": 66.10370972382077, "avg_bleu": 53.06174166847961}
{"id": "Wikivoyage_1:2276", "en": "Leave them for healthcare workers.", "fr": "Laissez-les aux professionnels de la santé.", "perturbation": "omission", "pert_fr": "Laissez-les aux professionnels.", "bt_pert_fr": "Leave them to the professionals.", "questions": "[\"Who should leave them for?\", \"What should be left for healthcare workers?\", \"What is being left for healthcare workers?\"]", "answers": "[\"Professionals\", \"them\", \"them\"]", "scores": [{"f1": 0, "em": false, "chrf": 15.70622854340363, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 71.90207618113455, "avg_bleu": 66.6666666666667}
{"id": "Wikivoyage_1:2281", "en": "At petrol/gas stations, use gloves or wipe down the handle with a disinfectant wipe if you can.", "fr": "Dans les stations-services, utilisez des gants ou essuyez la poignée à l’aide d’une lingette désinfectante dans la mesure du possible.", "perturbation": "omission", "pert_fr": "Dans les stations-services, utilisez des gants ou essuyez la poignée à l’aide d’une lingette dans la mesure du possible.", "bt_pert_fr": "At gas stations, use gloves or wipe the handle with a wipe whenever possible.", "questions": "[\"What should you do at petrol/gas stations to prevent contamination?\", \"What is recommended when touching the handle at petrol/gas stations?\", \"What is an alternative method to prevent contamination at petrol/gas stations?\", \"What type of gloves should be used at petrol/gas stations?\", \"What can be used to disinfect the handle at petrol/gas stations?\"]", "answers": "[\"Use gloves or wipe the handle with a wipe\", \"Use gloves or wipe the handle with a wipe\", \"Wipe the handle with a wipe\", \"Gloves\", \"A wipe\"]", "scores": [{"f1": 0.8750000000000001, "em": false, "chrf": 54.699181332309365, "bleu": 38.185022210613596}, {"f1": 0.8750000000000001, "em": false, "chrf": 54.699181332309365, "bleu": 38.185022210613596}, {"f1": 0.8, "em": false, "chrf": 37.440983769768714, "bleu": 23.04318198457308}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 16.206046055919778, "bleu": 42.88819424803536}], "avg_f1": 0.8700000000000001, "avg_em": 0.2, "avg_chrf": 52.60907849806144, "avg_bleu": 48.460284130767135}
{"id": "Wikivoyage_1:2283", "en": "The U.S. and Canadian governments recommend avoiding travel by cruise ship.", "fr": "Les gouvernements américain et canadien recommandent d’éviter de voyager sur un paquebot de croisière.", "perturbation": "omission", "pert_fr": "Les gouvernements américain recommandent d’éviter de voyager sur un paquebot de croisière.", "bt_pert_fr": "The American government recommends avoiding travel on a cruise ship.", "questions": "[\"What type of travel is recommended to avoid?\"]", "answers": "[\"Cruise ship travel\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 57.76793203669687, "bleu": 19.716118825581447}], "avg_f1": 0.28571428571428575, "avg_em": 0.0, "avg_chrf": 57.76793203669687, "avg_bleu": 19.716118825581447}
{"id": "Wikivoyage_1:2284", "en": "Infections spread easily on board, and medical care is limited.", "fr": "Les infections se propagent facilement à bord, et les services médicaux y sont limités.", "perturbation": "omission", "pert_fr": "Les infections se propagent facilement, et les services médicaux y sont limités.", "bt_pert_fr": "Infections spread easily, and medical services are limited.", "questions": "[\"How do infections spread on board?\", \"Why is medical care limited?\", \"What factors contribute to the ease of infection spread on board?\"]", "answers": "[\"Easily\", \"Medical services are limited\", \"The limited medical services\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.22222222222222224, "em": false, "chrf": 40.61993203600364, "bleu": 12.44023474812678}, {"f1": 0.75, "em": false, "chrf": 77.22958181122337, "bleu": 59.460355750136046}], "avg_f1": 0.6574074074074074, "avg_em": 0.3333333333333333, "avg_chrf": 72.61650461574233, "avg_bleu": 57.30019683275429}
{"id": "Wikivoyage_1:2286", "en": "Even cruise ships without confirmed cases have been denied permission to dock due to virus fears, and in the high-profile case of the Diamond Princess in Japan, hundreds of people were infected on the ship.", "fr": "Même les paquebots de croisière sans cas confirmés se sont vu refuser l’autorisation de mise à quai en raison des craintes suscitées par le virus et, dans le cas très médiatisé du Diamond Princess au Japon, des centaines de personnes ont été infectées à bord.", "perturbation": "omission", "pert_fr": "Même les paquebots de croisière sans cas confirmés se sont vu refuser l’autorisation de mise à quai en raison des craintes suscitées par le virus et, dans le cas du Diamond Princess au Japon, des centaines de personnes ont été infectées à bord.", "bt_pert_fr": "Even cruise ships without confirmed cases have been refused permission to dock due to fears over the virus and, in the case of Japan's Diamond Princess, hundreds of people were infected on board.", "questions": "[\"Why have cruise ships without confirmed cases been denied permission to dock?\", \"What is the reason for denying cruise ships permission to dock?\", \"What happened to the Diamond Princess in Japan?\", \"How many people were infected on the Diamond Princess?\", \"What is the impact of virus fears on cruise ship docking permissions?\"]", "answers": "[\"Fears over the virus\", \"Fears over the virus\", \"Hundreds of people were infected on board\", \"Hundreds\", \"Cruise ships without confirmed cases have been refused permission to dock\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 34.3404185850879, "bleu": 19.716118825581447}, {"f1": 0, "em": false, "chrf": 34.40904422473751, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 86.71217855295386, "bleu": 80.91067115702207}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9090909090909091, "em": false, "chrf": 88.95402737645222, "bleu": 70.16879391277372}], "avg_f1": 0.6103896103896104, "avg_em": 0.2, "avg_chrf": 68.8831337478463, "avg_bleu": 54.159116779075454}
{"id": "Wikivoyage_1:2287", "en": "If you believe you may be infected, call a hospital or local emergency medical services instead of going in person to avoid infecting others.", "fr": "Si vous pensez être infecté, appelez un hôpital ou les services d’aide médicale d’urgence locaux plutôt que de vous y rendre en personne, afin d’éviter d’infecter les autres.", "perturbation": "omission", "pert_fr": "Si vous pensez être infecté, appelez un hôpital ou les services d’aide médicale d’urgence locaux plutôt que de vous y rendre en personne, afin d’éviter d’infecter.", "bt_pert_fr": "If you think you may be infected, call a hospital or local emergency medical services rather than going there in person, to avoid becoming infected.", "questions": "[\"What should you do if you believe you may be infected?\", \"What is the recommended alternative to going in person if you believe you may be infected?\", \"Why is it important to avoid going in person if you believe you may be infected?\", \"What services should you call if you believe you may be infected?\"]", "answers": "[\"Call a hospital or local emergency medical services\", \"Call a hospital or local emergency medical services\", \"To avoid becoming infected\", \"A hospital or local emergency medical services\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 45.54669473760832, "bleu": 31.947155212313625}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.875, "avg_em": 0.75, "avg_chrf": 86.38667368440208, "avg_bleu": 82.98678880307844}
{"id": "Wikivoyage_1:2288", "en": "Mention your symptoms and travel history.", "fr": "Indiquez vos symptômes et l’historique de vos déplacements.", "perturbation": "omission", "pert_fr": "Indiquez vos symptômes et vos déplacements.", "bt_pert_fr": "Indicate your symptoms and your movements.", "questions": "[\"What symptoms should be mentioned?\"]", "answers": "[\"Your symptoms\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2291", "en": "On a plane, follow the same hygiene practices as anywhere else: wash hands frequently, or use alcohol-based hand sanitizer if it's not convenient to leave your seat, and avoid touching your face.", "fr": "En avion, adoptez les mêmes pratiques d’hygiène que partout ailleurs : lavez-vous les mains fréquemment ou utilisez une solution hydro-alcoolique s’il n’est pas pratique de quitter votre siège, et évitez de vous toucher le visage.", "perturbation": "omission", "pert_fr": "En avion, adoptez les mêmes pratiques d’hygiène que partout ailleurs : lavez-vous les mains fréquemment ou utilisez une solution hydro-alcoolique s’il n’est pas pratique de quitter votre siège.", "bt_pert_fr": "When flying, follow the same hygiene practices as anywhere else: wash your hands frequently or use an alcohol-based hand sanitizer if it is not practical to leave your seat.", "questions": "[\"What hygiene practices should be followed on a plane?\", \"Why is it important to wash hands frequently on a plane?\", \"Why should you avoid touching your face on a plane?\", \"What are the recommended hygiene practices on a plane?\"]", "answers": "[\"Wash your hands frequently or use an alcohol-based hand sanitizer if it is not practical to leave your seat\", \"To reduce the risk of spreading germs or getting infected\", \"To prevent the spread of germs to your face\", \"Wash your hands frequently or use an alcohol-based hand sanitizer if it is not practical to leave your seat\"]", "scores": [{"f1": 0.7692307692307692, "em": false, "chrf": 65.51494402216296, "bleu": 47.366090824786475}, {"f1": 0.8, "em": false, "chrf": 88.20725730858547, "bleu": 58.73949094699213}, {"f1": 0.5333333333333333, "em": false, "chrf": 37.506056262331114, "bleu": 13.134549472120788}, {"f1": 0.7692307692307692, "em": false, "chrf": 65.51494402216296, "bleu": 47.366090824786475}], "avg_f1": 0.717948717948718, "avg_em": 0.0, "avg_chrf": 64.18580040381063, "avg_bleu": 41.65155551717147}
{"id": "Wikivoyage_1:2293", "en": "Try to book a window seat, and avoid moving around the cabin during the flight.", "fr": "Essayez de réserver un siège côté hublot et évitez de vous déplacer dans la cabine pendant le vol.", "perturbation": "omission", "pert_fr": "Essayez de réserver un siège côté hublot et évitez de vous déplacer pendant le vol.", "bt_pert_fr": "Try to reserve a window seat and avoid moving around during the flight.", "questions": "[\"What should you try to do when booking a seat?\", \"What should you avoid doing during the flight?\", \"Why is it important to avoid moving around during the flight?\"]", "answers": "[\"Reserve a window seat\", \"Moving around during the flight\", \"To maintain a stable seat position during the flight\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 61.20989799306401, "bleu": 55.03212081491043}, {"f1": 0.5714285714285715, "em": false, "chrf": 62.06256286131007, "bleu": 31.947155212313625}, {"f1": 0.5, "em": false, "chrf": 39.31340035884534, "bleu": 14.535768424205482}], "avg_f1": 0.5793650793650794, "avg_em": 0.0, "avg_chrf": 54.195287071073146, "avg_bleu": 33.83834815047651}
{"id": "Wikivoyage_1:2294", "en": "After washing your hands and before sitting down, use disinfectant wipes to wipe down the area around your seat.", "fr": "Après vous être lavé les mains et avant de vous asseoir, utilisez des lingettes désinfectantes pour essuyer la zone autour de votre siège.", "perturbation": "omission", "pert_fr": "Après vous être lavé les mains, utilisez des lingettes désinfectantes pour essuyer la zone autour de votre siège.", "bt_pert_fr": "After washing your hands, use disinfectant wipes to wipe down the area around your seat.", "questions": "[\"What should you do after washing your hands?\", \"What should you do before sitting down?\", \"What is used to wipe down the area around your seat?\", \"What is the purpose of using disinfectant wipes?\", \"What areas should be wiped down with disinfectant wipes?\"]", "answers": "[\"Use disinfectant wipes to wipe down the area around your seat\", \"Wipe down the area around your seat\", \"Disinfectant wipes\", \"To clean the area around the seat\", \"The area around your seat\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.625, "em": false, "chrf": 54.67303882179107, "bleu": 39.01126486653949}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.925, "avg_em": 0.8, "avg_chrf": 90.93460776435822, "avg_bleu": 87.80225297330793}
{"id": "Wikivoyage_1:2295", "en": "Wipe hard surfaces, and if your seat is leather you can wipe that too.", "fr": "Essuyez les surfaces dures et, si votre siège est en cuir, essuyez-le également.", "perturbation": "omission", "pert_fr": "Essuyez les surfaces dures et essuyez-le également.", "bt_pert_fr": "Wipe down hard surfaces and wipe it dry as well.", "questions": "[\"What surfaces should be wiped?\", \"Can leather seats be wiped?\"]", "answers": "[\"Hard surfaces\", \"No\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 50.0, "avg_bleu": 50.00000000000002}
{"id": "Wikivoyage_1:2304", "en": "If a group of passengers is connecting from an area with a severe outbreak, the flight attendants may be able to seat them away from the rest of the passengers (and if you were recently in a high-risk area, consider telling the flight attendants for this reason).", "fr": "Si un groupe de passagers en correspondance provient d’une région touchée par une épidémie sévère, le personnel de cabine pourra peut-être les faire s'asseoir à l’écart du reste des passagers (et si vous vous êtes récemment rendu dans une région à haut risque, envisagez de le signaler au personnel de cabine pour cette raison).", "perturbation": "omission", "pert_fr": "Si un groupe de passagers en correspondance provient d’une région touchée par une épidémie, le personnel de cabine pourra peut-être les faire s'asseoir à l’écart du reste des passagers.", "bt_pert_fr": "If a group of connecting passengers is coming from an area affected by an outbreak, cabin crew may be able to seat them apart from the rest of the passengers.", "questions": "[\"What happens if a group of passengers is connecting from an area with a severe outbreak?\", \"Can flight attendants seat connecting passengers away from others?\", \"Why might flight attendants seat connecting passengers separately?\", \"What should passengers do if they were recently in a high-risk area?\", \"What is a high-risk area in this context?\"]", "answers": "[\"They may be seated apart from the rest of the passengers\", \"Yes\", \"To prevent the spread of the outbreak\", \"They should avoid traveling or inform the cabin crew\", \"An area affected by an outbreak\"]", "scores": [{"f1": 0.5217391304347826, "em": false, "chrf": 43.16886015336367, "bleu": 20.365268977284835}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.14285714285714285, "em": false, "chrf": 18.946908895514575, "bleu": 4.799810699119212}, {"f1": 0, "em": false, "chrf": 15.86705987648628, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 42.934943584257084, "bleu": 23.643540225079395}], "avg_f1": 0.4529192546583851, "avg_em": 0.2, "avg_chrf": 44.18355450192432, "avg_bleu": 29.7617239802967}
{"id": "Wikivoyage_1:2306", "en": "This is so that, if someone on the flight turns out to be infected, the authorities can track down the people who were sitting near them for testing or quarantine.", "fr": "Si un passager du vol est infecté, cette mesure permet aux autorités de retrouver les personnes assises à côté de lui pour les tester ou les mettre en quarantaine.", "perturbation": "omission", "pert_fr": "Si un passager du vol est infecté, cette mesure permet aux autorités de retrouver les personnes pour les tester ou les mettre en quarantaine.", "bt_pert_fr": "If a passenger on the flight becomes infected, this measure allows authorities to trace the people for testing or quarantine.", "questions": "[\"What is the purpose of tracking people who were sitting near an infected individual?\", \"Who needs to be tracked down if someone on the flight is infected?\", \"What actions are taken if someone on the flight is infected?\", \"What is the goal of tracking people sitting near an infected individual?\", \"What is the role of authorities in this scenario?\"]", "answers": "[\"To identify individuals for testing or quarantine\", \"People sitting near an infected individual\", \"Authorities can trace the people for testing or quarantine\", \"To enable testing or quarantine of potentially exposed individuals\", \"To trace people for testing or quarantine\"]", "scores": [{"f1": 0.43478260869565216, "em": false, "chrf": 32.15054571716038, "bleu": 12.01799094826536}, {"f1": 0.6153846153846154, "em": false, "chrf": 73.46336765261593, "bleu": 36.70124608961282}, {"f1": 0.33333333333333326, "em": false, "chrf": 48.584141696823984, "bleu": 9.519340818348473}, {"f1": 0.4166666666666667, "em": false, "chrf": 40.769385286130536, "bleu": 10.353028267053118}, {"f1": 0.4166666666666667, "em": false, "chrf": 31.858672678792814, "bleu": 10.41813075244897}], "avg_f1": 0.44336677814938685, "avg_em": 0.0, "avg_chrf": 45.36522260630473, "avg_bleu": 15.80194737514575}
{"id": "Wikivoyage_1:2311", "en": "Mild symptoms may be relieved by taking paracetamol (acetaminophen).", "fr": "Les symptômes légers peuvent être soulagés par la prise de paracétamol (acétaminophène).", "perturbation": "omission", "pert_fr": "Les symptômes légers peuvent être soulagés par la prise de paracétamol.", "bt_pert_fr": "Mild symptoms can be relieved by taking paracetamol.", "questions": "[\"What symptoms may be relieved by taking paracetamol (acetaminophen)?\", \"What medication can relieve mild symptoms?\", \"What is paracetamol (acetaminophen) used for?\"]", "answers": "[\"Mild symptoms\", \"Paracetamol\", \"Relieving mild symptoms\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 44.57386008048413, "bleu": 36.78794411714425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8888888888888888, "avg_em": 0.6666666666666666, "avg_chrf": 81.52462002682805, "avg_bleu": 78.92931470571477}
{"id": "Wikivoyage_1:2312", "en": "If you are infected with COVID-19, countries will isolate you until several consecutive tests for COVID-19 are negative.", "fr": "Si vous êtes infecté par le virus de la COVID-19, les pays vous isoleront jusqu’à ce que plusieurs tests consécutifs de dépistage de la COVID-19 soient négatifs.", "perturbation": "omission", "pert_fr": "Si vous êtes infecté par le virus de la COVID-19, les pays vous isoleront jusqu’à ce que plusieurs tests consécutifs soient négatifs.", "bt_pert_fr": "If you are infected with the COVID-19 virus, countries will isolate you until you have several consecutive negative tests.", "questions": "[\"What happens if you are infected with COVID-19?\", \"What is required for isolation to end?\", \"How many consecutive negative tests are needed to end isolation?\", \"What is the condition for ending isolation due to COVID-19 infection?\"]", "answers": "[\"Countries will isolate you\", \"Several consecutive negative tests\", \"Several\", \"Several consecutive negative tests\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7272727272727273, "em": false, "chrf": 68.29868398205133, "bleu": 17.946048174042403}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 78.03653973846691, "bleu": 60.653065971263366}], "avg_f1": 0.8818181818181818, "avg_em": 0.5, "avg_chrf": 86.58380593012956, "avg_bleu": 69.64977853632647}
{"id": "Wikivoyage_1:2313", "en": "If you have been in close contact with someone infected with COVID-19, many countries will quarantine you for 14 days since the last exposure and monitor you for signs and symptoms.", "fr": "Si vous avez été en contact étroit avec une personne infectée par le virus de la COVID-19, de nombreux pays vous mettront en quarantaine pendant 14 jours à compter de la dernière exposition et vous placeront sous surveillance pour déceler les signes et symptômes.", "perturbation": "omission", "pert_fr": "Si vous avez été en contact avec une personne infectée par le virus de la COVID-19, de nombreux pays vous mettront en quarantaine pendant 14 jours à compter de la dernière exposition et vous placeront sous surveillance pour déceler les signes.", "bt_pert_fr": "If you have been in contact with someone infected with the COVID-19 virus, many countries will quarantine you for 14 days from the last exposure and monitor you for signs.", "questions": "[\"What should you do if you have been in close contact with someone infected with COVID-19?\", \"How long is the quarantine period after close contact with someone infected with COVID-19?\", \"What do many countries monitor during quarantine?\", \"What is the reason for quarantine after close contact with a COVID-19 infected person?\"]", "answers": "[\"Be quarantined for 14 days from the last exposure and be monitored for signs\", \"14 days\", \"Signs\", \"To prevent the spread of the virus\"]", "scores": [{"f1": 0.5161290322580646, "em": false, "chrf": 46.89323992951706, "bleu": 14.957166830762677}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5, "em": false, "chrf": 24.503112283887315, "bleu": 13.533528323661276}, {"f1": 0.8000000000000002, "em": false, "chrf": 68.51380432386797, "bleu": 66.87403049764218}], "avg_f1": 0.7040322580645162, "avg_em": 0.25, "avg_chrf": 59.977539134318086, "avg_bleu": 48.84118141301654}
{"id": "Wikivoyage_1:2314", "en": "Some countries will also test you even if you don't have symptoms.", "fr": "Certains pays vous testeront également même si vous ne présentez aucun symptôme.", "perturbation": "omission", "pert_fr": "Certains pays vous testeront même si vous ne présentez aucun symptôme.", "bt_pert_fr": "Some countries will test you even if you have no symptoms.", "questions": "[\"Which countries will test you even if you don't have symptoms?\", \"What happens if you don't have symptoms?\", \"Under what conditions will countries test you?\", \"Are there countries that test people without symptoms?\"]", "answers": "[\"Some countries\", \"You will be tested\", \"If you don't have symptoms\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2315", "en": "In many countries, the healthcare system has been stretched to the point of not being able to handle the sheer number of patients, and there is a chance you may be refused treatment due to the lack of available medical staff, supplies or equipment.", "fr": "Dans de nombreux pays, le système de santé a été mis à rude épreuve au point de ne pas être en mesure de prendre en charge le grand nombre de patients, et il se peut que vous vous voyiez refuser un traitement en raison du manque de personnel, fournitures et équipements médicaux.", "perturbation": "omission", "pert_fr": "Dans de nombreux pays, le système de santé a été mis à rude épreuve au point de ne pas être en mesure de prendre en charge le grand nombre de patients, et il se peut que vous vous voyiez refuser un traitement en raison du manque de personnel et équipements médicaux.", "bt_pert_fr": "In many countries, the healthcare system has been strained to the point where it is unable to care for the large number of patients, and you may be denied treatment due to lack of medical staff and equipment.", "questions": "[\"What has been stretched in many countries?\", \"Why can the healthcare system not handle the sheer number of patients?\", \"What might cause a patient to be refused treatment?\", \"What is the impact of the healthcare system being stretched?\"]", "answers": "[\"The healthcare system\", \"Lack of medical staff and equipment\", \"Lack of medical staff and equipment\", \"It is unable to care for the large number of patients and may result in denial of treatment\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7142857142857143, "em": false, "chrf": 48.724767226813334, "bleu": 17.39350277271197}, {"f1": 0.7142857142857143, "em": false, "chrf": 48.724767226813334, "bleu": 17.39350277271197}, {"f1": 0.25, "em": false, "chrf": 29.879137225518765, "bleu": 3.234245292096216}], "avg_f1": 0.6696428571428572, "avg_em": 0.25, "avg_chrf": 56.83216791978636, "avg_bleu": 34.50531270938005}
{"id": "Wikivoyage_1:2317", "en": "Even more countries have imposed restrictions on arriving travelers, either barring entry (maybe with an exception for local citizens and permanent residents) or requiring you to be quarantined, typically for 14 days.", "fr": "Un plus grand nombre de pays encore a imposé des restrictions aux voyageurs à l’arrivée, soit en refusant l’entrée (sauf peut-être aux citoyens et résidents permanents du pays), soit en vous imposant une quarantaine, généralement de 14 jours.", "perturbation": "omission", "pert_fr": "Un plus grand nombre de pays encore a imposé des restrictions aux voyageurs à l’arrivée, soit en refusant l’entrée (sauf peut-être aux citoyens et résidents permanents du pays), soit en vous imposant une quarantaine.", "bt_pert_fr": "Even more countries have imposed restrictions on arriving travelers, either by refusing entry (except perhaps to citizens and permanent residents of the country) or by requiring you to quarantine.", "questions": "[\"What countries have imposed restrictions on arriving travelers?\", \"What types of restrictions have been imposed on arriving travelers?\", \"Are there exceptions to entry restrictions for certain individuals?\", \"Who might be exempt from entry restrictions?\", \"What is the typical quarantine period for arriving travelers?\", \"What is the purpose of imposing quarantine on arriving travelers?\"]", "answers": "[\"Even more countries\", \"Refusing entry (except perhaps to citizens and permanent residents of the country) or by requiring you to quarantine\", \"Yes\", \"Citizens and permanent residents of the country\", \"Not specified\", \"To prevent the spread of diseases\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.3636363636363636, "em": false, "chrf": 50.65870541931532, "bleu": 3.234245292096216}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5454545454545454, "em": false, "chrf": 79.84660215185944, "bleu": 30.213753973567677}, {"f1": 0, "em": false, "chrf": 4.62962962962963, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 99.0727785353643, "bleu": 66.87403049764218}], "avg_f1": 0.6181818181818182, "avg_em": 0.3333333333333333, "avg_chrf": 72.36795262269477, "avg_bleu": 50.05367162721769}
{"id": "Wikivoyage_1:2318", "en": "Even if a mandatory quarantine is not imposed, you may be asked to \"self-quarantine\" by staying at home and not interacting with other people.", "fr": "Même si une quarantaine obligatoire n’est pas imposée, il peut vous être demandé de vous mettre en « auto-quarantaine » en restant chez vous et en évitant toute interaction avec les autres.", "perturbation": "omission", "pert_fr": "Même si une quarantaine obligatoire n’est pas imposée, il peut vous être demandé de vous mettre en « auto-quarantaine » en restant chez vous.", "bt_pert_fr": "Even if a mandatory quarantine is not imposed, you may be asked to “self-quarantine” by staying at home.", "questions": "[\"What happens if a mandatory quarantine is not imposed?\", \"What does 'self-quarantine' involve?\", \"What is the purpose of self-quarantine?\"]", "answers": "[\"You may be asked to 'self-quarantine' by staying at home\", \"Staying at home\", \"To prevent the spread of disease\"]", "scores": [{"f1": 0.7692307692307693, "em": false, "chrf": 61.825402926856576, "bleu": 54.88116360940266}, {"f1": 0.5, "em": false, "chrf": 28.95064522522946, "bleu": 13.533528323661276}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7564102564102564, "avg_em": 0.3333333333333333, "avg_chrf": 63.59201605069535, "avg_bleu": 56.13823064435466}
{"id": "Wikivoyage_1:2319", "en": "The most severe restrictions are on travellers who have recently been to affected areas, but increasingly many countries are applying them to incoming travellers overall.", "fr": "Les restrictions les plus strictes concernent les voyageurs qui se trouvaient récemment dans des régions touchées mais, de plus en plus, de nombreux pays les appliquent à tous les voyageurs entrants.", "perturbation": "omission", "pert_fr": "Les restrictions les plus strictes concernent les voyageurs qui se trouvaient récemment dans des régions touchées mais, de plus en plus, de nombreux pays les appliquent à tous les voyageurs.", "bt_pert_fr": "The strictest restrictions apply to travelers who were recently in affected regions, but increasingly many countries are applying them to all travelers.", "questions": "[\"What are the most severe restrictions applied to?\", \"Which travellers are subject to the most severe restrictions?\", \"What areas trigger the most severe restrictions?\", \"Are restrictions being applied to all incoming travellers?\", \"How are restrictions changing for incoming travellers?\"]", "answers": "[\"Travelers who were recently in affected regions\", \"Travelers who were recently in affected regions\", \"Affected regions\", \"Yes\", \"Increasingly, restrictions are being applied to all travelers\"]", "scores": [{"f1": 0.39999999999999997, "em": false, "chrf": 50.59900772334539, "bleu": 7.492442692259767}, {"f1": 0.39999999999999997, "em": false, "chrf": 50.59900772334539, "bleu": 7.492442692259767}, {"f1": 0.5, "em": false, "chrf": 54.27019064358895, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2222222222222222, "em": false, "chrf": 53.520525020355656, "bleu": 5.522397783539471}], "avg_f1": 0.5044444444444445, "avg_em": 0.2, "avg_chrf": 61.79774622212708, "avg_bleu": 34.10145663361181}
{"id": "Wikivoyage_1:2322", "en": "Well, this is a fast-changing situation, and each country/region/organization has its own list of what areas are subject to restrictions.", "fr": "Il s’agit ici d’une situation évoluant rapidement, et chaque pays/région/organisation a sa propre liste de zones soumises à restrictions.", "perturbation": "omission", "pert_fr": "Il s’agit ici d’une situation évoluant rapidement, et chaque pays a sa propre liste de zones soumises à restrictions.", "bt_pert_fr": "This is a rapidly evolving situation, and each country has its own list of restricted areas.", "questions": "[\"What makes this situation fast-changing?\"]", "answers": "[\"The rapid evolution of the situation\"]", "scores": [{"f1": 0.19047619047619047, "em": false, "chrf": 11.318460711085379, "bleu": 1.4075678340715925}], "avg_f1": 0.19047619047619047, "avg_em": 0.0, "avg_chrf": 11.318460711085379, "avg_bleu": 1.4075678340715925}
{"id": "Wikivoyage_1:2323", "en": "The city of Wuhan is on every list and the rest of mainland China is on most.", "fr": "La ville de Wuhan figure sur toutes les listes, et le reste de la Chine continentale sur la plupart.", "perturbation": "omission", "pert_fr": "La ville de Wuhan figure sur toutes les listes, et le reste sur la plupart.", "bt_pert_fr": "The city of Wuhan is on every list, and still is on most.", "questions": "[\"What cities are on every list?\", \"Which regions of mainland China are on most lists?\", \"What does 'on every list' indicate about the city of Wuhan?\", \"What does 'on most' indicate about the rest of mainland China?\"]", "answers": "[\"Wuhan\", \"Not specified\", \"The city of Wuhan is consistently included in all lists\", \"The rest of mainland China is included in most lists\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 7.575757575757576, "bleu": 0.0}, {"f1": 0.9473684210526316, "em": false, "chrf": 85.72840903981051, "bleu": 65.80370064762461}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.736842105263158, "avg_em": 0.5, "avg_chrf": 73.32604165389202, "avg_bleu": 66.45092516190617}
{"id": "Wikivoyage_1:2325", "en": "Some countries have imposed restrictions based on citizenship or residency from severely affected areas.", "fr": "Certains pays imposent des restrictions aux citoyens et résidents des zones sévèrement touchées.", "perturbation": "omission", "pert_fr": "Certains pays imposent des restrictions aux citoyens des zones sévèrement touchées.", "bt_pert_fr": "Some countries are imposing restrictions on citizens in severely affected areas.", "questions": "[\"What restrictions have some countries imposed?\", \"Based on what criteria have countries imposed restrictions?\", \"What is the basis for restrictions in some countries?\", \"What types of restrictions are based on citizenship or residency?\"]", "answers": "[\"Restrictions on citizens in severely affected areas\", \"Severely affected areas\", \"Severely affected areas\", \"Restrictions on citizens in severely affected areas\"]", "scores": [{"f1": 0.588235294117647, "em": false, "chrf": 60.48042589833022, "bleu": 18.094495256969623}, {"f1": 0.4, "em": false, "chrf": 44.435280068493554, "bleu": 14.506309551249304}, {"f1": 0.4, "em": false, "chrf": 44.435280068493554, "bleu": 14.506309551249304}, {"f1": 0.588235294117647, "em": false, "chrf": 60.48042589833022, "bleu": 18.094495256969623}], "avg_f1": 0.4941176470588235, "avg_em": 0.0, "avg_chrf": 52.45785298341188, "avg_bleu": 16.300402404109462}
{"id": "Wikivoyage_1:2326", "en": "A detailed list of entry restrictions is maintained by the IATA.", "fr": "Une liste détaillée des restrictions d’entrée est tenue à jour par l’IATA.", "perturbation": "omission", "pert_fr": "Une liste détaillée des restrictions est tenue à jour par l’IATA.", "bt_pert_fr": "A detailed list of restrictions is maintained by IATA.", "questions": "[\"What is maintained by the IATA?\", \"What type of restrictions is the list about?\"]", "answers": "[\"A detailed list of restrictions\", \"Restrictions\"]", "scores": [{"f1": 0.9090909090909091, "em": false, "chrf": 76.75075668672086, "bleu": 57.89300674674101}, {"f1": 0, "em": false, "chrf": 62.38411897844034, "bleu": 0.0}], "avg_f1": 0.45454545454545453, "avg_em": 0.0, "avg_chrf": 69.5674378325806, "avg_bleu": 28.946503373370504}
{"id": "Wikivoyage_1:2328", "en": "Keep up to date—the outbreak and the travel restrictions are changing rapidly.", "fr": "Tenez-vous au courant : l’épidémie et les restrictions de voyage évoluent rapidement.", "perturbation": "omission", "pert_fr": "Tenez-vous au courant : l’épidémie évolue rapidement.", "bt_pert_fr": "Stay informed: the epidemic is evolving rapidly.", "questions": "[\"What is changing rapidly?\", \"Why is it important to keep up to date?\"]", "answers": "[\"The epidemic\", \"To stay informed\"]", "scores": [{"f1": 0.28571428571428575, "em": false, "chrf": 7.90835638451041, "bleu": 11.15650800742149}, {"f1": 0, "em": false, "chrf": 4.726356816120035, "bleu": 0.0}], "avg_f1": 0.14285714285714288, "avg_em": 0.0, "avg_chrf": 6.317356600315222, "avg_bleu": 5.578254003710745}
{"id": "Wikivoyage_1:2329", "en": "For travel in the near future, consider making refundable reservations in case the changing situation forces you to change your plans.", "fr": "Pour les voyages dans un avenir proche, envisagez d’effectuer des réservations remboursables pour le cas où l’évolution de la situation vous contraindrait à modifier vos plans.", "perturbation": "omission", "pert_fr": "Pour les voyages dans un avenir proche, envisagez d’effectuer des réservations pour le cas où l’évolution de la situation vous contraindrait à modifier vos plans.", "bt_pert_fr": "For trips in the near future, consider making reservations in case developments force you to change your plans.", "questions": "[\"What should be considered for travel in the near future?\", \"Why is it recommended to make refundable reservations?\", \"What might force a change in travel plans?\", \"What is the reason for changing travel plans?\"]", "answers": "[\"Making reservations\", \"To ensure flexibility in case of changes\", \"Developments\", \"To adjust plans due to developments\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 61.16795887599661, "bleu": 42.88819424803536}, {"f1": 0.11764705882352941, "em": false, "chrf": 20.792408784769886, "bleu": 4.278179264606695}, {"f1": 0, "em": false, "chrf": 4.528985507246376, "bleu": 0.0}, {"f1": 0.5454545454545454, "em": false, "chrf": 28.236084368451053, "bleu": 17.965205598154213}], "avg_f1": 0.3657754010695187, "avg_em": 0.0, "avg_chrf": 28.681359384115982, "avg_bleu": 16.282894777699067}
{"id": "Wikivoyage_1:2330", "en": "Avoid buying tickets with a connection in an affected area – even changing planes can make you subject to restrictions.", "fr": "Évitez d’acheter des billets avec une correspondance dans une région touchée : un simple changement d’avion peut vous soumettre à des restrictions.", "perturbation": "omission", "pert_fr": "Évitez d’acheter des billets avec une correspondance  : un simple changement d’avion peut vous soumettre à des restrictions.", "bt_pert_fr": "Avoid purchasing tickets with a connection: a simple change of plane may subject you to restrictions.", "questions": "[\"What should you avoid when traveling?\", \"What happens if you change planes in an affected area?\", \"What is considered an affected area?\", \"What is the risk of traveling with a connection in an affected area?\"]", "answers": "[\"Purchasing tickets with a connection\", \"You may be subject to restrictions\", \"Not specified\", \"Being subject to restrictions\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 60.52519009680052, "bleu": 28.087083270446133}, {"f1": 0.6666666666666666, "em": false, "chrf": 70.8031472414081, "bleu": 32.46679154750989}, {"f1": 0, "em": false, "chrf": 5.208333333333333, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.553030303030303, "avg_em": 0.25, "avg_chrf": 59.134167667885485, "avg_bleu": 40.138468704489014}
{"id": "Wikivoyage_1:2332", "en": "You might also be delayed for hours upon arrival waiting for temperature checks and related procedures and paperwork, or even get quarantined for two weeks.", "fr": "Vous pouvez également être retardé des heures à l’arrivée pour les contrôles de température, et les procédures et formalités associées, voire être mis en quarantaine pendant deux semaines.", "perturbation": "omission", "pert_fr": "Vous pouvez également être retardé des heures à l’arrivée pour les procédures et formalités associées, voire être mis en quarantaine pendant deux semaines.", "bt_pert_fr": "You may also be delayed for hours on arrival for associated procedures and formalities, or even be quarantined for two weeks.", "questions": "[\"What might cause a delay upon arrival?\", \"What is the potential duration of quarantine?\", \"What are the possible reasons for being quarantined?\"]", "answers": "[\"Associated procedures and formalities\", \"Two weeks\", \"Being associated with procedures and formalities\"]", "scores": [{"f1": 0.36363636363636365, "em": false, "chrf": 36.863003537416624, "bleu": 15.090767577522726}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.30769230769230765, "em": false, "chrf": 31.869965946947225, "bleu": 13.74127285540009}], "avg_f1": 0.5571095571095571, "avg_em": 0.3333333333333333, "avg_chrf": 56.244323161454616, "avg_bleu": 42.94401347764096}
{"id": "Wikivoyage_1:2334", "en": "Even if you're nowhere near affected areas there's a risk that you'll have to stay at the destination longer than planned if you've shared a building or vessel with an infected person.", "fr": "Même si vous êtes très loin des régions touchées, vous risquez de devoir rester plus longtemps que prévu au lieu de destination si vous vous êtes trouvé dans le même bâtiment ou navire qu’une personne infectée.", "perturbation": "omission", "pert_fr": "Même si vous êtes très loin des régions touchées, vous risquez de devoir rester plus longtemps que prévu au lieu de destination si vous vous êtes trouvé dans le même bâtiment qu’une personne infectée.", "bt_pert_fr": "Even if you are very far from the affected areas, you may have to stay longer than expected at your destination if you have been in the same building as an infected person.", "questions": "[\"What is the risk if you've shared a building or vessel with an infected person?\", \"Under what circumstances might you have to stay at a destination longer than planned?\", \"What factors increase the risk of extended stay at a destination?\"]", "answers": "[\"You may have to stay longer than expected at your destination\", \"If you have been in the same building as an infected person\", \"Having been in the same building as an infected person\"]", "scores": [{"f1": 0.7000000000000001, "em": false, "chrf": 58.866414700632696, "bleu": 19.081654556856684}, {"f1": 0.4210526315789474, "em": false, "chrf": 48.57642070001193, "bleu": 9.980099403873663}, {"f1": 0.39999999999999997, "em": false, "chrf": 50.717225062201365, "bleu": 12.223075560872525}], "avg_f1": 0.5070175438596491, "avg_em": 0.0, "avg_chrf": 52.720020154282, "avg_bleu": 13.761609840534291}
{"id": "Wikivoyage_1:2335", "en": "For example, in late February an Italian doctor on vacation in Costa Adeje (Canary Islands) was diagnosed with COVID-19, and as a result all the guests in the hotel he stayed at were quarantined.", "fr": "Fin février, par exemple, la COVID-19 a été diagnostiquée chez un médecin italien en vacances à Costa Adeje (îles Canaries) et, en conséquence, tous les clients de l’hôtel dans lequel il séjournait ont été mis en quarantaine.", "perturbation": "omission", "pert_fr": "Fin février, par exemple, la COVID-19 a été diagnostiquée chez un médecin en vacances à Costa Adeje (îles Canaries) et, en conséquence, tous les clients de l’hôtel dans lequel il séjournait ont été mis en quarantaine.", "bt_pert_fr": "At the end of February, for example, a doctor on vacation in Costa Adeje (Canary Islands) was diagnosed with COVID-19 and, as a result, all guests of the hotel where he was staying were quarantined.", "questions": "[\"What happened to an Italian doctor in late February?\", \"Where was the Italian doctor on vacation?\", \"What was the doctor diagnosed with?\", \"What was the consequence for the guests in the hotel?\", \"What action was taken as a result of the doctor's diagnosis?\"]", "answers": "[\"He was diagnosed with COVID-19 and all guests of the hotel where he was staying were quarantined\", \"Costa Adeje (Canary Islands)\", \"COVID-19\", \"They were quarantined\", \"All guests of the hotel where he was staying were quarantined\"]", "scores": [{"f1": 0.34782608695652173, "em": false, "chrf": 53.50347569173308, "bleu": 15.310245441182436}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.625, "em": false, "chrf": 70.86237231148857, "bleu": 12.549310621989482}], "avg_f1": 0.7945652173913043, "avg_em": 0.6, "avg_chrf": 84.87316960064433, "avg_bleu": 65.5719112126344}
{"id": "Wikivoyage_1:2336", "en": "Lockdowns and other internal restrictions", "fr": "Confinements et autres restrictions internes", "perturbation": "omission", "pert_fr": "Confinements", "bt_pert_fr": "Confinements", "questions": "[\"What is the purpose of lockdowns and other internal restrictions?\"]", "answers": "[\"The sentence does not provide information about the purpose of lockdowns and other internal restrictions.\"]", "scores": [{"f1": 0.7407407407407408, "em": false, "chrf": 72.76061922851224, "bleu": 47.27526606311562}], "avg_f1": 0.7407407407407408, "avg_em": 0.0, "avg_chrf": 72.76061922851224, "avg_bleu": 47.27526606311562}
{"id": "Wikivoyage_1:2338", "en": "These include the temporary reintroduction of some border controls, restrictions on travel within the country, closing or limiting service at restaurants and other establishments, banning large public events, and in the most severe cases prohibiting people from leaving the house except for essential reasons.", "fr": "Celles-ci incluent la réintroduction temporaire de certains contrôles frontaliers, les restrictions sur les déplacements au sein du pays, la fermeture ou la limitation de l’activité des restaurants et d’autres établissements, l’interdiction des grands événements publics et, dans les cas les plus sévères, l’interdiction de quitter son domicile, sauf pour raisons essentielles.", "perturbation": "omission", "pert_fr": "Celles-ci incluent la réintroduction temporaire de certains contrôles frontaliers, les restrictions sur les déplacements au sein du pays, la fermeture ou la limitation de l’activité des restaurants et d’autres établissements, l’interdiction des grands événements publics et, dans les cas les plus sévères, l’interdiction de quitter son domicile.", "bt_pert_fr": "These include the temporary reintroduction of certain border controls, restrictions on travel within the country, the closure or limitation of the activity of restaurants and other establishments, the ban on large public events and, in the most severe cases, the ban on leaving one's home.", "questions": "[\"What measures are included in the temporary reintroduction of border controls?\", \"What restrictions are placed on travel within the country?\", \"What changes are made to restaurant and other establishment services?\", \"What public events are banned?\", \"What is prohibited in the most severe cases regarding people leaving the house?\"]", "answers": "[\"the temporary reintroduction of certain border controls\", \"restrictions on travel within the country\", \"the closure or limitation of the activity of restaurants and other establishments\", \"large public events\", \"the ban on leaving one's home\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 56.39053825554969, "bleu": 16.233395773754946}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5263157894736842, "em": false, "chrf": 67.19762473154218, "bleu": 27.77619034011791}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.14285714285714285, "em": false, "chrf": 14.931125276520941, "bleu": 4.799810699119212}], "avg_f1": 0.6227234753550543, "avg_em": 0.4, "avg_chrf": 67.70385765272256, "avg_bleu": 49.761879362598435}
{"id": "Wikivoyage_1:2339", "en": "Beyond government restrictions, individual establishments are shutting their doors and cancelling events to try to reduce the spread of the virus.", "fr": "En plus des restrictions gouvernementales, des établissements individuels ferment leurs portes et annulent des événements afin d’essayer de réduire la propagation du virus.", "perturbation": "omission", "pert_fr": "En plus des restrictions gouvernementales, des établissements individuels ferment leurs portes afin d’essayer de réduire la propagation du virus.", "bt_pert_fr": "In addition to government restrictions, individual establishments are closing their doors in an attempt to reduce the spread of the virus.", "questions": "[\"What actions are individual establishments taking to reduce the spread of the virus?\", \"What specific measures are being taken by individual establishments?\", \"What is the reason for individual establishments shutting their doors and cancelling events?\", \"What is the goal of shutting doors and cancelling events?\"]", "answers": "[\"Closing their doors\", \"Closing their doors\", \"To reduce the spread of the virus\", \"To reduce the spread of the virus\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 35.24404630529858, "bleu": 20.24518585186855}, {"f1": 0.4444444444444444, "em": false, "chrf": 35.24404630529858, "bleu": 20.24518585186855}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7222222222222222, "avg_em": 0.5, "avg_chrf": 67.62202315264929, "avg_bleu": 60.1225929259343}
{"id": "Wikivoyage_1:2340", "en": "In China, there are extensive restrictions on transportation and activity, which vary widely by province, city, and even by district or village.", "fr": "En Chine, d’importantes restrictions variant considérablement selon la province, la ville, voire le district ou le village ont été mises en place sur les transports et l’activité.", "perturbation": "omission", "pert_fr": "En Chine, d’importantes restrictions variant considérablement selon la province ont été mises en place sur les transports et l’activité.", "bt_pert_fr": "In China, significant restrictions varying considerably depending on the province have been put in place on transport and activity.", "questions": "[\"What restrictions are in place in China?\", \"What aspects of transportation and activity are restricted in China?\", \"How do restrictions vary in China?\", \"What is the level of variation in restrictions by province?\", \"What is the level of variation in restrictions by city?\", \"What is the level of variation in restrictions by district or village?\"]", "answers": "[\"Significant restrictions on transport and activity\", \"Transport and activity\", \"Depending on the province\", \"Varying considerably\", \"Not mentioned\", \"Not mentioned\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 68.38013714934053, "bleu": 22.957488466614326}, {"f1": 0.6666666666666666, "em": false, "chrf": 72.92759941132694, "bleu": 55.03212081491043}, {"f1": 0.13333333333333333, "em": false, "chrf": 16.158916739405427, "bleu": 1.3699439807202476}, {"f1": 0, "em": false, "chrf": 18.842184808526667, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.944444444444444, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.944444444444444, "bleu": 0.0}], "avg_f1": 0.24444444444444444, "avg_em": 0.0, "avg_chrf": 31.699621166248075, "avg_bleu": 13.226592210374166}
{"id": "Wikivoyage_1:2341", "en": "Many governments recommend against traveling to China at this time.", "fr": "De nombreux gouvernements déconseillent de se rendre en Chine pour le moment.", "perturbation": "omission", "pert_fr": "De nombreux gouvernements déconseillent de se rendre pour le moment.", "bt_pert_fr": "Many governments are advising against travel at this time.", "questions": "[\"What do many governments recommend against?\", \"To which country is travel recommended against?\", \"Why is travel to China recommended against?\"]", "answers": "[\"Travel\", \"China\", \"Not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 55.77101053281037, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 12.75252525252525, "bleu": 0.0}], "avg_f1": 0.3333333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 56.174511928445206, "avg_bleu": 33.33333333333335}
{"id": "Wikivoyage_1:2343", "en": "People who have traveled to Hubei face particularly severe restrictions.", "fr": "Les personnes qui se sont rendues dans la province de Hubei sont soumises à des restrictions particulièrement sévères.", "perturbation": "omission", "pert_fr": "Les personnes qui se sont rendues dans la province sont soumises à des restrictions particulièrement sévères.", "bt_pert_fr": "People who have traveled to the province are subject to particularly severe restrictions.", "questions": "[\"What restrictions do people who have traveled to Hubei face?\", \"Why do people who have traveled to Hubei face particularly severe restrictions?\", \"What does 'particularly severe restrictions' imply?\"]", "answers": "[\"Severe restrictions\", \"Because they have traveled to the province\", \"That the restrictions are more strict than usual\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8333333333333334, "em": false, "chrf": 81.08693841239966, "bleu": 75.98356856515926}, {"f1": 0.8750000000000001, "em": false, "chrf": 77.08753011576185, "bleu": 44.68310718440574}], "avg_f1": 0.9027777777777778, "avg_em": 0.3333333333333333, "avg_chrf": 86.05815617605384, "avg_bleu": 73.55555858318836}
{"id": "Wikivoyage_1:2344", "en": "Examples of restrictions that you may encounter in some parts of China (this is not an exhaustive list):", "fr": "Exemples de restrictions possibles dans certaines parties de la Chine (cette liste n’est pas exhaustive) :", "perturbation": "omission", "pert_fr": "Exemples de restrictions possibles dans certaines parties de la Chine :", "bt_pert_fr": "Examples of possible restrictions in parts of China:", "questions": "[\"What examples of restrictions may you encounter in some parts of China?\", \"Is the list of restrictions exhaustive?\"]", "answers": "[\"Possible restrictions in parts of China\", \"No\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 44.05047026392691, "bleu": 16.66900658055424}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.5, "avg_chrf": 72.02523513196346, "avg_bleu": 58.33450329027714}
{"id": "Wikivoyage_1:2345", "en": "14-day quarantine, self-quarantine, or COVID-19 test upon arrival from other parts of China or from other countries, at your expense", "fr": "Quarantaine de 14 jours, auto-quarantaine ou test de dépistage de la COVID-19 à l’arrivée en provenance d’autres parties de la Chine ou d’autres pays, à vos frais", "perturbation": "omission", "pert_fr": "Quarantaine de 14 jours ou test de dépistage de la COVID-19 à l’arrivée en provenance d’autres parties de la Chine ou d’autres pays, à vos frais", "bt_pert_fr": "14-day quarantine or COVID-19 test upon arrival from other parts of China or other countries, at your expense", "questions": "[\"Is quarantine required upon arrival from other parts of China or other countries?\", \"What is the duration of quarantine?\", \"Is self-quarantine an option upon arrival?\", \"Is a COVID-19 test required upon arrival?\", \"Who is responsible for the cost of quarantine or testing?\"]", "answers": "[\"Yes\", \"14 days\", \"Not mentioned\", \"Yes\", \"You\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 6.944444444444445, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8, "avg_em": 0.8, "avg_chrf": 81.38888888888889, "avg_bleu": 80.00000000000003}
{"id": "Wikivoyage_1:2348", "en": "requirement to wear a face mask in public", "fr": "Obligation de porter un masque de protection en public", "perturbation": "omission", "pert_fr": "Obligation de porter un masque en public", "bt_pert_fr": "Obligation to wear a mask in public", "questions": "[\"What does the requirement involve?\", \"What is the purpose of wearing a face mask in public?\"]", "answers": "[\"Wearing a mask in public\", \"To comply with the obligation\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 70.08809144251329, "bleu": 49.76093899250716}, {"f1": 0.22222222222222224, "em": false, "chrf": 6.387182192432612, "bleu": 12.44023474812678}], "avg_f1": 0.5555555555555556, "avg_em": 0.0, "avg_chrf": 38.23763681747295, "avg_bleu": 31.100586870316967}
{"id": "Wikivoyage_1:2354", "en": "access in and out of a town, village, or city completely blocked", "fr": "Bouclage complet d’une ville, d’un village ou d’une métropole", "perturbation": "omission", "pert_fr": "Bouclage complet d’une ville ou d’une métropole", "bt_pert_fr": "Complete closure of a city or metropolis", "questions": "[\"What happens to access in and out of a town, village, or city when it is completely blocked?\", \"What does 'completely blocked' mean in this context?\", \"What is blocked when access to a town, village, or city is completely blocked?\"]", "answers": "[\"Access in and out of a town, village, or city is completely stopped\", \"It means that no movement or entry is allowed into or out of the area\", \"Access in and out of a town, village, or city\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 42.512429702094465, "bleu": 6.772997136689072}, {"f1": 0.32, "em": false, "chrf": 21.508641686753606, "bleu": 6.754312828675709}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5233333333333333, "avg_em": 0.3333333333333333, "avg_chrf": 54.67369046294936, "avg_bleu": 37.84243665512161}
{"id": "Wikivoyage_1:2355", "en": "non-resident visitors prohibited from entering apartment complexes", "fr": "Interdiction d’entrer dans des complexes résidentiels pour les personnes qui n’y habitent pas", "perturbation": "omission", "pert_fr": "Interdiction d’entrer dans des complexes pour les personnes qui n’y habitent pas", "bt_pert_fr": "Ban on entering complexes for people who do not live there", "questions": "[\"What is prohibited for non-resident visitors?\", \"What type of visitors are prohibited from entering apartment complexes?\", \"What are apartment complexes restricted from allowing entry to?\"]", "answers": "[\"Entering complexes\", \"Non-resident visitors\", \"Non-resident visitors\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 54.40575492913676, "bleu": 42.88819424803536}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9333333333333332, "avg_em": 0.6666666666666666, "avg_chrf": 84.80191830971226, "avg_bleu": 80.96273141601182}
{"id": "Wikivoyage_1:2359", "en": "restaurants (if they are even open) require a minimum distance between customers", "fr": "Obligation de maintenir une distance minimum entre les clients dans les restaurants (s’ils sont ouverts)", "perturbation": "omission", "pert_fr": "Obligation de maintenir une distance minimum entre les clients dans les restaurants.", "bt_pert_fr": "Obligation to maintain a minimum distance between customers in restaurants.", "questions": "[\"What condition must be met for restaurants to operate?\"]", "answers": "[\"Obligation to maintain a minimum distance between customers\"]", "scores": [{"f1": 0.5333333333333333, "em": false, "chrf": 74.26497302385225, "bleu": 35.64026463354184}], "avg_f1": 0.5333333333333333, "avg_em": 0.0, "avg_chrf": 74.26497302385225, "avg_bleu": 35.64026463354184}
{"id": "Wikivoyage_1:2361", "en": "As of mid-March 2020, Europe is the epicenter of the epidemic, and many European countries have closed their borders to international travel - only border commuters and freight are allowed to cross.", "fr": "À la mi-mars 2020, l’Europe est l’épicentre de l’épidémie, et de nombreux pays européens ont fermé leurs frontières aux voyages internationaux : seuls les transfrontaliers et le fret sont autorisés à passer.", "perturbation": "omission", "pert_fr": "À la mi-mars 2020, l’Europe est l’épicentre de l’épidémie, et de nombreux pays européens ont fermé leurs frontières aux voyages internationaux : seuls les transfrontaliers sont autorisés à passer.", "bt_pert_fr": "As of mid-March 2020, Europe is the epicenter of the epidemic, and many European countries have closed their borders to international travel: only cross-border travelers are allowed to cross.", "questions": "[\"What was the situation in Europe as of mid-March 2020?\", \"Where was the epicenter of the epidemic as of mid-March 2020?\", \"Which European countries closed their borders to international travel?\", \"What types of people are allowed to cross borders in Europe?\", \"What restrictions were imposed on international travel in Europe?\"]", "answers": "[\"Europe is the epicenter of the epidemic, and many European countries have closed their borders to international travel: only cross-border travelers are allowed to cross\", \"Europe\", \"Many European countries\", \"Cross-border travelers\", \"Borders were closed to international travel, and only cross-border travelers are allowed to cross\"]", "scores": [{"f1": 0.8749999999999999, "em": false, "chrf": 84.92354506554314, "bleu": 76.2541667289299}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 18.8270297990973, "bleu": 0.0}, {"f1": 0.8275862068965518, "em": false, "chrf": 71.9035249674647, "bleu": 51.812942206142694}], "avg_f1": 0.7405172413793103, "avg_em": 0.4, "avg_chrf": 75.13081996642103, "avg_bleu": 65.61342178701453}
{"id": "Wikivoyage_1:2362", "en": "Also businesses other than food stores and pharmacies are closed, and public transport has been reduced or stopped.", "fr": "Par ailleurs, les entreprises autres que les magasins d’alimentation et les pharmacies sont fermées, et les transports en commun ont été réduits ou arrêtés.", "perturbation": "omission", "pert_fr": "Par ailleurs, les entreprises autres que les pharmacies sont fermées, et les transports en commun ont été réduits ou arrêtés.", "bt_pert_fr": "In addition, businesses other than pharmacies are closed, and public transportation has been reduced or stopped.", "questions": "[\"What types of businesses are closed besides food stores and pharmacies?\", \"What has been done to public transport?\", \"Are all businesses closed?\", \"What specific changes have been made to public transport?\"]", "answers": "[\"None specified\", \"Reduced or stopped\", \"No\", \"Reduced or stopped\"]", "scores": [{"f1": 0, "em": false, "chrf": 7.906743755583942, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.75, "avg_chrf": 76.97668593889598, "avg_bleu": 75.00000000000003}
{"id": "Wikivoyage_1:2365", "en": "COVID-19 is prevalent also in North America.", "fr": "La COVID-19 est également répandue en Amérique du Nord.", "perturbation": "omission", "pert_fr": "La COVID-19 est également répandue en Amérique.", "bt_pert_fr": "COVID-19 is also prevalent in America.", "questions": "[\"Where is COVID-19 prevalent?\", \"Is COVID-19 present in North America?\"]", "answers": "[\"America\", \"Yes\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 51.132491751735685, "bleu": 36.78794411714425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8333333333333333, "avg_em": 0.5, "avg_chrf": 75.56624587586785, "avg_bleu": 68.39397205857215}
{"id": "Wikivoyage_1:2366", "en": "The borders between Canada, the U.S., and Mexico are closed to non-essential travel, and in many areas bans on big gatherings are in effect (this means places like restaurants are closed, and events are canceled).", "fr": "Les frontières entre le Canada, les États-Unis et le Mexique sont fermées aux déplacements non essentiels et, dans de nombreuses zones, les grands rassemblements sont interdits (ce qui signifie que les établissements tels que les restaurants sont fermés et que les événements sont annulés).", "perturbation": "omission", "pert_fr": "Les frontières entre le Canada et les États-Unis sont fermées aux déplacements non essentiels et, dans de nombreuses zones, les grands rassemblements sont interdits.", "bt_pert_fr": "The borders between Canada and the United States are closed to non-essential travel, and in many areas large gatherings are prohibited.", "questions": "[\"What borders are closed to non-essential travel?\", \"Which countries have closed borders to non-essential travel?\", \"What type of travel is restricted?\", \"What restrictions are in place regarding big gatherings?\", \"What specific places are closed due to the bans on big gatherings?\", \"What events are canceled due to the bans on big gatherings?\"]", "answers": "[\"The borders between Canada and the United States\", \"Canada and the United States\", \"Non-essential travel\", \"Large gatherings are prohibited\", \"Many areas\", \"Events\"]", "scores": [{"f1": 0.7142857142857143, "em": false, "chrf": 68.21212820842068, "bleu": 43.47208719449914}, {"f1": 0.5, "em": false, "chrf": 31.48949630651702, "bleu": 18.99589214128981}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.36363636363636365, "em": false, "chrf": 44.150917358826234, "bleu": 15.090767577522726}, {"f1": 0, "em": false, "chrf": 11.170177530471646, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.5963203463203463, "avg_em": 0.3333333333333333, "avg_chrf": 59.170453234039265, "avg_bleu": 46.25979115221863}
{"id": "Wikivoyage_1:2372", "en": "On the other hand, the good news is that many flights are cheaper than usual due to decreased demand, and there's a decent chance you'll get an empty seat next to you.", "fr": "En revanche, la bonne nouvelle est que de nombreux vols sont moins chers que d’habitude en raison de la baisse de la demande, et vous avez de bonnes chances d’avoir un siège vide à côté de vous.", "perturbation": "omission", "pert_fr": "En revanche, la bonne nouvelle est que de nombreux vols sont moins chers que d’habitude en raison de la baisse de la demande, et vous avez de bonnes chances d’avoir un siège vide.", "bt_pert_fr": "The good news, however, is that many flights are cheaper than usual due to lower demand, and you have a good chance of getting an empty seat.", "questions": "[\"What is the good news mentioned in the sentence?\", \"Why are many flights cheaper than usual?\", \"What is the reason for decreased flight prices?\", \"What is the chance of getting an empty seat next to you?\", \"What factor contributes to the availability of empty seats?\"]", "answers": "[\"Many flights are cheaper than usual due to lower demand\", \"Lower demand\", \"Lower demand\", \"A good chance\", \"Lower demand\"]", "scores": [{"f1": 0.9, "em": false, "chrf": 77.60066916315695, "bleu": 78.25422900366438}, {"f1": 0.5, "em": false, "chrf": 30.72422158650523, "bleu": 49.99999999999999}, {"f1": 0.5, "em": false, "chrf": 30.72422158650523, "bleu": 49.99999999999999}, {"f1": 0.6666666666666666, "em": false, "chrf": 35.33864936762706, "bleu": 34.66806371753173}, {"f1": 0.5, "em": false, "chrf": 30.72422158650523, "bleu": 49.99999999999999}], "avg_f1": 0.6133333333333333, "avg_em": 0.0, "avg_chrf": 41.02239665805994, "avg_bleu": 52.58445854423921}
{"id": "Wikivoyage_1:2376", "en": "This is a real concern if you're trying to get out of an affected area.", "fr": "Cela est un réel problème si vous essayez de quitter une zone touchée.", "perturbation": "omission", "pert_fr": "Cela est un problème si vous essayez de quitter une zone touchée.", "bt_pert_fr": "This is a problem if you are trying to leave an affected area.", "questions": "[\"What is a real concern when trying to get out of an affected area?\", \"Why is it a concern to get out of an affected area?\"]", "answers": "[\"This is a problem\", \"Because you are trying to leave an affected area\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 57.04713932712412, "bleu": 27.516060407455225}, {"f1": 0.15384615384615385, "em": false, "chrf": 28.74410683232238, "bleu": 5.522397783539471}], "avg_f1": 0.3269230769230769, "avg_em": 0.0, "avg_chrf": 42.89562307972325, "avg_bleu": 16.519229095497348}
{"id": "Wikivoyage_1:2377", "en": "For instance, most aggregators are not selling tickets from China to the United States (presumably to avoid falling afoul of restrictions and being on the hook for a passenger's flight out).", "fr": "Par exemple, la plupart des agrégateurs ne vendent pas de billets de la Chine vers les États-Unis (vraisemblablement pour éviter le risque d’aller à l’encontre des restrictions et de se voir contraints d’assumer le vol d’un passager pour sortir du pays).", "perturbation": "omission", "pert_fr": "Par exemple, la plupart des agrégateurs ne vendent pas de billets vers les États-Unis.", "bt_pert_fr": "For example, most aggregators do not sell tickets to the United States.", "questions": "[\"Why might aggregators not be selling tickets from China to the United States?\", \"What restrictions are likely being avoided by aggregators?\", \"What is the likely reason for the absence of ticket sales between China and the United States?\"]", "answers": "[\"Because most aggregators do not sell tickets to the United States\", \"Sales to the United States\", \"Most aggregators do not sell tickets to the United States\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.750454034359585, "bleu": 0.0}, {"f1": 0.22222222222222224, "em": false, "chrf": 12.663289343812522, "bleu": 12.44023474812678}, {"f1": 0, "em": false, "chrf": 12.510368996467552, "bleu": 0.0}], "avg_f1": 0.07407407407407408, "avg_em": 0.0, "avg_chrf": 12.641370791546555, "avg_bleu": 4.14674491604226}
{"id": "Wikivoyage_1:2378", "en": "To buy a ticket for an itinerary like this, you may have to contact the airline or use a lesser-known aggregator.", "fr": "Pour acheter un billet pour un itinéraire de ce type, vous devrez peut-être contacter la compagnie aérienne ou utiliser un agrégateur moins connu.", "perturbation": "omission", "pert_fr": "Pour acheter un billet pour un itinéraire de ce type, vous devrez peut-être contacter la compagnie aérienne ou utiliser un agrégateur.", "bt_pert_fr": "To purchase a ticket for a route of this type, you may need to contact the airline or use an aggregator.", "questions": "[\"How can you buy a ticket for an itinerary like this?\", \"Do you need to contact the airline to buy a ticket for this itinerary?\", \"Can you use a lesser-known aggregator to buy a ticket for this itinerary?\", \"What are the options for purchasing a ticket for this itinerary?\"]", "answers": "[\"Contact the airline or use an aggregator\", \"Yes\", \"No\", \"Contact the airline or use an aggregator\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 48.016550167594154, "bleu": 15.84873897212071}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.5454545454545454, "em": false, "chrf": 52.50392628891974, "bleu": 19.357693493908812}], "avg_f1": 0.5113636363636364, "avg_em": 0.25, "avg_chrf": 50.130119114128476, "avg_bleu": 33.80160811650739}
{"id": "Wikivoyage_1:2385", "en": "In uncertain times, plans can change.", "fr": "En période d’incertitude, les plans peuvent changer.", "perturbation": "omission", "pert_fr": "En période d’incertitude, les plans changer.", "bt_pert_fr": "In times of uncertainty, plans change.", "questions": "[\"What happens in uncertain times?\", \"What can change in uncertain times?\"]", "answers": "[\"Plans change\", \"Plans\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 59.512075302768466, "bleu": 42.88819424803536}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9, "avg_em": 0.5, "avg_chrf": 79.75603765138423, "avg_bleu": 71.4440971240177}
{"id": "Wikivoyage_1:2386", "en": "Many embassies and consulates have evacuated nonessential staff, and some have shut down operations completely.", "fr": "De nombreux consulats et ambassades ont évacué le personnel non essentiel, et certains ont complètement cessé leur activité.", "perturbation": "omission", "pert_fr": "De nombreux consulats ont évacué le personnel non essentiel, et certains ont complètement cessé leur activité.", "bt_pert_fr": "Many consulates have evacuated non-essential staff, and some have ceased operations completely.", "questions": "[\"What action have some embassies and consulates taken regarding operations?\", \"What does 'shut down operations completely' mean in this context?\"]", "answers": "[\"Evacuated non-essential staff and ceased operations completely\", \"To stop all operations entirely\"]", "scores": [{"f1": 0.375, "em": false, "chrf": 43.8189770263148, "bleu": 10.923299908191149}, {"f1": 0.3333333333333333, "em": false, "chrf": 41.423491896430455, "bleu": 14.320952289897704}], "avg_f1": 0.35416666666666663, "avg_em": 0.0, "avg_chrf": 42.62123446137262, "avg_bleu": 12.622126099044426}
{"id": "Wikivoyage_1:2389", "en": "At the very least they can keep you informed about the local situation and notify you about recently introduced travel requirements and restrictions.", "fr": "Il peut tout au moins vous tenir informé de la situation locale et vous notifier les exigences et restrictions de voyage récemment introduites.", "perturbation": "omission", "pert_fr": "Il peut tout au moins vous tenir informé de la situation locale et vous notifier les exigences récemment introduites.", "bt_pert_fr": "At the very least, it can keep you informed of the local situation and notify you of recently introduced requirements.", "questions": "[\"What can they keep you informed about?\", \"What do they notify you about?\", \"What travel requirements and restrictions are mentioned?\"]", "answers": "[\"the local situation\", \"recently introduced requirements\", \"none\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 56.95981556920393, "bleu": 23.174952587773145}, {"f1": 0, "em": false, "chrf": 3.020239212571896, "bleu": 0.0}], "avg_f1": 0.5555555555555555, "avg_em": 0.3333333333333333, "avg_chrf": 53.32668492725861, "avg_bleu": 41.05831752925773}
{"id": "Wikivoyage_1:2390", "en": "Ordinary consular services such as visa and passport processing may be suspended or restricted to urgent need, depending on the location and the consulate.", "fr": "Les services consulaires habituels, tels que le traitement des visas et des passeports, peuvent être suspendus ou limités aux urgences, selon le lieu et le consulat.", "perturbation": "omission", "pert_fr": "Les services consulaires habituels, tels que le traitement des visas, peuvent être suspendus ou limités aux urgences, selon le lieu et le consulat.", "bt_pert_fr": "Regular consular services, such as visa processing, may be suspended or limited to emergencies, depending on the location and consulate.", "questions": "[\"What ordinary consular services may be suspended or restricted?\", \"What determines whether consular services are suspended or restricted?\", \"What is the basis for suspending or restricting consular services?\", \"What is the role of location and the consulate in consular service restrictions?\"]", "answers": "[\"Visa processing\", \"The location and consulate\", \"The location and consulate\", \"The location and consulate\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 41.03877982339387, "bleu": 18.393972058572114}, {"f1": 0.8571428571428571, "em": false, "chrf": 96.6586836331179, "bleu": 59.460355750136046}, {"f1": 0, "em": false, "chrf": 9.25925925925926, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 31.353473246467956, "bleu": 13.533528323661276}], "avg_f1": 0.4226190476190476, "avg_em": 0.0, "avg_chrf": 44.57754899055975, "avg_bleu": 22.84696403309236}
{"id": "Wikivoyage_1:2392", "en": "It is still common to refer the disease as \"Wuhan pneumonia\" or \"Chinese virus\" in places like Hong Kong and Taiwan.", "fr": "Il est quand même fréquent de désigner la maladie comme « la pneumonie de Wuhan » ou « le virus chinois » dans des lieux tels que Hong Kong et Taïwan.", "perturbation": "omission", "pert_fr": "Il est quand même fréquent de désigner la maladie comme « la pneumonie de Wuhan » ou « le virus chinois » dans des lieux tels que Hong Kong.", "bt_pert_fr": "It is still common to refer to the disease as “Wuhan pneumonia” or “Chinese virus” in places such as Hong Kong.", "questions": "[\"Where is 'Wuhan pneumonia' or 'Chinese virus' still commonly referred to?\", \"What are the alternative names for the disease mentioned in the sentence?\", \"In which regions is the disease referred to as 'Wuhan pneumonia' or 'Chinese virus'?\", \"What is the disease being referred to in the sentence?\"]", "answers": "[\"Hong Kong\", \"Wuhan pneumonia or Chinese virus\", \"Hong Kong\", \"the disease\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 42.3851179025738, "bleu": 36.78794411714425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 42.3851179025738, "bleu": 36.78794411714425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8333333333333333, "avg_em": 0.5, "avg_chrf": 71.1925589512869, "avg_bleu": 68.39397205857215}
{"id": "Wikivoyage_1:2397", "en": "There has been a worldwide spike in racist incidents targeting people of East Asian origin, including in major cities such as New York, London and San Francisco.", "fr": "Dans le monde entier, on constate une montée des incidents racistes à l’encontre des personnes originaires d’Asie orientale, y compris dans les grandes métropoles telles que New York, Londres et San Francisco.", "perturbation": "omission", "pert_fr": "Dans le monde entier, on constate une montée des incidents à l’encontre des personnes originaires d’Asie orientale, y compris dans les grandes métropoles telles que New York, Londres et San Francisco.", "bt_pert_fr": "Across the world, there is a rise in incidents against people from East Asia, including in major cities such as New York, London and San Francisco.", "questions": "[\"What has been observed worldwide?\", \"Where have racist incidents targeting people of East Asian origin been reported?\", \"What type of incidents are targeting people of East Asian origin?\", \"Which major cities have experienced these incidents?\"]", "answers": "[\"A rise in incidents against people from East Asia\", \"Major cities such as New York, London and San Francisco\", \"Racist incidents\", \"New York, London, and San Francisco\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 38.582650786837974, "bleu": 5.708765135015525}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.875, "avg_em": 0.75, "avg_chrf": 84.6456626967095, "avg_bleu": 76.42719128375391}
{"id": "Wikivoyage_1:2398", "en": "In Hong Kong, Sinophobia, which was already high to begin with, has intensified as a result of the pandemic, with the result that many shops and restaurants are now denying service to mainland Chinese customers and banning Mandarin speakers from their premises (with the exception of Taiwanese).", "fr": "À Hong Kong, la sinophobie, qui était déjà élevée au départ, s’est intensifiée du fait de la pandémie, si bien que de nombreux magasins et restaurants refusent désormais de servir les clients de Chine continentale et interdisent l’entrée aux personnes qui parlent le mandarin (à l’exception des Taïwanais).", "perturbation": "omission", "pert_fr": "À Hong Kong, la sinophobie, qui était déjà élevée au départ, s’est intensifiée du fait de la pandémie, si bien que de nombreux magasins et restaurants refusent désormais de servir les clients et interdisent l’entrée aux personnes qui parlent le mandarin.", "bt_pert_fr": "In Hong Kong, Sinophobia, which was already high to begin with, has intensified due to the pandemic, with many stores and restaurants now refusing to serve customers and barring entry to Mandarin speakers.", "questions": "[\"What is Sinophobia?\", \"Why has Sinophobia intensified in Hong Kong?\", \"What is the result of the intensified Sinophobia?\", \"Which businesses are denying service to mainland Chinese customers?\", \"Are there any exceptions to the ban on Mandarin speakers?\", \"Who is exempt from the ban on Mandarin speakers?\"]", "answers": "[\"A negative attitude or prejudice against the Chinese people\", \"Due to the pandemic\", \"Many stores and restaurants are now refusing to serve customers and barring entry to Mandarin speakers\", \"Many stores and restaurants\", \"No\", \"None\"]", "scores": [{"f1": 0.823529411764706, "em": false, "chrf": 79.70114737602401, "bleu": 62.401954419369176}, {"f1": 0.28571428571428575, "em": false, "chrf": 42.02611168737177, "bleu": 19.716118825581447}, {"f1": 0.5714285714285714, "em": false, "chrf": 51.30017495033863, "bleu": 18.13423031516851}, {"f1": 0.75, "em": false, "chrf": 72.30384334079432, "bleu": 35.35533905932737}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 9.827044025157232, "bleu": 0.0}], "avg_f1": 0.40511204481792723, "avg_em": 0.0, "avg_chrf": 42.526386896614326, "avg_bleu": 22.60127376990775}
{"id": "Wikivoyage_1:2399", "en": "Levels of xenophobia have also risen in East Asia, with some restaurants and other businesses in Japan and China refusing service to foreign customers.", "fr": "Les niveaux de xénophobie ont également augmenté en Asie orientale, avec certains restaurants et autres entreprises refusant de servir les clients étrangers au Japon et en Chine.", "perturbation": "omission", "pert_fr": "Les niveaux de xénophobie ont également augmenté en Asie orientale, avec certains restaurants et autres entreprises refusant de servir les clients au Japon et en Chine.", "bt_pert_fr": "Levels of xenophobia have also increased in East Asia, with some restaurants and other businesses refusing to serve customers in Japan and China.", "questions": "[\"What specific actions have restaurants and businesses in Japan and China taken?\", \"Which countries in East Asia are mentioned in the sentence?\", \"What is the impact of xenophobia on businesses in Japan and China?\"]", "answers": "[\"Refusing to serve customers\", \"Japan and China\", \"Businesses in Japan and China are refusing to serve customers\"]", "scores": [{"f1": 0.6666666666666665, "em": false, "chrf": 48.9307328315944, "bleu": 16.37226966703825}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428572, "em": false, "chrf": 74.42491737054911, "bleu": 61.562869795905165}], "avg_f1": 0.8412698412698413, "avg_em": 0.3333333333333333, "avg_chrf": 74.45188340071451, "avg_bleu": 59.31171315431448}
{"id": "Wikivoyage_1:2400", "en": "In China, there have been incidents of foreigners being refused rooms by hotel staff, and foreign residents, particularly black people, being kicked out of their apartments on short notice by their landlords.", "fr": "En Chine, on a recensé des incidents avec le personnel hôtelier refusant des chambres aux étrangers, et les résidents étrangers, particulièrement les personnes noires, se voyant chasser de leur appartement par leur propriétaire avec un court préavis.", "perturbation": "omission", "pert_fr": "En Chine, on a recensé des incidents avec le personnel hôtelier refusant des chambres, et les résidents étrangers se voyant chasser de leur appartement par leur propriétaire avec un court préavis.", "bt_pert_fr": "In China, there have been incidents of hotel staff refusing rooms, and foreign residents being kicked out of their apartments by their landlords on short notice.", "questions": "[\"What incidents have occurred in China regarding foreigners and hotels?\", \"Why were foreigners refused rooms by hotel staff?\", \"What happened to foreign residents, particularly black people, in China?\", \"Why were foreign residents kicked out of their apartments?\", \"What is the specific group mentioned in the context of being kicked out of apartments?\"]", "answers": "[\"Hotel staff refusing rooms to foreigners\", \"Because they are foreigners\", \"They were kicked out of their apartments by their landlords on short notice\", \"Because they are foreign residents\", \"Foreign residents\"]", "scores": [{"f1": 0.30769230769230765, "em": false, "chrf": 53.664473326415106, "bleu": 8.170609724417774}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": false, "chrf": 92.95901374916727, "bleu": 67.86502681586727}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 4.166666666666666, "bleu": 0.0}], "avg_f1": 0.6615384615384615, "avg_em": 0.4, "avg_chrf": 70.15803074844982, "avg_bleu": 55.207127308057025}
{"id": "Wikivoyage_1:2401", "en": "Sources for further information on the coronavirus outbreak include:", "fr": "Voici certaines sources d’informations complémentaires sur l’épidémie de coronavirus :", "perturbation": "omission", "pert_fr": "Voici certaines sources d’informations complémentaires sur le coronavirus :", "bt_pert_fr": "Here are some sources of additional information about the coronavirus:", "questions": "[\"What sources are available for further information on the coronavirus outbreak?\"]", "answers": "[\"Here are some sources of additional information about the coronavirus\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 50.2868892740997, "bleu": 5.669791110976001}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 50.2868892740997, "avg_bleu": 5.669791110976001}
{"id": "Wikivoyage_1:2402", "en": "The US government Centers for Disease Control and Prevention", "fr": "Centres pour le contrôle et la prévention des maladies du gouvernement américain", "perturbation": "omission", "pert_fr": "Centres pour la prévention des maladies du gouvernement américain", "bt_pert_fr": "US Government Centers for Disease Prevention", "questions": "[\"What is the US government agency mentioned in the sentence?\", \"What is the role of the Centers for Disease Control and Prevention?\", \"What is the full name of the agency mentioned?\"]", "answers": "[\"Centers for Disease Control and Prevention\", \"The role is not specified in the sentence\", \"Centers for Disease Control and Prevention\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5333333333333333, "em": false, "chrf": 48.130876381525255, "bleu": 8.051153633013374}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8444444444444444, "avg_em": 0.6666666666666666, "avg_chrf": 82.71029212717508, "avg_bleu": 69.35038454433781}
{"id": "Wikivoyage_1:2403", "en": "European Centre for Disease Prevention and Control (daily updates)", "fr": "Centre européen de prévention et de contrôle des maladies (mises à jour quotidiennes)", "perturbation": "omission", "pert_fr": "Centre européen de contrôle des maladies (mises à jour quotidiennes)", "bt_pert_fr": "European Center for Disease Control (daily updates)", "questions": "[\"What kind of updates does the European Centre for Disease Prevention and Control provide?\", \"What is the frequency of the updates from the European Centre for Disease Prevention and Control?\"]", "answers": "[\"Daily updates\", \"Daily\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "Wikivoyage_1:2404", "en": "United Kingdom government, - Foreign and Commonwealth Office advice for Travellers", "fr": "Gouvernement du Royaume-Uni : conseils aux voyageurs du ministère des Affaires étrangères et du Commonwealth", "perturbation": "omission", "pert_fr": "Gouvernement du Royaume-Uni : conseils aux voyageurs du ministère des Affaires étrangères", "bt_pert_fr": "UK Government: Foreign Office travel advice", "questions": "[\"What advice does the United Kingdom government's Foreign and Commonwealth Office provide for travellers?\", \"What is the purpose of the Foreign and Commonwealth Office advice for travellers?\", \"Which government department provides travel advice in the United Kingdom?\"]", "answers": "[\"Travel advice\", \"To inform travellers about safety and health risks in foreign countries\", \"Foreign Office\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5000000000000001, "em": false, "chrf": 48.071081628334774, "bleu": 8.913765521398126}, {"f1": 0.6666666666666666, "em": false, "chrf": 34.62133742329557, "bleu": 26.013004751144457}], "avg_f1": 0.7222222222222223, "avg_em": 0.3333333333333333, "avg_chrf": 60.89747301721011, "avg_bleu": 44.97559009084754}
{"id": "Wikivoyage_1:2407", "en": "A variety of misinformation and conspiracy theories about the virus are being promoted online and even by some government officials, so be careful which sources you check for information.", "fr": "Toute une série d’informations erronées et de théories de complot sur le virus sont actuellement mises en avant en ligne et même par certains fonctionnaires d’État, alors faites attention aux sources que vous consultez pour obtenir des informations.", "perturbation": "omission", "pert_fr": "Toute une série d’informations erronées sur le virus sont actuellement mises en avant en ligne et même par certains fonctionnaires d’État, alors faites attention aux sources que vous consultez pour obtenir des informations.", "bt_pert_fr": "A variety of misinformation about the virus is currently being promoted online and even by some state officials, so be careful which sources you consult for information.", "questions": "[\"What types of misinformation are being promoted online?\", \"What should people be careful about when checking sources for information?\", \"Where is misinformation about the virus being promoted?\"]", "answers": "[\"A variety of misinformation about the virus\", \"Which sources they consult\", \"Online and even by some state officials\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 37.62075071473981, "bleu": 16.233395773754946}, {"f1": 0.75, "em": false, "chrf": 76.5278403984704, "bleu": 59.460355750136046}, {"f1": 0.8571428571428571, "em": false, "chrf": 67.2400543885078, "bleu": 64.34588841607616}], "avg_f1": 0.669047619047619, "avg_em": 0.0, "avg_chrf": 60.46288183390601, "avg_bleu": 46.679879979989046}
{"id": "Wikivoyage_1:2410", "en": "If you normally watch the news twice per day then stick to this schedule and do something else, rather than having the 24-hour news on continuously.", "fr": "Si vous regardez normalement les informations deux fois par jour, tenez-vous en à ces horaires et faites autre chose plutôt que de laisser les chaînes d’information 24 h/24 allumées continuellement.", "perturbation": "omission", "pert_fr": "Si vous regardez normalement les informations deux fois par jour, tenez-vous en à ces horaires et faites autre chose plutôt que de laisser les chaînes allumées continuellement.", "bt_pert_fr": "If you normally watch the news twice a day, stick to those times and do something else rather than leaving the channels on continuously.", "questions": "[\"What is the recommended news watching schedule?\", \"What should you do instead of having 24-hour news on continuously?\", \"Why is it recommended to stick to a specific news schedule?\", \"What is the alternative to watching 24-hour news?\", \"How often should you normally watch the news?\"]", "answers": "[\"Watch the news twice a day\", \"Do something else\", \"To avoid leaving the channels on continuously\", \"Do something else\", \"Twice a day\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 73.06630570492028, "bleu": 49.76093899250716}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6153846153846153, "em": false, "chrf": 58.53572879895944, "bleu": 19.43309443637607}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 38.52643170006746, "bleu": 42.88819424803536}], "avg_f1": 0.8608547008547008, "avg_em": 0.4, "avg_chrf": 74.02569324078944, "avg_bleu": 62.41644553538373}
{"id": "wiki_26:2435", "en": "b'Bat SARS-like coronavirus WIV1 (Bat SL-CoV-WIV1), also sometimes called SARS-like coronavirus WIV1, is a strain of Severe acute respiratory syndrome-related coronavirus (SARSr-CoV) isolated from Chinese rufous horseshoe bats (Rhinolophus sinicus).", "fr": "b’Le coronavirus de chauves-souris WIV1-CoV semblable au SRAS (BAT SL-CoV-WIV1), également appelé parfois coronavirus WIV1-CoV semblable au SRAS, est une souche du coronavirus du syndrome respiratoire aigu sévère (SARSr-CoV) isolé chez la chauve-souris rousse chinoise en fer à cheval (Rhinolophus sinicus).", "perturbation": "omission", "pert_fr": "Le coronavirus de chauves-souris WIV1-CoV semblable au SRAS (BAT SL-CoV-WIV1), également appelé parfois coronavirus WIV1-CoV semblable au SRAS, est une souche du coronavirus du syndrome respiratoire aigu sévère (SARSr-CoV) isolé chez la chauve-souris en fer à cheval (Rhinolophus sinicus).", "bt_pert_fr": "Bat SARS-like coronavirus WIV1-CoV (BAT SL-CoV-WIV1), also sometimes called SARS-like coronavirus WIV1-CoV, is a strain of severe acute respiratory syndrome coronavirus (SARSr-CoV) isolated from the horseshoe bat (Rhinolophus sinicus).", "questions": "[\"What is the name of the bat SARS-like coronavirus mentioned?\", \"What is another name for Bat SARS-like coronavirus WIV1?\", \"From which animals was the coronavirus isolated?\", \"What type of coronavirus is Bat SL-CoV-WIV1?\", \"What is the host species of the virus?\"]", "answers": "[\"Bat SARS-like coronavirus WIV1-CoV (BAT SL-CoV-WIV1)\", \"SARS-like coronavirus WIV1-CoV\", \"horseshoe bat (Rhinolophus sinicus)\", \"severe acute respiratory syndrome coronavirus (SARSr-CoV)\", \"horseshoe bat (Rhinolophus sinicus)\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 88.64674202122929, "bleu": 30.213753973567677}, {"f1": 0.6666666666666666, "em": false, "chrf": 97.13950678202072, "bleu": 55.03212081491043}, {"f1": 0.6, "em": false, "chrf": 64.3383246525574, "bleu": 21.444097124017667}, {"f1": 0.6666666666666666, "em": false, "chrf": 82.40741369437528, "bleu": 22.957488466614326}, {"f1": 0.6, "em": false, "chrf": 64.3383246525574, "bleu": 21.444097124017667}], "avg_f1": 0.6266666666666667, "avg_em": 0.0, "avg_chrf": 79.37406236054802, "avg_bleu": 30.218311500625553}
{"id": "wiki_26:2436", "en": "Like all coronaviruses, virions consist of single-stranded positive-sense RNA enclosed within an envelope.", "fr": "Comme tous les coronavirus, les virions sont constitués d’ARN à simple brin à polarité positive enfermé dans une enveloppe.", "perturbation": "omission", "pert_fr": "Comme tous les coronavirus, les virions sont constitués d’ARN à simple brin enfermé dans une enveloppe.", "bt_pert_fr": "Like all coronaviruses, virions are made of single-stranded RNA enclosed in an envelope.", "questions": "[\"What do virions consist of?\", \"What is the structure of virions?\", \"What type of RNA do virions contain?\", \"What surrounds the RNA in virions?\", \"What is common to all coronaviruses in terms of virion structure?\"]", "answers": "[\"Single-stranded RNA enclosed in an envelope\", \"An envelope enclosing single-stranded RNA\", \"Single-stranded RNA\", \"An envelope\", \"Virions are made of single-stranded RNA enclosed in an envelope\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 57.152292245041366, "bleu": 19.357693493908812}, {"f1": 0.5454545454545454, "em": false, "chrf": 49.90664977926721, "bleu": 11.51015341649912}, {"f1": 0.4, "em": false, "chrf": 45.652683270967636, "bleu": 30.326532985631665}, {"f1": 0.6666666666666666, "em": false, "chrf": 92.72100013663068, "bleu": 49.99999999999999}, {"f1": 0.5555555555555556, "em": false, "chrf": 53.39398042786995, "bleu": 14.25876976452075}], "avg_f1": 0.5426262626262626, "avg_em": 0.0, "avg_chrf": 59.76532117195537, "avg_bleu": 25.09062993211207}
{"id": "wiki_26:2437", "en": "The discovery confirms that bats are the natural reservoir of SARS-CoV.", "fr": "La découverte confirme que les chauves-souris sont le réservoir naturel du SARS-CoV.", "perturbation": "omission", "pert_fr": "La découverte confirme que les chauves-souris sont le réservoir du SARS-CoV.", "bt_pert_fr": "The finding confirms that bats are the reservoir for SARS-CoV.", "questions": "[\"What does the discovery confirm?\", \"What is the natural reservoir of SARS-CoV?\", \"What role do bats play in the context of SARS-CoV?\"]", "answers": "[\"That bats are the reservoir for SARS-CoV\", \"Bats\", \"Reservoir\"]", "scores": [{"f1": 0.7692307692307692, "em": false, "chrf": 61.136140443650824, "bleu": 29.05925408079185}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 22.373950344391442, "bleu": 0.0}], "avg_f1": 0.5897435897435898, "avg_em": 0.3333333333333333, "avg_chrf": 61.17003026268076, "avg_bleu": 43.01975136026397}
{"id": "wiki_26:2438", "en": "Phylogenetic analysis shows the possibility of direct transmission of SARS from bats to humans without the intermediary Chinese civets, as previously believed.", "fr": "Une analyse phylogénétique montre la possibilité d’une transmission directe du SARS des chauves-souris vers l’humain sans l’intermédiaire des civettes chinoises contrairement à ce que l’on pensait jusqu’à présent.", "perturbation": "omission", "pert_fr": "Une analyse phylogénétique montre la possibilité d’une transmission directe du SARS des chauves-souris vers l’humain sans l’intermédiaire des civettes.", "bt_pert_fr": "A phylogenetic analysis shows the possibility of direct transmission of SARS from bats to humans without the intermediary of civets.", "questions": "[\"What does phylogenetic analysis show about SARS transmission?\", \"What was previously believed about SARS transmission?\", \"Is there direct transmission of SARS from bats to humans?\", \"What role do Chinese civets play in SARS transmission according to the previous belief?\", \"What does the phylogenetic analysis suggest about the transmission pathway of SARS?\"]", "answers": "[\"The possibility of direct transmission of SARS from bats to humans without the intermediary of civets\", \"SARS transmission was believed to involve civets as an intermediary\", \"Yes\", \"Chinese civets were believed to play an intermediary role in SARS transmission\", \"Direct transmission from bats to humans without the intermediary of civets\"]", "scores": [{"f1": 0.9333333333333333, "em": false, "chrf": 89.89586068443751, "bleu": 86.66415730847507}, {"f1": 0.6250000000000001, "em": false, "chrf": 75.40980376451414, "bleu": 22.31618068926664}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428572, "em": false, "chrf": 87.01339218350267, "bleu": 48.326978309062206}, {"f1": 0.8421052631578948, "em": false, "chrf": 80.7791195276263, "bleu": 66.06328636027612}], "avg_f1": 0.851516290726817, "avg_em": 0.2, "avg_chrf": 86.61963523201612, "avg_bleu": 64.67412053341602}
{"id": "wiki_13:2489", "en": "b'COVID-19 drug development is the research process to develop a preventative vaccine or therapeutic prescription drug that would alleviate the severity of 2019-20 coronavirus disease (COVID-19).", "fr": "Le développement de médicaments contre la COVID-19 désigne la procédure de recherche visant à développer un vaccin prophylactique ou un médicament thérapeutique sur ordonnance permettant de réduire la sévérité de la maladie à coronavirus 2019-20 (COVID-19).", "perturbation": "omission", "pert_fr": "Le développement de médicaments contre la COVID-19 désigne la procédure de recherche visant à développer un vaccin prophylactique ou un médicament thérapeutique permettant de réduire la sévérité de la maladie à coronavirus 2019-20 (COVID-19).", "bt_pert_fr": "COVID-19 drug development refers to the research process to develop a prophylactic vaccine or therapeutic drug to reduce the severity of coronavirus disease 2019-20 (COVID-19).", "questions": "[\"What does COVID-19 drug development aim to achieve?\", \"What disease is the drug development targeting?\"]", "answers": "[\"To develop a prophylactic vaccine or therapeutic drug to reduce the severity of coronavirus disease 2019-20 (COVID-19)\", \"Coronavirus disease 2019-20 (COVID-19)\"]", "scores": [{"f1": 0.7500000000000001, "em": false, "chrf": 57.53865224941701, "bleu": 15.224337726639405}, {"f1": 0.75, "em": false, "chrf": 78.1486314328361, "bleu": 21.02241038134286}], "avg_f1": 0.75, "avg_em": 0.0, "avg_chrf": 67.84364184112655, "avg_bleu": 18.12337405399113}
{"id": "wiki_13:2490", "en": "The International Clinical Trials Registry Platform of the WHO recorded 536 clinical studies to develop post-infection therapies for COVID-19 infections, with numerous established antiviral compounds for treating other infections under clinical research to be repurposed.", "fr": "Le Système d’enregistrement international des essais cliniques de l’OMS a enregistré 536 études cliniques visant au développement de traitements post-infection de la COVID-19, incluant de nombreux composés antiviraux établis dans le traitement d’autres infections et faisant l’objet de recherches cliniques pour repositionnement.", "perturbation": "omission", "pert_fr": "Le Système d’enregistrement international des essais cliniques de l’OMS a enregistré 536 études cliniques visant au développement de traitements post-infection de la COVID-19, incluant de nombreux composés antiviraux établis dans le traitement d’autres infections.", "bt_pert_fr": "The WHO International Clinical Trials Registry System has registered 536 clinical studies aimed at the development of post-infection treatments for COVID-19, including many antiviral compounds established in the treatment of other infections.", "questions": "[\"How many clinical studies were recorded by the International Clinical Trials Registry Platform of the WHO?\", \"What is the purpose of the 536 clinical studies?\", \"What type of therapies are the studies developing?\", \"What is being repurposed in the clinical research?\", \"What infections do the established antiviral compounds treat?\"]", "answers": "[\"536\", \"The development of post-infection treatments for COVID-19\", \"Post-infection treatments for COVID-19\", \"Antiviral compounds\", \"Other infections\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.42857142857142855, "em": false, "chrf": 54.90948942119527, "bleu": 14.535768424205482}, {"f1": 0.6666666666666665, "em": false, "chrf": 55.23655531432827, "bleu": 27.534765745159184}, {"f1": 0.22222222222222224, "em": false, "chrf": 32.06569339667224, "bleu": 4.104249931194939}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6634920634920635, "avg_em": 0.4, "avg_chrf": 68.44234762643916, "avg_bleu": 49.23495682011194}
{"id": "wiki_13:2491", "en": "In March, the WHO initiated the \"SOLIDARITY Trial\" in 10 countries, enrolling thousands of people infected with COVID-19 to assess treatment effects of four existing antiviral compounds with the most promise of efficacy.", "fr": "En mars, l’OMS a lancé « l’essai SOLIDARITY » dans 10 pays, recrutant des milliers de personnes infectées par la COVID-19 afin d’évaluer les effets thérapeutiques de quatre composés antiviraux existants les plus prometteurs en termes d’efficacité.", "perturbation": "omission", "pert_fr": "En mars, l’OMS a lancé « l’essai SOLIDARITY » dans 10 pays, recrutant des milliers de personnes infectées par la COVID-19 afin d’évaluer les effets thérapeutiques de quatre composés existants les plus prometteurs en termes d’efficacité.", "bt_pert_fr": "In March, WHO launched the “SOLIDARITY trial” in 10 countries, recruiting thousands of people infected with COVID-19 to evaluate the therapeutic effects of four existing compounds with the most promise in terms of effectiveness.", "questions": "[\"What did the WHO initiate in March?\", \"In which countries was the SOLIDARITY Trial conducted?\", \"How many people were enrolled in the SOLIDARITY Trial?\", \"What was the purpose of the SOLIDARITY Trial?\", \"What antiviral compounds were assessed in the SOLIDARITY Trial?\", \"Why were the antiviral compounds selected for assessment?\"]", "answers": "[\"The WHO launched the ‘SOLIDARITY trial’\", \"10 countries\", \"Thousands of people\", \"To evaluate the therapeutic effects of four existing compounds\", \"Four existing compounds with the most promise in terms of effectiveness\", \"Because they had the most promise in terms of effectiveness\"]", "scores": [{"f1": 0.25, "em": false, "chrf": 54.484187843763074, "bleu": 10.682175159905853}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5454545454545454, "em": false, "chrf": 40.41571368307792, "bleu": 18.07288326053167}, {"f1": 0.7368421052631577, "em": false, "chrf": 66.16805702067757, "bleu": 32.46679154750989}, {"f1": 0.75, "em": false, "chrf": 72.21859038158492, "bleu": 46.713797772820016}], "avg_f1": 0.7137161084529505, "avg_em": 0.3333333333333333, "avg_chrf": 72.21442482151724, "avg_bleu": 51.32260795679459}
{"id": "wiki_13:2496", "en": "New chemical entities (NCEs, also known as new molecular entities or NMEs) are compounds that emerge from the process of drug discovery to specify a vaccine or antiviral candidate.", "fr": "Les nouvelles entités chimiques (NCE, également appelées nouvelles entités moléculaires ou NME) sont des composés qui émergent du processus de découverte d’un médicament pour déterminer un candidat vaccin ou antiviral.", "perturbation": "omission", "pert_fr": "Les nouvelles entités chimiques (NCE, également appelées nouvelles entités moléculaires ou NME) sont des composés qui émergent du processus de découverte pour déterminer un candidat vaccin ou antiviral.", "bt_pert_fr": "Novel chemical entities (NCEs, also called novel molecular entities or NMEs) are compounds that emerge from the discovery process to determine a vaccine or antiviral candidate.", "questions": "[\"What are new chemical entities (NCEs)?\", \"What are NCEs also known as?\", \"What is the purpose of new chemical entities in drug discovery?\", \"What do new chemical entities specify?\", \"What type of candidates do new chemical entities target?\"]", "answers": "[\"Compounds that emerge from the discovery process to determine a vaccine or antiviral candidate\", \"Novel molecular entities or NMEs\", \"To determine a vaccine or antiviral candidate\", \"A vaccine or antiviral candidate\", \"Vaccine or antiviral\"]", "scores": [{"f1": 0.8461538461538461, "em": false, "chrf": 73.37085063552472, "bleu": 38.86618887275215}, {"f1": 0.8000000000000002, "em": false, "chrf": 86.96388593298336, "bleu": 66.87403049764218}, {"f1": 0.8333333333333334, "em": false, "chrf": 74.50311728546058, "bleu": 53.7284965911771}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8958974358974359, "avg_em": 0.4, "avg_chrf": 86.96757077079374, "avg_bleu": 71.8937431923143}
{"id": "wiki_13:2497", "en": "These have promising activity against a biological target related to COVID-19 disease.", "fr": "Ces entités ont une activité prometteuse contre une cible biologique liée à la COVID-19.", "perturbation": "omission", "pert_fr": "Ces entités ont une activité prometteuse contre la COVID-19.", "bt_pert_fr": "These entities have promising activity against COVID-19.", "questions": "[\"What has promising activity?\", \"What is the activity related to?\", \"What disease is the biological target associated with?\"]", "answers": "[\"These entities\", \"Activity against COVID-19\", \"COVID-19\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 63.76840278306412, "bleu": 49.99999999999999}, {"f1": 0, "em": false, "chrf": 7.751937984496124, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 43.10193081147925, "bleu": 36.78794411714425}], "avg_f1": 0.4444444444444444, "avg_em": 0.0, "avg_chrf": 38.20742385967983, "avg_bleu": 28.929314705714745}
{"id": "wiki_13:2499", "en": "It is the function and obligation of drug development to assess all of these parameters prior to human clinical trials to prove safety and efficacy.", "fr": "Le développement d’un médicament a pour fonction et obligation d’évaluer tous ces paramètres avant les essais cliniques chez l’être humain visant à évaluer sa sécurité et son efficacité.", "perturbation": "omission", "pert_fr": "Le développement d’un médicament a pour fonction et obligation d’évaluer tous ces paramètres avant les essais cliniques chez l’être humain visant à évaluer son efficacité.", "bt_pert_fr": "The function and obligation of developing a drug is to evaluate all these parameters before clinical trials in humans aimed at evaluating its effectiveness.", "questions": "[\"What is the function of drug development?\", \"What parameters must be assessed prior to human clinical trials?\", \"What must be proven prior to human clinical trials?\", \"What is the goal of assessing parameters before human clinical trials?\"]", "answers": "[\"To evaluate all these parameters before clinical trials in humans aimed at evaluating its effectiveness\", \"All these parameters\", \"Its effectiveness\", \"To evaluate its effectiveness\"]", "scores": [{"f1": 0.38709677419354843, "em": false, "chrf": 43.58389737787041, "bleu": 7.695447435442227}, {"f1": 0.8571428571428571, "em": false, "chrf": 78.11838079699068, "bleu": 45.13864405503391}, {"f1": 0, "em": false, "chrf": 12.227204645905886, "bleu": 0.0}, {"f1": 0.22222222222222224, "em": false, "chrf": 15.26346342993696, "bleu": 12.44023474812678}], "avg_f1": 0.36661546338965695, "avg_em": 0.0, "avg_chrf": 37.29823656267598, "avg_bleu": 16.318581559650728}
{"id": "wiki_13:2501", "en": "In addition, drug development must establish the physicochemical properties of the NCE: its chemical makeup, stability, and solubility.", "fr": "En outre, le développement d’un médicament doit définir les propriétés physicochimiques de la NCE : sa composition chimique, sa stabilité et sa solubilité.", "perturbation": "omission", "pert_fr": "En outre, le développement d’un médicament doit définir les propriétés physicochimiques de la NCE : sa composition chimique et sa solubilité.", "bt_pert_fr": "Additionally, drug development must define the physicochemical properties of the NCE: its chemical composition and solubility.", "questions": "[\"What must drug development establish regarding the NCE?\", \"What physicochemical properties of the NCE are important?\", \"What specific properties of the NCE are mentioned?\", \"What is the chemical makeup of the NCE?\", \"What is the stability of the NCE?\"]", "answers": "[\"The physicochemical properties of the NCE\", \"Chemical composition and solubility\", \"Chemical composition and solubility\", \"Its chemical composition\", \"The stability of the NCE is not mentioned\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666665, "em": false, "chrf": 51.844238263778664, "bleu": 27.534765745159184}, {"f1": 0.6666666666666665, "em": false, "chrf": 51.844238263778664, "bleu": 27.534765745159184}, {"f1": 0.6666666666666666, "em": false, "chrf": 56.14044101969514, "bleu": 55.03212081491043}, {"f1": 0.22222222222222224, "em": false, "chrf": 50.29464960676459, "bleu": 6.567274736060395}], "avg_f1": 0.6444444444444444, "avg_em": 0.2, "avg_chrf": 62.02471343080341, "avg_bleu": 43.333785408257846}
{"id": "wiki_13:2502", "en": "Manufacturers must optimize the process they use to make the chemical so they can scale up from a medicinal chemist producing milligrams, to manufacturing on the kilogram and ton scale.", "fr": "Les fabricants doivent optimiser le processus qu’ils utilisent pour produire la substance chimique afin de passer de la fabrication de quelques milligrammes par un chimiste médicinal à une production de kilogrammes et de tonnes.", "perturbation": "omission", "pert_fr": "Les fabricants doivent optimiser le processus qu’ils utilisent pour produire la substance chimique afin de passer de la fabrication de quelques milligrammes à une production de kilogrammes et de tonnes.", "bt_pert_fr": "Manufacturers must optimize the process they use to produce the chemical to move from manufacturing a few milligrams to producing kilograms and tons.", "questions": "[\"What must manufacturers do to the process they use to make the chemical?\", \"What is the goal of optimizing the process?\", \"What is the scale difference in chemical production mentioned?\", \"What is the final scale of production?\"]", "answers": "[\"Optimize\", \"To move from manufacturing a few milligrams to producing kilograms and tons\", \"From a few milligrams to kilograms and tons\", \"Tons\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.45454545454545453, "em": false, "chrf": 48.35945873651918, "bleu": 9.425159511373677}, {"f1": 0.5714285714285714, "em": false, "chrf": 72.70767960165495, "bleu": 15.619699684601283}, {"f1": 0, "em": false, "chrf": 41.85983092446141, "bleu": 0.0}], "avg_f1": 0.5064935064935064, "avg_em": 0.25, "avg_chrf": 65.73174231565889, "avg_bleu": 31.261214798993752}
{"id": "wiki_13:2506", "en": "The Canadian government announced CA$275 million in funding for 96 research projects on medical countermeasures against COVID-19, including numerous vaccine candidates at Canadian universities, with plans to establish a \"vaccine bank\" of new vaccines for implementation if another coronavirus outbreak occurs.", "fr": "Le gouvernement canadien a annoncé l’attribution d’une subvention de 275 millions de dollars canadiens à 96 projets de recherche portant sur des contre-mesures médicales contre la COVID-19, notamment plusieurs candidats vaccins dans des universités canadiennes, avec des projets d’établissement d’une « banque de vaccins » contenant de nouveaux vaccins à utiliser en cas d’une autre épidémie de coronavirus.", "perturbation": "omission", "pert_fr": "Le gouvernement canadien a annoncé l’attribution d’une subvention de 275 millions de dollars canadiens à 96 projets de recherche portant sur des contre-mesures médicales contre la COVID-19, notamment plusieurs candidats vaccins dans des universités canadiennes.", "bt_pert_fr": "The Canadian government announced C$275 million in funding for 96 research projects into medical countermeasures against COVID-19, including several vaccine candidates at Canadian universities.", "questions": "[\"How much funding did the Canadian government announce?\", \"How many research projects were funded?\", \"What are the research projects focused on?\", \"Where are the vaccine candidates being developed?\", \"What is the purpose of the 'vaccine bank'?\", \"What will happen if another coronavirus outbreak occurs?\"]", "answers": "[\"C$275 million\", \"96\", \"Medical countermeasures against COVID-19\", \"Canadian universities\", \"Not mentioned\", \"The vaccine bank will be used to respond quickly to another coronavirus outbreak\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 81.37031111409578, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 7.060296487486152, "bleu": 0.0}, {"f1": 0.3636363636363637, "em": false, "chrf": 34.37785622620283, "bleu": 8.737167851715874}], "avg_f1": 0.6439393939393939, "avg_em": 0.5, "avg_chrf": 70.4680773046308, "avg_bleu": 59.789527975286}
{"id": "wiki_13:2513", "en": "In addition to the tests required to move a novel vaccine or antiviral drug into the clinic for the first time, manufacturers must ensure that any long-term or chronic toxicities are well-defined, including effects on systems not previously monitored (fertility, reproduction, immune system, among others).", "fr": "Outre les tests obligatoires pour faire entrer un nouveau vaccin ou médicament antiviral en clinique pour la première fois, les fabricants doivent s’assurer que les éventuelles toxicités à long terme ou chroniques sont bien définies, notamment les effets sur des systèmes non précédemment étudiés (fertilité, reproduction, système immunitaire, entre autres).", "perturbation": "omission", "pert_fr": "Outre les tests obligatoires pour faire entrer un nouveau vaccin ou médicament en clinique pour la première fois, les fabricants doivent s’assurer que les éventuelles toxicités à long terme ou chroniques sont bien définies, notamment les effets sur des systèmes non précédemment étudiés.", "bt_pert_fr": "In addition to the testing required to bring a new vaccine or drug into the clinic for the first time, manufacturers must ensure that potential long-term or chronic toxicities are well defined, including effects on systems not previously studied.", "questions": "[\"What additional requirements must manufacturers meet when moving a novel vaccine or antiviral drug into the clinic?\", \"What types of long-term or chronic toxicities must be well-defined?\", \"What are the systems not previously monitored that may be affected by toxicities?\"]", "answers": "[\"The testing required to bring a new vaccine or drug into the clinic for the first time and ensuring that potential long-term or chronic toxicities are well defined\", \"Long-term or chronic toxicities\", \"Systems not previously studied\"]", "scores": [{"f1": 0.24489795918367346, "em": false, "chrf": 38.67184479214878, "bleu": 14.757581190431866}, {"f1": 0.5333333333333333, "em": false, "chrf": 39.412680469533825, "bleu": 17.37739434504452}, {"f1": 0, "em": false, "chrf": 15.446422505086643, "bleu": 0.0}], "avg_f1": 0.2594104308390022, "avg_em": 0.0, "avg_chrf": 31.17698258892308, "avg_bleu": 10.711658511825462}
{"id": "wiki_13:2514", "en": "In the United States, this process is called a \"new drug application\" or NDA.", "fr": "Aux États-Unis, ce processus est appelé « demande de nouveau médicament » ou NDA.", "perturbation": "omission", "pert_fr": "Aux États-Unis, ce processus est appelé « demande de nouveau médicament ».", "bt_pert_fr": "In the United States, this process is called a new drug application.", "questions": "[\"What is the process called in the United States?\", \"What is a 'new drug application' or NDA?\", \"What does NDA stand for?\"]", "answers": "[\"a new drug application\", \"a new drug application\", \"new drug application\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7499999999999999, "em": false, "chrf": 79.33563510246447, "bleu": 51.341711903259224}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}], "avg_f1": 0.5833333333333334, "avg_em": 0.3333333333333333, "avg_chrf": 59.778545034154824, "avg_bleu": 50.447237301086425}
{"id": "wiki_13:2515", "en": "A clinical trial design in progress may be modified as an \"adaptive design\" if accumulating data in the trial provide early insights about positive or negative efficacy of the treatment.", "fr": "La conception d’un essai clinique en cours peut être modifiée dans le cadre d’une « conception adaptative » si les données accumulées lors de l’essai fournissent des informations initiales sur l’efficacité positive ou négative du traitement.", "perturbation": "omission", "pert_fr": "La conception d’un essai clinique en cours peut être modifiée dans le cadre d’une « conception adaptative » si les données accumulées lors de l’essai fournissent des informations initiales sur l’efficacité négative du traitement.", "bt_pert_fr": "The design of an ongoing clinical trial may be modified as part of an “adaptive design” if data accumulated during the trial provide initial information about the negative effectiveness of the treatment.", "questions": "[\"What is a clinical trial design in progress possibly modified into?\", \"What triggers a modification of a clinical trial design?\", \"What type of data can lead to modifications in a clinical trial design?\", \"What does an adaptive design allow in a clinical trial?\", \"What insights from the trial can lead to design changes?\"]", "answers": "[\"An adaptive design\", \"Data accumulated during the trial\", \"Data accumulated during the trial\", \"Modifications to the design based on initial information about the treatment's effectiveness\", \"Initial information about the negative effectiveness of the treatment\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.11111111111111112, "em": false, "chrf": 15.222250279864163, "bleu": 1.3111910958201225}, {"f1": 0.16666666666666666, "em": false, "chrf": 13.32590256976, "bleu": 5.876350803261633}, {"f1": 0.5555555555555556, "em": false, "chrf": 53.82377383099415, "bleu": 19.64073254502565}, {"f1": 0.5, "em": false, "chrf": 45.73752738403127, "bleu": 11.737849637633069}], "avg_f1": 0.4666666666666667, "avg_em": 0.2, "avg_chrf": 45.62189081292992, "avg_bleu": 27.713224816348106}
{"id": "wiki_13:2517", "en": "Adaptive designs within ongoing Phase II-III clinical trials on candidate therapeutics may shorten trial durations and use fewer subjects, possibly expediting decisions for early termination or success, and coordinating design changes for a specific trial across its international locations.", "fr": "Les conceptions adaptatives des essais cliniques de phases II-III en cours portant sur des candidats thérapeutiques peuvent raccourcir la durée des essais et entraîner l’utilisation d’un plus petit nombre de sujets, ce qui peut accélérer les décisions de réussite ou d’interruption prématurée et permettre de coordonner les modifications de conception d’un essai spécifique dans les centres internationaux où il est effectué.", "perturbation": "omission", "pert_fr": "Les conceptions adaptatives des essais cliniques de phases II-III en cours portant sur des candidats thérapeutiques peuvent raccourcir la durée des essais et entraîner l’utilisation d’un plus petit nombre de sujets, ce qui peut accélérer les décisions de réussite ou d’interruption et permettre de coordonner les modifications de conception d’un essai spécifique dans les centres internationaux où il est effectué.", "bt_pert_fr": "Adaptive designs of ongoing Phase II-III clinical trials of therapeutic candidates can shorten trial duration and result in the use of fewer subjects, which can expedite pass or discontinue decisions and allow for coordinated design changes to a specific trial across international centers where it is conducted.", "questions": "[\"What are adaptive designs in clinical trials?\", \"How might adaptive designs shorten trial durations?\", \"How might adaptive designs reduce the number of subjects?\", \"What could adaptive designs possibly expedite in clinical trials?\", \"How can adaptive designs coordinate design changes across international locations of a trial?\"]", "answers": "[\"Designs that allow for modifications during ongoing clinical trials\", \"By enabling changes based on interim data, adaptive designs can optimize trial flow and reduce unnecessary phases\", \"By adjusting trial parameters based on real-time data, fewer subjects may be needed to achieve statistical significance\", \"Pass or discontinue decisions\", \"By allowing centralized updates and adjustments that are applied consistently across international trial centers\"]", "scores": [{"f1": 0.47058823529411764, "em": false, "chrf": 61.780675453878466, "bleu": 29.84745896009822}, {"f1": 0.4166666666666667, "em": false, "chrf": 43.5995173029104, "bleu": 15.13851459876605}, {"f1": 0.3333333333333333, "em": false, "chrf": 32.24787509964961, "bleu": 5.439330544349823}, {"f1": 0.2, "em": false, "chrf": 26.445650808704634, "bleu": 9.688464563433238}, {"f1": 0.36363636363636365, "em": false, "chrf": 44.81514302184972, "bleu": 6.754312828675709}], "avg_f1": 0.3568449197860962, "avg_em": 0.0, "avg_chrf": 41.77777233739857, "avg_bleu": 13.373616299064608}
{"id": "wiki_13:2518", "en": "Most novel drug candidates (NCEs) fail during drug development, either because they have unacceptable toxicity or because they simply do not prove efficacy on the targeted disease, as shown in Phase II-III clinical trials.", "fr": "La plupart des nouveaux candidats médicaments (NCE) échouent pendant le développement d’un médicament, en raison d’une toxicité inacceptable ou simplement d’une absence de preuve d’efficacité sur la maladie ciblée dans le cadre des essais cliniques de phases II-III.", "perturbation": "omission", "pert_fr": "La plupart des nouveaux candidats médicaments (NCE) échouent pendant le développement d’un médicament, en raison d’une absence de preuve d’efficacité sur la maladie ciblée dans le cadre des essais cliniques de phases II-III.", "bt_pert_fr": "Most new drug candidates (NCEs) fail during drug development, due to a lack of evidence of efficacy on the targeted disease in phase II-III clinical trials.", "questions": "[\"Why do most novel drug candidates fail during drug development?\", \"What are the reasons for the failure of novel drug candidates in drug development?\", \"What causes drug candidates to fail in proving efficacy on the targeted disease?\", \"What phase of clinical trials shows the failure of drug candidates?\"]", "answers": "[\"A lack of evidence of efficacy on the targeted disease in phase II-III clinical trials\", \"A lack of evidence of efficacy on the targeted disease in phase II-III clinical trials\", \"A lack of evidence of efficacy on the targeted disease\", \"Phase II-III clinical trials\"]", "scores": [{"f1": 0.26666666666666666, "em": false, "chrf": 34.20089124150335, "bleu": 15.411659730503565}, {"f1": 0.5217391304347826, "em": false, "chrf": 57.32022589148127, "bleu": 29.420957081163703}, {"f1": 0.6666666666666667, "em": false, "chrf": 87.79594832823179, "bleu": 44.63236137853328}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.613768115942029, "avg_em": 0.25, "avg_chrf": 69.82926636530411, "avg_bleu": 47.366244547550146}
{"id": "wiki_13:2519", "en": "The high failure rates associated with pharmaceutical development are referred to as an \"attrition rate\", requiring decisions during the early stages of drug development to \"kill\" projects early to avoid costly failures.", "fr": "Les taux d’échec élevés associés au développement pharmaceutique sont qualifiés de « taux d’attrition », nécessitant la prise de décisions, dès les premiers stades de développement d’un médicament, de « tuer » rapidement des projets pour éviter des échecs coûteux.", "perturbation": "omission", "pert_fr": "Les taux d’échec élevés associés au développement sont qualifiés de « taux d’attrition », nécessitant la prise de décisions, dès les premiers stades de développement d’un médicament, de « tuer » rapidement des projets pour éviter des échecs coûteux.", "bt_pert_fr": "High failure rates associated with development are referred to as “attrition rates,” requiring decisions to be made early in a drug's development to quickly “kill” projects to avoid costly failures.", "questions": "[\"What are the high failure rates in pharmaceutical development called?\", \"What is the attrition rate in drug development?\", \"Why are decisions made during early stages of drug development important?\", \"What action is taken to avoid costly failures in drug development?\", \"What is the purpose of 'killing' projects early in drug development?\"]", "answers": "[\"Attrition rates\", \"The high failure rates associated with development\", \"To quickly eliminate projects and avoid costly failures\", \"Projects are quickly terminated or 'killed'\", \"To avoid costly failures in drug development\"]", "scores": [{"f1": 0, "em": false, "chrf": 88.48936178331398, "bleu": 0.0}, {"f1": 0.9333333333333333, "em": false, "chrf": 73.87228917139214, "bleu": 72.89545183625967}, {"f1": 0.6666666666666666, "em": false, "chrf": 70.84829642280792, "bleu": 22.089591134157878}, {"f1": 0.6, "em": false, "chrf": 57.02120800661626, "bleu": 17.965205598154213}, {"f1": 0.7272727272727273, "em": false, "chrf": 84.41632314742802, "bleu": 41.11336169005198}], "avg_f1": 0.5854545454545454, "avg_em": 0.0, "avg_chrf": 74.92949570631166, "avg_bleu": 30.812722051724744}
{"id": "wiki_13:2524", "en": "Repurposed antiviral drugs make up most of the Chinese research, with 9 Phase III trials on remdesivir across several countries due to report by the end of April.", "fr": "Les médicaments antiviraux repositionnés constituent la majorité des recherches chinoises, avec 9 essais cliniques de phase III sur le remdesivir dans plusieurs pays dont des résultats sont attendus fin avril.", "perturbation": "omission", "pert_fr": "Les médicaments antiviraux repositionnés constituent la majorité des recherches chinoises, avec 9 essais cliniques de phase III sur le remdesivir dans plusieurs pays.", "bt_pert_fr": "Repositioned antiviral drugs make up the majority of Chinese research, with 9 phase III clinical trials of remdesivir in several countries.", "questions": "[\"What makes up most of the Chinese research?\", \"What antiviral drug is being studied in the Phase III trials?\", \"How many Phase III trials are there on remdesivir?\", \"When is the report on remdesivir trials due?\", \"Which countries are involved in the remdesivir Phase III trials?\"]", "answers": "[\"Repositioned antiviral drugs\", \"remdesivir\", \"9\", \"Not specified\", \"several countries\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 69.16102935503837, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 8.333333333333332, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7333333333333333, "avg_em": 0.6, "avg_chrf": 75.49887253767434, "avg_bleu": 71.00642416298211}
{"id": "wiki_13:2525", "en": "Led by the Bill and Melinda Gates Foundation with partners investing US$125 million and coordinating with the World Health Organization, the COVID-19 Therapeutics Accelerator began in March, facilitating drug development researchers to rapidly identify, assess, develop, and scale up potential treatments.", "fr": "Mené par la Bill and Melinda Gates Foundation avec un investissement 125 millions de dollars américains provenant de partenaires et en coordination avec l’Organisation mondiale de la santé, l’initiative COVID-19 Therapeutics Accelerator a commencé en mars et a aidé les chercheurs en développement de médicaments à rapidement identifier, évaluer, développer et produire des traitements potentiels.", "perturbation": "omission", "pert_fr": "Mené par la Bill and Melinda Gates Foundation avec un investissement de 125 millions de dollars américains provenant de partenaires, l’initiative COVID-19 Therapeutics Accelerator a commencé en mars et a aidé les chercheurs en développement de médicaments à rapidement identifier, évaluer, développer et produire des traitements potentiels.", "bt_pert_fr": "Led by the Bill and Melinda Gates Foundation with an investment of US$125 million from partners, the COVID-19 Therapeutics Accelerator initiative began in March and helped drug development researchers rapidly identify, evaluate, develop and produce potential treatments.", "questions": "[\"Who led the COVID-19 Therapeutics Accelerator?\", \"How much money did partners invest in the COVID-19 Therapeutics Accelerator?\", \"Which organization did the accelerator coordinate with?\", \"When did the COVID-19 Therapeutics Accelerator begin?\", \"What did the COVID-19 Therapeutics Accelerator facilitate researchers to do?\", \"What was the main goal of the COVID-19 Therapeutics Accelerator?\"]", "answers": "[\"The Bill and Melinda Gates Foundation\", \"US$125 million\", \"Drug development researchers\", \"In March\", \"Rapidly identify, evaluate, develop and produce potential treatments\", \"Help drug development researchers rapidly identify, evaluate, develop and produce potential treatments\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 8.505827875698147, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 73.45238095238095, "bleu": 49.99999999999999}, {"f1": 0.5555555555555556, "em": false, "chrf": 66.00952225545927, "bleu": 12.862534787413379}, {"f1": 0.5454545454545454, "em": false, "chrf": 62.0789242666821, "bleu": 11.731175160264002}], "avg_f1": 0.6001683501683502, "avg_em": 0.3333333333333333, "avg_chrf": 68.34110922503675, "avg_bleu": 45.76561832461291}
{"id": "wiki_13:2526", "en": "The COVID-19 Clinical Research Coalition formed to coordinate and expedite results from international clinical trials on the most promising post-infection treatments.", "fr": "La COVID-19 Clinical Research Coalition a été formée pour coordonner et accélérer les résultats des essais cliniques internationaux concernant les traitements post-infection les plus prometteurs.", "perturbation": "omission", "pert_fr": "La COVID-19 Clinical Research Coalition a été formée pour coordonner et accélérer les résultats des essais cliniques internationaux concernant les traitements les plus prometteurs.", "bt_pert_fr": "The COVID-19 Clinical Research Coalition was formed to coordinate and accelerate international clinical trial results for the most promising treatments.", "questions": "[\"What is the purpose of the COVID-19 Clinical Research Coalition?\", \"What does the coalition aim to coordinate?\", \"What does the coalition aim to expedite?\", \"What type of trials is the coalition involved in?\", \"What is the focus of the clinical trials conducted by the coalition?\"]", "answers": "[\"To coordinate and accelerate international clinical trial results for the most promising treatments\", \"International clinical trial results\", \"International clinical trial results\", \"Clinical trials for the most promising treatments\", \"The most promising treatments\"]", "scores": [{"f1": 0.6923076923076924, "em": false, "chrf": 65.05694950891255, "bleu": 16.7005818572343}, {"f1": 0.5714285714285715, "em": false, "chrf": 91.99581297786753, "bleu": 31.947155212313625}, {"f1": 0.22222222222222224, "em": false, "chrf": 75.50673025154639, "bleu": 12.44023474812678}, {"f1": 0.2222222222222222, "em": false, "chrf": 44.73889368700285, "bleu": 8.116697886877475}, {"f1": 0.3333333333333333, "em": false, "chrf": 43.752454319823734, "bleu": 15.97357760615681}], "avg_f1": 0.40830280830280835, "avg_em": 0.0, "avg_chrf": 64.21016814903061, "avg_bleu": 17.035649462141798}
{"id": "wiki_13:2527", "en": "In early 2020, numerous established antiviral compounds for treating other infections were being repurposed or developed in new clinical research efforts to alleviate the illness of COVID-19.", "fr": "Au début 2020, de nombreux composés antiviraux établis dans le traitement d’autres infections étaient en cours de repositionnement ou de développement dans le cadre de nouveaux efforts de recherche clinique visant à soulager la maladie COVID-19.", "perturbation": "omission", "pert_fr": "Au début 2020, de nombreux composés antiviraux établis dans le traitement d’autres infections étaient en cours de développement dans le cadre de nouveaux efforts de recherche clinique visant à soulager la maladie COVID-19.", "bt_pert_fr": "As of early 2020, many antiviral compounds established in the treatment of other infections were being developed in new clinical research efforts aimed at providing relief from COVID-19 disease.", "questions": "[\"What was being done with established antiviral compounds in early 2020?\", \"What was the goal of repurposing established antiviral compounds?\", \"What was the purpose of new clinical research efforts in early 2020?\", \"What illness were the antiviral compounds being developed to alleviate?\", \"What types of antiviral compounds were involved in the research?\"]", "answers": "[\"Being developed in new clinical research efforts aimed at providing relief from COVID-19 disease\", \"Providing relief from COVID-19 disease\", \"Providing relief from COVID-19 disease\", \"COVID-19 disease\", \"Established antiviral compounds\"]", "scores": [{"f1": 0.6086956521739131, "em": false, "chrf": 70.08086428439668, "bleu": 36.36227046500072}, {"f1": 0.20000000000000004, "em": false, "chrf": 26.030347934469717, "bleu": 10.682175159905853}, {"f1": 0.20000000000000004, "em": false, "chrf": 26.030347934469717, "bleu": 10.682175159905853}, {"f1": 0.6666666666666666, "em": false, "chrf": 75.18681556865215, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.535072463768116, "avg_em": 0.2, "avg_chrf": 59.46567514439765, "avg_bleu": 41.545324156962494}
{"id": "wiki_13:2529", "en": "As of early April 2020, 103 candidate therapeutics were in preclinical or a stage of Phase I-IV development, with trial results for 29 drug candidates expected during April.", "fr": "Début avril 2020, 103 candidats thérapeutiques étaient en développement préclinique ou en cours d’étude de phases I-IV, les résultats d’essais concernant 29 candidats médicaments étant attendus dans le courant du mois d’avril.", "perturbation": "omission", "pert_fr": "Début avril 2020, 103 candidats thérapeutiques étaient en développement préclinique ou en cours d’étude de phases I-IV, les résultats d’essais concernant 29 candidats étant attendus dans le courant du mois d’avril.", "bt_pert_fr": "At the beginning of April 2020, 103 therapeutic candidates were in preclinical development or undergoing phase I-IV studies, with trial results for 29 candidates expected during the month of April.", "questions": "[\"How many candidate therapeutics were in preclinical or Phase I-IV development as of early April 2020?\", \"How many drug candidates had trial results expected during April?\", \"What stage of development were the candidate therapeutics in?\", \"When were the trial results for the drug candidates expected?\", \"What is the significance of the 29 drug candidates with expected trial results?\"]", "answers": "[103, 29, \"preclinical development or undergoing phase I-IV studies\", \"during the month of April\", \"The trial results for these 29 candidates were expected in April 2020\"]", "scores": [{"f1": 0.5714285714285714, "em": false, "chrf": 59.041997497303086, "bleu": 9.287528999566801}, {"f1": 0.4, "em": false, "chrf": 52.50542863176819, "bleu": 15.97357760615681}, {"f1": 0.8333333333333334, "em": false, "chrf": 76.44071751576477, "bleu": 54.52469119630863}], "avg_f1": 0.6015873015873016, "avg_em": 0.0, "avg_chrf": 62.66271454827868, "avg_bleu": 26.59526593401075}
{"id": "wiki_13:2530", "en": "In March, the World Health Organization (WHO) launched the coordinated \"Solidarity trial\" in 10 countries to rapidly assess in thousands of COVID-19 infected people the potential efficacy of existing antiviral and anti-inflammatory agents not yet evaluated specifically for COVID-19 illness.", "fr": "En mars, l’Organisation mondiale de la santé (OMS) a lancé « l’essai Solidarity » coordonné dans 10 pays afin d’évaluer rapidement chez des milliers de patients infectés par la COVID-19 l’efficacité potentielle d’agents antiviraux et anti-inflammatoires existants qui n’ont pas encore été spécifiquement évalués pour la COVID-19.", "perturbation": "omission", "pert_fr": "En mars, l’Organisation mondiale de la santé (OMS) a lancé « l’essai Solidarity » coordonné dans 10 pays afin d’évaluer rapidement chez des milliers de patients l’efficacité potentielle d’agents antiviraux et anti-inflammatoires existants qui n’ont pas encore été spécifiquement évalués pour la COVID-19.", "bt_pert_fr": "In March, the World Health Organization (WHO) launched the 10-country coordinated “Solidarity Trial” to rapidly evaluate the potential effectiveness of existing antiviral and anti-inflammatory agents that have not yet been specifically evaluated for COVID-19 in thousands of patients.", "questions": "[\"What did the World Health Organization (WHO) launch in March?\", \"In which countries was the 'Solidarity trial' conducted?\", \"What was the goal of the 'Solidarity trial'?\", \"What types of agents were evaluated in the 'Solidarity trial'?\", \"What was the scope of the evaluation in the 'Solidarity trial'?\", \"What was the purpose of assessing the agents in thousands of COVID-19 infected people?\"]", "answers": "[\"the 10-country coordinated ‘Solidarity Trial’ to rapidly evaluate the potential effectiveness of existing antiviral and anti-inflammatory agents that have not yet been specifically evaluated for COVID-19 in thousands of patients\", \"10 countries\", \"to rapidly evaluate the potential effectiveness of existing antiviral and anti-inflammatory agents that have not yet been specifically evaluated for COVID-19\", \"existing antiviral and anti-inflammatory agents\", \"in thousands of patients\", \"to determine the potential effectiveness of the agents in treating COVID-19\"]", "scores": [{"f1": 0.06451612903225806, "em": false, "chrf": 31.744057786770746, "bleu": 1.3353534059549443}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7894736842105262, "em": false, "chrf": 72.67489897223338, "bleu": 33.35910322759462}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6, "em": false, "chrf": 38.768933303131455, "bleu": 36.06452879987789}, {"f1": 0.6666666666666667, "em": false, "chrf": 69.57736682330294, "bleu": 22.31618068926664}], "avg_f1": 0.6867760799849085, "avg_em": 0.3333333333333333, "avg_chrf": 68.79420948090642, "avg_bleu": 48.845861020449036}
{"id": "wiki_13:2532", "en": "Do any of the drugs reduce the time a patient is hospitalized?", "fr": "Certains des médicaments réduisent-ils la durée d’hospitalisation des patients ?", "perturbation": "omission", "pert_fr": "Certains médicaments réduisent-ils la durée d’hospitalisation des patients ?", "bt_pert_fr": "Do certain medications reduce the length of hospital stay for patients?", "questions": "[\"Do any drugs reduce the time a patient is hospitalized?\"]", "answers": "[\"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_13:2533", "en": "Do the treatments affect the need for people with COVID-19-induced pneumonia to be ventilated or maintained in intensive care?", "fr": "Les traitements influencent-ils la nécessité de ventilation ou de maintien en soins intensifs des patients atteints de pneumonie induite par la COVID-19 ?", "perturbation": "omission", "pert_fr": "Les traitements influencent-ils la nécessité de ventilation des patients atteints de pneumonie induite par la COVID-19 ?", "bt_pert_fr": "Do treatments influence the need for ventilation in patients with COVID-19-induced pneumonia?", "questions": "[\"Do treatments affect the need for people with COVID-19-induced pneumonia to be ventilated?\", \"Do treatments affect the need for people with COVID-19-induced pneumonia to be maintained in intensive care?\", \"What condition is associated with the need for ventilation or intensive care?\", \"What is the impact of treatments on patient care in severe cases of COVID-19?\"]", "answers": "[\"Yes\", \"No\", \"COVID-19-induced pneumonia\", \"Treatments can influence the need for ventilation in patients with COVID-19-induced pneumonia\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4799999999999999, "em": false, "chrf": 51.455039717794406, "bleu": 13.977689291213357}], "avg_f1": 0.62, "avg_em": 0.5, "avg_chrf": 62.863759929448605, "avg_bleu": 53.49442232280336}
{"id": "wiki_13:2535", "en": "After the trial staff determines the drugs available at the hospital, the WHO website randomizes the hospitalized subject to one of the trial drugs or to the hospital standard of care for treating COVID-19.", "fr": "Une fois que le personnel de l’essai détermine les médicaments disponibles à l’hôpital, le site Web de l’OMS randomise le sujet hospitalisé dans un groupe recevant l’un des médicaments de l’essai ou le traitement standard de l’hôpital pour la COVID-19.", "perturbation": "omission", "pert_fr": "Une fois que le personnel de l’essai détermine les médicaments disponibles à l’hôpital, le site Web de l’OMS randomise le sujet hospitalisé dans un groupe recevant l’un des médicaments de l’essai ou le traitement de l’hôpital pour la COVID-19.", "bt_pert_fr": "Once trial staff determine which drugs are available at the hospital, the WHO website randomizes the hospitalized subject to one of the trial drugs or the hospital's treatment for COVID-19.", "questions": "[\"What happens after the trial staff determines the available drugs?\", \"How are hospitalized subjects assigned in the trial?\", \"What are the options for hospitalized subjects in the trial?\"]", "answers": "[\"The WHO website randomizes the hospitalized subject to one of the trial drugs or the hospital's treatment for COVID-19\", \"They are randomized to one of the trial drugs or the hospital's treatment for COVID-19\", \"One of the trial drugs or the hospital's treatment for COVID-19\"]", "scores": [{"f1": 0.7777777777777777, "em": false, "chrf": 75.95657695055705, "bleu": 58.45161696278339}, {"f1": 0.6666666666666666, "em": false, "chrf": 72.68619390047127, "bleu": 59.994143560271205}, {"f1": 0.6666666666666666, "em": false, "chrf": 62.66844383089574, "bleu": 34.78700554542393}], "avg_f1": 0.7037037037037036, "avg_em": 0.0, "avg_chrf": 70.43707156064136, "avg_bleu": 51.07758868949284}
{"id": "wiki_13:2537", "en": "A global safety monitoring board of WHO physicians examine interim results to assist decisions on safety and effectiveness of the trial drugs, and alter the trial design or recommend an effective therapy.", "fr": "Un comité international de surveillance de la sécurité composé de médecins de l’OMS examine les résultats provisoires afin de guider les décisions sur la sécurité et l’efficacité des médicaments de l’essai, et modifie la conception de l’essai ou recommande un traitement efficace.", "perturbation": "omission", "pert_fr": "Un comité international de surveillance de la sécurité composé de médecins de l’OMS examine les résultats provisoires afin de guider les décisions sur l’efficacité des médicaments de l’essai, et modifie la conception de l’essai ou recommande un traitement efficace.", "bt_pert_fr": "An international safety monitoring committee made up of WHO doctors reviews the interim results to guide decisions on the effectiveness of the trial drugs, and changes the trial design or recommends an effective treatment.", "questions": "[\"What does a global safety monitoring board of WHO physicians examine?\", \"What is the purpose of examining interim results?\", \"What decisions can be made based on the examination of interim results?\", \"What actions can the board take regarding the trial design?\", \"What can the board recommend regarding therapy?\"]", "answers": "[\"The interim results\", \"To guide decisions on the effectiveness of the trial drugs\", \"Changes to the trial design or recommendations of an effective treatment\", \"Changes to the trial design\", \"An effective treatment\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 94.9566147882592, "bleu": 55.03212081491043}, {"f1": 0.6666666666666665, "em": false, "chrf": 65.38959000777918, "bleu": 32.01911827891038}, {"f1": 0.5, "em": false, "chrf": 64.6897175432482, "bleu": 19.070828081828378}, {"f1": 0.5714285714285715, "em": false, "chrf": 61.83358268101474, "bleu": 31.947155212313625}, {"f1": 0.4, "em": false, "chrf": 54.73702597552194, "bleu": 27.516060407455225}], "avg_f1": 0.5876190476190477, "avg_em": 0.0, "avg_chrf": 68.32130619916465, "avg_bleu": 33.11705655908361}
{"id": "wiki_13:2538", "en": "A similar web-based study to Solidarity, called \"Discovery\", was initiated in March across seven countries by INSERM (Paris, France).During March, funding for the Solidarity trial reached US$108 million from 203,000 individuals, organizations and governments, with 45 countries involved in financing or trial management.", "fr": "Une étude basée sur le Web semblable à Solidarity, appelée « Discovery », a été lancée en mars dans sept pays par l’INSERM (Paris, France). En mars, le financement de l’essai Solidarity a atteint 108 millions de dollars américains provenant de 203 000 particuliers, organisations et gouvernements, 45 pays participant au financement ou à la gestion de l’essai.", "perturbation": "omission", "pert_fr": "Une étude basée sur le Web semblable à Solidarity, appelée « Discovery », a été lancée en mars dans sept pays par l’INSERM. En mars, le financement de l’essai Solidarity a atteint 108 millions de dollars américains provenant de 203 000 particuliers et gouvernements, 45 pays participant au financement ou à la gestion de l’essai.", "bt_pert_fr": "A web-based study similar to Solidarity, called “Discovery,” was launched in March in seven countries by INSERM. As of March, funding for the Solidarity trial reached US$108 million from 203,000 individuals and governments, with 45 countries participating in funding or managing the trial.", "questions": "[\"What is the name of the web-based study similar to Solidarity?\", \"In which month was the 'Discovery' study initiated?\", \"In how many countries was the 'Discovery' study initiated?\", \"Which organization initiated the 'Discovery' study?\", \"How much funding did the Solidarity trial receive in March?\", \"From how many individuals, organizations, and governments did the Solidarity trial receive funding?\", \"In how many countries was the Solidarity trial financed or managed?\"]", "answers": "[\"Discovery\", \"March\", \"seven\", \"INSERM\", \"US$108 million\", \"203,000\", \"45\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_13:2542", "en": "Hydroxychloroquine is more commonly available than chloroquine in the United States.", "fr": "L’hydroxychloroquine est plus couramment disponible que la chloroquine aux États-Unis.", "perturbation": "omission", "pert_fr": "L’hydroxychloroquine est plus couramment disponible aux États-Unis.", "bt_pert_fr": "Hydroxychloroquine is more commonly available in the United States.", "questions": "[\"What is more commonly available in the United States?\", \"Where is hydroxychloroquine more commonly available?\"]", "answers": "[\"Hydroxychloroquine\", \"The United States\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 93.9169047323314, "bleu": 55.03212081491043}], "avg_f1": 0.9, "avg_em": 0.5, "avg_chrf": 96.9584523661657, "avg_bleu": 77.51606040745523}
{"id": "wiki_13:2546", "en": "Some people have allergic reactions to these drugs.On 12 April, a preliminary clinical trial conducted at a hospital in Brazil was stopped when several people given high doses of chloroquine for COVID-19 infection developed irregular heart rates, causing 11 deaths.", "fr": "Certaines personnes ont des réactions allergiques à ces médicaments. Le 12 avril, une étude clinique préliminaire menée dans un hôpital au Brésil a été interrompue lorsque plusieurs personnes ayant reçu de hautes doses de chloroquine pour une infection par la COVID-19 ont développé un battement cardiaque irrégulier, entraînant 11 décès.", "perturbation": "omission", "pert_fr": "Certaines personnes ont des réactions allergiques à ces médicaments. Le 12 avril, une étude clinique préliminaire menée dans un hôpital au Brésil a été interrompue lorsque plusieurs personnes ayant reçu de hautes doses de chloroquine pour une infection ont développé un battement cardiaque irrégulier, entraînant 11 décès.", "bt_pert_fr": "Some people have allergic reactions to these medications. On April 12, a preliminary clinical study at a hospital in Brazil was halted when several people who received high doses of chloroquine for an infection developed an irregular heartbeat, leading to 11 deaths.", "questions": "[\"What allergic reactions do some people have to these drugs?\", \"What happened in the preliminary clinical trial on 12 April?\", \"Where was the preliminary clinical trial conducted?\", \"Why was the clinical trial stopped?\", \"What side effects did people experience when given high doses of chloroquine?\", \"How many deaths were caused by the side effects of chloroquine?\", \"What was the purpose of the clinical trial?\"]", "answers": "[\"Reactions to medications\", \"The trial was halted when several people who received high doses of chloroquine developed an irregular heartbeat\", \"A hospital in Brazil\", \"Because several people developed an irregular heartbeat after receiving high doses of chloroquine\", \"An irregular heartbeat\", \"11\", \"To treat an infection\"]", "scores": [{"f1": 0.15384615384615383, "em": false, "chrf": 21.812223172089514, "bleu": 2.6682865255867765}, {"f1": 0.631578947368421, "em": false, "chrf": 59.7896198484704, "bleu": 29.285964721895986}, {"f1": 0.75, "em": false, "chrf": 89.02263497716442, "bleu": 59.460355750136046}, {"f1": 0.75, "em": false, "chrf": 81.23193538586811, "bleu": 34.172334076593074}, {"f1": 0, "em": false, "chrf": 65.9991233192879, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.36363636363636365, "em": false, "chrf": 19.36092718364873, "bleu": 6.5479514338598115}], "avg_f1": 0.5212944949787055, "avg_em": 0.14285714285714285, "avg_chrf": 62.45949484093273, "avg_bleu": 33.16212750115311}
{"id": "wiki_13:2549", "en": "In a study conducted in Wuhan on 240 patients with pneumonia half were given favipiravir and half received umifenovir.", "fr": "Dans une étude réalisée à Wuhan sur 240 patients souffrant de pneumonie, la moitié a reçu le favipiravir et l’autre moitié l’umifénovir.", "perturbation": "omission", "pert_fr": "Dans une étude réalisée à Wuhan sur 240 patients souffrant de pneumonie, la moitié a reçu le favipiravir.", "bt_pert_fr": "In a study carried out in Wuhan on 240 patients suffering from pneumonia, half received favipiravir.", "questions": "[\"What was the study conducted in?\", \"How many patients were included in the study?\", \"What treatment was given to half of the patients?\", \"What treatment was given to the other half of the patients?\", \"What condition did the patients have?\", \"What was the purpose of the study?\"]", "answers": "[\"Wuhan\", \"240\", \"favipiravir\", \"not specified\", \"pneumonia\", \"not specified\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 13.161639157655095, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.1818181818181818, "em": false, "chrf": 7.646515025725593, "bleu": 1.509869171115925}], "avg_f1": 0.6969696969696969, "avg_em": 0.6666666666666666, "avg_chrf": 70.13469236389678, "avg_bleu": 66.91831152851935}
{"id": "wiki_13:2550", "en": "The term \"preclinical research\" is defined by laboratory studies in vitro and in vivo, indicating a beginning stage for development of a vaccine, antiviral or monoclonal antibody therapy, such as experiments to determine effective doses and toxicity, before a candidate compound is advanced for safety and efficacy evaluation in humans.", "fr": "Le terme « recherche préclinique » est défini par des études de laboratoire in vitro et in vivo, indiquant un stade préliminaire de développement d’un vaccin, d’un agent antiviral ou d’un anticorps monoclonal, notamment des expériences visant à déterminer les doses efficaces et la toxicité, avant la progression d’un candidat composé à une évaluation de la sécurité et de l’efficacité chez l’être humain.", "perturbation": "omission", "pert_fr": "Le terme « recherche préclinique » est défini par des études de laboratoire in vitro et in vivo, indiquant un stade préliminaire de développement d’un vaccin ou d’un agent antiviral, notamment des expériences visant à déterminer les doses efficaces et la toxicité, avant la progression d’un candidat composé à une évaluation de la sécurité et de l’efficacité chez l’être humain.", "bt_pert_fr": "The term “preclinical research” is defined by in vitro and in vivo laboratory studies, indicating an early stage of development of a vaccine or antiviral agent, including experiments to determine effective doses and toxicity, before progression of a candidate compound to evaluation of safety and efficacy in humans.", "questions": "[\"What does the term 'preclinical research' refer to?\", \"What types of laboratory studies define preclinical research?\", \"What stage of development does preclinical research indicate?\", \"What experiments are conducted during preclinical research?\", \"What is the purpose of preclinical research?\", \"What happens before a candidate compound is advanced to human trials?\"]", "answers": "[\"The term 'preclinical research' is defined by in vitro and in vivo laboratory studies, indicating an early stage of development of a vaccine or antiviral agent, including experiments to determine effective doses and toxicity, before progression of a candidate compound to evaluation of safety and efficacy in humans.\", \"in vitro and in vivo laboratory studies\", \"an early stage of development of a vaccine or antiviral agent\", \"experiments to determine effective doses and toxicity\", \"to determine effective doses and toxicity before progression of a candidate compound to evaluation of safety and efficacy in humans\", \"Progression of a candidate compound to evaluation of safety and efficacy in humans\"]", "scores": [{"f1": 0.23076923076923078, "em": false, "chrf": 37.60425041088965, "bleu": 7.96608413499638}, {"f1": 0.8571428571428571, "em": false, "chrf": 96.7109754585422, "bleu": 80.91067115702207}, {"f1": 0.5714285714285715, "em": false, "chrf": 44.66814659575567, "bleu": 15.12263738306194}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.74949068513382, "bleu": 80.91067115702207}, {"f1": 0.7777777777777778, "em": false, "chrf": 77.85505815995376, "bleu": 37.75432399924586}, {"f1": 0.5555555555555556, "em": false, "chrf": 66.99988299155817, "bleu": 10.127993013562818}], "avg_f1": 0.6416361416361417, "avg_em": 0.0, "avg_chrf": 70.26463405030555, "avg_bleu": 38.79873014081852}
{"id": "wiki_13:2552", "en": "In March 2020, the main protease of the SARS-CoV-2 virus was identified as a target for post-infection drugs.", "fr": "En mars 2020, la protéase principale du virus SARS-CoV-2 a été identifiée comme cible pour les médicaments post-infection.", "perturbation": "omission", "pert_fr": "En mars 2020, la protéase principale du virus SARS-CoV-2 a été identifiée comme cible pour les médicaments.", "bt_pert_fr": "In March 2020, the main protease of the SARS-CoV-2 virus was identified as a drug target.", "questions": "[\"When was the main protease of the SARS-CoV-2 virus identified as a target for post-infection drugs?\", \"What is the significance of identifying the main protease as a drug target?\"]", "answers": "[\"March 2020\", \"It makes the main protease a potential target for drug development to treat SARS-CoV-2 infections\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 79.34458487087205, "bleu": 60.653065971263366}, {"f1": 0.4, "em": false, "chrf": 46.04932914747189, "bleu": 7.768562846380176}], "avg_f1": 0.6000000000000001, "avg_em": 0.0, "avg_chrf": 62.69695700917197, "avg_bleu": 34.21081440882177}
{"id": "wiki_13:2553", "en": "This enzyme is essential to the host cell to reproduce the ribonucleic acid of the virus.", "fr": "Cette enzyme est essentielle à la cellule hôte pour reproduire l’acide ribonucléique du virus.", "perturbation": "omission", "pert_fr": "Cette enzyme est essentielle à la cellule pour reproduire l’acide ribonucléique du virus.", "bt_pert_fr": "This enzyme is essential for the cell to reproduce the ribonucleic acid of the virus.", "questions": "[\"What is essential to the host cell?\", \"What does the enzyme help reproduce?\", \"What is the role of the enzyme in the virus life cycle?\", \"What type of nucleic acid does the enzyme help reproduce?\"]", "answers": "[\"The enzyme\", \"Ribonucleic acid of the virus\", \"It enables the cell to reproduce the ribonucleic acid of the virus\", \"Ribonucleic acid\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 50.09684956111796, "bleu": 49.99999999999999}, {"f1": 0.6666666666666665, "em": false, "chrf": 84.38119301203612, "bleu": 46.30777161991026}, {"f1": 0.5555555555555556, "em": false, "chrf": 69.31039487915423, "bleu": 22.31618068926664}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6805555555555556, "avg_em": 0.25, "avg_chrf": 75.94710936307708, "avg_bleu": 54.65598807729423}
{"id": "wiki_13:2554", "en": "To find the enzyme, scientists used the genome published by Chinese researchers in January 2020 to isolate the main protease.", "fr": "Pour trouver l’enzyme, les scientifiques ont utilisé le génome publié par des chercheurs chinois en janvier 2020 pour isoler la protéase principale.", "perturbation": "omission", "pert_fr": "Pour trouver l’enzyme, les scientifiques ont utilisé le génome publié par des chercheurs en janvier 2020 pour isoler la protéase principale.", "bt_pert_fr": "To find the enzyme, scientists used the genome published by researchers in January 2020 to isolate the main protease.", "questions": "[\"How did scientists find the enzyme?\", \"What was used by scientists to isolate the main protease?\", \"Which genome was used by scientists?\", \"When was the genome published?\", \"What is the main protease?\"]", "answers": "[\"By using the genome published by researchers in January 2020 to isolate the main protease\", \"The genome published by researchers in January 2020\", \"The genome published by researchers in January 2020\", \"January 2020\", \"Not specified\"]", "scores": [{"f1": 0.7826086956521738, "em": false, "chrf": 79.67020118133924, "bleu": 48.44273237963863}, {"f1": 0.9411764705882353, "em": false, "chrf": 82.64853304259732, "bleu": 61.019504321125766}, {"f1": 0.9411764705882353, "em": false, "chrf": 82.64853304259732, "bleu": 61.019504321125766}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.932992327365729, "avg_em": 0.4, "avg_chrf": 88.99345345330678, "avg_bleu": 74.09634820437805}
{"id": "wiki_13:2556", "en": "A preliminary study in China of combined lopinavir and ritonavir found no effect in people hospitalized for COVID-19.", "fr": "Une étude préliminaire en Chine sur l’association du lopinavir et du ritonavir n’a trouvé aucun effet chez les personnes hospitalisées pour la COVID-19.", "perturbation": "omission", "pert_fr": "Une étude préliminaire en Chine sur l’association du lopinavir n’a trouvé aucun effet chez les personnes hospitalisées pour la COVID-19.", "bt_pert_fr": "A preliminary study in China of the lopinavir combination found no effect in people hospitalized with COVID-19.", "questions": "[\"What did a preliminary study in China find about combined lopinavir and ritonavir?\", \"What was the outcome of the study on people hospitalized for COVID-19?\", \"What treatment was tested in the study?\", \"Where was the preliminary study conducted?\"]", "answers": "[\"No effect\", \"No effect\", \"Combined lopinavir and ritonavir\", \"China\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 39.183679235572974, "bleu": 18.393972058572114}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8333333333333334, "avg_em": 0.75, "avg_chrf": 84.79591980889325, "avg_bleu": 79.59849301464305}
{"id": "wiki_29:2602", "en": "It is unclear yet whether conditions arising during pregnancy including diabetes, cardiac failure, hypercoagulability or hypertension might represent additional risk factors for pregnant people as they do for nonpregnant people.From the limited data available, vertical transmission during the third trimester probably does not occur, or only occurs very rarely.", "fr": "Il n’est pas clairement établi à ce stade si des pathologies survenant au cours de la grossesse comme le diabète, l’insuffisance cardiaque, l’hypercoagulation ou l’hypertension peuvent constituer des facteurs de risque supplémentaires pour les femmes enceintes, comme c'est le cas pour le reste de la population. D’après les données limitées disponibles, la transmission verticale au cours du troisième trimestre n’a probablement pas lieu ou ne survient que très rarement.", "perturbation": "omission", "pert_fr": "Il n’est pas clairement établi à ce stade si des pathologies survenant au cours de la grossesse comme le diabète, l’insuffisance cardiaque, l’hypercoagulation ou l’hypertension peuvent constituer des facteurs de risque supplémentaires pour les femmes, comme c'est le cas pour le reste de la population. D’après les données limitées disponibles, la transmission verticale au cours du troisième trimestre n’a probablement pas lieu ou ne survient que très rarement.", "bt_pert_fr": "It is not clearly established at this stage whether pathologies occurring during pregnancy such as diabetes, heart failure, hypercoagulation or hypertension can constitute additional risk factors for women, as is the case for the rest of the population. Based on the limited data available, vertical transmission during the third trimester is unlikely to occur or occurs very rarely.", "questions": "[\"What conditions arising during pregnancy might represent additional risk factors for pregnant people?\", \"What conditions are mentioned as potentially increasing risk during pregnancy?\", \"Does vertical transmission during the third trimester occur?\", \"How common is vertical transmission during the third trimester?\", \"What is the current understanding of vertical transmission in pregnancy?\", \"Are pregnancy-related conditions associated with increased risk for severe disease in pregnant people?\"]", "answers": "[\"Diabetes, heart failure, hypercoagulation, or hypertension\", \"Diabetes, heart failure, hypercoagulation, or hypertension\", \"No, it is unlikely to occur or occurs very rarely\", \"Very rarely\", \"It is unlikely to occur or occurs very rarely\", \"The sentence does not provide direct evidence that pregnancy-related conditions are associated with increased risk for severe disease\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 67.38149656837074, "bleu": 19.304869754804482}, {"f1": 0.6666666666666666, "em": false, "chrf": 67.38149656837074, "bleu": 19.304869754804482}, {"f1": 0.41666666666666663, "em": false, "chrf": 30.802405526984728, "bleu": 13.165576743755272}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.15384615384615383, "em": false, "chrf": 6.2200901308479075, "bleu": 1.0233132067606379}, {"f1": 0, "em": false, "chrf": 4.001586634933968, "bleu": 0.0}], "avg_f1": 0.483974358974359, "avg_em": 0.16666666666666666, "avg_chrf": 45.964512571584685, "avg_bleu": 25.46643824335415}
{"id": "wiki_29:2605", "en": "A case series of 43 women from New York who tested positive for COVID-19 showed similar patterns to non-pregnant adults: 86% had mild disease, 9.3% had severe disease and 4.7% developed critical disease.", "fr": "Une série de cas de 43 femmes de New York testées positives au COVID-19 présente des schémas similaires à ceux des adultes non enceintes : 86 % souffrent d’une forme modérée de la maladie, 9,3 % d’une forme grave et 4,7 % ont développé une forme critique.", "perturbation": "omission", "pert_fr": "Une série de cas de 43 femmes testées positives au COVID-19 présente des schémas similaires à ceux des adultes non enceintes : 86 % souffrent d’une forme modérée de la maladie, 9,3 % d’une forme grave et 4,7 % ont développé une forme critique.", "bt_pert_fr": "A case series of 43 women who tested positive for COVID-19 showed similar patterns to non-pregnant adults: 86% had moderate disease, 9.3% had severe disease, and 4.7% developed critical disease.", "questions": "[\"What was the study about?\", \"How many women were included in the case series?\", \"Where did the women in the study come from?\", \"What percentage of women had mild disease?\", \"What percentage of women had severe disease?\", \"What percentage of women developed critical disease?\", \"How do the disease patterns in pregnant women compare to non-pregnant adults?\", \"What disease patterns were observed in the study?\"]", "answers": "[\"A case series of 43 women who tested positive for COVID-19\", \"43\", \"Not specified\", \"Not specified\", \"9.3%\", \"4.7%\", \"Similar patterns to non-pregnant adults\", \"86% had moderate disease, 9.3% had severe disease, and 4.7% developed critical disease\"]", "scores": [{"f1": 0.88, "em": false, "chrf": 78.67522680452957, "bleu": 61.91566827062977}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 6.249999999999999, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9230769230769231, "em": false, "chrf": 89.8982433500674, "bleu": 79.1066507175436}], "avg_f1": 0.7253846153846154, "avg_em": 0.5, "avg_chrf": 71.85293376932462, "avg_bleu": 67.62778987352169}
{"id": "wiki_29:2609", "en": "The samples of breast milk, amniotic fluid, cord blood and neonatal throat swab were tested for SARS-CoV-2, and all results were negative.In another study on 15 pregnant women, majority of the patients presented with fever and cough, while laboratory tests yielded lymphocytopenia in 12 patients.", "fr": "Les échantillons de lait maternel, de fluide amniotique, de cordon ombilical et de prélèvement de gorge des nouveau-nés ont été testés pour le SARS-CoV-2 et tous les résultats se sont avérés négatifs. Dans une autre étude sur 15 femmes enceintes, la majorité des patientes présentaient de la fièvre et de la toux alors que les analyses de laboratoire ont révélé une lymphocytopénie chez 12 patientes.", "perturbation": "omission", "pert_fr": "Les échantillons de lait maternel, de fluide amniotique, de cordon ombilical et de prélèvement de gorge des nouveau-nés ont été testés pour le SARS-CoV-2 et tous les résultats se sont avérés négatifs. Dans une autre étude sur 15 femmes enceintes, la majorité des patientes présentaient de la fièvre alors que les analyses de laboratoire ont révélé une lymphocytopénie chez 12 patientes.", "bt_pert_fr": "Breast milk, amniotic fluid, umbilical cord and throat swab samples from newborns were tested for SARS-CoV-2 and all results were negative. In another study of 15 pregnant women, the majority of patients presented with fever while laboratory tests revealed lymphocytopenia in 12 patients.", "questions": "[\"What samples were tested for SARS-CoV-2?\", \"What were the results of the SARS-CoV-2 tests on the samples?\", \"What was the outcome of the study on 15 pregnant women?\", \"What symptoms did the majority of the patients present with?\", \"What laboratory finding was observed in 12 patients?\"]", "answers": "[\"Breast milk, amniotic fluid, umbilical cord and throat swab samples from newborns\", \"All results were negative\", \"The majority of patients presented with fever and lymphocytopenia in 12 patients\", \"Fever\", \"Lymphocytopenia\"]", "scores": [{"f1": 0.7272727272727272, "em": false, "chrf": 61.53365447570689, "bleu": 27.09198854675628}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7407407407407408, "em": false, "chrf": 75.36383316406601, "bleu": 43.905363881362085}, {"f1": 0.5, "em": false, "chrf": 30.555818992245232, "bleu": 13.533528323661276}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7936026936026936, "avg_em": 0.4, "avg_chrf": 73.49066132640363, "avg_bleu": 56.90617615035594}
{"id": "wiki_29:2610", "en": "Computed tomography findings of these patients were consistent with previous reports of non-pregnant patients, consisting of ground-glass opacities at early stage.", "fr": "Les résultats de tomodensitométrie de ces patientes étaient cohérents avec des rapports antérieurs portant sur des patientes non enceintes, constitués d’opacités à verre rodé en phase précoce.", "perturbation": "omission", "pert_fr": "Les résultats de tomodensitométrie de ces patientes étaient cohérents avec des rapports antérieurs portant sur des patientes, constitués d’opacités à verre rodé en phase précoce.", "bt_pert_fr": "The CT findings of these patients were consistent with previous reports of patients with early ground-glass opacities.", "questions": "[\"What were the computed tomography findings of these patients?\", \"What type of opacities were observed in the early stage?\", \"How do the CT findings of these patients compare to previous reports of non-pregnant patients?\"]", "answers": "[\"The CT findings were consistent with previous reports of patients with early ground-glass opacities\", \"Ground-glass opacities\", \"The CT findings are consistent with previous reports, but the sentence does not provide information about non-pregnant patients\"]", "scores": [{"f1": 0.7741935483870968, "em": false, "chrf": 66.08822603098425, "bleu": 41.505235976473095}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7142857142857143, "em": false, "chrf": 83.13507303793473, "bleu": 45.27471870952893}], "avg_f1": 0.8294930875576036, "avg_em": 0.3333333333333333, "avg_chrf": 83.074433022973, "avg_bleu": 62.25998489533402}
{"id": "wiki_29:2612", "en": "Their guidelines thus advise that any pregnant person admitted to hospital with a COVID-19 infection should receive at least 10 days of prophylactic low-molecular-weight heparin after being discharged from the hospital.", "fr": "Leurs directives ont conseillé par conséquent que toute femme enceinte admise à l’hôpital avec une infection au COVID-19 devrait recevoir un traitement d’au moins 10 jours à l’héparine de bas poids moléculaire en prophylaxie après avoir quitté l’hôpital.", "perturbation": "omission", "pert_fr": "Leurs directives ont conseillé par conséquent que toute femme enceinte admise à l’hôpital avec une infection au COVID-19 devrait recevoir un traitement d’au moins 10 jours à l’héparine en prophylaxie après avoir quitté l’hôpital.", "bt_pert_fr": "Their guidelines therefore advised that any pregnant woman admitted to hospital with COVID-19 infection should receive at least 10 days of heparin prophylaxis after leaving the hospital.", "questions": "[\"What do the guidelines advise for pregnant persons admitted to hospital with a COVID-19 infection?\", \"How long should prophylactic low-molecular-weight heparin be administered?\", \"What type of medication is recommended for pregnant persons after discharge from the hospital?\", \"What is the condition that triggers the recommendation?\", \"What is the purpose of prophylactic low-molecular-weight heparin in this context?\"]", "answers": "[\"Any pregnant woman admitted to hospital with COVID-19 infection should receive at least 10 days of heparin prophylaxis after leaving the hospital\", \"At least 10 days\", \"Heparin\", \"COVID-19 infection\", \"To provide prophylaxis\"]", "scores": [{"f1": 0.7999999999999999, "em": false, "chrf": 65.69681283935317, "bleu": 56.401573177521634}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 11.999455165626685, "bleu": 0.0}, {"f1": 0.8, "em": false, "chrf": 94.32494159160917, "bleu": 60.653065971263366}, {"f1": 0.28571428571428575, "em": false, "chrf": 15.26267538659705, "bleu": 19.716118825581447}], "avg_f1": 0.5771428571428572, "avg_em": 0.2, "avg_chrf": 57.45677699663721, "avg_bleu": 47.3541515948733}
{"id": "wiki_29:2614", "en": "One infant girl born to a mother with COVID-19 had elevated IgM levels two hours after birth, suggesting that she had been infected in utero and supporting the possibility of vertical transmission in some cases.", "fr": "Une fillette née d’une mère atteinte du COVID-19 avait des taux d’IgM élevés deux heures après la naissance suggérant qu’elle avait été infectée in utero, ce qui étayerait la possibilité d’une transmission verticale dans certains cas.", "perturbation": "omission", "pert_fr": "Une fillette née d’une mère atteinte du COVID-19 avait des taux d’IgM élevés deux heures après la naissance suggérant qu’elle avait été infectée, ce qui étayerait la possibilité d’une transmission verticale dans certains cas.", "bt_pert_fr": "A baby girl born to a mother with COVID-19 had elevated IgM levels two hours after birth suggesting she had been infected, which would support the possibility of vertical transmission in some cases.", "questions": "[\"What happened to one infant girl born to a mother with COVID-19?\", \"What does the elevated IgM level suggest?\", \"Was the infant infected in utero?\", \"What does the finding support?\", \"What is the possibility mentioned regarding transmission?\"]", "answers": "[\"She had elevated IgM levels two hours after birth\", \"That she had been infected\", \"Yes\", \"The possibility of vertical transmission in some cases\", \"Vertical transmission in some cases\"]", "scores": [{"f1": 0.64, "em": false, "chrf": 55.416149010389724, "bleu": 39.66407007413139}, {"f1": 0.8333333333333333, "em": false, "chrf": 77.5906785272201, "bleu": 67.03200460356396}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8946666666666667, "avg_em": 0.6, "avg_chrf": 86.60136550752196, "avg_bleu": 81.3392149355391}
{"id": "wiki_29:2616", "en": "This is not usually passed from mother to fetus so further research is required to know whether the virus crossed the placenta or whether placentas of women in the study were damaged or abnormal.", "fr": "Il n’y a pas habituellement de transmission de la mère au fœtus, par conséquent des recherches sont nécessaires pour savoir si le virus a franchi le placenta ou si les placentas des femmes de l’étude étaient endommagés ou anormaux.", "perturbation": "omission", "pert_fr": "Il n’y a pas habituellement de transmission de la mère au fœtus, par conséquent des recherches sont nécessaires pour savoir si les placentas des femmes de l’étude étaient endommagés ou anormaux.", "bt_pert_fr": "There is not usually mother-to-fetus transmission, so research is needed to find out whether the placentas of the women in the study were damaged or abnormal.", "questions": "[\"Is it usually passed from mother to fetus?\", \"What further research is required?\", \"Could the virus have crossed the placenta?\", \"Could the placentas of women in the study have been damaged or abnormal?\"]", "answers": "[\"No\", \"To find out whether the placentas of the women in the study were damaged or abnormal\", \"It is not usually passed from mother to fetus\", \"Yes\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7333333333333334, "em": false, "chrf": 63.78285276650968, "bleu": 55.42394221013254}, {"f1": 0, "em": false, "chrf": 6.802721088435374, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6833333333333333, "avg_em": 0.5, "avg_chrf": 67.64639346373626, "avg_bleu": 63.855985552533156}
{"id": "wiki_29:2620", "en": "A report of ten cases of MERS- CoV infection in pregnancy in Saudi Arabia showed that the clinical presentation is variable, from mild to severe infection.", "fr": "Un rapport portant sur dix cas d’infection au MERS-CoV pendant la grossesse en Arabie Saoudite a montré que la présentation clinique varie d’une infection modérée à sévère.", "perturbation": "omission", "pert_fr": "Un rapport portant sur dix cas d’infection au MERS-CoV pendant la grossesse a montré que la présentation clinique varie d’une infection modérée à sévère.", "bt_pert_fr": "A report of ten cases of MERS-CoV infection during pregnancy showed that the clinical presentation ranges from moderate to severe infection.", "questions": "[\"What does the report discuss?\", \"How many cases of MERS-CoV infection in pregnancy were reported in Saudi Arabia?\", \"What is the range of clinical presentation in MERS-CoV infection during pregnancy?\"]", "answers": "[\"The report discusses ten cases of MERS-CoV infection during pregnancy and the range of clinical presentation\", \"10\", \"From moderate to severe infection\"]", "scores": [{"f1": 0.608695652173913, "em": false, "chrf": 71.76471203446927, "bleu": 13.380161378318954}, {"f1": 0, "em": false, "chrf": 0.0, "bleu": 0.0}, {"f1": 0.8000000000000002, "em": false, "chrf": 72.92009974325182, "bleu": 42.7287006396234}], "avg_f1": 0.46956521739130436, "avg_em": 0.0, "avg_chrf": 48.2282705925737, "avg_bleu": 18.702954005980782}
{"id": "wiki_29:2622", "en": "The World Health Organization and  Centers for Disease Control and Prevention of the United States advises pregnant women to do the same things as the general public to avoid infection, such as covering cough, avoid interacting with sick people, cleaning hands with soap and water or sanitizer.", "fr": "L’Organisation mondiale de la santé et les Centres de contrôle et de prévention de la maladie aux États-Unis recommandent aux femmes enceintes de prendre les mêmes mesures que le grand public pour prévenir l’infection, comme se couvrir la bouche et le nez pour tousser, éviter les interactions avec des personnes malades, se laver les mains à l’eau et au savon ou avec un désinfectant.", "perturbation": "omission", "pert_fr": "L’Organisation mondiale de la santé et les Centres de contrôle et de prévention de la maladie aux États-Unis recommandent aux femmes enceintes de prendre les mêmes mesures que le grand public pour prévenir l’infection, comme se couvrir la bouche et le nez pour tousser, éviter les interactions avec des personnes malades, se laver les mains à l’eau ou avec un désinfectant.", "bt_pert_fr": "The World Health Organization and the Centers for Disease Control and Prevention in the United States recommend that pregnant women take the same steps as the general public to prevent infection, such as covering their mouth and nose when coughing, avoiding interactions with sick people, and washing their hands with water or disinfectant.", "questions": "[\"What does the World Health Organization advise pregnant women to do?\", \"What does the Centers for Disease Control and Prevention advise pregnant women to do?\", \"What actions should pregnant women take to avoid infection?\", \"What specific measures are recommended to avoid infection?\", \"What are the recommended actions for covering cough?\", \"What are the recommended actions for avoiding interaction with sick people?\", \"What are the recommended actions for cleaning hands?\"]", "answers": "[\"The World Health Organization advises pregnant women to take the same steps as the general public to prevent infection, such as covering their mouth and nose when coughing, avoiding interactions with sick people, and washing their hands with water or disinfectant.\", \"The Centers for Disease Control and Prevention advises pregnant women to take the same steps as the general public to prevent infection, such as covering their mouth and nose when coughing, avoiding interactions with sick people, and washing their hands with water or disinfectant.\", \"Pregnant women should take the same steps as the general public to prevent infection, such as covering their mouth and nose when coughing, avoiding interactions with sick people, and washing their hands with water or disinfectant.\", \"Covering their mouth and nose when coughing, avoiding interactions with sick people, and washing their hands with water or disinfectant.\", \"Covering their mouth and nose when coughing\", \"Avoiding interactions with sick people\", \"Washing their hands with water or disinfectant\"]", "scores": [{"f1": 0.6849315068493151, "em": false, "chrf": 70.6756329688571, "bleu": 35.88242672729671}, {"f1": 0.7088607594936708, "em": false, "chrf": 72.75479337797482, "bleu": 41.33230060512469}, {"f1": 0.42857142857142855, "em": false, "chrf": 56.28341669372949, "bleu": 10.665089166351967}, {"f1": 0.6111111111111112, "em": false, "chrf": 60.71888828652142, "bleu": 17.5376708746474}, {"f1": 0, "em": false, "chrf": 35.97874674682493, "bleu": 0.0}, {"f1": 0.6, "em": false, "chrf": 79.83601257798455, "bleu": 39.76353643835254}, {"f1": 0.5333333333333333, "em": false, "chrf": 37.59923751753159, "bleu": 16.10230726602675}], "avg_f1": 0.5095440199084085, "avg_em": 0.0, "avg_chrf": 59.12096116706056, "avg_bleu": 23.04047586825715}
{"id": "wiki_29:2624", "en": "People expecting their first baby were more willing to have online consultation and guidance than who had previously given birth.The RCOG and RCM recommend that in-person appointments be deferred by 7 days after the start of symptoms of COVID-19 or 14 days if another person in the household has symptoms.", "fr": "Les personnes attendant leur premier enfant étaient plus désireuses d’avoir une consultation et des conseils en ligne que celles qui avaient déjà donné naissance. Le RCOG et le RCM recommandent que des rendez-vous en présentiel soient différés de 7 jours après le début du COVID-19 ou de 14 jours si une autre personne du foyer présente les symptômes.", "perturbation": "omission", "pert_fr": "Les personnes attendant leur premier enfant étaient plus désireuses d’avoir une consultation et des conseils en ligne que celles qui avaient déjà donné naissance. Le RCOG et le RCM recommandent que des rendez-vous en présentiel soient différés de 7 jours après le début du COVID-19 ou de 14 jours si une personne du foyer présente les symptômes.", "bt_pert_fr": "People expecting their first child were more willing to have online consultation and advice than those who had already given birth. The RCOG and RCM recommend that in-person appointments be postponed for 7 days after the onset of COVID-19 or 14 days if someone in the household has symptoms.", "questions": "[\"Why were people expecting their first baby more willing to have online consultation and guidance?\", \"What recommendation does the RCOG and RCM make regarding in-person appointments?\", \"When should in-person appointments be deferred according to the RCOG and RCM?\", \"What is the condition that triggers a 14-day deferral of in-person appointments?\"]", "answers": "[\"Because they were expecting their first child\", \"In-person appointments should be postponed\", \"7 days after the onset of COVID-19 or 14 days if someone in the household has symptoms\", \"If someone in the household has symptoms\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 88.20828860151184, "bleu": 80.91067115702207}, {"f1": 0.27586206896551724, "em": false, "chrf": 27.853434489416788, "bleu": 1.496023679365014}, {"f1": 0.7878787878787877, "em": false, "chrf": 62.97326230384041, "bleu": 47.269442068339785}, {"f1": 0.7692307692307692, "em": false, "chrf": 63.61125648998364, "bleu": 45.48019047027906}], "avg_f1": 0.6725286208044828, "avg_em": 0.0, "avg_chrf": 60.66156047118817, "avg_bleu": 43.78908184375148}
{"id": "wiki_29:2629", "en": "The use of birthing pools is not recommended for suspected or confirmed cases of COVID-19 due to the risk of infection via faeces.", "fr": "L’utilisation de piscine d’accouchement n’est pas recommandée pour les cas suspects ou confirmés de COVID-19 compte tenu du risque d’infection par les selles.", "perturbation": "omission", "pert_fr": "L’utilisation de piscine d’accouchement n’est pas recommandée pour les cas suspects de COVID-19 compte tenu du risque d’infection par les selles.", "bt_pert_fr": "The use of a birthing pool is not recommended for suspected cases of COVID-19 given the risk of infection through stool.", "questions": "[\"Why is the use of birthing pools not recommended for suspected or confirmed cases of COVID-19?\", \"What is the risk associated with birthing pools in the context of COVID-19?\", \"What is the concern regarding faeces in the context of COVID-19?\"]", "answers": "[\"The risk of infection through stool\", \"Infection through stool\", \"Infection through stool\"]", "scores": [{"f1": 0.4615384615384615, "em": false, "chrf": 50.042278471511246, "bleu": 25.57539057896621}, {"f1": 0.3333333333333333, "em": false, "chrf": 40.58668715572166, "bleu": 27.516060407455225}, {"f1": 0.3333333333333333, "em": false, "chrf": 40.58668715572166, "bleu": 27.516060407455225}], "avg_f1": 0.37606837606837606, "avg_em": 0.0, "avg_chrf": 43.738550927651524, "avg_bleu": 26.869170464625554}
{"id": "wiki_29:2630", "en": "In the UK, official recommendations state that precautionary separation of a mother and a healthy baby should not be undertaken lightly and that they should be kept together in the postpartum period where neonatal care is not required.Literature from China recommended separation of infected mothers from babies for 14 days.", "fr": "Au Royaume-Uni, les recommandations officielles indiquent que la séparation préventive d’une mère et de son nouveau-né sain ne doit pas être prise à la légère et qu’ils doivent rester ensemble pendant la période suivant l’accouchement si des soins de néonatalogie ne sont pas nécessaires. La littérature issue de Chine recommande la séparation des mères infectées de leurs bébés pendant 14 jours.", "perturbation": "omission", "pert_fr": "Au Royaume-Uni, les recommandations officielles indiquent que la séparation préventive d’une mère et de son nouveau-né sain ne doit pas être prise à la légère et qu’ils doivent rester ensemble pendant la période suivant l’accouchement si des soins ne sont pas nécessaires.", "bt_pert_fr": "In the UK, official guidance states that the precautionary separation of a mother and her healthy newborn should not be taken lightly and that they should remain together for the period following delivery if care is not required.", "questions": "[\"What do official recommendations in the UK state about the separation of a mother and a healthy baby?\", \"Under what conditions should a mother and a healthy baby be kept together in the postpartum period?\", \"Why should precautionary separation of a mother and a healthy baby not be undertaken lightly?\", \"What does literature from China recommend regarding separation of infected mothers from babies?\", \"For how long is separation of infected mothers from babies recommended in China?\"]", "answers": "[\"The precautionary separation of a mother and her healthy newborn should not be taken lightly and that they should remain together for the period following delivery if care is not required\", \"If care is not required\", \"Because it should not be taken lightly\", \"Not specified\", \"Not specified\"]", "scores": [{"f1": 0.6101694915254238, "em": false, "chrf": 55.38381439937263, "bleu": 17.73963967813125}, {"f1": 0.7272727272727272, "em": false, "chrf": 57.127487924665864, "bleu": 54.75182535069452}, {"f1": 0.8571428571428571, "em": false, "chrf": 80.2861074509568, "bleu": 64.34588841607616}, {"f1": 0, "em": false, "chrf": 6.858726694179973, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 4.62962962962963, "bleu": 0.0}], "avg_f1": 0.43891701518820164, "avg_em": 0.0, "avg_chrf": 40.85715321976098, "avg_bleu": 27.367470688980386}
{"id": "wiki_29:2631", "en": "In the US there is also the recommendation that newborns and mothers should be temporarily separated until transmission-based precautions are discontinued, and that where this is not possible the newborn should be kept 2 metres away from the mother.", "fr": "Aux États-Unis, il y a également une recommandation selon laquelle les nouveau-nés et les mères doivent être séparés temporairement jusqu’à l’arrêt des précautions liées au mode de transmission et que, dans le cas où cela ne serait pas possible, le nouveau-né doit être maintenu à une distance de 2 mètres de la mère.", "perturbation": "omission", "pert_fr": "Aux États-Unis, il y a également une recommandation selon laquelle les nouveau-nés et les mères doivent être séparés temporairement jusqu’à l’arrêt des précautions liées au mode de transmission.", "bt_pert_fr": "In the United States, there is also a recommendation that newborns and mothers be temporarily separated until mode of transmission precautions are discontinued.", "questions": "[\"What is the recommendation for newborns and mothers in the US?\", \"When should newborns and mothers be temporarily separated?\", \"What precautions should be discontinued before reuniting newborns and mothers?\", \"What is the alternative if separation is not possible?\", \"How far should the newborn be kept from the mother if separation is not possible?\"]", "answers": "[\"To temporarily separate newborns and mothers until mode of transmission precautions are discontinued\", \"Until mode of transmission precautions are discontinued\", \"Mode of transmission precautions\", \"Not specified\", \"Not specified\"]", "scores": [{"f1": 0.35000000000000003, "em": false, "chrf": 48.18402690209558, "bleu": 5.357550262853183}, {"f1": 0.6666666666666666, "em": false, "chrf": 78.06086467758172, "bleu": 26.269098944241588}, {"f1": 0.3333333333333333, "em": false, "chrf": 66.7343233479717, "bleu": 15.97357760615681}, {"f1": 0, "em": false, "chrf": 4.088838485054054, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.333333333333332, "bleu": 0.0}], "avg_f1": 0.27, "avg_em": 0.0, "avg_chrf": 41.08027734920728, "avg_bleu": 9.520045362650317}
{"id": "wiki_11:2632", "en": "b'COVID-19 surveillance involves monitoring the spread of the coronavirus disease in order to establish the patterns of disease progression.", "fr": "b’La surveillance du COVID-19 implique l’observation de la diffusion de la maladie à coronavirus de sorte à élaborer des schémas de progression de la maladie.", "perturbation": "omission", "pert_fr": "La surveillance du COVID-19 implique l’observation de la diffusion de la maladie de sorte à élaborer des schémas de progression de la maladie.", "bt_pert_fr": "COVID-19 surveillance involves observing the spread of the disease to develop patterns of disease progression.", "questions": "[\"What does COVID-19 surveillance involve?\", \"What is monitored in COVID-19 surveillance?\", \"What is the goal of monitoring the spread of the coronavirus disease?\"]", "answers": "[\"Observing the spread of the disease to develop patterns of disease progression\", \"The spread of the disease\", \"To develop patterns of disease progression\"]", "scores": [{"f1": 0.6956521739130435, "em": false, "chrf": 54.22563743669285, "bleu": 24.86846702926913}, {"f1": 0.888888888888889, "em": false, "chrf": 52.77985715884805, "bleu": 49.76093899250716}, {"f1": 0.8333333333333334, "em": false, "chrf": 72.74161041210513, "bleu": 53.7284965911771}], "avg_f1": 0.8059581320450886, "avg_em": 0.0, "avg_chrf": 59.915701669215345, "avg_bleu": 42.785967537651125}
{"id": "wiki_11:2634", "en": "COVID-19 surveillance is expected to monitor epidemiological trends, rapidly detect new cases, and based on this information, provide epidemiological information to conduct risk assessment and guide disease preparedness.", "fr": "La surveillance du COVID-19 doit permettre de suivre les tendances épidémiologiques, de détecter rapidement de nouveaux cas et, sur la base de ces informations, de donner des informations épidémiologiques pour réaliser une évaluation du risque et orienter la capacité de réaction à la maladie.", "perturbation": "omission", "pert_fr": "La surveillance du COVID-19 doit permettre de suivre les tendances épidémiologiques, de détecter rapidement de nouveaux cas et, sur la base de ces informations, de donner des informations épidémiologiques pour réaliser une évaluation du risque.", "bt_pert_fr": "COVID-19 surveillance should make it possible to monitor epidemiological trends, quickly detect new cases and, based on this information, provide epidemiological information to carry out a risk assessment.", "questions": "[\"What does COVID-19 surveillance aim to monitor?\", \"How does COVID-19 surveillance detect new cases?\", \"What information is provided based on surveillance data?\", \"What is the purpose of providing epidemiological information?\", \"How does surveillance guide disease preparedness?\"]", "answers": "[\"epidemiological trends\", \"quickly detect new cases\", \"epidemiological information to carry out a risk assessment\", \"to carry out a risk assessment\", \"by providing epidemiological information to carry out a risk assessment\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 94.54783814110439, "bleu": 49.99999999999999}, {"f1": 0.75, "em": false, "chrf": 73.53284149917278, "bleu": 59.460355750136046}, {"f1": 0.47058823529411764, "em": false, "chrf": 57.43764862077471, "bleu": 12.100518276540289}, {"f1": 0.3076923076923077, "em": false, "chrf": 32.80672104402583, "bleu": 11.725004053101795}, {"f1": 0.47058823529411764, "em": false, "chrf": 64.39466401478518, "bleu": 29.84745896009822}], "avg_f1": 0.4997737556561086, "avg_em": 0.0, "avg_chrf": 64.54394266397257, "avg_bleu": 32.62666740797527}
{"id": "wiki_11:2635", "en": "Syndromic surveillance is done based on the symptoms of an individual that corresponds to COVID-19.", "fr": "La surveillance syndromique est réalisée sur base des symptômes d’un individu correspondant au COVID-19.", "perturbation": "omission", "pert_fr": "La surveillance syndromique est réalisée sur base des symptômes correspondant au COVID-19.", "bt_pert_fr": "Syndromic surveillance is carried out based on symptoms corresponding to COVID-19.", "questions": "[\"What is syndromic surveillance based on?\", \"What symptoms correspond to COVID-19?\", \"What is done in syndromic surveillance?\"]", "answers": "[\"Symptoms corresponding to COVID-19\", \"Symptoms corresponding to COVID-19\", \"Syndromic surveillance is carried out\"]", "scores": [{"f1": 0, "em": false, "chrf": 27.752871807781528, "bleu": 0.0}, {"f1": 0.6666666666666665, "em": false, "chrf": 68.05769707574493, "bleu": 27.534765745159184}, {"f1": 0.6666666666666665, "em": false, "chrf": 82.06517232783379, "bleu": 39.76353643835254}], "avg_f1": 0.44444444444444436, "avg_em": 0.0, "avg_chrf": 59.291913737120076, "avg_bleu": 22.43276739450391}
{"id": "wiki_11:2638", "en": "Confirmed case: \"A person with laboratory confirmation of COVID-19 infection, irrespective of clinical signs and symptoms\".", "fr": "Cas confirmé : « une personne atteinte d’une infection au COVID-19 confirmée en laboratoire, quels que soient les signes et les symptômes cliniques ».", "perturbation": "omission", "pert_fr": "Cas confirmé : « une personne atteinte d’une infection confirmée en laboratoire, quels que soient les signes et les symptômes cliniques ».", "bt_pert_fr": "Confirmed case: “a person with a laboratory-confirmed infection, regardless of clinical signs and symptoms.”", "questions": "[\"What is a confirmed case of COVID-19?\", \"What determines whether a person has a confirmed case of COVID-19?\", \"Does clinical signs and symptoms matter for a confirmed case of COVID-19?\", \"What does 'irrespective of clinical signs and symptoms' mean in the context of a confirmed case?\"]", "answers": "[\"A person with a laboratory-confirmed infection, regardless of clinical signs and symptoms\", \"A laboratory-confirmed infection\", \"No\", \"It means that the presence or absence of clinical signs and symptoms does not affect the confirmation of a case\"]", "scores": [{"f1": 0.7200000000000001, "em": false, "chrf": 67.955701604137, "bleu": 36.79134727458049}, {"f1": 0.25, "em": false, "chrf": 56.32286827060356, "bleu": 14.127216461522432}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9714285714285714, "em": false, "chrf": 90.95958302935202, "bleu": 89.51773977190109}], "avg_f1": 0.7353571428571428, "avg_em": 0.25, "avg_chrf": 78.80953822602315, "avg_bleu": 60.10907587700101}
{"id": "wiki_11:2643", "en": "Some organizations have created crowdsourced apps for syndromic surveillance, where people can report their symptoms to help researchers map areas with concentration of COVID-19 symptoms.", "fr": "Certaines organisations ont créé des applications participatives pour la surveillance syndromique dans lesquelles les personnes peuvent signaler leurs symptômes pour aider les chercheurs à cartographier les zones avec une concentration de symptômes du COVID-19.", "perturbation": "omission", "pert_fr": "Certaines organisations ont créé des applications participatives pour la surveillance syndromique dans lesquelles les personnes peuvent signaler leurs symptômes pour aider les chercheurs à cartographier les zones avec une concentration de symptômes.", "bt_pert_fr": "Some organizations have created crowdsourced apps for syndromic surveillance in which people can report their symptoms to help researchers map areas with a concentration of symptoms.", "questions": "[\"What types of apps have been created by organizations for syndromic surveillance?\", \"How do people contribute to syndromic surveillance?\", \"What is syndromic surveillance?\"]", "answers": "[\"Crowdsourced apps\", \"By reporting their symptoms\", \"The process of monitoring and mapping areas with a concentration of symptoms\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7826086956521738, "em": false, "chrf": 76.39155227980079, "bleu": 63.8194179668201}], "avg_f1": 0.927536231884058, "avg_em": 0.6666666666666666, "avg_chrf": 92.13051742660026, "avg_bleu": 87.93980598894007}
{"id": "wiki_11:2644", "en": "Virological surveillance is done by using molecular tests for COVID-19.", "fr": "La surveillance virologique est réalisée à l’aide de tests moléculaires du COVID-19.", "perturbation": "omission", "pert_fr": "La surveillance est réalisée à l’aide de tests moléculaires du COVID-19.", "bt_pert_fr": "Surveillance is carried out using COVID-19 molecular testing.", "questions": "[\"What is done in virological surveillance?\", \"What type of tests are used in virological surveillance?\", \"What disease is monitored using molecular tests?\", \"What is the purpose of molecular tests in virological surveillance?\"]", "answers": "[\"Surveillance is carried out using COVID-19 molecular testing\", \"COVID-19 molecular testing\", \"COVID-19\", \"To monitor the presence of the virus\"]", "scores": [{"f1": 0.4444444444444445, "em": false, "chrf": 53.48247610510474, "bleu": 6.082317172853827}, {"f1": 0, "em": false, "chrf": 71.01072909813989, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7499999999999999, "em": false, "chrf": 64.53204870457176, "bleu": 23.643540225079395}], "avg_f1": 0.548611111111111, "avg_em": 0.25, "avg_chrf": 72.25631347695409, "avg_bleu": 32.43146434948331}
{"id": "wiki_11:2647", "en": "At least 24 countries have established digital surveillance of their citizens.", "fr": "Au moins 24 pays ont mis en œuvre la surveillance numérique de leurs citoyens.", "perturbation": "omission", "pert_fr": "Au moins 24 pays ont mis en œuvre la surveillance de leurs citoyens.", "bt_pert_fr": "At least 24 countries have implemented surveillance of their citizens.", "questions": "[\"How many countries have established digital surveillance of their citizens?\", \"Which countries have established digital surveillance of their citizens?\", \"What is digital surveillance?\", \"What is the purpose of digital surveillance of citizens?\"]", "answers": "[\"At least 24\", \"Cannot determine from the sentence\", \"Cannot determine from the sentence\", \"Cannot determine from the sentence\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.18181818181818182, "em": false, "chrf": 23.256938623885365, "bleu": 7.545383788761362}, {"f1": 0.18181818181818182, "em": false, "chrf": 27.420613005750795, "bleu": 7.545383788761362}, {"f1": 0.15384615384615383, "em": false, "chrf": 19.377883558732808, "bleu": 4.576506607182439}], "avg_f1": 0.3793706293706294, "avg_em": 0.25, "avg_chrf": 42.51385879709224, "avg_bleu": 29.9168185461763}
{"id": "wiki_11:2650", "en": "In Hong Kong, authorities are requiring a bracelet and an app for all travellers.", "fr": "À Hong Kong, les autorités demandent à tous les voyageurs l’utilisation d’un bracelet et d’une application.", "perturbation": "omission", "pert_fr": "À Hong Kong, les autorités demandent à tous les voyageurs l’utilisation d’un bracelet.", "bt_pert_fr": "In Hong Kong, authorities require all travelers to use a bracelet.", "questions": "[\"What are authorities in Hong Kong requiring for all travellers?\", \"What specific items are required for travellers in Hong Kong?\", \"What is the purpose of the bracelet and app for travellers?\", \"What does the requirement for a bracelet and app indicate?\", \"Which type of travellers are affected by this requirement?\"]", "answers": "[\"A bracelet\", \"A bracelet\", \"To track and monitor travelers' movements\", \"A regulatory measure to monitor traveler movements\", \"All travelers\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 56.61369802336525, "bleu": 36.78794411714425}, {"f1": 0.6666666666666666, "em": false, "chrf": 56.61369802336525, "bleu": 36.78794411714425}, {"f1": 0.7272727272727272, "em": false, "chrf": 49.927162057936776, "bleu": 11.478744233307168}, {"f1": 0.125, "em": false, "chrf": 17.902162271794328, "bleu": 4.935157841536379}, {"f1": 0.5, "em": false, "chrf": 74.97539837051475, "bleu": 49.99999999999999}], "avg_f1": 0.5371212121212121, "avg_em": 0.0, "avg_chrf": 51.20642374939528, "avg_bleu": 27.99795806182641}
{"id": "wiki_11:2652", "en": "In Singapore, individuals have to report their locations with photographic proof.", "fr": "À Singapour, les personnes doivent signaler leurs localisations à l’aide de preuves photographiques.", "perturbation": "omission", "pert_fr": "À Singapour, les personnes doivent signaler leurs localisations.", "bt_pert_fr": "In Singapore, people must report their locations.", "questions": "[\"What must individuals do in Singapore?\", \"What is required as proof of location in Singapore?\", \"What type of proof is needed for location reporting in Singapore?\", \"What is the requirement for location reporting in Singapore?\"]", "answers": "[\"Report their locations\", \"None specified\", \"None specified\", \"Report their locations\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 5.144032921810699, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.144032921810699, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 50.91183186806838, "bleu": 36.78794411714425}], "avg_f1": 0.41666666666666663, "avg_em": 0.25, "avg_chrf": 40.29997442792244, "avg_bleu": 34.19698602928607}
{"id": "wiki_11:2653", "en": "Thailand is using an app and SIM cards for all travelers to enforce their quarantine.", "fr": "La Thaïlande utilise une application et des cartes SIM pour que tous les voyageurs respectent leur quarantaine.", "perturbation": "omission", "pert_fr": "La Thaïlande utilise des cartes SIM pour que tous les voyageurs respectent leur quarantaine.", "bt_pert_fr": "Thailand uses SIM cards to ensure all travelers comply with their quarantine.", "questions": "[\"What is Thailand using to enforce quarantine for travelers?\", \"What tools are used for enforcing quarantine?\", \"What does the app and SIM cards do for travelers?\", \"What is the purpose of the app and SIM cards?\"]", "answers": "[\"SIM cards\", \"SIM cards\", \"Ensure all travelers comply with their quarantine\", \"Ensure all travelers comply with their quarantine\"]", "scores": [{"f1": 0.5714285714285715, "em": false, "chrf": 45.211889914926005, "bleu": 22.31301601484299}, {"f1": 0.5714285714285715, "em": false, "chrf": 45.211889914926005, "bleu": 22.31301601484299}, {"f1": 0.4, "em": false, "chrf": 57.00070508108295, "bleu": 13.134549472120794}, {"f1": 0.36363636363636365, "em": false, "chrf": 51.47622666393297, "bleu": 7.809849842300641}], "avg_f1": 0.47662337662337667, "avg_em": 0.0, "avg_chrf": 49.72517789371698, "avg_bleu": 16.392607836026855}
{"id": "wiki_11:2654", "en": "Human rights organizations have criticized some of these measures, asking the governments not to use the pandemic as a cover to introduce invasive digital surveillance.", "fr": "Les organisations des droits de l’homme ont critiqué certaines de ces mesures, demandant aux gouvernements de ne pas utiliser la pandémie comme prétexte pour introduire une surveillance numérique invasive.", "perturbation": "omission", "pert_fr": "Les organisations des droits de l’homme ont critiqué certaines de ces mesures, demandant aux gouvernements de ne pas utiliser la pandémie comme prétexte pour introduire une surveillance invasive.", "bt_pert_fr": "Human rights organizations have criticized some of these measures, calling on governments not to use the pandemic as a pretext to introduce invasive surveillance.", "questions": "[\"What have human rights organizations criticized?\", \"What are the governments being asked not to do?\", \"Why are governments being asked not to take certain actions?\"]", "answers": "[\"Some of these measures\", \"Use the pandemic as a pretext to introduce invasive surveillance\", \"Because human rights organizations have criticized such measures\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.823529411764706, "em": false, "chrf": 70.18867637967027, "bleu": 31.708476589333063}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9411764705882354, "avg_em": 0.6666666666666666, "avg_chrf": 90.06289212655675, "avg_bleu": 77.23615886311104}
{"id": "wiki_5:2716", "en": "b'Coronaviruses are a group of related viruses that cause diseases in mammals and birds.", "fr": "Les coronavirus sont un groupe de virus apparentés qui causent des pathologies chez les mammifères et les oiseaux.", "perturbation": "omission", "pert_fr": "Les coronavirus sont un groupe de virus qui causent des pathologies chez les mammifères et les oiseaux.", "bt_pert_fr": "Coronaviruses are a group of viruses that cause illness in mammals and birds.", "questions": "[\"What is a group of related viruses?\", \"What diseases do coronaviruses cause?\", \"In which animals do coronaviruses cause diseases?\"]", "answers": "[\"Coronaviruses\", \"Illness\", \"Mammals and birds\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 4.7115958829521905, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 68.23719862765073, "avg_bleu": 66.6666666666667}
{"id": "wiki_5:2717", "en": "In humans, coronaviruses cause respiratory tract infections that can range from mild to lethal.", "fr": "Chez les humains, les coronavirus provoquent des infections des voies respiratoires qui peuvent varier de modérées à létales.", "perturbation": "omission", "pert_fr": "Chez les humains, les coronavirus provoquent des infections qui peuvent varier de modérées à létales.", "bt_pert_fr": "In humans, coronaviruses cause infections that can range from moderate to lethal.", "questions": "[\"What diseases do coronaviruses cause in humans?\", \"What parts of the body are affected by coronaviruses in humans?\", \"What is the range of severity of infections caused by coronaviruses in humans?\", \"What types of infections can coronaviruses cause in humans?\"]", "answers": "[\"Infections that can range from moderate to lethal\", \"Not specified\", \"From moderate to lethal\", \"Infections that can range from moderate to lethal\"]", "scores": [{"f1": 0, "em": false, "chrf": 33.293632487165716, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 8.849215740412049, "bleu": 0.0}, {"f1": 0.75, "em": false, "chrf": 54.83643889731753, "bleu": 35.35533905932737}, {"f1": 0, "em": false, "chrf": 33.293632487165716, "bleu": 0.0}], "avg_f1": 0.1875, "avg_em": 0.0, "avg_chrf": 32.56822990301525, "avg_bleu": 8.838834764831843}
{"id": "wiki_5:2721", "en": "Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Coronaviridae, order Nidovirales, and realm Riboviria.", "fr": "Les coronavirus constituent la sous-famille des Orthocoronavirinae, dans la famille des Coronaviridae, l’ordre des Nidovirales et le domaine des Riboviria.", "perturbation": "omission", "pert_fr": "Les coronavirus constituent la sous-famille des Orthocoronavirinae, dans la famille des Coronaviridae et le domaine des Riboviria.", "bt_pert_fr": "Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Coronaviridae and the domain Riboviria.", "questions": "[\"What subfamily do coronaviruses belong to?\", \"What family do coronaviruses belong to?\", \"What order do coronaviruses belong to?\", \"What realm do coronaviruses belong to?\"]", "answers": "[\"Orthocoronavirinae\", \"Coronaviridae\", \"Not specified\", \"Not specified\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 10.416666666666666, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 5.208333333333333, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.5, "avg_chrf": 53.90625, "avg_bleu": 50.00000000000002}
{"id": "wiki_5:2722", "en": "They are enveloped viruses with a positive-sense single-stranded RNA genome and a nucleocapsid of helical symmetry.", "fr": "Ce sont des virus enveloppés à génome d’ARN à simple brin de sens positif et un nucléocapside à symétrie hélicoïdale.", "perturbation": "omission", "pert_fr": "Ce sont des virus enveloppés à génome d’ARN à simple brin de sens positif et un nucléocapside hélicoïdale.", "bt_pert_fr": "They are enveloped viruses with a positive-sense single-stranded RNA genome and a helical nucleocapsid.", "questions": "[\"What type of viruses are they?\", \"What is the genome type of these viruses?\", \"What is the structure of the nucleocapsid?\", \"What symmetry does the nucleocapsid have?\"]", "answers": "[\"Enveloped viruses\", \"Positive-sense single-stranded RNA\", \"Helical\", \"Helical\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 65.18012012882424, "bleu": 18.393972058572114}, {"f1": 0.6666666666666666, "em": false, "chrf": 96.34951744721859, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 30.50107118081911, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 73.45238095238095, "bleu": 0.0}], "avg_f1": 0.25, "avg_em": 0.0, "avg_chrf": 66.37077242731073, "avg_bleu": 18.356523218370636}
{"id": "wiki_5:2726", "en": "In the 1940s, two more animal coronaviruses, mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV), were isolated.Human coronaviruses were discovered in the 1960s.", "fr": "Dans les années 40, deux autres coronavirus d’origine animale, le virus de l'hépatite murine (VHM) et le virus de la gastroentérite transmissible (VGET), ont été isolés. Les coronavirus humains ont été découverts dans les années 60.", "perturbation": "omission", "pert_fr": "Dans les années 40, deux autres coronavirus d’origine animale, le virus de l'hépatite murine (VHM) et le virus de la gastroentérite transmissible (VGET), ont été isolés. Les humains ont été découverts dans les années 60.", "bt_pert_fr": "In the 1940s, two other coronaviruses of animal origin, murine hepatitis virus (MHV) and transmissible gastroenteritis virus (TSV), were isolated. Humans were discovered in the 1960s.", "questions": "[\"When were two more animal coronaviruses isolated?\", \"What are the two animal coronaviruses mentioned?\", \"When were human coronaviruses discovered?\", \"What type of coronaviruses were isolated in the 1940s?\", \"What is the significance of the isolation of mouse hepatitis virus and transmissible gastroenteritis virus?\"]", "answers": "[\"In the 1940s\", \"Murine hepatitis virus (MHV) and transmissible gastroenteritis virus (TSV)\", \"In the 1960s\", \"Animal coronaviruses\", \"They were the first coronaviruses of animal origin to be isolated\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7777777777777778, "em": false, "chrf": 89.03203942379227, "bleu": 72.59795291154772}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 46.752999171367264, "bleu": 9.287528999566801}], "avg_f1": 0.8355555555555556, "avg_em": 0.6, "avg_chrf": 87.15700771903191, "avg_bleu": 76.37709638222293}
{"id": "wiki_5:2727", "en": "The earliest ones studied were from human patients with the common cold, which were later named human coronavirus 229E and human coronavirus OC43.", "fr": "Les premiers coronavirus étudiés étaient issus de patients humains présentant un rhume commun ; ils ont ensuite été appelés coronavirus humain 229E et coronavirus humain OC43.", "perturbation": "omission", "pert_fr": "Les premiers coronavirus étudiés étaient issus de patients humains  ; ils ont ensuite été appelés coronavirus humain 229E et coronavirus humain OC43.", "bt_pert_fr": "The first coronaviruses studied came from human patients; they were later called human coronavirus 229E and human coronavirus OC43.", "questions": "[\"What were the earliest ones studied?\", \"What are the names of the coronaviruses named from human patients with the common cold?\", \"What is the origin of the names human coronavirus 229E and human coronavirus OC43?\"]", "answers": "[\"The first coronaviruses studied\", \"human coronavirus 229E and human coronavirus OC43\", \"human patients\"]", "scores": [{"f1": 0, "em": false, "chrf": 10.486828800109688, "bleu": 0.0}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.52646005366397, "bleu": 80.91067115702207}, {"f1": 0.5, "em": false, "chrf": 41.92937414493519, "bleu": 13.533528323661276}], "avg_f1": 0.4523809523809524, "avg_em": 0.0, "avg_chrf": 49.98088766623628, "avg_bleu": 31.481399826894446}
{"id": "wiki_5:2732", "en": "The name refers to the characteristic appearance of virions (the infective form of the virus) by electron microscopy, which have a fringe of large, bulbous surface projections creating an image reminiscent of a crown or of a solar corona.", "fr": "Ce nom se réfère à l’apparence caractéristique des virions (la forme infectieuse du virus) au microscope électronique, ces derniers possédant une frange de projections superficielles larges et bulbeuses qui donne une image rappelant la couronne solaire.", "perturbation": "omission", "pert_fr": "Ce nom se réfère à l’apparence caractéristique des virions au microscope électronique, ces derniers possédant une frange de projections superficielles larges et bulbeuses qui donne une image rappelant la couronne solaire.", "bt_pert_fr": "This name refers to the characteristic appearance of virions under the electron microscope, the latter having a fringe of large and bulbous surface projections which gives an image reminiscent of the solar corona.", "questions": "[\"What does the name refer to?\", \"What is the characteristic appearance of virions?\", \"How do virions appear under electron microscopy?\", \"What features create the characteristic appearance of virions?\", \"What does the appearance of virions resemble?\", \"What is the infective form of the virus called?\"]", "answers": "[\"The characteristic appearance of virions under the electron microscope\", \"The characteristic appearance of virions under the electron microscope\", \"The latter having a fringe of large and bulbous surface projections\", \"A fringe of large and bulbous surface projections\", \"The solar corona\", \"Virions\"]", "scores": [{"f1": 0.32432432432432434, "em": false, "chrf": 34.21998079972349, "bleu": 3.9195868105808866}, {"f1": 0.13333333333333333, "em": false, "chrf": 18.45112208303736, "bleu": 5.522397783539471}, {"f1": 0.4615384615384615, "em": false, "chrf": 47.17795650717751, "bleu": 14.416787170305081}, {"f1": 0.9333333333333333, "em": false, "chrf": 91.41394216760807, "bleu": 50.000000000000014}, {"f1": 0.5, "em": false, "chrf": 54.29299281996598, "bleu": 28.254432923044853}, {"f1": 0, "em": false, "chrf": 73.45238095238095, "bleu": 0.0}], "avg_f1": 0.3920882420882421, "avg_em": 0.0, "avg_chrf": 53.16806255498222, "avg_bleu": 17.018867447911717}
{"id": "wiki_5:2735", "en": "The envelope of the virus in electron micrographs appears as a distinct pair of electron dense shells.The viral envelope consists of a lipid bilayer where the membrane (M), envelope (E) and spike (S) structural proteins are anchored.", "fr": "L’enveloppe du virus sous microscope électronique ressemble à une paire distincte de coquilles denses en électron. L’enveloppe virale est constituée d’une bicouche lipidique où sont ancrées les protéines structurales de la membrane (M), de l’enveloppe (E) et de la spicule (S).", "perturbation": "omission", "pert_fr": "L’enveloppe du virus sous microscope électronique ressemble à une paire distincte de coquilles denses en électron. L’enveloppe virale est constituée d’une bicouche lipidique où sont ancrées les protéines structurales de la membrane (M) et de l’enveloppe (E).", "bt_pert_fr": "The virus envelope under an electron microscope looks like a distinct pair of electron-dense shells. The viral envelope is made up of a lipid bilayer where the structural proteins of the membrane (M) and envelope (E) are anchored.", "questions": "[\"What does the envelope of the virus appear as in electron micrographs?\", \"What consists of the viral envelope?\", \"What structural proteins are anchored in the viral envelope?\", \"What is the structure of the viral envelope according to the electron micrographs?\"]", "answers": "[\"A distinct pair of electron-dense shells\", \"A lipid bilayer where the structural proteins of the membrane (M) and envelope (E) are anchored\", \"Structural proteins of the membrane (M) and envelope (E)\", \"A distinct pair of electron-dense shells\"]", "scores": [{"f1": 0.7692307692307692, "em": false, "chrf": 100.0, "bleu": 45.48019047027906}, {"f1": 0.35294117647058826, "em": false, "chrf": 47.842247205460346, "bleu": 10.571070857151538}, {"f1": 0.5333333333333333, "em": false, "chrf": 49.5784172961458, "bleu": 13.134549472120788}, {"f1": 0.7692307692307692, "em": false, "chrf": 100.0, "bleu": 45.48019047027906}], "avg_f1": 0.606184012066365, "avg_em": 0.0, "avg_chrf": 74.35516612540154, "avg_bleu": 28.66650031745761}
{"id": "wiki_5:2737", "en": "Coronaviruses contain a positive-sense, single-stranded RNA genome.", "fr": "Les coronavirus contiennent un virus à ARN à simple brin de sens positif.", "perturbation": "omission", "pert_fr": "Les coronavirus contiennent un virus à simple brin de sens positif.", "bt_pert_fr": "Coronaviruses contain a positive-sense, single-stranded virus.", "questions": "[\"What type of genome do coronaviruses contain?\", \"What is the structure of the coronavirus genome?\", \"What does the genome of coronaviruses consist of?\", \"What is the sense of the RNA genome in coronaviruses?\"]", "answers": "[\"Positive-sense, single-stranded RNA\", \"Positive-sense, single-stranded\", \"Positive-sense, single-stranded RNA\", \"Positive\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2738", "en": "The genome size for coronaviruses ranges from 26.4 to 31.7 kilobases.", "fr": "La taille du génome des coronavirus varie de 26,4 à 31,7 kilobases.", "perturbation": "omission", "pert_fr": "La taille du génome varie de 26,4 à 31,7 kilobases.", "bt_pert_fr": "Genome size ranges from 26.4 to 31.7 kilobases.", "questions": "[\"What is the range of genome size for coronaviruses?\", \"What unit is used to measure the genome size of coronaviruses?\", \"What type of virus has this genome size range?\"]", "answers": "[\"26.4 to 31.7 kilobases\", \"kilobases\", \"coronaviruses\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 90.21205646205644, "bleu": 0.0}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 96.73735215401882, "avg_bleu": 66.6666666666667}
{"id": "wiki_5:2741", "en": "The replicase/transcriptase polyprotein self cleaves to form nonstructural proteins.The later reading frames encode the four major structural proteins: spike, envelope, membrane, and nucleocapsid.", "fr": "La polyprotéine réplicase/transcriptase s’autoclive pour former des protéines non structurales. Les cadres de lecture ultérieurs codent les quatre principales protéines structurales : spicule, enveloppe, membrane et nucléocapside.", "perturbation": "omission", "pert_fr": "La polyprotéine réplicase/transcriptase s’autoclive pour former des protéines non structurales. Les cadres de lecture ultérieurs codent les quatre principales protéines structurales : spicule, enveloppe et nucléocapside.", "bt_pert_fr": "The polyprotein replicase/transcriptase self-cleaves to form non-structural proteins. Later reading frames encode the four major structural proteins: spike, envelope, and nucleocapsid.", "questions": "[\"What does the replicase/transcriptase polyprotein do?\", \"What forms as a result of the self-cleavage of the replicase/transcriptase polyprotein?\", \"What are the four major structural proteins encoded by the later reading frames?\", \"What are the names of the four major structural proteins?\", \"What is the function of the later reading frames?\"]", "answers": "[\"It self-cleaves\", \"Non-structural proteins\", \"Spike, envelope, and nucleocapsid\", \"Spike, envelope, and nucleocapsid\", \"To encode the four major structural proteins\"]", "scores": [{"f1": 0.4, "em": false, "chrf": 100.0, "bleu": 30.326532985631665}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.888888888888889, "em": false, "chrf": 74.39376036665728, "bleu": 35.186297399811885}, {"f1": 0.888888888888889, "em": false, "chrf": 74.39376036665728, "bleu": 35.186297399811885}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8355555555555556, "avg_em": 0.4, "avg_chrf": 89.75750414666291, "avg_bleu": 60.13982555705111}
{"id": "wiki_5:2742", "en": "Interspersed between these reading frames are the reading frames for the accessory proteins.", "fr": "Entre ces cadres de lecture se trouvent les cadres de lecture des protéines accessoires.", "perturbation": "omission", "pert_fr": "Entre ces cadres de lecture se trouvent les protéines accessoires.", "bt_pert_fr": "Between these reading frames are the accessory proteins.", "questions": "[\"What are the reading frames for?\", \"What are accessory proteins?\"]", "answers": "[\"The accessory proteins\", \"Proteins that are located between the reading frames\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4, "em": false, "chrf": 32.58574038186714, "bleu": 6.628576403773604}], "avg_f1": 0.7, "avg_em": 0.5, "avg_chrf": 66.29287019093357, "avg_bleu": 53.314288201886825}
{"id": "wiki_5:2744", "en": "Infection begins when the viral spike (S) glycoprotein attaches to its complementary host cell receptor.", "fr": "L’infection commence lorsque la glycoprotéine virale à spicule (S) s’attache à son récepteur hôte complémentaire.", "perturbation": "omission", "pert_fr": "L’infection commence lorsque la glycoprotéine virale s’attache à son récepteur hôte complémentaire.", "bt_pert_fr": "Infection begins when the viral glycoprotein attaches to its complementary host receptor.", "questions": "[\"What starts the infection?\", \"What part of the virus attaches to the host cell receptor?\", \"What is the viral spike (S) glycoprotein?\", \"What is the host cell receptor?\", \"What is the mechanism of infection initiation?\"]", "answers": "[\"The infection\", \"The viral glycoprotein\", \"Not specified\", \"The host cell receptor\", \"The viral glycoprotein attaching to its complementary host receptor\"]", "scores": [{"f1": 0, "em": false, "chrf": 76.13583122066679, "bleu": 0.0}, {"f1": 0.7499999999999999, "em": false, "chrf": 66.48341103651549, "bleu": 32.34325178227722}, {"f1": 0, "em": false, "chrf": 4.444834660066448, "bleu": 0.0}, {"f1": 0.888888888888889, "em": false, "chrf": 64.53955243263583, "bleu": 29.588031349552907}, {"f1": 0.7272727272727274, "em": false, "chrf": 62.18705049718879, "bleu": 22.75857642217292}], "avg_f1": 0.4732323232323233, "avg_em": 0.0, "avg_chrf": 54.758135969414674, "avg_bleu": 16.93797191080061}
{"id": "wiki_5:2747", "en": "The host ribosome translates the initial overlapping open reading frame of the virus genome and forms a long polyprotein.", "fr": "Le ribosome hôte convertit le cadre de lecture ouvert initial se chevauchant du génome viral et forme une longue polyprotéine.", "perturbation": "omission", "pert_fr": "Le ribosome hôte convertit le cadre de lecture ouvert initial du génome viral et forme une longue polyprotéine.", "bt_pert_fr": "The host ribosome converts the initial open reading frame of the viral genome and forms a long polyprotein.", "questions": "[\"What does the host ribosome translate?\", \"What is formed when the host ribosome translates the initial overlapping open reading frame?\", \"What is a long polyprotein?\", \"What process involves the translation of the initial overlapping open reading frame?\"]", "answers": "[\"The initial open reading frame of the viral genome\", \"A long polyprotein\", \"A long polyprotein is a single protein chain produced from the translation of a viral genome's open reading frame\", \"Translation\"]", "scores": [{"f1": 0.823529411764706, "em": false, "chrf": 67.34712837583632, "bleu": 37.70794596593209}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.48484848484848486, "em": false, "chrf": 51.33042598644392, "bleu": 21.507070017014073}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8270944741532977, "avg_em": 0.5, "avg_chrf": 79.66938859057007, "avg_bleu": 64.80375399573656}
{"id": "wiki_5:2748", "en": "The polyprotein has its own proteases which cleave the polyprotein into multiple nonstructural proteins.", "fr": "La polyprotéine dispose de sa propre protéase qui clive la polyprotéine en de multiples protéines non structurales.", "perturbation": "omission", "pert_fr": "La polyprotéine dispose de sa propre protéase qui clive en de multiples protéines non structurales.", "bt_pert_fr": "The polyprotein has its own protease which cleaves into multiple non-structural proteins.", "questions": "[\"What does the polyprotein have?\", \"What cleaves the polyprotein?\", \"What are the products of the cleavage of the polyprotein?\", \"What type of proteins are produced from the cleavage?\", \"What is the role of the proteases in the polyprotein?\"]", "answers": "[\"Its own protease\", \"The protease\", \"Multiple non-structural proteins\", \"Non-structural proteins\", \"The protease cleaves the polyprotein into multiple non-structural proteins\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 93.36837027445603, "bleu": 55.03212081491043}, {"f1": 0.5, "em": false, "chrf": 91.09666585944807, "bleu": 49.99999999999999}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.75, "em": false, "chrf": 90.28468072817833, "bleu": 54.10822690539397}], "avg_f1": 0.7833333333333333, "avg_em": 0.4, "avg_chrf": 94.94994337241648, "avg_bleu": 71.8280695440609}
{"id": "wiki_5:2752", "en": "The other nonstructural proteins in the complex assist in the replication and transcription process.", "fr": "Les autres protéines non structurales du complexe assistent le processus de réplication et de transcription.", "perturbation": "omission", "pert_fr": "Les autres protéines non structurales du complexe assistent le processus de réplication.", "bt_pert_fr": "The other non-structural proteins of the complex assist the replication process.", "questions": "[\"What does the other nonstructural proteins in the complex assist with?\", \"What process do the nonstructural proteins assist in?\", \"What are the other nonstructural proteins involved in?\"]", "answers": "[\"The replication process\", \"The replication process\", \"The replication process\"]", "scores": [{"f1": 0.7499999999999999, "em": false, "chrf": 58.415492767753605, "bleu": 32.34325178227722}, {"f1": 0.7499999999999999, "em": false, "chrf": 58.415492767753605, "bleu": 32.34325178227722}, {"f1": 0.7499999999999999, "em": false, "chrf": 58.415492767753605, "bleu": 32.34325178227722}], "avg_f1": 0.7499999999999999, "avg_em": 0.0, "avg_chrf": 58.4154927677536, "avg_bleu": 32.34325178227722}
{"id": "wiki_5:2753", "en": "The exoribonuclease nonstructural protein, for instance, provides extra fidelity to replication by providing a proofreading function which the RNA-dependent RNA polymerase lacks.One of the main functions of the complex is to replicate the viral genome.", "fr": "La protéine non structurale exoribonucléase, par exemple, apporte une fidélité supplémentaire dans la réplication en fournissant une fonction de relecture dont manque l’ARN polymérase ARN dépendante. L’une des fonctions principales du complexe est la réplication du génome viral.", "perturbation": "omission", "pert_fr": "La protéine non structurale exoribonucléase, par exemple, apporte une fidélité supplémentaire dans la réplication en fournissant une fonction de relecture dont manque l’ARN polymérase. L’une des fonctions principales du complexe est la réplication du génome viral.", "bt_pert_fr": "The non-structural protein exoribonuclease, for example, provides additional fidelity in replication by providing a proofreading function that RNA polymerase lacks. One of the main functions of the complex is the replication of the viral genome.", "questions": "[\"What is the function of the exoribonuclease nonstructural protein?\", \"How does the exoribonuclease nonstructural protein improve replication fidelity?\", \"What does the RNA-dependent RNA polymerase lack?\", \"What is the main function of the complex?\", \"What is the role of the exoribonuclease nonstructural protein in viral replication?\"]", "answers": "[\"Providing a proofreading function\", \"By providing a proofreading function that RNA polymerase lacks\", \"A proofreading function\", \"The replication of the viral genome\", \"It provides additional fidelity in replication by providing a proofreading function that RNA polymerase lacks\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 47.193818801426644, "bleu": 8.525588607164655}, {"f1": 0.823529411764706, "em": false, "chrf": 74.32278513207007, "bleu": 44.12484512922978}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.4444444444444445, "em": false, "chrf": 69.54533863457286, "bleu": 21.3643503198117}, {"f1": 0.6666666666666666, "em": false, "chrf": 76.82188941139269, "bleu": 31.614875844889426}], "avg_f1": 0.6869281045751634, "avg_em": 0.2, "avg_chrf": 73.57676639589245, "avg_bleu": 41.12593198021912}
{"id": "wiki_5:2756", "en": "The other important function of the complex is to transcribe the viral genome.", "fr": "L'autre fonction importante du complexe est la réplication du génome viral.", "perturbation": "omission", "pert_fr": "L'autre fonction importante du complexe est la réplication viral.", "bt_pert_fr": "The other important function of the complex is viral replication.", "questions": "[\"What is the other important function of the complex?\", \"What does the complex transcribe?\"]", "answers": "[\"Viral replication\", \"The sentence does not provide information about what the complex transcribes.\"]", "scores": [{"f1": 0, "em": false, "chrf": 14.283915610038825, "bleu": 0.0}, {"f1": 0.15384615384615383, "em": false, "chrf": 14.989718948433586, "bleu": 4.196114906296549}], "avg_f1": 0.07692307692307691, "avg_em": 0.0, "avg_chrf": 14.636817279236205, "avg_bleu": 2.0980574531482743}
{"id": "wiki_5:2758", "en": "This is followed by the transcription of these negative-sense subgenomic RNA molecules to their corresponding positive-sense mRNAs.", "fr": "Ceci est suivi par la transcription de ces molécules d'ARN subgénomique de sens négatif en leurs ARNm de sens positif correspondants.", "perturbation": "omission", "pert_fr": "Ceci est suivi par la transcription de ces molécules d'ARN subgénomique en leurs ARNm de sens positif correspondants.", "bt_pert_fr": "This is followed by transcription of these subgenomic RNA molecules into their corresponding positive-sense mRNAs.", "questions": "[\"What are the resulting molecules from transcription?\", \"What is the process of transcription in this context?\"]", "answers": "[\"positive-sense mRNAs\", \"transcription of these subgenomic RNA molecules into their corresponding positive-sense mRNAs\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 93.46837666690608, "bleu": 49.99999999999999}, {"f1": 0.7826086956521738, "em": false, "chrf": 81.57946747293686, "bleu": 34.53155548318878}], "avg_f1": 0.6413043478260869, "avg_em": 0.0, "avg_chrf": 87.52392206992147, "avg_bleu": 42.26577774159439}
{"id": "wiki_5:2759", "en": "The replicated positive-sense genomic RNA becomes the genome of the progeny viruses.", "fr": "L'ARN génomique de sens positif répliqué devient le génome des virus descendants.", "perturbation": "omission", "pert_fr": "L'ARN génomique répliqué devient le génome des virus descendants.", "bt_pert_fr": "The replicated genomic RNA becomes the genome of the descendant viruses.", "questions": "[\"What becomes the genome of the progeny viruses?\", \"What is the result of the replication of positive-sense RNA?\"]", "answers": "[\"The replicated genomic RNA\", \"The genome of the descendant viruses\"]", "scores": [{"f1": 0.888888888888889, "em": false, "chrf": 57.823960339669, "bleu": 35.186297399811885}, {"f1": 0.8000000000000002, "em": false, "chrf": 57.46430631576517, "bleu": 42.7287006396234}], "avg_f1": 0.8444444444444446, "avg_em": 0.0, "avg_chrf": 57.644133327717086, "avg_bleu": 38.957499019717645}
{"id": "wiki_5:2760", "en": "The mRNAs are gene transcripts of the last third of the virus genome after the initial overlapping reading frame.", "fr": "Les ARNm sont des transcrits géniques du dernier tiers du génome, qui suit les cadres de lecture initiaux se chevauchant.", "perturbation": "omission", "pert_fr": "Les ARNm sont des transcrits géniques du dernier tiers du génome, qui suit les cadres de lecture initiaux.", "bt_pert_fr": "mRNAs are gene transcripts from the last third of the genome, which follows the initial reading frames.", "questions": "[\"What are mRNAs in the context of the virus genome?\", \"What part of the virus genome do mRNAs originate from?\", \"What is the process of gene transcription in the virus genome?\"]", "answers": "[\"Gene transcripts from the last third of the genome\", \"The last third of the genome\", \"Gene transcripts are produced from the last third of the genome following the initial reading frames\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 39.41552155841739, "bleu": 13.653323887370865}, {"f1": 0.625, "em": false, "chrf": 30.109397513270014, "bleu": 21.297646969725616}, {"f1": 0.4571428571428572, "em": false, "chrf": 49.160588068936114, "bleu": 14.471067859881398}], "avg_f1": 0.5607142857142857, "avg_em": 0.0, "avg_chrf": 39.56183571354117, "avg_bleu": 16.474012905659293}
{"id": "wiki_5:2763", "en": "The viral structural proteins S, E, and M move along the secretory pathway into the Golgi intermediate compartment.", "fr": "Les protéines structurales virales S, E et M se déplacent le long de la voie de sécrétion dans le compartiment intermédiaire de Golgi.", "perturbation": "omission", "pert_fr": "Les protéines structurales virales S et M se déplacent le long de la voie de sécrétion dans le compartiment intermédiaire de Golgi.", "bt_pert_fr": "The viral S and M structural proteins move along the secretory pathway into the Golgi intermediate compartment.", "questions": "[\"What viral structural proteins move along the secretory pathway?\", \"Which compartment do the viral structural proteins move into?\", \"What is the path of the viral structural proteins?\"]", "answers": "[\"S and M\", \"The Golgi intermediate compartment\", \"The secretory pathway into the Golgi intermediate compartment\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 47.4481658692185, "bleu": 45.13864405503391}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6, "em": false, "chrf": 71.97874857556096, "bleu": 24.446151121745054}], "avg_f1": 0.8190476190476191, "avg_em": 0.3333333333333333, "avg_chrf": 73.14230481492649, "avg_bleu": 56.52826505892634}
{"id": "wiki_5:2764", "en": "There, the M proteins direct most protein-protein interactions required for assembly of viruses following its binding to the nucleocapsid.", "fr": "Là, les protéines M dirigent la plupart des interactions protéine-protéine nécessaires à l'assemblage des virus après sa liaison à la nucléocapside.", "perturbation": "omission", "pert_fr": "Là, les protéines dirigent la plupart des interactions protéine-protéine nécessaires à l'assemblage des virus après sa liaison à la nucléocapside.", "bt_pert_fr": "There, proteins direct most of the protein-protein interactions necessary for virus assembly after it binds to the nucleocapsid.", "questions": "[\"What role do M proteins play in virus assembly?\", \"What interactions do M proteins direct?\", \"What is required for virus assembly?\", \"What does the M protein bind to?\", \"What is the nucleocapsid?\"]", "answers": "[\"The role of M proteins in virus assembly is not mentioned in the sentence\", \"Protein-protein interactions\", \"Protein-protein interactions necessary for virus assembly\", \"The sentence does not specify what the M protein binds to\", \"The sentence does not define what the nucleocapsid is\"]", "scores": [{"f1": 0.18181818181818185, "em": false, "chrf": 33.19085032585919, "bleu": 3.673526562988939}, {"f1": 0.4, "em": false, "chrf": 84.2062332956558, "bleu": 30.326532985631665}, {"f1": 0.42857142857142855, "em": false, "chrf": 59.69429591616569, "bleu": 7.654112967106117}, {"f1": 0.16666666666666669, "em": false, "chrf": 13.831054707638321, "bleu": 4.196114906296549}, {"f1": 0.16666666666666666, "em": false, "chrf": 34.67557973908521, "bleu": 5.522397783539471}], "avg_f1": 0.2687445887445888, "avg_em": 0.0, "avg_chrf": 45.11960279688084, "avg_bleu": 10.274537041112549}
{"id": "wiki_5:2766", "en": "The interaction of the coronavirus spike protein with its complement host cell receptor is central in determining the tissue tropism, infectivity, and species range of the virus.", "fr": "L’interaction du spicule du coronavirus avec le récepteur de la cellule hôte complémentaire est essentielle dans la détermination du tropisme tissulaire, de l’infectivité et de la variété d’espèces du virus.", "perturbation": "omission", "pert_fr": "L’interaction du spicule du coronavirus avec le récepteur de la cellule hôte est essentielle dans la détermination du tropisme tissulaire, de l’infectivité et de la variété d’espèces du virus.", "bt_pert_fr": "The interaction of the coronavirus spike with the host cell receptor is essential in determining the tissue tropism, infectivity, and species variety of the virus.", "questions": "[\"What is central in determining the tissue tropism, infectivity, and species range of the virus?\", \"What does the coronavirus spike protein interact with?\", \"What determines the species range of the virus?\"]", "answers": "[\"The interaction of the coronavirus spike with the host cell receptor\", \"The host cell receptor\", \"The interaction of the coronavirus spike with the host cell receptor\"]", "scores": [{"f1": 0.8571428571428571, "em": false, "chrf": 68.04638961458714, "bleu": 44.05149609594086}, {"f1": 0.6666666666666665, "em": false, "chrf": 55.509421257835875, "bleu": 46.30777161991026}, {"f1": 0.8571428571428571, "em": false, "chrf": 68.04638961458714, "bleu": 44.05149609594086}], "avg_f1": 0.7936507936507935, "avg_em": 0.0, "avg_chrf": 63.867400162336715, "avg_bleu": 44.80358793726399}
{"id": "wiki_5:2767", "en": "The SARS coronavirus, for example, infects human cells by attaching to the angiotensin-converting enzyme 2 (ACE2) receptor.", "fr": "Le coronavirus du SRAS, par exemple, infecte les cellules humaines en se liant au récepteur de l’enzyme de conversion de l’angiotensine 2 (ACE2).", "perturbation": "omission", "pert_fr": "Le coronavirus du SRAS, par exemple, infecte les cellules en se liant au récepteur de l’enzyme de conversion de l’angiotensine 2 (ACE2).", "bt_pert_fr": "The SARS coronavirus, for example, infects cells by binding to the angiotensin-converting enzyme 2 (ACE2) receptor.", "questions": "[\"How does the SARS coronavirus infect human cells?\", \"What receptor does the SARS coronavirus attach to?\", \"What is the role of the ACE2 receptor in infection?\"]", "answers": "[\"By binding to the angiotensin-converting enzyme 2 (ACE2) receptor\", \"The angiotensin-converting enzyme 2 (ACE2) receptor\", \"It serves as the receptor that the SARS coronavirus binds to in order to infect cells\"]", "scores": [{"f1": 0.875, "em": false, "chrf": 85.76941372276401, "bleu": 70.71067811865478}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6153846153846153, "em": false, "chrf": 53.924116672026926, "bleu": 16.06455374563062}], "avg_f1": 0.8301282051282052, "avg_em": 0.3333333333333333, "avg_chrf": 79.89784346493032, "avg_bleu": 62.25841062142848}
{"id": "wiki_5:2768", "en": "The scientific name for coronavirus is Orthocoronavirinae or Coronavirinae.", "fr": "Le nom scientifique du coronavirus est Orthocoronavirinae ou Coronavirinae.", "perturbation": "omission", "pert_fr": "Le nom scientifique du coronavirus est Coronavirinae.", "bt_pert_fr": "The scientific name of the coronavirus is Coronavirinae.", "questions": "[\"What is the scientific name for coronavirus?\", \"What are the two scientific names mentioned for coronavirus?\"]", "answers": "[\"Coronavirinae\", \"Coronavirinae\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 39.403468117067355, "bleu": 13.533528323661276}, {"f1": 0.5, "em": false, "chrf": 39.403468117067355, "bleu": 13.533528323661276}], "avg_f1": 0.5, "avg_em": 0.0, "avg_chrf": 39.403468117067355, "avg_bleu": 13.533528323661276}
{"id": "wiki_5:2769", "en": "Coronaviruses belong to the family of Coronaviridae, order Nidovirales, and realm Riboviria.", "fr": "Les coronavirus appartiennent à la famille des Coronaviridae, à l’ordre des Nidovirales et au domaine des Riboviria.", "perturbation": "omission", "pert_fr": "Les coronavirus appartiennent à la famille des Coronaviridae et au domaine des Riboviria.", "bt_pert_fr": "Coronaviruses belong to the Coronaviridae family and the Riboviria domain.", "questions": "[\"To which family do coronaviruses belong?\", \"What order do coronaviruses belong to?\", \"What realm do coronaviruses belong to?\"]", "answers": "[\"Coronaviridae\", \"Not specified\", \"Riboviria\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 10.416666666666666, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.6666666666666666, "avg_em": 0.6666666666666666, "avg_chrf": 70.13888888888889, "avg_bleu": 66.6666666666667}
{"id": "wiki_5:2773", "en": "The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed as recently as 8000 BCE, although some models place the common ancestor as far back as 55 million years or more, implying long term coevolution with bat and avian species.", "fr": "On estime que le plus récent ancêtre commun (MRCA) de tous les coronavirus a existé 8 000 ans avant notre ère, bien que certains modèles placent l’ancêtre commun il y a 55 millions d’années ou plus, ce qui implique une coévolution à long terme au sein des espèces de chauves-souris et d’oiseaux.", "perturbation": "omission", "pert_fr": "On estime que le plus récent ancêtre commun (MRCA) de tous les coronavirus a existé 8 000 ans avant notre ère, bien que certains modèles placent l’ancêtre commun il y a 55 millions d’années ou plus, ce qui implique une coévolution à long terme au sein des espèces de chauves-souris.", "bt_pert_fr": "The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed 8,000 BCE, although some models place the common ancestor 55 million years ago or more, implying long-term coevolution within bat species.", "questions": "[\"When is the most recent common ancestor (MRCA) of all coronaviruses estimated to have existed?\", \"What is the range of estimated times for the MRCA of all coronaviruses?\", \"What does the estimate imply about the relationship between coronaviruses and bat and avian species?\"]", "answers": "[\"8,000 BCE\", \"From 8,000 BCE to 55 million years ago\", \"Long-term coevolution within bat species\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5217391304347827, "em": false, "chrf": 41.43525040791268, "bleu": 14.411786453067819}, {"f1": 0.4615384615384615, "em": false, "chrf": 70.13884955889826, "bleu": 7.715486568024961}], "avg_f1": 0.6610925306577481, "avg_em": 0.3333333333333333, "avg_chrf": 70.52469998893697, "avg_bleu": 40.70909100703094}
{"id": "wiki_5:2774", "en": "The most recent common ancestor of the alphacoronavirus line has been placed at about 2400 BCE, the betacoronavirus line at 3300 BCE, the gammacoronavirus line at 2800 BCE, and the deltacoronavirus line at about 3000 BCE.", "fr": "Le plus récent ancêtre commun de la lignée de l’alphacoronavirus a été positionné environ 2 400 ans avant notre ère, la lignée des bêtacoronavirus environ 3 300 ans avant notre ère, la lignée des gammacoronavirus environ 2 800 ans avant notre ère et la lignée des deltacoronavirus environ 3 000 ans avant notre ère.", "perturbation": "omission", "pert_fr": "Le plus récent ancêtre commun de la lignée de l’alphacoronavirus a été positionné environ 2 400 ans avant notre ère, la lignée des bêtacoronavirus environ 3 300 ans avant notre ère, la lignée des gammacoronavirus environ 2 800 ans avant notre ère et la lignée des deltacoronavirus environ notre ère.", "bt_pert_fr": "The most recent common ancestor of the alphacoronavirus lineage has been positioned around 2400 BCE, the betacoronavirus lineage around 3300 BCE, the gammacoronavirus lineage around 2800 BCE, and the deltacoronavirus lineage around 2800 BCE.", "questions": "[\"When was the most recent common ancestor of the alphacoronavirus line placed?\", \"When was the most recent common ancestor of the betacoronavirus line placed?\", \"When was the most recent common ancestor of the gammacoronavirus line placed?\", \"When was the most recent common ancestor of the deltacoronavirus line placed?\"]", "answers": "[\"around 2400 BCE\", \"around 3300 BCE\", \"around 2800 BCE\", \"around 2800 BCE\"]", "scores": [{"f1": 0.6666666666666666, "em": false, "chrf": 50.22379405084957, "bleu": 55.03212081491043}, {"f1": 0.8, "em": false, "chrf": 77.84608846029838, "bleu": 55.03212081491043}, {"f1": 0.8, "em": false, "chrf": 77.84608846029838, "bleu": 55.03212081491043}, {"f1": 0.3333333333333333, "em": false, "chrf": 28.927733315739673, "bleu": 27.516060407455225}], "avg_f1": 0.65, "avg_em": 0.0, "avg_chrf": 58.7109260717965, "avg_bleu": 48.15310571304663}
{"id": "wiki_5:2775", "en": "The large number of host bat and avian species, and their global range, has enabled extensive evolution and dissemination of coronaviruses.Many human coronavirus have their origin in bats.", "fr": "Le grand nombre d’espèces de chauves-souris et d’oiseaux hôtes et leur répartition mondiale ont permis une évolution et une dissémination importantes des coronavirus. De nombreux coronavirus humains trouvent leur origine chez les chauves-souris.", "perturbation": "omission", "pert_fr": "Le grand nombre d’espèces de chauves-souris hôtes et leur répartition mondiale ont permis une évolution et une dissémination importantes des coronavirus. De nombreux coronavirus humains trouvent leur origine chez les chauves-souris.", "bt_pert_fr": "The large number of bat host species and their global distribution have enabled significant evolution and dissemination of coronaviruses. Many human coronaviruses originate in bats.", "questions": "[\"What has enabled the extensive evolution and dissemination of coronaviruses?\", \"What host species are mentioned in relation to coronaviruses?\", \"What is the global range of host species?\", \"What is the origin of many human coronaviruses?\", \"Which animals are associated with the origin of human coronaviruses?\"]", "answers": "[\"The large number of bat host species and their global distribution\", \"bat host species\", \"global\", \"bats\", \"bats\"]", "scores": [{"f1": 0.8333333333333333, "em": false, "chrf": 64.7354050516158, "bleu": 41.36817680097793}, {"f1": 0.3333333333333333, "em": false, "chrf": 10.628468070346267, "bleu": 27.516060407455225}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 58.011049723756905, "bleu": 36.78794411714425}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7666666666666666, "avg_em": 0.4, "avg_chrf": 66.67498456914379, "avg_bleu": 61.1344362651155}
{"id": "wiki_5:2777", "en": "MERS-CoV emerged in humans from bats through the intermediate host of camels.", "fr": "Le MERS-CoV est apparu chez l’humain, issu des chauves-souris via l’hôte intermédiaire des chameaux.", "perturbation": "omission", "pert_fr": "Le MERS-CoV est apparu chez l’humain, issu des chauves-souris via des chameaux.", "bt_pert_fr": "MERS-CoV appeared in humans, originating from bats via camels.", "questions": "[\"How did MERS-CoV emerge in humans?\", \"What is the origin of MERS-CoV?\", \"What are the intermediate hosts involved in MERS-CoV transmission?\", \"What role do camels play in MERS-CoV transmission?\", \"What is the transmission pathway of MERS-CoV?\"]", "answers": "[\"Originating from bats via camels\", \"Bats\", \"Camels\", \"Camels act as intermediate hosts\", \"From bats to camels to humans\"]", "scores": [{"f1": 0.3333333333333333, "em": false, "chrf": 27.904706285945075, "bleu": 8.515289178380433}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.37499999999999994, "em": false, "chrf": 37.93731450412947, "bleu": 7.1212974649072365}, {"f1": 0.4444444444444444, "em": false, "chrf": 30.10934796089303, "bleu": 8.44558802779791}], "avg_f1": 0.6305555555555555, "avg_em": 0.4, "avg_chrf": 59.19027375019351, "avg_bleu": 44.81643493421713}
{"id": "wiki_5:2778", "en": "MERS-CoV, although related to several bat coronavirus species, appears to have diverged from these several centuries ago.", "fr": "Le MERS-CoV, bien qu’apparenté à plusieurs espèces de coronavirus de chauves-souris, semble s’être éloigné de ces derniers il y a plusieurs siècles.", "perturbation": "omission", "pert_fr": "Le MERS-CoV, bien qu’apparenté à plusieurs espèces de coronavirus, semble s’être éloigné de ces derniers il y a plusieurs siècles.", "bt_pert_fr": "MERS-CoV, although related to several species of coronaviruses, appears to have moved away from them several centuries ago.", "questions": "[\"What is MERS-CoV related to?\", \"When did MERS-CoV diverge from bat coronavirus species?\", \"What does the divergence of MERS-CoV indicate?\", \"What is the significance of MERS-CoV diverging from bat coronaviruses centuries ago?\"]", "answers": "[\"Several species of coronaviruses\", \"Several centuries ago\", \"That MERS-CoV has evolved independently from its relatives\", \"That MERS-CoV has a long evolutionary history separate from bat coronaviruses\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 67.06147167784839, "bleu": 18.99589214128981}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.47058823529411764, "em": false, "chrf": 33.71485075439825, "bleu": 19.493995755254467}, {"f1": 0.608695652173913, "em": false, "chrf": 50.131612329429, "bleu": 20.225232797581672}], "avg_f1": 0.6448209718670077, "avg_em": 0.25, "avg_chrf": 62.726983690418905, "avg_bleu": 39.6787801735315}
{"id": "wiki_5:2779", "en": "The most closely related bat coronavirus and SARS-CoV diverged in 1986.", "fr": "Le coronavirus le plus proche du coronavirus de chauve-souris et le SARS-CoV se sont éloignés en 1986.", "perturbation": "omission", "pert_fr": "Le coronavirus le plus proche du SARS-CoV se sont éloignés en 1986.", "bt_pert_fr": "The closest coronavirus to SARS-CoV became distant in 1986.", "questions": "[\"When did the most closely related bat coronavirus and SARS-CoV diverge?\", \"What is the relationship between the most closely related bat coronavirus and SARS-CoV?\", \"What event is associated with the divergence of the bat coronavirus and SARS-CoV?\"]", "answers": "[\"1986\", \"The most closely related bat coronavirus became distant from SARS-CoV\", \"The divergence of the bat coronavirus and SARS-CoV\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7499999999999999, "em": false, "chrf": 87.11352074171901, "bleu": 51.697315395717055}, {"f1": 0, "em": false, "chrf": 48.40659185937734, "bleu": 0.0}], "avg_f1": 0.5833333333333334, "avg_em": 0.3333333333333333, "avg_chrf": 78.50670420036545, "avg_bleu": 50.56577179857237}
{"id": "wiki_5:2781", "en": "In the 1790s, equine coronavirus diverged from the bovine coronavirus after a cross-species jump.", "fr": "Dans les années 1790, un coronavirus équin a divergé du coronavirus bovin après avoir franchi la barrière d’espèces.", "perturbation": "omission", "pert_fr": "Dans les années 1790, un coronavirus équin a divergé après avoir franchi la barrière d’espèces.", "bt_pert_fr": "In the 1790s, an equine coronavirus diverged after crossing the species barrier.", "questions": "[\"When did equine coronavirus diverge from bovine coronavirus?\", \"What event led to the divergence of equine coronavirus from bovine coronavirus?\", \"What type of jump caused the divergence?\", \"What is the significance of the cross-species jump?\"]", "answers": "[\"In the 1790s\", \"Crossing the species barrier\", \"Cross-species jump\", \"It led to the divergence of equine coronavirus from bovine coronavirus\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 39.99162321330539, "bleu": 0.0}, {"f1": 0.5, "em": false, "chrf": 92.47065434565434, "bleu": 49.99999999999999}, {"f1": 0.608695652173913, "em": false, "chrf": 66.02648863226399, "bleu": 47.334069360457725}], "avg_f1": 0.5271739130434783, "avg_em": 0.25, "avg_chrf": 74.62219154780593, "avg_bleu": 49.33351734011444}
{"id": "wiki_5:2782", "en": "Later in the 1890s, human coronavirus OC43 diverged from bovine coronavirus after another cross-species spillover event.", "fr": "Plus tard dans les années 1890, le coronavirus humain OC43 a divergé du coronavirus bovin après un autre événement de contagion interespèces.", "perturbation": "omission", "pert_fr": "Plus tard dans les années 1890, le coronavirus humain OC43 a divergé du coronavirus bovin après un événement de contagion interespèces.", "bt_pert_fr": "Later in the 1890s, the human coronavirus OC43 diverged from the bovine coronavirus after an interspecies contagion event.", "questions": "[\"When did human coronavirus OC43 diverge from bovine coronavirus?\", \"What event led to the divergence of human coronavirus OC43 from bovine coronavirus?\"]", "answers": "[\"Later in the 1890s\", \"An interspecies contagion event\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.25, "em": false, "chrf": 28.897719313119552, "bleu": 15.97357760615681}], "avg_f1": 0.625, "avg_em": 0.5, "avg_chrf": 64.44885965655978, "avg_bleu": 57.986788803078426}
{"id": "wiki_5:2784", "en": "Human coronavirus OC43 besides causing respiratory infections is also suspected of playing a role in neurological diseases.", "fr": "Le coronavirus humain OC43 est également suspecté de jouer un rôle dans des maladies neurologiques en plus de causer des symptômes respiratoires.", "perturbation": "omission", "pert_fr": "Le coronavirus humain OC43 est également suspecté de jouer un rôle dans des maladies en plus de causer des symptômes respiratoires.", "bt_pert_fr": "The human coronavirus OC43 is also suspected of playing a role in illnesses in addition to causing respiratory symptoms.", "questions": "[\"What other diseases is human coronavirus OC43 suspected of causing?\", \"What diseases is human coronavirus OC43 associated with?\", \"What is human coronavirus OC43 known for besides respiratory infections?\", \"What role does human coronavirus OC43 play in neurological diseases?\"]", "answers": "[\"illnesses\", \"illnesses\", \"causing respiratory symptoms\", \"not specified\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.460292971455388, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 12.460292971455388, "bleu": 0.0}, {"f1": 0.6666666666666666, "em": false, "chrf": 63.386407271222176, "bleu": 55.03212081491043}, {"f1": 0, "em": false, "chrf": 7.440476190476191, "bleu": 0.0}], "avg_f1": 0.16666666666666666, "avg_em": 0.0, "avg_chrf": 23.936867351152287, "avg_bleu": 13.758030203727607}
{"id": "wiki_5:2786", "en": "Phylogentically, mouse hepatitis virus (Murine coronavirus), which infects the mouse's liver and the central nervous system, is related to  human coronavirus OC43 and bovine coronavirus.", "fr": "D’un point de vue phylogénétique, le virus de l’hépatite de la souris (coronavirus murin), qui infecte le foie et le système nerveux central de la souris, est apparenté au coronavirus humain OC43 et au coronavirus bovin.", "perturbation": "omission", "pert_fr": "D’un point de vue phylogénétique, le virus de l’hépatite de la souris, qui infecte le système nerveux central de la souris, est apparenté au coronavirus humain OC43 et au coronavirus bovin.", "bt_pert_fr": "Phylogenetically, mouse hepatitis virus, which infects the central nervous system of mice, is related to the human coronavirus OC43 and the bovine coronavirus.", "questions": "[\"What is mouse hepatitis virus?\", \"What organs does mouse hepatitis virus infect?\", \"What is the relationship between mouse hepatitis virus and human coronavirus OC43?\", \"What is the relationship between mouse hepatitis virus and bovine coronavirus?\", \"What type of virus is mouse hepatitis virus?\"]", "answers": "[\"A virus that infects the central nervous system of mice\", \"The central nervous system of mice\", \"Mouse hepatitis virus is related to human coronavirus OC43\", \"Mouse hepatitis virus is related to bovine coronavirus\", \"A virus\"]", "scores": [{"f1": 0, "em": false, "chrf": 22.654016925859892, "bleu": 0.0}, {"f1": 0.6153846153846153, "em": false, "chrf": 58.81374122370878, "bleu": 27.48254571080018}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 18.804737505088763, "bleu": 0.0}], "avg_f1": 0.5230769230769231, "avg_em": 0.4, "avg_chrf": 60.05449913093149, "avg_bleu": 45.49650914216005}
{"id": "wiki_5:2787", "en": "Human coronavirus HKU1, like the aforementioned viruses, also has its origins in rodents.", "fr": "Le coronavirus humain HKU1, comme les virus précités, tire également ses origines des rongeurs.", "perturbation": "omission", "pert_fr": "Le coronavirus humain HKU1 tire également ses origines des rongeurs.", "bt_pert_fr": "The human coronavirus HKU1 also has its origins in rodents.", "questions": "[\"What is the origin of Human coronavirus HKU1?\", \"What animals are mentioned as the origin of Human coronavirus HKU1?\", \"What is the origin of the aforementioned viruses?\", \"Does Human coronavirus HKU1 share a common origin with other viruses?\", \"What is the relationship between Human coronavirus HKU1 and rodents?\"]", "answers": "[\"Rodents\", \"Rodents\", \"Rodents\", \"Yes\", \"Human coronavirus HKU1 originates in rodents\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.7142857142857143, "em": false, "chrf": 73.6315844798709, "bleu": 27.22230298303347}], "avg_f1": 0.9428571428571428, "avg_em": 0.8, "avg_chrf": 94.72631689597418, "avg_bleu": 85.44446059660672}
{"id": "wiki_5:2791", "en": "Coronaviruses can cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).", "fr": "Les coronavirus peuvent causer des pneumonies (soit des pneumonies virales directes soit des pneumonies bactériennes secondaires) et des bronchites (soit des bronchites virales directes soit des bronchites bactériennes secondaires).", "perturbation": "omission", "pert_fr": "Les coronavirus peuvent causer des pneumonies (soit des pneumonies virales directes soit des pneumonies bactériennes secondaires) et des bronchites virales directes.", "bt_pert_fr": "Coronaviruses can cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and direct viral bronchitis.", "questions": "[\"What types of bronchitis can coronaviruses cause?\"]", "answers": "[\"Direct viral bronchitis\"]", "scores": [{"f1": 0.6, "em": false, "chrf": 43.44931991793338, "bleu": 26.359713811572682}], "avg_f1": 0.6, "avg_em": 0.0, "avg_chrf": 43.44931991793338, "avg_bleu": 26.359713811572682}
{"id": "wiki_5:2792", "en": "The human coronavirus discovered in 2003, SARS-CoV, which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes both upper and lower respiratory tract infections.Six species of human coronaviruses are known, with one species subdivided into two different strains, making seven strains of human coronaviruses altogether.", "fr": "Le coronavirus humain découvert en 2003, le SARS-CoV, qui cause le syndrome respiratoire aigu sévère (SRAS), présente une pathogenèse unique étant donné qu’il cause à la fois des infections des voies respiratoires supérieures et inférieures. Six espèces de coronavirus humains sont connues, l’une d’entre elles étant divisée en deux souches différentes, ce qui fait en tout sept souches de coronavirus humain.", "perturbation": "omission", "pert_fr": "Le coronavirus humain découvert en 2003, le SARS-CoV, qui cause le syndrome respiratoire aigu sévère (SRAS), présente une pathogenèse unique étant donné qu’il cause des infections des voies respiratoires supérieures et inférieures. Six espèces de coronavirus humains sont connues, ce qui fait en tout sept souches de coronavirus humain.", "bt_pert_fr": "The human coronavirus discovered in 2003, SARS-CoV, which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis as it causes upper and lower respiratory tract infections. Six species of human coronaviruses are known, making a total of seven strains of human coronavirus.", "questions": "[\"What is the name of the human coronavirus discovered in 2003?\", \"What disease does SARS-CoV cause?\", \"What makes the pathogenesis of SARS-CoV unique?\", \"How many species of human coronaviruses are known?\", \"How many strains of human coronaviruses are there in total?\"]", "answers": "[\"SARS-CoV\", \"Severe acute respiratory syndrome (SARS)\", \"It causes upper and lower respiratory tract infections\", \"Six\", \"Seven\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.9411764705882353, "em": false, "chrf": 87.90662185007275, "bleu": 67.52918218126553}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.9882352941176471, "avg_em": 0.8, "avg_chrf": 97.58132437001454, "avg_bleu": 93.50583643625313}
{"id": "wiki_5:2795", "en": "The majority of colds are caused by rhinoviruses.", "fr": "La majorité des rhumes sont causés par les rhinovirus.", "perturbation": "omission", "pert_fr": "La majorité des rhumes sont causés par les virus.", "bt_pert_fr": "The majority of colds are caused by viruses.", "questions": "[\"What causes the majority of colds?\", \"What type of virus is responsible for most colds?\", \"What is the most common cause of colds?\"]", "answers": "[\"Viruses\", \"Not specified\", \"Viruses\"]", "scores": [{"f1": 0, "em": false, "chrf": 38.772293074406036, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 6.4102564102564115, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 38.772293074406036, "bleu": 0.0}], "avg_f1": 0.0, "avg_em": 0.0, "avg_chrf": 27.984947519689495, "avg_bleu": 0.0}
{"id": "wiki_5:2796", "en": "The four mild coronaviruses have a seasonal incidence occurring in the winter months in temperate climates.", "fr": "Les quatre coronavirus modérés ont une incidence saisonnière et apparaissent au cours des mois d’hiver dans les climats tempérés.", "perturbation": "omission", "pert_fr": "Les quatre coronavirus modérés ont une incidence et apparaissent au cours des mois d’hiver dans les climats tempérés.", "bt_pert_fr": "The four moderate coronaviruses have an incidence and appear during the winter months in temperate climates.", "questions": "[\"What are the four mild coronaviruses?\", \"When do the four mild coronaviruses have a seasonal incidence?\", \"In what type of climates do the four mild coronaviruses have a seasonal incidence?\", \"What is the seasonal pattern of the four mild coronaviruses?\"]", "answers": "[\"The four moderate coronaviruses\", \"during the winter months\", \"temperate climates\", \"They appear during the winter months\"]", "scores": [{"f1": 0.46153846153846156, "em": false, "chrf": 40.92907090977306, "bleu": 10.129474235115733}, {"f1": 0.6666666666666666, "em": false, "chrf": 80.26548410013731, "bleu": 55.03212081491043}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.5714285714285715, "em": false, "chrf": 74.57339604059442, "bleu": 21.3643503198117}], "avg_f1": 0.674908424908425, "avg_em": 0.25, "avg_chrf": 73.9419877626262, "avg_bleu": 46.631486342459475}
{"id": "wiki_5:2799", "en": "The virus was officially named the SARS coronavirus (SARS-CoV).", "fr": "Le virus a été nommé officiellement SRAS coronavirus (SARS-CoV).", "perturbation": "omission", "pert_fr": "Le virus a été nommé officiellement SARS.", "bt_pert_fr": "The virus was officially named SARS.", "questions": "[\"What is the full name of the virus?\"]", "answers": "[\"SARS\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 14.483765654621402, "bleu": 13.533528323661276}], "avg_f1": 0.5, "avg_em": 0.0, "avg_chrf": 14.483765654621402, "avg_bleu": 13.533528323661276}
{"id": "wiki_5:2802", "en": "The World Health Organization issued a global alert soon after.", "fr": "L’Organisation mondiale de la santé a émis une alerte mondiale peu de temps après.", "perturbation": "omission", "pert_fr": "L’Organisation mondiale de la santé a émis une alerte peu de temps après.", "bt_pert_fr": "The World Health Organization issued an alert shortly after.", "questions": "[\"What did the World Health Organization issue?\", \"What is the significance of the global alert?\"]", "answers": "[\"an alert\", \"The significance of the global alert is not specified in the sentence\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 33.310548831508605, "bleu": 13.533528323661276}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.75, "avg_em": 0.5, "avg_chrf": 66.6552744157543, "avg_bleu": 56.76676416183066}
{"id": "wiki_5:2804", "en": "However, on 12 May 2013, a case of human-to-human transmission in France was confirmed by the French Ministry of Social Affairs and Health.", "fr": "Cependant, le 12 mai 2013, un cas de transmission d’homme à homme a été confirmé en France par le ministère français des affaires sociales et de la santé.", "perturbation": "omission", "pert_fr": "Cependant, le 12 mai 2013, un cas de transmission d’homme à homme a été confirmé par le ministère français des affaires sociales et de la santé.", "bt_pert_fr": "However, on May 12, 2013, a case of human-to-human transmission was confirmed by the French Ministry of Social Affairs and Health.", "questions": "[\"When was a case of human-to-human transmission in France confirmed?\", \"Which country confirmed a case of human-to-human transmission?\", \"Which ministry confirmed the case of human-to-human transmission?\", \"What was confirmed by the French Ministry of Social Affairs and Health?\", \"What type of transmission was confirmed in France?\"]", "answers": "[\"May 12, 2013\", \"France\", \"French Ministry of Social Affairs and Health\", \"A case of human-to-human transmission\", \"Human-to-human transmission\"]", "scores": [{"f1": 1.0, "em": false, "chrf": 39.08730158730158, "bleu": 39.68502629920498}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.6666666666666666, "em": false, "chrf": 79.59827249725828, "bleu": 49.99999999999999}], "avg_f1": 0.9333333333333333, "avg_em": 0.6, "avg_chrf": 83.73711481691197, "avg_bleu": 77.93700525984102}
{"id": "wiki_5:2806", "en": "Two confirmed cases involved people who seemed to have caught the disease from their late father, who became ill after a visit to Qatar and Saudi Arabia.", "fr": "Deux cas confirmés impliquaient des personnes qui semblaient avoir attrapé la maladie de leur père décédé qui était tombé malade après une visite au Qatar et en Arabie Saoudite.", "perturbation": "omission", "pert_fr": "Deux cas confirmés impliquaient des personnes qui semblaient avoir attrapé la maladie de leur père décédé qui était tombé malade après une visite en Arabie Saoudite.", "bt_pert_fr": "Two confirmed cases involved people who appeared to have caught the illness from their deceased father who fell ill after a visit to Saudi Arabia.", "questions": "[\"Who were the two confirmed cases involved?\", \"How did the two confirmed cases catch the disease?\", \"Which countries did the late father visit?\", \"What was the relationship between the confirmed cases and the late father?\"]", "answers": "[\"People who appeared to have caught the illness from their deceased father\", \"From their deceased father\", \"Saudi Arabia\", \"The confirmed cases were related to the late father as his children\"]", "scores": [{"f1": 0.7272727272727273, "em": false, "chrf": 59.68211432995607, "bleu": 21.200626759025184}, {"f1": 0.75, "em": false, "chrf": 58.08133203401429, "bleu": 35.35533905932737}, {"f1": 0.6666666666666666, "em": false, "chrf": 56.5271353532257, "bleu": 36.78794411714425}, {"f1": 0.8421052631578948, "em": false, "chrf": 93.50684959792811, "bleu": 67.86502681586727}], "avg_f1": 0.7465111642743222, "avg_em": 0.0, "avg_chrf": 66.94935782878105, "avg_bleu": 40.302234187841016}
{"id": "wiki_5:2807", "en": "Despite this, it appears the virus had trouble spreading from human to human, as most individuals who are infected do not transmit the virus.", "fr": "Malgré cela, il semble que le virus ait eu des difficultés à se propager d’homme à homme étant donné que la plupart des individus infectés ne transmettent pas le virus.", "perturbation": "omission", "pert_fr": "Malgré cela, il semble que le virus ait eu des difficultés à se propager d’homme à homme étant donné que la plupart des individus ne transmettent pas le virus.", "bt_pert_fr": "Despite this, it appears that the virus has had difficulty spreading from human to human as most individuals do not transmit the virus.", "questions": "[\"What does the virus have trouble with in terms of transmission?\", \"Why do most infected individuals not transmit the virus?\"]", "answers": "[\"Spreading from human to human\", \"Because most individuals do not transmit the virus\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8235294117647058, "em": false, "chrf": 71.71210134083897, "bleu": 38.734798110329905}], "avg_f1": 0.9117647058823529, "avg_em": 0.5, "avg_chrf": 85.85605067041948, "avg_bleu": 69.36739905516498}
{"id": "wiki_5:2810", "en": "This caused one of the largest outbreaks of MERS-CoV outside the Middle East.", "fr": "Ceci a causé l’une des plus importantes épidémies de MERS-CoV en dehors du Moyen-Orient.", "perturbation": "omission", "pert_fr": "Ceci a causé l’une des plus importantes épidémies en dehors du Moyen-Orient.", "bt_pert_fr": "This caused one of the largest outbreaks outside the Middle East.", "questions": "[\"What caused one of the largest outbreaks of MERS-CoV outside the Middle East?\", \"What is MERS-CoV?\", \"What is the significance of the outbreak outside the Middle East?\"]", "answers": "[\"This\", \"MERS-CoV is not specified in the sentence\", \"It was one of the largest outbreaks of MERS-CoV outside the Middle East\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.2857142857142857, "em": false, "chrf": 47.81128545810261, "bleu": 8.116697886877475}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.7619047619047619, "avg_em": 0.6666666666666666, "avg_chrf": 82.60376181936753, "avg_bleu": 69.37223262895918}
{"id": "wiki_5:2815", "en": "The Wuhan strain has been identified as a new strain of Betacoronavirus from group 2B with approximately 70% genetic similarity to the SARS-CoV.", "fr": "La souche de Wuhan a été identifiée comme une nouvelle souche de bêtacoronavirus du groupe 2B avec environ 70 % de similitude génétique par rapport au SARS-CoV.", "perturbation": "omission", "pert_fr": "La souche de Wuhan a été identifiée comme une nouvelle souche de bêtacoronavirus avec environ 70 % de similitude génétique par rapport au SARS-CoV.", "bt_pert_fr": "The Wuhan strain was identified as a new strain of betacoronavirus with approximately 70% genetic similarity to SARS-CoV.", "questions": "[\"What is the Wuhan strain?\", \"What group does the Wuhan strain belong to?\", \"What is the genetic similarity between the Wuhan strain and SARS-CoV?\", \"What type of coronavirus is the Wuhan strain?\", \"What is known about the Wuhan strain's genetic makeup?\"]", "answers": "[\"a new strain of betacoronavirus\", \"betacoronavirus\", \"approximately 70%\", \"a betacoronavirus\", \"It has approximately 70% genetic similarity to SARS-CoV\"]", "scores": [{"f1": 0.5454545454545454, "em": false, "chrf": 61.53565590825525, "bleu": 28.087083270446133}, {"f1": 0, "em": false, "chrf": 8.009577768784567, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 91.84565434565434, "bleu": 0.0}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.509090909090909, "avg_em": 0.4, "avg_chrf": 72.27817760453884, "avg_bleu": 45.61741665408924}
{"id": "wiki_5:2816", "en": "The virus has a 96% similarity to a bat coronavirus, so it is widely suspected to originate from bats as well.", "fr": "Le virus présentait une similarité de 96 % avec un coronavirus de chauve-souris, par conséquent il est fortement suspecté de trouver son origine chez la chauve-souris également.", "perturbation": "omission", "pert_fr": "Le virus présentait une similarité de 96 % avec un coronavirus de chauve-souris, par conséquent il est fortement suspecté de trouver son origine également.", "bt_pert_fr": "The virus had 96% similarity to a bat coronavirus, therefore it is highly suspected of originating there as well.", "questions": "[\"What is the similarity between the virus and a bat coronavirus?\", \"Why is the virus widely suspected to originate from bats?\", \"What does the 96% similarity indicate?\", \"What is the origin of the virus suspected to be?\"]", "answers": "[\"96%\", \"Because it has 96% similarity to a bat coronavirus\", \"That the virus is very similar to a bat coronavirus\", \"Bats\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.625, "em": false, "chrf": 47.24028982542915, "bleu": 23.356898886410004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.90625, "avg_em": 0.75, "avg_chrf": 86.81007245635729, "avg_bleu": 80.83922472160253}
{"id": "wiki_5:2817", "en": "The pandemic has resulted in travel restrictions and nationwide lockdowns in several countries.", "fr": "La pandémie engendre des restrictions de voyage et des confinements nationaux dans plusieurs pays.", "perturbation": "omission", "pert_fr": "La pandémie engendre des restrictions de voyage dans plusieurs pays.", "bt_pert_fr": "The pandemic is causing travel restrictions in several countries.", "questions": "[\"What has the pandemic resulted in?\", \"What specific measures have been implemented in several countries?\", \"What types of restrictions have been imposed due to the pandemic?\", \"What is the impact of the pandemic on travel?\", \"What are nationwide lockdowns?\", \"Which countries have implemented travel restrictions and nationwide lockdowns?\"]", "answers": "[\"Travel restrictions in several countries\", \"Travel restrictions\", \"Travel restrictions\", \"Negative impact on travel\", \"Not specified in the sentence\", \"Not specified in the sentence\"]", "scores": [{"f1": 0.4000000000000001, "em": false, "chrf": 47.22216234034246, "bleu": 21.3643503198117}, {"f1": 0.5714285714285715, "em": false, "chrf": 46.70236623703914, "bleu": 22.31301601484299}, {"f1": 0.5714285714285715, "em": false, "chrf": 46.70236623703914, "bleu": 22.31301601484299}, {"f1": 0, "em": false, "chrf": 19.063974667672497, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 7.327882047021604, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 10.77864647391363, "bleu": 0.0}], "avg_f1": 0.2571428571428572, "avg_em": 0.0, "avg_chrf": 29.63289966717141, "avg_bleu": 10.998397058249614}
{"id": "wiki_5:2819", "en": "Except for avian infectious bronchitis, the major related diseases have mainly an intestinal location.", "fr": "À l’exception de la bronchite aviaire infectieuse, les maladies majeures associées résident essentiellement dans l’intestin.", "perturbation": "omission", "pert_fr": "À l’exception de la bronchite infectieuse, les maladies majeures associées résident essentiellement dans l’intestin.", "bt_pert_fr": "With the exception of infectious bronchitis, the major associated diseases reside mainly in the intestine.", "questions": "[\"What is the location of the major related diseases?\", \"Which disease is excluded from the major related diseases?\", \"What is the primary site of infection for the major related diseases?\", \"What is the exception to the intestinal location of the diseases?\"]", "answers": "[\"The intestine\", \"Infectious bronchitis\", \"The intestine\", \"Infectious bronchitis\"]", "scores": [{"f1": 0, "em": false, "chrf": 68.10612599704045, "bleu": 0.0}, {"f1": 0.4, "em": false, "chrf": 76.60086368949509, "bleu": 30.326532985631665}, {"f1": 0.6666666666666666, "em": false, "chrf": 91.1574824683062, "bleu": 49.99999999999999}, {"f1": 0.4, "em": false, "chrf": 76.60086368949509, "bleu": 30.326532985631665}], "avg_f1": 0.3666666666666667, "avg_em": 0.0, "avg_chrf": 78.11633396108421, "avg_bleu": 27.66326649281583}
{"id": "wiki_5:2820", "en": "Coronaviruses primarily infect the upper respiratory and gastrointestinal tract of mammals and birds.", "fr": "Les coronavirus infectent principalement les voies respiratoires supérieures et les voies gastro-intestinales des mammifères et des oiseaux.", "perturbation": "omission", "pert_fr": "Les coronavirus infectent principalement les voies respiratoires supérieures des mammifères et des oiseaux.", "bt_pert_fr": "Coronaviruses mainly infect the upper respiratory tract of mammals and birds.", "questions": "[\"What parts of the body do coronaviruses primarily infect?\", \"Which animals are affected by coronaviruses?\", \"What is the primary site of infection for coronaviruses?\"]", "answers": "[\"The upper respiratory tract\", \"Mammals and birds\", \"The upper respiratory tract\"]", "scores": [{"f1": 0.8, "em": false, "chrf": 51.45618545008999, "bleu": 38.75385825373298}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8, "em": false, "chrf": 51.45618545008999, "bleu": 38.75385825373298}], "avg_f1": 0.8666666666666667, "avg_em": 0.3333333333333333, "avg_chrf": 67.63745696672666, "avg_bleu": 59.169238835822}
{"id": "wiki_5:2821", "en": "They also cause a range of diseases in farm animals and domesticated pets, some of which can be serious and are a threat to the farming industry.", "fr": "Ils causent également une série de maladies chez les animaux de ferme et les animaux domestiques, certaines pouvant être sérieuses et menacer le secteur agricole.", "perturbation": "omission", "pert_fr": "Ils causent également une série de maladies chez les animaux de ferme, certaines pouvant être sérieuses et menacer le secteur agricole.", "bt_pert_fr": "They also cause a range of diseases in farm animals, some of which can be serious and threaten the agricultural sector.", "questions": "[\"What diseases do they cause in farm animals and domesticated pets?\", \"What is a threat to the farming industry?\", \"What types of animals are affected by these diseases?\"]", "answers": "[\"None specified in the sentence\", \"The serious diseases in farm animals\", \"Farm animals\"]", "scores": [{"f1": 0, "em": false, "chrf": 12.62750643490419, "bleu": 0.0}, {"f1": 0.16666666666666666, "em": false, "chrf": 29.88530696740973, "bleu": 8.116697886877475}, {"f1": 0.5714285714285715, "em": false, "chrf": 35.57585493069516, "bleu": 22.31301601484299}], "avg_f1": 0.24603174603174605, "avg_em": 0.0, "avg_chrf": 26.02955611100303, "avg_bleu": 10.143237967240156}
{"id": "wiki_5:2822", "en": "In chickens, the infectious bronchitis virus (IBV), a coronavirus, targets not only the respiratory tract but also the urogenital tract.", "fr": "Chez les poulets, le virus de la bronchite infectieuse (VBI), un coronavirus, ne cible pas seulement les voies respiratoires, mais aussi l’appareil urogénital.", "perturbation": "omission", "pert_fr": "Chez les poulets, le virus de la bronchite infectieuse (VBI), un coronavirus, ne cible pas seulement les voies respiratoires, mais aussi l’appareil.", "bt_pert_fr": "In chickens, the infectious bronchitis virus (IBV), a coronavirus, not only targets the respiratory tract, but also the apparatus.", "questions": "[\"Which parts of the chicken's body does the infectious bronchitis virus target?\", \"What type of virus is the infectious bronchitis virus?\", \"What is the full name of the virus mentioned?\", \"What is the significance of the virus targeting both the respiratory and urogenital tracts?\"]", "answers": "[\"The respiratory tract and the apparatus\", \"A coronavirus\", \"Infectious bronchitis virus\", \"It indicates a broad impact on the chicken's health, affecting both respiratory and urogenital systems\"]", "scores": [{"f1": 0.7272727272727272, "em": false, "chrf": 61.25670880117675, "bleu": 54.75182535069452}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0.8571428571428571, "em": false, "chrf": 90.31681892330171, "bleu": 71.65313105737896}, {"f1": 0.6666666666666667, "em": false, "chrf": 50.29369208394899, "bleu": 12.640504935009755}], "avg_f1": 0.8127705627705628, "avg_em": 0.25, "avg_chrf": 75.46680495210686, "avg_bleu": 59.76136533577082}
{"id": "wiki_5:2824", "en": "Economically significant coronaviruses of farm animals include porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and bovine coronavirus, which both result in diarrhea in young animals.", "fr": "Parmi les coronavirus des animaux d’élevage importants du point de vue économique, on trouve le coronavirus porcin (coronavirus de la gastroentérite transmissible, GET) et le coronavirus bovin, engendrant tous deux des diarrhées chez les animaux jeunes.", "perturbation": "omission", "pert_fr": "Parmi les coronavirus des animaux d’élevage importants du point de vue économique, on trouve le coronavirus porcin et le coronavirus bovin, engendrant tous deux des diarrhées chez les animaux.", "bt_pert_fr": "Economically important livestock coronaviruses include porcine coronavirus and bovine coronavirus, both of which cause diarrhea in animals.", "questions": "[\"What are economically significant coronaviruses of farm animals?\", \"What specific coronaviruses are mentioned?\", \"What disease do porcine coronavirus and bovine coronavirus cause in young animals?\", \"What is the effect of these coronaviruses in young animals?\"]", "answers": "[\"Porcine coronavirus and bovine coronavirus\", \"Porcine coronavirus and bovine coronavirus\", \"Diarrhea\", \"Diarrhea\"]", "scores": [{"f1": 0.7142857142857143, "em": false, "chrf": 47.66674905990854, "bleu": 22.466448205861074}, {"f1": 0.7142857142857143, "em": false, "chrf": 47.66674905990854, "bleu": 22.466448205861074}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 0.8571428571428572, "avg_em": 0.5, "avg_chrf": 73.83337452995427, "avg_bleu": 61.233224102930556}
{"id": "wiki_5:2828", "en": "Mouse hepatitis virus (MHV) is a coronavirus that causes an epidemic murine illness with high mortality, especially among colonies of laboratory mice.", "fr": "Le virus de l’hépatite murine (VHM) est un coronavirus qui cause une maladie murine épidémique avec un taux de mortalité élevé, en particulier parmi les colonies de souris de laboratoire.", "perturbation": "omission", "pert_fr": "Le virus de l’hépatite murine (VHM) est un coronavirus qui cause une maladie épidémique avec un taux de mortalité élevé, en particulier parmi les colonies de souris de laboratoire.", "bt_pert_fr": "Murine hepatitis virus (HMV) is a coronavirus that causes epidemic disease with a high mortality rate, particularly among colonies of laboratory mice.", "questions": "[\"What is mouse hepatitis virus (MHV)?\", \"What type of virus is MHV?\", \"What disease does MHV cause?\", \"What is the impact of MHV on laboratory mice?\"]", "answers": "[\"Murine hepatitis virus (HMV) is a coronavirus that causes epidemic disease with a high mortality rate, particularly among colonies of laboratory mice\", \"A coronavirus\", \"Epidemic disease\", \"A high mortality rate, particularly among colonies of laboratory mice\"]", "scores": [{"f1": 0.75, "em": false, "chrf": 75.05943547169431, "bleu": 44.64617303464354}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 16.47296770387723, "bleu": 0.0}, {"f1": 0.6666666666666665, "em": false, "chrf": 76.38770862316649, "bleu": 41.11336169005198}], "avg_f1": 0.6041666666666666, "avg_em": 0.25, "avg_chrf": 66.98002794968451, "avg_bleu": 46.43988368117389}
{"id": "wiki_5:2831", "en": "Significant research efforts have been focused on elucidating the viral pathogenesis of these animal coronaviruses, especially by virologists interested in veterinary and zoonotic diseases.", "fr": "Des efforts importants dans la recherche ont été centrés sur l’éclaircissement de la pathogenèse virale de ces coronavirus animaux, en particulier par les virologues intéressés par les maladies vétérinaires et zoonotiques.", "perturbation": "omission", "pert_fr": "Des efforts importants dans la recherche ont été centrés sur l’éclaircissement de la pathogenèse de ces coronavirus animaux, en particulier par les virologues intéressés par les maladies vétérinaires et zoonotiques.", "bt_pert_fr": "Significant research efforts have been focused on unraveling the pathogenesis of these animal coronaviruses, particularly by virologists interested in veterinary and zoonotic diseases.", "questions": "[\"What research efforts have been focused on?\", \"What is being studied in relation to animal coronaviruses?\", \"Who is interested in the viral pathogenesis of animal coronaviruses?\", \"What types of diseases are of interest to virologists?\"]", "answers": "[\"Significant research efforts focused on unraveling the pathogenesis of these animal coronaviruses\", \"The pathogenesis of animal coronaviruses\", \"Virologists interested in veterinary and zoonotic diseases\", \"Veterinary and zoonotic diseases\"]", "scores": [{"f1": 0.5555555555555556, "em": false, "chrf": 67.52554883211758, "bleu": 35.08439695638686}, {"f1": 0.28571428571428575, "em": false, "chrf": 58.966880105803675, "bleu": 10.682175159905853}, {"f1": 0.8571428571428571, "em": false, "chrf": 97.97738825481093, "bleu": 80.91067115702207}, {"f1": 0.75, "em": false, "chrf": 96.2106285583297, "bleu": 59.460355750136046}], "avg_f1": 0.6121031746031746, "avg_em": 0.0, "avg_chrf": 80.17011143776547, "avg_bleu": 46.53439975586271}
{"id": "wiki_5:2835", "en": "the two types of canine coronavirus (CCoV) (one causing enteritis, the other found in respiratory diseases).", "fr": "Deux types de coronavirus canins (CCoV) (l’un causant une entérite, l’autre trouvé dans des maladies respiratoires).", "perturbation": "omission", "pert_fr": "Deux types de coronavirus canins (CCoV) (l’un causant une entérite).", "bt_pert_fr": "Two types of canine coronaviruses (CCoV) (one causing enteritis).", "questions": "[\"What are the two types of canine coronavirus?\", \"What disease does one type of canine coronavirus cause?\", \"What disease is associated with the other type of canine coronavirus?\"]", "answers": "[\"One causing enteritis\", \"Enteritis\", \"No disease is associated with the other type\"]", "scores": [{"f1": 0.5, "em": false, "chrf": 37.67499669017534, "bleu": 13.533528323661276}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 0, "em": false, "chrf": 30.862258764999957, "bleu": 0.0}], "avg_f1": 0.5, "avg_em": 0.3333333333333333, "avg_chrf": 56.1790851517251, "avg_bleu": 37.84450944122044}
{"id": "wiki_5:2836", "en": "Turkey coronavirus (TCV) causes enteritis in turkeys.", "fr": "Le coronavirus de la dinde (TCV) cause des entérites chez les dindes.", "perturbation": "omission", "pert_fr": "Le coronavirus (TCV) cause des entérites chez les dindes.", "bt_pert_fr": "Coronavirus (TCV) causes enteritis in turkeys.", "questions": "[\"What disease does Turkey coronavirus (TCV) cause?\", \"Which animals are affected by Turkey coronavirus (TCV)?\", \"What is the effect of Turkey coronavirus (TCV) on turkeys?\"]", "answers": "[\"Enteritis\", \"Turkeys\", \"Enteritis\"]", "scores": [{"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}, {"f1": 1.0, "em": true, "chrf": 100.0, "bleu": 100.00000000000004}], "avg_f1": 1.0, "avg_em": 1.0, "avg_chrf": 100.0, "avg_bleu": 100.00000000000004}
{"id": "wiki_5:2840", "en": "Porcine epidemic diarrhea virus (PED or PEDV), has emerged around the world.", "fr": "Le virus de la diarrhée épidémique porcine (DEP ou VDEP) est présent dans le monde entier.", "perturbation": "omission", "pert_fr": "Le virus de la diarrhée épidémique porcine est présent dans le monde entier.", "bt_pert_fr": "Porcine epidemic diarrhea virus is present worldwide.", "questions": "[\"What is Porcine epidemic diarrhea virus (PED or PEDV)?\", \"Where has PED or PEDV emerged?\", \"What is the significance of PED or PEDV's emergence?\"]", "answers": "[\"Porcine epidemic diarrhea virus is a virus that causes disease in pigs\", \"Worldwide\", \"It has caused significant impact on pig health and farming operations\"]", "scores": [{"f1": 0.4444444444444444, "em": false, "chrf": 66.23415541228871, "bleu": 23.462350320528007}, {"f1": 0, "em": false, "chrf": 22.44970402599969, "bleu": 0.0}, {"f1": 0, "em": false, "chrf": 13.725753824914689, "bleu": 0.0}], "avg_f1": 0.14814814814814814, "avg_em": 0.0, "avg_chrf": 34.13653775440103, "avg_bleu": 7.820783440176002}
